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The mammalian immune system is capable of detecting and responding to different 
infectious conditions with specificity at the adaptive level, however whether this 
ability extends to individual cells of the innate immune system is unclear. The 
hypothesis of this thesis is that macrophages, as individual cells, can distinguish 
between productive and non-productive virus infections and respond differently at 
the gene expression and secreted protein level. To test the hypothesis, mouse bone 
marrow derived macrophages (BMDMs) were infected in parallel with either a 
productive (live) and non-productive (attenuated) strain of murine cytomegalovirus 
(MCMV) and profiled temporally using a range of techniques. Both productive and 
non-productive MCMV infection resulted in strong type I IFN induction in BMDMs, 
however induction was significantly more rapid in response to productive infection. 
In addition, chemoattractant and pro-inflammatory cytokines TNFα, IL-6, RANTES, 
MIG and MIP-2 were secreted to significantly higher levels in response to productive 
MCMV infection, and curtailed in response to non-productive MCMV infection. 
Furthermore, genome-wide microarray profiling revealed a number of co-expressed 
gene networks regulated differentially in response to the two conditions. This 
consisted of macrophage gene networks targeted for modulation by de novo MCMV 
proteins, and late macrophage response genes regulated specifically in response to 
productive MCMV infection. To further explore the mechanisms of transcriptional 
regulation during macrophage antiviral response, BMDMs from mice lacking either 
the type I IFN receptor (Ifnar1) or the IFNβ (Ifnb1) gene were profiled using a 
similar approach. The resulting genome-wide transcriptional data provided a unique 
insight into the relationship between type I IFN regulation and the macrophage 
transcriptome in response to MCMV infection. Overall, the study utilizes a 
combination of genetic mutants from both host and pathogen to investigate 
mechanisms of virus detection and host transcriptional regulation during the innate 
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1.1 Overview of the thesis 
 
In this thesis, the concept of host discrimination between productive (live) and non-
productive (attenuated) viral infection will be examined during the innate immune 
response in macrophages. The central hypothesis of the thesis is that macrophages 
respond differentially to productive and non-productive murine cytomegalovirus 
(MCMV) infection at the gene expression and secreted protein level. To test the 
hypothesis, a controlled in vitro experimental system of mouse bone marrow-derived 
macrophages (BMDMs) is implemented. To represent productive and non-productive 
viral infections respectively, wild-type MCMV is used alongside a replication-
deficient and transcriptionally inert recombinant MC V deletion mutant strain 
(MCMVdie3). The mutant strain acts as a genetic tool and control reagent to 
represent non-productive viral infection, as an alternative to UV-inactivated virions. 
BMDMs are infected in parallel with the two MCMV strains and the innate immune 
response profiled using a systems-level approach. One of the main focuses of the 
thesis is the dynamic genome-wide expression profiling of macrophages using 
microarray technology. 
 
Following the Introduction and Materials and Methods sections, four results chapters 
will be presented. The first results chapter describes the characterization work 
required for the non-productive mutant MCMVdie3 strain. The second results 
chapter is a systems-level investigation of the macrophage host-response to 
productive and non-productive MCMV infection. The tird results chapter focuses 
on macrophage gene expression networks targeted for modulation by MCMV during 
productive viral infection. The fourth results chapter focuses on the role of type I 
interferon (IFN) in the detection and response to MCMV infection in macrophages, 
and will involve the use of BMDMs derived from mice lacking either the type I IFN 
receptor (Ifnar1) or the IFNβ (Ifnb1) gene. Finally, a conclusion and discussion 





In the following Introduction section, the model pathogen (MCMV) and the cell type 
(BMDMs) will be introduced. Subsequently, an overviw of pathogen detection 
systems will be given, followed by an overview of the innate immune response to 
virus infection, with a particular focus on type I IFN signalling. This will include a 
literature review of studies using IFN-deficient mice in the context of virus infection. 
The concept of virus evasion of the host innate immune response will then be 
introduced, with particular focus on the ability of CMV to subvert the innate immune 
response.  Following this, a literature review of all comparable studies measuring the 
host response to live (productive) versus attenuated (non-productive) viral infection 
will be given. A brief rationale section will also be included as part of the 
Introduction. 
 
1.2 Cytomegalovirus (CMV) 
 
1.2.1 CMV overview and pathogenesis 
 
Cytomegalovirus (CMV) is a large double-stranded DNA virus and member of the 
beta-herpesvirus family. CMV is a ubiquitous and opp rtunistic pathogen capable of 
achieving life-long infection (latency) in a highly species-specific manner. Human 
CMV (HCMV) has a high incidence in human populations with positive 
seroprevalence ranging from 40-100%, with rates of infection varying with age, race, 
geographic distribution and socio-economic status(52). High seropositivity rates have 
been reported especially in blood transfusion patients, intravenous drug users, organ 
transplant recipients, and haemodialysis patients(375). HCMV is shed in most bodily 
fluids and, therefore, can be transmitted sexually or through saliva. HCMV infection 
is usually sub-clinical and non-threatening in healthy individuals, however can be 
serious in immunocompromised patients including organ transplant recipients, 
patients undergoing haemodialysis, patients with cancer, patients receiving 
immunosuppressive drugs and HIV-positive individuals.  HCMV infection in 
immune-compromised cases can lead to liver failure, retinitis, colitis, and 
pneumonia. Congenital HCMV infection is a major problem, and reactivation in 





foetus, potentially resulting in permanent hearing loss, vision loss and neurological 
defects for the foetus in extreme cases. Long-term HCMV infection has also been 
linked to the development of atherosclerosis(4) and immunosenescence(54) later in 
life.  
 
1.2.2 CMV diagnosis and treatment 
 
Several methods are currently used for the diagnosis of HCMV such as ELISA-based 
serological tests for HCMV-specific antibodies, and PCR to monitor viral DNA 
levels in the bloodstream. A number of antiviral drugs have also been developed to 
combat HCMV infection, the most common of which areGanciclovir and Foscarnet, 
both targeting CMV DNA polymerase to inhibit viral replication. These drugs, 
however, are limited by toxicity issues and the emergence of drug resistance(219). A 
vaccine against HCMV is also under investigation but has yet to be approved for 
clinical use(324). 
 
1.2.3 MCMV as a model for cytomegalovirus infection 
 
CMVs are highly host-adapted viruses and therefore exhibit species-specificity in 
regards to infectivity and tropism. As a result, HCMV cannot be used to infect 
animal models and experimental studies on HCMV are restricted to in vitro. Murine 
CMV (MCMV) has, therefore, become an established moel for the study of CMV 
pathogenesis. There are similarities between MCMV and HCMV infection with 
respect to events during acute infection, establishment of latency and reactivation, 
and organ tropism (5). Similar to HCMV infection, the pathological outcomes of 
MCMV infection are defined by the immune status of the host(198). MCMV also 
shares biological similarity with HCMV regarding virion structure, genome structure, 
patterns of gene expression, and dynamics of the infect ous cycle(361). The mouse 
model of CMV infection has been useful for the in vivo study of host–pathogen 
interactions, responses to antiviral drugs, host suceptibility to infection, and 






Murine CMV can be used to infect its natural host, meaning host/pathogen 
interactions can be studied in a physiologically reevant context. A range of deletion 
mutants are available for MCMV(34, 42) adding to its u ility as a model. The 
MCMV genome (Smith strain) has been sequenced and co sists of 230,278 bp with 
an overall GC content of 58.7%(299). The distribution of G/C content is similar to 
that seen in the HCMV genome. Sequence similarity also exists for 78 open reading 
frames encoded within the core herpesvirus region(299). Homologs of the HCMV 
gene families UL25, UL82, and US22 and GCR can also be found in the MCMV 
genome (299).  
 
Despite the similarities between MCMV and HCMV, there are important differences 
between the viruses that must be considered. MCMV and HCMV have co-evolved 
with their respective hosts over long periods in a highly species-specific manner. 
This is particularly the case with regards to evasion of the innate and adaptive 
immune response (237, 323) and sites of latency/reactivation (198, 258, 302). The 
function of homologous MCMV and HCMV proteins can also vary considerably, 
and many genes exist only in one species of the virus(299). There are also important 
differences in protein function at immediate early stages of infection, and with 
regards to host cell interactions (243). For example, the HCMV IE1 protein has been 
shown to bind chromatin, but this is not the case for the MCMV IE1 homolog (243). 







Table 1.1 Key differences between HCMV and MCMV proteins. Adapted from 
Maul et al. (243) and Rawlinson et al (299).  
 
Property HCMV MCMV 
Binding of chromatin Achieved by IE1 (UL123) Not achieved by IE1 
(M123) 
Blocking of the cell 
cycle 
Achieved by IE2 (UL122) Not achieved by IE3 (the 
MCMV equivalent of 
HCMV IE2) (M122) 
Binding of the repressor 
Daxx 
Achieved by pp71 Achieved by IE1 
RL11, US1, US2, US6 
and US12 gene families  




HCMV pUL97 accumulates 
in the nucleus 
pM97 is predominantly 
located in the cytoplasm 
Alkaline exonuclease 
(DNase)  
No short inverted repeat in 
the HCMV DNase gene 
(UL98) 
Short (22-base) inverted 
repeat close to the start of 
MCMV DNase gene (M98) 
Viral DNA replication UL101 is required for DNA 
replication in HCMV 
MCMV does 
not possess a sequence or 
positional homolog of 
UL101 
Origin of replication HCMV does not contain 
homologs for MCMV genes 
m58 and m59 
Contains ORFs m58 and 




1.2.4 MCMV structure and life cycle  
 
The MCMV virion structure is similar to that of all herpesviruses with an outer lipid 
envelope containing glycoproteins capable of interacting with the host cell 
membrane to facilitate viral entry. The envelope encapsulates an icosahedral capsid 
structure, within which the dsDNA genome of MCMV is located (Figure 1.1). 
Between the outer envelope and the capsid structure is a layer of virion-associated 
proteins known as the tegument. Tegument proteins are released into the host cell 
during viral entry as the viral envelope fuses with the host cell membrane. Up to 38 
different MCMV proteins have been detected in the MCMV virion by mass 
spectrometry (184). Although the function of many of these proteins remains 










apoptosis, and modulation the host cell environment (181, 182). HCMV tegument 
proteins have been suggested to contribute to the delivery of viral genomes to the 
nucleus and initiation of viral gene expression(182). Viral DNA polymerase and viral 
RNAs are also packaged within the MCMV and HCMV tegument. 
 
Figure 1.1 Structure of the CMV virion. The lipid envelope of the CMV virion 













All herpesviruses share a common virion structure, and other characteristics 
including a) the use of genome-encoded enzymes for nucleotide metabolism and 
DNA replication, b) viral replication occurring within the nucleus, c) destruction of 
host cells after lytic infection, and d) establishment of latency within the infected 
host.  
 
The viral entry process for HCMV and MCMV is complex and remains to be fully 
understood. Considerably more work, however, has been done on HCMV entry 
compared to MCMV. In both cases, viral envelope glycoproteins interact with host-
cell receptors to cause membrane fusion. For HCMV, fusion has been shown to 
occur in a pH-independent manner(66). After fusion, the viral capsid and tegument 






HCMV has been shown to utilize multiple receptors t facilitate viral entry, possibly 
reflecting the broad tropism of the virus. More than 10 HCMV envelope proteins 
have been identified (369), the most well-characterized of which are glycoproteins 
gB, gM, gL and gN. These glycoproteins form homodimeric (i.e. gB/gB) or 
heterodimeric complexes (i.e. gM/N, and gH/gL). The gB complex is required for 
virus entry and cell-to-cell spread(163). The gM/gN complex is thought to play a role 
in viral attachment to heparan sulfate proteoglycans (HSPGs) found on the surface of 
many cells(64). gH/gL complexes play a role in fusion together with gB complexes, 
possibly through integrin receptors(94). In addition, HCMV has been shown to 
interact with the epidermal growth factor receptor (EGFR)(64) and the DC-SIGN 
receptor (dendritic cell-specific ICAM3-grabbing non-integrin)(253).  
 
For MCMV, the host cell receptors required for viral entry have not been 
characterized.  MCMV gB and gH have been expressed a  recombinant 
proteins(297), however their direct role in MCMV entry has not been shown. The 
MCMV m74 protein (a functional homolog of HCMV gO) has also recently been 
shown to contribute to the viral entry and cell-to-cell spread of MCMV in fibroblasts 
by forming complexes with gH (m75)(326). 
 
The interaction of HCMV glycoproteins with host-cell membrane receptors has been 
shown to induce robust and rapid intracellular signalli g (34, 35, 65, 180, 330). The 
same may also be the case for MCMV proteins, however xperimental evidence is 
lacking. The interaction of HCMV glycoproteins with t e host cell membrane has 
been reported to induce the interferon response in a number of cell types (34, 35, 65, 
180, 330), suggesting viral particles are detected on the host cell surface as part of a 
rapid antiviral mechanism. This point will have important implications in the 
interpretation of data presented later in the thesis. 
 
After viral entry, CMV capsids migrate along microtubules to the nuclear pore 
complex where viral genomic DNA enters the nucleus. This has been shown for 
HCMV(181). Upon entry of viral DNA to the nucleus, transcription of viral mRNAs 
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genomic viral DNA 
at nuclear pore 
complex
some viral tegument proteins have also been proposed t  contribute (182). After 
transcription, MCMV proteins are expressed resulting in the establishment of 
productive infection.  
 
Figure 1.2 - CMV viral entry. Viral glycoproteins bind to the host cell membrane to 
cause membrane fusion. Viral capsids enter the cytoplasm and tegument proteins are 
released. Capsids then migrate along microtubules to the nuclear pore where they are 




















MCMV viral DNA replication occurs during the late stage of lytic infection and 
leads to the propogation of progeny virions. At the end of the lytic cycle, de novo 
MCMV particles are filled with nascent viral DNA (progeny genomes) and exported 
from the host cell, either via budding(252), or as a result of cell lysis. This process, 





particles and dense bodies (containing no viral DNA) are propagated during lytic 
infection. In the case of HCMV, dense bodies are comp sed of primarily the pp65 
tegument protein(182). Abortive infection by MCMV and HCMV can also occur, 
whereby some or all components of the virus are synthesized, but no infective viral 
particles are produced. This can occur as result of infection with defective viruses, or 
as a result of nonpermissive cells inhibiting viral replication. In comparison to some 
other herpesviruses, CMV has a relatively slow replication cycle and can be 
characterized by enlargement of infected host cells (cytomegalia).  
 
1.2.5 MCMV gene expression and genetics 
 
During lytic infection, the MCMV genome is transcribed in a classical cascade 
fashion(188). Immediate early (IE) viral gene products are the first to be transcribed, 
independently of viral protein synthesis. The expression of MCMV IE genes is under 
the control of the major immediate early promoter (MIEP), a complex regulatory 
region that exhibits a high degree of functional similarity among the different 
members of the CMV family(340). The MCMV MIEP controls the expression of two 
bi-directional open reading frames (ORFs) encoding three spliced mRNA transcripts 
expressed abundantly at immediate early times (ie1, ie2, and ie3) (see Figure 1.3). 
The ie1 and ie3 transcripts share the same first three exons which are spliced either 
with a fourth exon into the mature i 1 mRNA(188, 189) or with a fifth exon into the 
2.75-kb ie3 mRNA(249). The ie2 mRNA of 1.75-kb is transcribed in the opposite 
direction and spliced from three separate exons(251).  
 
The MIE region of MCMV is roughly colinear with that of HCMV, and splicing of 
IE mRNAs occurs in a similar manner (188-190, 249). In both viruses, transcription 
of the MIE genes is controlled by a strong enhancer region containing immune-
stimulated transcription factor binding sites. Predicted or known sites for AP1, 
NFkB, CREB/ATF, SP1, RAR/RXR and NF1 have been located within the MCMV 
and HCMV MIEP regions(111, 112, 164, 166, 167, 212). It is hypothesized that 
these sites reflect the ability of the virus to utilize innate immune signalling pathways 





The 88-kDa MCMV IE3 protein is essential for viral growth in cell culture and has 
an indispensable regulatory function during the lytic replication cycle of MCMV(12). 
On the basis of transient transfection assays IE3 also exerts a strong transcriptional 
trans-activator function on MCMV early promoters, and has auto-regulatory function 
through repression of the i l/ie3 promoter(249, 350). The expression of downstream 
early (E) MCMV genes is dependent on immediate early gene products. Early genes 
are generally associated with functions related to viral DNA replication. After the 
expression of early genes, late MCMV  genes are transcribed, dependently of the 
early gene products. Proteins encoded by late genes are generally associated with 
structural components of the MCMV virion required for egress(252). 
 
Figure 1.3 - Schematic representation of MCMV genome and recombinant 
MCMV IE deletion mutants The MCMV genome is shown at the top and the 
immediate early (IE) region is expanded to show the MCMV enhancer (grey box) 
and structure of the i 1, ie2 and ie3 transcripts (line 1). Coding exons are shown in 
black with arrows indicating the direction of transcription and noncoding exons 
shown as white rectangles. Starting with the parentl MCMV strain (line 1), the other 
strains MCMVdie3 (line 2), MCMVdie3rev (line 3), and MCMVdie1 (line 4), were 
generated by rounds of homologous recombination in E. coli. The deletion of the 
fourth exon of the ie1 gene and the fifth exon of the i 3 gene are marked by delta 
(∆). The MCMVdie3rev strain (line 3) contains an inserted HCMV MIEP-GFP. 
































Recombinant deletion mutants have been generated for MCMV, including the 
removal of individual genes(29, 106) and the removal f large blocks of the MCMV 
genome(60). Deletion mutants for the ie1 (MCMVdie1) and ie3 genes (MCMVdie3) 
have been generated and characterized previously (reviewed in(49)). In the context 
of this thesis, it is notable that deletion of ie1 attenuates MCMV virulence but does 
not alter replication in cell culture, and disruption of ie2 causes no reported 
phenotype. Significantly, however, deletion of ie3 however renders the virus 
incapable of replicating on fibroblasts even at high multiplicities of infection, and 
therefore the MCMVdie3 virus must be propagated on a complementing cell line.  
 
1.2.6 CMV latency 
 
MCMV and HCMV have the ability to establish latent (life-long and asymptomatic) 
infection in their respective hosts. Reactivation from latency represents a serious 
clinical threat in the case of immune- compromised patients, particularly organ 
transplant recipients. Although no precise molecular definition of CMV latency 
exists, latency is generally considered to be the presence of viral DNA in cells not 
producing infectious virus particles. Latent HCMV DNA has been detected in 
humans in cells of the monocyte lineage including macrophages, but not in mature B 
or T cells(332, 333, 338). Latent MCMV DNA has been detected in endothelial cells, 
bone marrow, and macrophages in latently infected mice(193). Reactivation from 
latency is generally thought to occur as a result of immunosuppression. Detection of 
IE1 transcription is generally used as marker of reactivation(158). Mechanisms of 





1.3 Macrophages as a model cell for innate immunity 
 
Both mouse and human CMV have a unique relationship with macrophages as part 
of their viral life cycle. MCMV(271, 334, 335) and HCMV(271, 334, 335) can both 
establish productive infection in macrophages and have been reported to use 
macrophages as a source for dissemination during acute infection. Macrophages have 
also been reported as a reservoir site for latency in mouse (172, 256, 286) and 
human(172, 256, 286) . MCMV replication is more favourable in differentiated 
macrophages than in immature monocytes(132) and HCMV has been reported to 
reprogram monocyte differentiation toward an activated M1 phenotype to favour 
viral replication(56). At least three MCMV genes (m139, 140, 141) have also been 
shown to play a key role in viral replication in monocyte/macrophages, but little or 
no role in replication in fibroblasts (131, 248, 312, 313)  These genes are part of the 
US22 gene family(131, 248, 312, 313) including a MCV CC chemokine homolog 
MCK-2 (m131-129) which promotes monocyte-assocaited viremia in mice (131, 
248, 312, 313). These observations suggest MCMV and HCMV replication is 
favoured towards monocyte-derived macrophages in comparison to other cell types. 
 
Macrophages are mononuclear phagocytes found ubiquitously in different tissues and 
represent a heterogeneous population of cells with varying function(154). 
Macrophages have the ability to phagocytose (engulf and digest) pathogens and other 
cells, and are involved in a range of physiological processes including immune 
surveillance, tissue repair, maintenance of homeostasis, and tumorigenesis(156).  
 
The abundance and widespread tissue distribution of macrophages makes them well-
suited to their role as a sentinel cell of the innate immune system. Macrophages are 
often therefore considered the first line of defence against invading bacteria and 
viruses in the mammalian immune system. Macrophages re capable of detecting 
foreign material and respond to infection rapidly through the up-regulation of 
antimicrobial defence mechanisms and secretion of cyt kines. Macrophages also 
play an important role in antigen presentation and immune cell recruitment, 






1.3.1 Macrophage differentiation  
 
Macrophages are leukocytes of the myeloid lineage and derive from haematopoietic 
progenitor cells produced in the bone marrow(109, 154). Progenitor cells leave the 
bone marrow as immature monocytes and circulate the bloodstream, undergoing 
partial differentiation. Circulating monocytes reprsent a mobile source of immune 
cells capable of differentiating into a wide range of macrophage sub-populations with 
varying function depending on the environmental signals they receive(154). 
Monocytes in the bloodstream come into contact withstimuli to induce entry into 
tissue sites, where further differentiation into mature macrophages occurs(109). The 
final differentiation phenotype of macrophages is defined by the combination of 
growth factors and cytokines present in the final tissue site (reviewed in (63, 86, 87)). 
The macrophage differentiation process, however, is driven primarily by two growth 
factors; the granulocyte-macrophage colony-stimulating factor (GM-CSF) and the 
macrophage colony-stimulating factor (M-CSF or CSF-1). Differentiated 
macrophages exhibit heterogeneity in phenotype and function based on their tissue 
location, and can have considerable plasticity upon migration to different sites in the 
body(108).  
 
CSF-1 regulates the survival, proliferation and differentiation of monocytes into 
macrophages(55), and the survival and function of mature macrophages(123). CSF-1 
binds to the colony stimulating factor-1 receptor (CSF-1R) to induce receptor 
phosphoylation, dimerization and downstream kinase signalling (40, 285, 343). CSF-
1R expression is restricted to myeloid cells(123) and signalling through the CSF-1 
receptor leads to changes in gene expression associted with macrophage cell 
survival and growth(130). Removal of CSF-1 from mouse macrophage cultures leads 
to apoptosis(144), suggesting CSF-1 is essential for macrophage survival.  
 
1.3.2 Macrophage polarization 
 
Macrophages are often classified into two distinct sub-groups based on their 
activation status. These are described as the “classical” (M1) and “alternative” (M2) 





by either IFNγ or microbial stimuli (e.g. LPS) and mount pro-inflammatory 
responses. Alternatively, (M2) activated macrophages ar  more associated with the 
resolution of inflammation and are thought to inhibit classical macrophage 
activation. M2 polarization is generally induced by IL-4 and IL-13, rather than by 
pro-inflammatory cytokines or microbial stimuli(121).  M2 macrophages have also 
been further sub-divided into M2a, M2b and M2c sub-classes based on different 
combinations of cytokines used for differentiation. In general, M1 macrophages 
produce more antimicrobial effector molecules such as reactive oxygen species, 
nitrogen intermediates and pro-inflammatory cytokines(240), whereas M2 
macrophages play more of an anti-inflammatory role with variable capacity to 
produce pro-inflammatory cytokines(121). M1 and M2 macrophages have also been 
shown to have distinct transcriptional profiles during differentiation and immune 
stimulation(239).  
 
Although the classification of macrophages into M1 and M2 phenotypes may be 
considered by some to be useful in describing macrophage plasticity(233), the 
categorization is also considered to be an over-simplification of the potential 
spectrum of macrophage phenotypes in vivo. This issue has been discussed in depth 
recently(108), along with the ongoing debate regarding the distinct classification of 
macrophages and dendritic cells (DCs) into different cell types(155). In relation to 
CMV infection, the polarization state macrophages may contribute to tropism and 
permissiveness to infection(207), and define sites of latency for both MCMV(256) 
and HCMV(194). 
 
1.3.3 Cytokine secretion 
 
Activated macrophages contribute to inflammation by secreting pro-inflammatory 
cytokines including TNF, IL-1β, IL-6 and IL-18 which are regulated by NF-kB(71, 
367). This results in a localized anti-microbial response and can also lead to TNF-
mediated apoptosis(223). Macrophages can also be de-activated or given anti-





suppress the ability of macrophages to secrete pro-inflammatory cytokines including 
TNF(36, 37) and can inhibit antigen presentation(309).  
 
Activated macrophages secrete a range of chemokines to r cruit leukocytes to sites 
of infection and inflammation (206, 387). Some of the chemokines involved in this 
process include CCL3 (macrophage inflammatory protein-1α; MIP-1α), CCL4 (MIP-
1β), CCL5 (RANTES), CXCL10 (Interferon gamma-induced protein 10, IP-10) and 
CXCL9 (Monokine induced by gamma interferon , MIG). These chemokines are up-
regulated by NF-kB and IFN (315, 317). The coordination of cytokine and 
chemokine responses also controls natural killer (NK) cell recruitment which is of 
central importance to the clearance of viral infection. Chemokine networks have also 
been shown to play a key role in the NK-mediated clarance of MCMV(86, 316).  
 
Plasmacytoid dendritic cells (pDCs) are another important cytokine-secreting cell 
and are closely involved in the response to MCMV infection. pDCs are a 
CD4+/CD11c- sub-set of dendritic cells produced in the bone marrow(329) and are 
found in peripheral lymphoid organs. pDCs areth  major source of type I IFN in 
response to virus infection i vivo and account for the majority of type I IFN 
production in response to MCMV(15, 68, 394, 395). pDCs also have the ability to 
activate T lymphocytes and express intracellular toll-like receptors to sense viral 
nucleic acids in early endosomes(168, 349).  In humans, pDCs selectively express 
TLR7 and TLR9, but not other TLRs(115), suggesting hey have a specified role in 
the detection of viruses and discrimination of self/non-self DNA. 
 
1.3.4 Mouse bone marrow-derived macrophages (BMDMs)  
 
For many years an ex-vivo experimental model system for mouse macrophage 
differentiation has been used to replicate the macrophage differentiation process. 
This model system consists of removing haematopoietic progenitor cells from mouse 
bone marrow cavities and differentiating the cells in culture in the presence of CSF-1 
to produce 'mature' macrophages. This can be done either by using growth medium 
supplemented with recombinant CSF-1, or by using conditioned medium from a cell-





(generally 5-7 days), monocyte cells can be assessed for the expression of 
macrophage-specific surface markers (such as CD11b and F4/80) to indicate the 
proportion of cells with macrophage-like phenotypes. At this point BMDMs will still 
be actively proliferating until receiving an immune-stimulus.  
 
Although the BMDM model system for macrophage differentiation is not ideal 
(primarily because it relies on the activity of one growth factor rather than a 
combination of many as is the case in vivo), BMDMs have nonetheless provided a 
useful and tractable model for the study of macrophage function for several 
decades(157). During this time, BMDMs have been used for focused immunological 
and host/pathogen studies, and are now being used increasingly as a cell type for 
systems-level and functional genomics studies due to their transcriptional 
responsiveness, flexibility and plasticity. BMDMs have been used in system-level 
studies to investigate macrophage transcriptional networks dynamics in response to 
LPS(270, 294), and to show ATF3 is a key negative regulator of the TLR4-mediated 
LPS response(114). These studies combine global expression profiling analysis with 
in silico transcription factor binding site prediction. The global response to different 
TLR ligands has also been measured and computationally modelled in bone marrow-
derived dendritic cells(7) and BMDMs have also been used as part of a broader 






1.4 Pattern recognition receptors and viral detection 
 
The ability of host cells to detect pathogens is a central aspect of innate immunity 
and is achieved primarily through pattern recognitio  receptors (PRRs). PRRs are 
genome-encoded receptor proteins evolved specifically to bind pathogen-derived 
molecules. The concept of PRRs was first proposed at the molecular level by Charles 
Janeway over 20 years ago(171). Since then, PRRs have been studied extensively 
and shown to be expressed in most cells types, particul rly in antigen-presenting 
cells (APCs) such as macrophages. Pathogen derived non-self structures, also known 
as pathogen-associated molecular patterns (PAMPs), range from components of the 
bacterial cell wall (lipopolysaccharide, muramyl dipeptide), to flagellin, to viral 
derived nucleic acids (dsRNA, uncapped ssRNA, cytosolic DNA) (see Table 1.2). 
PRRs capable of binding and detecting these foreign structures are expressed in 
different cellular locations based on criteria such as their target ligand, and life cycle 
of their target pathogen(s)(23).  
 
1.4.1 The toll-like receptor family 
 
The most well-studied PRR family is the toll-like rceptor (TLR) family, first 
identified in Drosophila(107), and conserved throughout insect and mammalian 
species (reviewed in (30, 186)). TLRs are transmembrane proteins capable of 
detecting PAMPs derived from fungi, bacteria, parasites, or viruses via leucine-rich 
repeat (LRR) sequence motifs. TLRs can be found in various different intracellular 
and extracellular locations based on the ligand they ar  capable of binding. TLRs 
play a crucial role in the initiation of innate immunity and inflammation in a range of 
cell types. In mouse, the TLR family consists of 13 members, each of which are 
capable of binding a different ligand and signalling through down-stream adapter 
proteins (Table 1.2). The main TLRs capable of binding virus-derived PAMPs are 
Tlr3, Tlr7, Tlr8 and Tlr9 (viral nucleic acids in endosomes), and Tlr2 and Tlr4 which 
function as homo- or hetero-dimers with other proteins at the cell surface (reviewed 







Table 1.2 Mouse Toll-Like Receptors (TLRs), target ligands, and adaptors(30). 
 
TLR Associate Proteins Ligands Adaptors 
TLR1/2 CD14, CD36, Dectin1 Ac3LP, Glycolipids Myd88, Tirap 
TLR2/6 CD14, Dectin Ac2LP. LTA, Zymosan Myd88, Tirap 
TLR3  polyIC, dsRNA TRIF 
TLR4 CD14, MD-2 LPS, taxol, heparin, others Myd88, Tirap, TRIF, TRAM 
TLR5  Flagellin Myd88 
TLR7  ssRNA, imiquimod, others Myd88 
TLR9  CpG, DNA Myd88 
TLR11  Profilin Myd88 
TLR12  ? ? 
TLR13  ? ? 
 
1.4.2 RIG-I-like receptors (RLRs) 
 
RLRs are a small family of PRRs characterized by a conserved DEAD protein motif 
(Asp-Glu-Ala-Asp). RLRs are putative RNA helicases involved in binding RNA 
within the cytoplasm and have, therefore, been implicated in the detection of RNA 
viruses. The primary RLR is the r tinoic acid-inducible gene-I (RIG-I) which is an 
RNA-helicase protein capable of detecting virus-derived double-stranded RNA 
within the cytoplasm(385). Along with RIG-I, the MDA-5 (melanoma differentiation 
associated gene 5) and LGP2 genes make up the RLR family. All RLR memb rs, in 
addition to binding RNA, have a conserved CARD-domain which is involved in the 
downstream activation of type I interferon (IFN) transcription. Engagement of RIG-I 
activates type I IFN transcription via signalling through downstream adapter proteins 
IPS-1, TRAF3, TANK, FADD, and RIP1, leading to activation of IRF3 and NF-κB 
(385).  
 
1.4.3 Nod-like receptors (NLRs) and the inflammasome 
 
Nod-like receptors (NLRs) are a large family of proteins with a conserved NOD 
motif for nucleotide binding and self-oligomerization(162). NLRs also have a 
conserved CARD-like caspase-recruitment domain(135) and a series of leucine-rich 
repeats (LRRs) at their carboxy-terminal, thought to be involved in the detection of 
microbial patterns. NOD signalling is generally linked to the regulation of apoptosis 
in response to pathogens, and 34 NLR genes have been pr dicted by bioinformatics 
studies to exist in the mouse genome(135, 162). The NOD genes (Nod1 and Nod2) 





signal through the mitochondrial antiviral signalling protein (MAVS; also known as 
VISA, CARDIF or IPS1) to induce the type I IFN response to viral infection(310).  
 
Other NLR family members such as NLRP1, NLRP3 and NLRC4, along with other 
proteins such as IPAF and AIM2, can also assemble into large protein complexes 
known as inflammasomes. The AIM2 inflammasome has been linked to the detection 
of double-stranded bacterial and viral DNA in the cytoplasm(298). Activated 
inflammasomes regulate caspase-1 and the downstream production of pro-
inflammatory cytokines interleukin-1β (IL-1β) and IL-18(241). Inflammasomes are 
linked to a range of different downstream processes, but play an important role in the 
cellular response to cytoplasmic DNA during viral infection (298, 380).  More 
recently, RNA polymerase III was also identified as a PRR capable of detecting 
cytosolic DNA and inducing type I interferons through the RIG-I pathway(58). ZBP-
1 and IFI16 have also recently been identified as innate immune sensors for 
intracellular DNA (191)(151). 
 
1.4.4 PRRs and the detection of cytomegalovirus 
 
The innate detection of CMV has been shown to occur through multiple PRRs. 
Structural HCMV envelope glycoproteins (gB) were first shown to the IFN response 
in fibroblasts in 2001 (330). Compton et al. later reported HCMV activates 
inflammatory cytokine responses via CD14 and TLR-2(65), and Boehme t al. 
showed soluble CMV gB proteins were capable of inducing IFN in an IRF3-
dependent manner(35). Although HCMV envelope glycoproteins B and H were 
again later reported to be necessary for TLR2 activtion in fibroblasts(34), 
alternative TLR2-independent pathways of activation were also reported during 
HCMV infection(180).  
 
The first intracellular PRRs shown to have a role CMV detection were Tlr3 and Tlr9, 
first identified by Bruce Beutler and colleagues in 2004 via mouse mutagenesis 
experiments(344). Mutation of the Tlr3 or Tlr9 genes resulted in highly increased 





was further shown to activate the type I IFN response via either Tlr9 or Tlr3 
pathways, however, neither pathway gave full protection against MCMV infection in 
the absence of the other(344). Further studies investigated the role of Tlr9 in 
response to MCMV infection and found Tlr9-dependent recognition of MCMV 
occurs in interferon-producing APCs, leading to coordinated cytokine induction and 
activation of antiviral NK cells(200). CpG DNA was lso found to play a pivotal role 
in Tlr9-mediated IFN-induction(169).  
 
The expression of Tlr9 varies between mouse and human, being expressed on all 
myeloid cells including macrophages in mice, but only on plasmacytoid dendritic 
cells (pDCs) in human(228, 357). In mouse macrophages, Tlr9 expression is 
regulated by the PU.1 and ICSBP transcription factors and is strongly inducible upon 
IFNγ and LPS stimulation (325, 342). Tlr9 expression is also strongly inducible in 
BMDMs in response to MCMV infection (see Results sections).   
 
More recently, there have been numerous reports of additional pathways used for the 
detection of MCMV and HCMV. These include two studies from the group of Klaus 
Fruh claiming activation of the IFN-response by HCMV occurs via cytoplasmic 
double-stranded DNA, and not by glycoprotein B(75), and also that HCMV induces 
the IFN-response via the DNA sensor ZBP1(76). In addition, Kate Fitzgerald and 
colleagues showed the Aim2 inflammasome is essential for host defence against 
MCMV infection in vivo using Aim2-deficient mice(298). In other studies, MCMV 
has also been shown to produce dsRNA during replication, and interact with protein 
kinase R during the antiviral response(48, 57, 365). The precise contribution of Tlr3 
in the detection and response to MCMV infection remains to be characterized.  
 
The body of literature discussed above shows multiple PRRs can be used by the cell 
to detect CMV during infection. Consistent with this notion, the use of multiple 
PRRs has also been reported for a number of other viruses, including HSV1(145, 






1.5 The innate antiviral immune response 
 
1.5.1 Type I interferon (IFN) 
 
Interferons (IFNs) are secreted cytokines capable of exerting potent autocrine and 
paracrine effects through the activation of signal transduction pathways and 
downstream transcriptional networks. IFNs exert their multiple cellular effects 
through the induction of interferon-stimulated genes (ISGs) with antiviral, anti-
proliferative and immunomodulatory properties. Type I IFNs are induced as a result 
of PRR activation, and the type I IFN response is the primary mechanism of innate 
antiviral defence in most cells. The production of type I IFNs (IFN-α, IFN-β, IFN-ω, 
IFN-ε, or IFN-κ) is induced both in vitro and in vivo through engagement with 
viruses, microbial products or other pro-inflammatory stimuli(38). Type I IFNs act 
through a common cell-surface receptor composed of two ubiquitously expressed 
transmembrane proteins, IFNAR1 and IFNAR2 (Figure 1.4). IFNγ, the only type II 
IFN, shares little sequence homology with the type I IFNs and binds to a separate 
receptor complex(16). Both type I and type II IFNs are capable of inducing direct 
anti-microbial and anti-tumor mechanisms, up-regulating antigen presentation and 
arresting the cell cycle in macrophages and other cell types(38). Type III IFNs (also 
known as IFN-lambda or IL-28/29) are less characterized than type I and II, but are 
biologically similar to type I IFNs in exerting immune protection on epithelial 
surfaces(13). 
 
Production of IFNs, whether it be in vitro or in vivo, occurs in a transient manner as 
inactive IFN genes are induced upon stimulation from pathogens, microbial products 
or synthetic ligands. The transcriptional induction of IFNβ is a particularly important 
event in response to viral infection, and the downstream consequences of IFNβ 
induction are widespread. For the induction of IFNβ to occur, a combination of 
transcription factors, (together known as the IFNβ enhanceosome) must converge on 
the IFNβ promoter(278) to induce the rapid expression of the IFNβ gene. Some of 
the key transcription factors involved in this regulatory event are interferon 
regulatory factors (IRF3 and IRF7), and members of the NFkB family. The secreted 





signalling through the JAK-STAT (Janus kinase/Signal Tr nsducers and Activators 
of Transcription) pathway (Figure 1.4). JAK-STAT signalling induces 
phosphorylation, dimerization and translocation of transcription factor complexes 
from the cytoplasm to the nucleus, primarily comprised of STAT1, STAT2 and IRF9 
(known collectively as ISGF3)(149). The IFN-induced transcription factor complex 
then bind to consensus DNA sequences in the nucleus known as the interferon-
stimulated response elements (ISREs). These sequences are located within promoter 
regions of downstream ISGs which become transcriptionally activated to exert the 
type I IFN response. The subsequent regulation of a diverse group of downstream 
interferon-regulated genes then mediates the biological effects of IFN. 
 
Figure 1.4 Type I interferon signalling. During viral infection, PRRs bind viral-
derived structures in different locations throughout the cell. PRR activation results in 
the formation of transcription factor complexes that bind the IFNα/β promoter and 
induce the production of type I IFNs. The action of type I IFNs is then mediated in 
an autocrine and/or paracrine manner through binding to dimeric IFNAR receptors, 
which signal through TYK2 and JAK1 proteins. This is followed by recruitment and 
phosphorylation of STAT proteins and IRF transcription factors to form the ISGF3 
complex which translocates to the nucleus to induce IFN-stimulated gene expression 

















1.5.2 Interferon-stimulated genes (ISGs) 
 
Although ISGs cover a broad spectrum of biological processes, gene targeting 
studies have distinguished four main antimicrobial effector pathways of the IFN-
mediated antiviral response(311). These are the Mx GTPase pathway(129), the 2',5'-
oligoadenylate-synthetase/RNase L pathway(32), the protein kinase R pathway(32) 
and the ISG15 ubiquitin-like pathway(136). Genes within each of these pathways 
encode proteins with direct antiviral capabilities nvolving inhibition of viral 
transcription, degradation of viral RNAs, inhibition f viral protein translation and 
modification of processes controlling viral replication(311). Many ISGs are also 
signalling proteins involved in regulation of the IFN-pathway, including IRF1, IRF7, 
STAT1, and STAT2. Genes involved directly in the detection of pathogens (i.e. 
TLR9, RIG-I, MDA-5, AIM-2) are also up-regulated asISGs during the antiviral 
response.  
 
Previous studies have attempted to characterize the global IFN response at the 
transcriptional level by measuring the sum of all gene expression changes occurring 
in response to IFNα, IFNβ or IFNγ cytokine treatment in different cell types (17, 62
140, 152, 175, 176, 191, 209, 220, 234, 283, 300, 35 52, 355, 377). As a result, 
databases have emerged summarizing the transcriptional data from many studies in 
an attempt to categorize ISGs into different classes (8, 72, 318).  Although these 
databases have been useful to some degree, they hav been limited in only describing 
IFN-responsiveness, rather than IFN-dependency at the gene expression level. They 
have only documented downstream gene expression after exogenous IFN treatment, 
but have not differentiated genes directly regulated by the type I IFN receptor from 
those regulated by secondary or tertiary factors. The only true way to mechanistically 
determine which genes are directly regulated through the type I IFN receptor is to to 
perform experiments using cells from animals lacking the Ifnar1 gene, then compare 
the response to that seen in cells from wild type anim ls. A systematic and genome-







1.5.3 Literature review of studies using IFN-deficient mice 
 
Mice lacking the type I IFN receptor (Ifnar1) and/or the IFNβ (Ifnb1) gene have been 
used to investigate virus susceptibility (28, 51, 80, 1, 120, 293) and other aspects of 
biology such as the functional crosstalk between type I and II interferons (122, 268), 
toll-like receptor (TLR) signalling(87, 341, 358), the response to dsDNA(328), the 
regulation of IFNα(90), IFN-feedback in B-cells(125), Il-6/TNFα signalling(160), 
and IFNβ pharmacokinetics(3). Despite these efforts however, g ne expression 
profiling of IFN-deficient virus-infected macrophages from Ifnar1-/- or Ifnb1-/- mice 
has not been done.  
 
The response to LPS in Ifnb1-/- macrophages has been characterized in some detail 
at the genome-wide level(355). In this study, distinct patterns of macrophage gene 
expression regulated by IFNβ were identified. Genes containing IFN-responsible 
elements in their promoter regions were also shown t  have dependency on IFNβ. 
The study also found LPS-induced activation of signalli g molecules such as AKT 
and STAT1 were significantly diminished in If b1-/- macrophages. The diminished 
signalling in Ifnb1-/- cells, however, was not seen for p38, JNK, and ERK proteins. 
In vivo experiments conducted as part of the study showed Ifnb1-/- mice have an 
increased survival in response to LPS challenge, suggesting IFNβ contributes to 
LPS-induced lethality in mice.  
 
In terms of virus infection, a comparable study hasnot been conducted a the genome-
wide level. Perhaps the closest effort has been the profiling of infected mouse brain 
tissue from Balb/c (WT) and 129SvEv (WT and IFNAR-/-) mice infected with 
mouse hepatitis coronavirus (MHV)(293). In this study, gene expression data was 
generated at day 2 and day 5 from in vivo infected mouse brains and the results 
identified type I IFN-dependent and -independent transcriptional responses 
occurring. The study, however, was not conducted on the same genetic background 
for both mutant and WT mice, resulting in substantial variation in viral load between 
the mouse strains, eventually leading to complications in interpretation of the data. 





Tlr9-/- cells in response to HSV (59), and transcriptional responses in tissues from 
Stat1-/- mice in response to coronavirus infection(393). These studies, however, have 
still not provided a temporal analysis of IFN-depend t gene expression. 
 
Another study using murine embryonic fibroblasts (MEFs) from wild type and 
IFNα/β receptor deficient mice infected with influenza measured cellular gene 
expression at the single time point of 24hpi (120). This study found that antiviral 
gene expression was lower in the Ifnar1-/- cells compared to wild type, but 
inflammatory and apoptotic gene expression was equivalent. This study also reported 
higher levels of viral gene expression and increased levels of viral replication from 
Ifnar1-/- cells, which was consistent with some other studies (28, 51, 120, 293). 
Despite these observations however, the authors themselves conceded that  “... one 
may be able to better understand immunity during virus nfection by infecting 
macrophages, dendritic cells, or lung epithelial cells isolated from mice lacking 
interferon receptors” (Goodman et al. 2010).  A transcriptional profiling analysis of 
Ifnar1-/- and Ifnb1-/- macrophages infected with productive and non-productive 
MCMV strains is presented in Chapter 6 of this thesis. 
 
1.5.4 The nuclear factor-kappaB (NF-kB) response 
 
Nuclear factor-kappaB (NF-kB) is a family of transcription factors forming homo- or 
hetero-dimers to regulate the expression of downstream genes involved in innate and 
adaptive immunity, inflammation, apoptosis, proliferation and the stress 
response(138). Upon detection of pathogens, the formation and activation of NF-kB 
transcription factor complexes occurs via the phosprylation and degradation of 
inhibitory kB (IkB) signalling proteins in the cytoplasm. Rapid phosphorylation of 
IkB proteins then results in formation of the IKK complex and translocation of active 
NF-kB dimers into the nucleus. NF-kB activation then l ads to the downstream 
induction of pro-inflammatory cytokines such as tumour necrosis factor-α (TNF-α) 
and IL-6(187). In mammalian cells, there are five mmbers of the NF-kB 
transcription factor family including RelA (p65), RelB, C-Rel, p105 (NF-kB1; a 





NF-kB dimer in the innate immune response is a heterodimer composed of RelA and 
p50(138). NF-kB activation occurs either through IRAK and NEMO signalling, or 
via the TRIF pathway. Myd88-NEMO signalling (i.e. the canonical NF-kB pathway) 
generally leads to the induction of inflammatory cytokine genes, whereas TRIF-
dependent signalling is more associated with the formation of IRF-3 homo-dimers 
and the activation of type I IFN(187). 
 
1.6 Viral evasion of the innate immune response 
 
Viruses have evolved an efficient ability to subvert and modulate the mammalian 
immune response at both the innate and adaptive level (6, 41, 105). This ability is a 
result of long periods of host/pathogen evolution during which viruses infect their 
hosts, multiply in large numbers, frequently undergo mutation and recombination 
events, and are then constantly subject to the strong selective pressures of the host 
immune system. Consequently, viral genomes evolve t become rich with immune-
evasion genes. Cytomegalovirus and the other herpesvi uses are prime examples, 
especially given their large genome sizes and long periods of species-specific co-
evolution(69). 
 
 1.6.1 Viral subversion of PRR signalling  
 
The ability of viruses to subvert cell-intrinsic innate immunity is particularly 
important for the establishment of infection and viral replication(308). One of the 
first aspects of the innate immune response the virus encounters, and therefore must 
subvert, is the pattern recognition receptors (PRRs). As a result, viruses have 
developed a range of strategies to avoid detection by PRRs during infection 
(reviewed in (41, 265). In particular, toll-like rec ptor signalling has been shown to 
be modulated by VACV and HCV proteins at key signalli g hubs Myd88, IRAK2, 
and TRIF(41).  Signalling through the RIG-I-like receptors is also modulated at 
various levels by RNA viruses such as influenza(254), paramyxoviruses(11) and 
poliovirus(22). Intracellular DNA detection pathways are also targeted by vaccinia 





RNA polymerase III-mediated dsDNA-sensing pathway by the VACV protein 
E3(366). 
 
1.6.2 Viral subversion of the IFN response  
 
The ability of viruses to subvert the type I IFN response is common given the central 
role of IFN in host defence against virus infection (295). The subversion of type I 
IFN signalling has been shown for a range of different viruses(185, 280, 282, 306, 
307, 376), including members of the herpesvirus family(141, 170, 262). The 
subversion of IFN by viruses can occur at various levels, including inhibition of 
IRF3 and IRF7 via the IKKs, modulation of NF-kB activity, and direct targeting of 
the IRFs (all reviewed in (41)). Several viruses also express viral IRF mimics that 
inhibit IRF3 and IRF7 signalling(178, 218, 227).  The influenza NS1 protein, in 
particular, has been shown to have a complex and multifunctional ability to inhibit 
IFN-signalling at different levels. This occurs either  through direct inhibition of type 
I IFN production, or through modulation of downstream IFN-stimulated genes (i.e. 
PKR, OAS/RNase)(128).  
 
1.6.3 Innate immune evasion by CMV 
 
The multifaceted ability of cytomegalovirus to modulate almost all levels of the 
immune response has been well studied and reviewed xt nsively in recently years 
(74, 225, 237, 288). The large ~230kb genome of MCMV encodes over 170 
predicted viral ORFs(299), many of which have known or predicted roles in 
immune-evasion. Although much of the literature on MCMV immune-evasion is 
related to NK-cell function, the ability of MCMV to evade the type I IFN system has 
also been described. Of particular note is the report d ability of MCMV to disrupt 
IFNβ induction in fibroblasts by controlling pathways leading to the IFNβ 
enhanceosome(208).This study demonstrates MCMV is capable of inhibiting IFNβ 
expression, and inhibition is dependent on viral gene xpression (does not occur 





blockage of IkBa degradation and a lack of nuclear IRF3 and ATF-2/c-Jun 
accumulation in fibroblasts, independently of the IFN-feedback loop.  
 
The MCMV protein M27 has also been shown to modulate IFN-γ signalling by 
selectively binding and down-regulating Stat2(392). M27 modulates ISRE-dependent 
gene expression by altering Stat2 phosphorylation, but has little or no effect on Stat1 
activation and signalling. This finding suggests a preference towards modulation of 
type I IFN signalling by M27. MCMV ORF M45 has also been shown to interact 
with the innate immune response by inhibiting pro-inflammatory and innate immune 
pathways through interaction with signalling protein RIP1(230, 364). M45 also has a 
potent anti-apoptotic function by inhibiting TNFα-induced activation of NF-κB, p38 
MAPK. The M45 protein can inhibit TLR3-mediated NF-κB activation and 
ubiquitination of RIP1, and function as a viral inhibitor of RIP1 signaling(230). The 
MCMV ORFs m142 and m143 have also been shown to inhibit t e protein kinase R 
(PKR)-mediated antiviral response by blocking PKR-mediated shutdown of protein 
synthesis during MCMV infection(48, 57, 365).  
 
MCMV also modulates the cell cycle and can arrest clls in G1 and G2 phase during 
infection (379). This is thought to favour the conditions required for MCMV 
replication. The ability of MCMV to inhibit apoptosis is well-established and has 
been reviewed in detail in recent years (10, 119, 244). The many mechanisms by 
which MCMV interferes with the adaptive immune response have also been covered 
in recent reviews, particularly in regards to the inhibition of NK-cell function (74, 
225, 237, 288). 
 
For HCMV, there is an equally extensive body of literature on immune-evasion 
(reviewed in (170, 225, 237, 244, 257, 288)). In relation to the IFN response, the 
HCMV IE2 protein has been shown to block virus-induced IFNβ production(353) 
and inhibit CCL5 (RANTES) chemokine production(354). HCMV has also been 
shown to reprogram monocyte differentiation toward n M1 macrophage phenotype 
(56), and modulate the cell cycle and apoptosis during infection(244). It is notable 





regards to immune evasion in their respective hosts, particularly at immediate early 
times of infection(243). Overall, however, both viruses encode a number of proteins 
capable of overcoming immune responses at a variety of different levels. 
 
1.7 The innate immune response to productive versus non-productive viral 
infection 
 
1.7.1 Principle  
 
The ability to compare the host innate immune respon e to productive (live) versus a 
non-productive (attenuated, replication deficient) virus infection s attractive for a 
number of reasons. Firstly, an attenuated virus will not express de novo viral proteins 
and will therefore represent an inactive infection. By infecting cells with an 
attenuated virus, the host response to membrane fusion and viral entry can be 
measured in the absence of de novo protein activity. As a result, the response to 
structural components of the virion alone can be measured, and the innate antiviral 
response can be investigated in the absence of viral immune-evasion by de novo 
proteins (the effects of tegument proteins will still be seen). Secondly, by comparing 
the innate immune response to productive and non-prductive viral infection directly, 
areas of the host response targeted by e novo viral proteins can be identified, and 
aspects of the response differentially regulated betwe n the two conditions can be 
identified.  
 
Traditionally it has been difficult to measure the innate immune response to a non-
productive viral infection without using UV-inactivation, a process whereby viral 
DNA is cross-linked using UV-radiation, rendering the virus incapable of DNA 
replication(202). UV-inactivation is considered the“gold standard” technique for 
attenuating viruses. UV-inactivation has, therefore, been used to attenuate a number 
of different viruses including HCMV (34, 43, 65, 180, 273, 386), MCMV(18, 48, 
373, 379), HSV (231, 263, 275), NDV/HCV(272), SFV(142), SNV(289), VV and Ad 
(63). The UV-inactivation technique, however, despite being the gold standard, has a 






To inactivate a virus using UV-radiation, an increasing dose of UV must be 
administered until only minimal levels of viral replication are detectable. The 
inactivation must, therefore, be confirmed using either a measure of viral replication 
(i.e. plaque assay) or a measure of viral gene expression (i.e. RT-PCR). In both 
cases, it is difficult to completely ensure that all viral particles are inactivated. 
Technically, there are also issues related to variability between batches of UV-
inactivation, and variability in instruments used to administer the UV-dose. 
Infectivity between viral stocks can also vary. UV-radiation is known to damage 
DNA to the point it can no longer replicate, but its effect on other viral structures 
such as RNA, capsid proteins, and membrane glycoproteins is largely unknown. It 
may be possible that UV-radiation damages viral proteins in addition to viral DNA, 
which has been suggested to be the case for Murine Oncornavirus(226). In addition, 
only a limited number of studies have provided an in-depth phenotypic 
characterization for an UV-inactivated virus(110, 279).  
 
1.7.2 Literature review of the host response to productive and non-productive viral 
infection 
 
Despite the above issues, many studies have been condu ted measuring the innate 
immune response to wild-type viruses versus UV-inact v ted virions(34, 43, 48, 63, 
65, 142, 180, 231, 263, 272, 273, 275, 289, 373, 379 86). A number of these 
studies have used microarrays to measure the transcriptional response at the genome-
wide level. The response to HCMV versus UV-inactivated HCMV was measured in 
fibroblasts using microarrays(43), with results indicating considerably more mRNAs 
induced by UV-HCMV than by HCMV. This suggests a possible suppression of host 
gene expression by de novo HCMV proteins, and amongst the genes suppressed were 
IFNβ (Ifnb1) and pro-inflammatory cytokines (RANTES, interleukin 8, MIG, 
MIP1a, and MIP3b). An overlapping response to HCMV and UV-HCMV was also 
reported suggesting common induction of some genes by membrane binding and 
viral entry. The study was, however, limited by only a single time point 





infections. A very high multiplicity of infection (MOI) of 6 PFU/cell was also used 
in this study. 
  
The host response to HSV and UV-HSV was measured in human embryonic lung 
cells in a similar fashion(263), and a suppression of ISGs by productive HSV 
infection was also reported. A high overlap between the response to UV-HSV and 
IFNα treatment was observed, and the study found that the establishment of an 
antiviral state occurred independently of viral replication in response to both HSV 
and UV-HSV. Again, however, the study was limited to a single time point 
measurement (24hpi), and the use of non-immune cells. Other studies using HSV-1 
mutants lacking the VP16 or VHS (UL41) genes also found significantly higher 
levels of pro-inflammatory cytokines expressed in response to attenuated HSV-1 
strains in comparison to wild-type strains (260, 345). Again, this suggested a 
suppression of innate immunity by productive viral nfection. These studies found 
more genes up-regulated early in infection by the att nuated viruses, and more genes 
suppressed late in infection by wild-type HSV(345).   
 
More recent studies have confirmed induction of the innate immune response does 
not require viral replication(211, 330, 359). Using UV-inactivated Sin Nombre 
Hantavirus (SNV) in human primary endothelial cells, Prescott et al. showed ISGs 
were induced in response to both live and attenuated SNV between 4hpi and 
24hpi(289). In this study, cellular gene expression was measured at multiple time 
points (24hpi and 72hpi) by microarray analysis, and by qRT-PCR analysis (for 
MXA and ISG56) at early time points (0-12hpi). In all cases, strong ISG expression 
was reported in response to both live and UV-inactiv ted SNV. This study provides 
considerably more insight into the differential response, and suggests more genes are 
induced in response to inactivated SNV at early time points (<24hpi), but more genes 
were induced in response to live SNV at later time points (>24hpi). This was a key 
observation suggesting host cells respond differently to ongoing and sustained viral 






Collins et al. later used a range of UV-inactivated viruses to illustrate the innate 
response to virus entry requires IRF3 but does not require viral replication in 
fibroblasts(63). Noyce t al. then showed the antiviral response and induction of ISG 
expression could occur independently of IRF3-activation in response to Newcastle 
Disease Virus (NDV)(272).  Other studies find early responses to SNV occur 
independently of IRF3, PRRs, and viral entry(290). The induction of type I IFN in 
myeloid dendritic cells (mDC) using UV-inactivated Semliki Forest virus (SFV) was 
also found by Hidmark et al. to require viral fusion, viral entry and IRF3 activation, 
but not require signalling through MyD88(142). These findings indicate variation in 
the way different viruses are detected by host cells depending on the context. 
 
Notably, the Hidmark et al. study on SFV reported that induction of IFNα/β in 
dendritic cells (DCs) occurs far more rapidly than in fibroblasts. Furthermore, type I 
IFN induction in fibroblasts was dependent on viral replication, but in DCs occurred 
independently of SFV replication. Together, these observations suggest fibroblasts 
(MEFs) and antigen-presenting cells (DCs) use different mechanisms to sense and 
respond to viral infection. It also suggests DCs detect viruses more rapidly and with 
greater sensitivity than fibroblasts. The study on SFV did not include any genome-
wide expression profiling analysis.  
 
More recently, Paladino et al. conducted a study using HSV, VSV and HCMV 
showing the initial response to virus particle entry can occur independently of IFN, 
TLRs and RIG-I(275). This study proposed a model whereby increasing numbers of 
virus particles (or increasing MOIs) elevate the complexity of the cellular antiviral 
response from a basal intracellular response which is IFN-independent, to a 
sustained, heightened response involving IFN signalling, cytokine secretion and 
attraction of immune cell infiltrates.  
 
Taken together, the body of literature on the host re ponse to productive and non-
productive viral infection suggests a) multiple mechanisms of innate viral detection 
occur within host cells, b) mechanisms of viral detection vary depending on the virus 





can occur via multiple signalling pathways. Some of the studies also allude to the 
concept of distinct waves of immune signalling which vary in complexity and 
intensity based on the amount of virus present. Taken together, these studies have 
been informative but are individually limited by single time point measurements and 
the use of non-immune cell types such as fibroblasts.  
 
Perhaps a more relevant study, therefore, is the recently conducted comprehensive 
gene expression profiling analysis of macrophages infected with wild type and 
attenuated strains of the intracellular bacterial pathogen Listeria monocytogenes 
(210). In this study, DNA microarrays were used to m nitor the macrophage 
transcriptional response at 30, 60, 120 and 180 minutes post infection using 
combinations of host and bacterial mutants. The study found compartment-specific 
host responses occurring to the different bacterial mutants, despite similar activation 
of transcription factors between the different conditions.  The results suggested 
combinatorial control of IFNβ induction can occur via recognition of both bacterial 
DNA and a bacterial cell wall component (muramyl dipeptide) as separate PAMP 
signals detected at different times and in different cellular locations during infection. 
The authors further suggest the innate immune system is capable of integrating 
differential responses from multiple PRRs to define th  overall transcriptional 
response to infection.   
 
An equivalent systems-level study for virus infection, whereby genetic mutants from 
both host and pathogen are combined with temporal profiling analysis in a highly 
relevant cell type, has been lacking. The aim of this t esis will be to address this gap 
in the field, and conduct an in-depth, systems-level analysis of the temporal response 
to productive and non-productive MCMV infection in macrophages, in greater depth 









1.7.3 Use of a recombinant MCMV deletion mutant as an alternative to UV-
inactivated virus 
 
An alternative method for achieving a non-productive viral infection, in place of UV-
inactivation, would be to use a genetic mutant virus that is mechanistically incapable 
of expressing viral proteins or replicating in the cell type of interest, yet still capable 
of viral entry and membrane fusion. This way the technical and biological variability 
and uncertainty introduced by the UV-inactivation procedure would be eliminated. 
Ideally, this genetic mutant virus would be capable of binding and entering host cells, 
but incapable of transcribing viral gene products or replicating. An example of this 
type of mutant is available for murine cytomegalovirus (MCMV), whereby removal 
of the immediate early gene 3 was found to render the virus incapable of replication, 
even at high multiplicities of infection(12). The MCMV ie3 gene is expressed in 
abundance at the beginning of the MCMV life cycle and has an essential trans-
activator role in the control of down-stream MCMV gene expression. Upon deletion 
of this gene, the virus is incapable of replicating or expressing viral gene products 
beyond the immediate early (IE) region (12).  
 
The mutant virus (termed MCMVdie3) is only capable of replication on a 
complementing cell line where expressing the IE3 protein is expressed in trans via a 
stably co-transfected plasmid. The complementing cell lin  (termed NIH 3T3-
Bam25) was derived from NIH 3T3 cells and was constructed in parallel with the 
MCMVdie3 virus (12). A revertant virus (MCMVdie3rev), whereby the ie3 gene was 
re-inserted into the MCMV genome, was also constructed and shown to be fully 
restoring of the virus replication cycle. The attenuated MCMVdie3 strain is capable 
of replicating to high titres in the complementing cell line and can therefore be 
propagated in large quantities and with consistency across batches. MCMVdie3 
provides a unique alternative to the use of UV-inactiv ted virions for representing 
non-productive viral infection.  
 
Replication-deficient mutants and complementing cell lines have also been 





glycoprotein gB (UL55)(163), protein kinase UL97(291), and the UL52 gene(39). 
Nonviable deletion mutants and complementing cell lines have also been constructed 
for HSV genes (118, 124) and genes from other viruses (98, 106, 143, 274). More 
recently, a conditional and reversible fusion protein system was also developed for 
complementation of essential CMV proteins MCMV IE1 and IE3 and HCMV IE1, 
IE2, pUL51, and pUL77(117). Despite these efforts, the attenuated viruses have 
never been used as control reagents to represent non-productive infection in host-
response experiments.  
 
1.8 Rationale and predictions of the thesis 
 
The central hypothesis of the thesis is that macrophages respond differently to 
productive and non-productive MCMV infections at the gene expression and protein 
level. This is worth investigating as it may help eucidate the ability of macrophages 
to detect and respond to different infectious conditions in vivo, thereby potentially 
influencing the outcome of downstream immunological events. It also relevant for 
considering why attenuated vaccines do not always generate effective immunity in 
comparison to live infections. To test the hypothesis xperimentally, mouse bone 
marrow-derived macrophages (BMDMs) will be infected in parallel with wild-type 
and attenuated strains of MCMV, then dynamically profiled over a 24 period using a 
range of different techniques. Particular focus will be made on the transcriptional 
response to MCMV using time-course microarray profiling. 
 
The main objectives of the study are; 
 a) Determine if the mutant MCMVdie3 can be used as an alternative to UV-
inactivated virions to represent non-productive MCMV infection (Chapter 3) 
 b) Characterize the macrophage innate immune response t  productive and non-
productive MCMV infection at the systems-level (Chapter 4) 
c) Identify macrophage transcriptional networks targeted for modulation during 
productive MCMV infection (Chapter 5) 
d) Determine the role of type I IFN in regulating the macrophage innate immune 






Before proceeding to the experimental sections, it i  important to first consider the 
events that may occur during MCMV infection of macrophages. Figure 1.5 shows 
the events known or predicted to occur during establi hment of productive MCMV 
infection. Firstly, during viral entry, MCMV will activate PRRs either at the cell 
surface or inside the cell (a). This will result in the induction of type I IFN (b) and 
subsequent up- and down-regulation of IFN-dependent g es(c). In the cytoplasm, 
activation of the inflammasome is also predicted to occur via the detection of 
MCMV genomic dsDNA by AIM2. This will lead to NF-kB activation and induction 
of pro-inflammatory cytokines independently of type I IFN (d). Simultaneously, the 
MCMV genome will be transcribed and viral proteins will be expressed e novo, 
resulting in the establishment of productive MCMV infection (e). The activity of 
these de novo MCMV proteins is then predicted to influence a sub- et of macrophage 
antiviral genes (f). The activity of the de novo MCMV proteins is not predicted to 
influence the expression of all macrophage genes during the innate immune 
response. There is also predicted to be a secondary macrophage reponse induced by 
de novo MCMV proteins (g).  
 
 
Figure 1.5 - Conceptualization of events known and predicted to occur during 
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The consequences of infecting macrophages with a non-pr ductive MCMV strain 
may be somewhat different from those described above. Figure 1.6 shows the events 
predicted to occur during non-productive MCMV infection using the attenuated 
MCMVdie3 strain.  In a similar fashion to viral entry during productive MCMV 
infection, the attenuated MCMVdie3 virion is predicted to enter host cells and 
activate PRR signalling either at the cell surface nd/or inside the cell (a). The 
MCMVdie3 virus, however, will be unable to transcribe viral genes or produce d  
novo viral proteins due to the removal of the ie3 gene (b). Therefore the MCMVdie3 
strain will be incapable of synthesizing viral proteins and establishing productive 
infection (c). As a result, in response to MCMVdie3, the expression of macrophage 
antiviral genes is predicted not be modulated by e novo viral proteins expressed 
beyond the IE region (d). The effect of tegument proteins packaged in the 
MCMVdie3 virion will still be functional in MCMVdie3-infected cells.  
 
Figure 1.6 - Conceptualization of events known and predicted to occur during 
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By comparing the macrophage response to productive and non-productive MCMV 
infection on a genome-wide scale using microarrays, lterations in macrophage gene 
expression elicited by productive MCMV infection will be identified. Such 
alterations may involve modulation of macrophage genes by de novo MCMV 
proteins, or host-regulated changes in response to ong ing and sustained MCMV 
activity. Both of these types of alterations in host gene expression will be informative 
of the macrophage/MCMV host/pathogen relationship.  In addition, genes during the 
response can be classified into kinetic classes through use of multiple time point 
measurements, and knock-out cells derived from Ifnb-/- and Ifnar1-/- mice can be 
used to identify transcriptional events regulated by type I IFN. 
 
Chapter 6 of the thesis will focus in particular on the role of type I IFN in regulating 
the macrophage transcriptome during the response to productive and non-productive 
MCMV infection. This will involve temporal gene expression profiling of wild type, 






Materials and methods 
  
2.1 Cell culture 
 
2.1.1 Cell lines 
 
The NIH 3T3 embryonic fibroblast-derived immortalized cell line (ATCC CRL1658 
was obtained from American Type Culture Collection (Manassas, VA, USA) and 
grown in Dulbecco's modified Eagle medium (DMEM) (Lonza, UK) supplemented 
with 10% calf serum (Invitrogen, UK), 2mM glutamine (Lonza, UK) and 100U of 
penicillin/streptomycin (Lonza, UK) per ml. The NIH 3T3-Bam25 cell line was 
derived from NIH 3T3 by co-transfection of the pBAM25 plasmid  as described 
previously(12). NIH 3T3-Bam25 was grown in the same edium as NIH 3T3.  
 
2.1.2 Passaging cell lines 
 
Cell lines were cultured at 37oC and 5% CO2 in tissue culture flasks (Corning, UK) 
according to sterile technique. Cells reaching 70-80% confluence were incubated 
with trypsin/EDTA (Lonza, UK) at 37oC for 1-2 minutes and upon detachment, were 
transferred to a 15ml tube, mixed with fresh medium and centrifuged at 1000 rpm for 
5 minutes. Cell pellets were re-suspended in 2-3ml fresh medium and re-seeded into 
sterile tissue culture flasks at a factor of 1:2 or 1:3. This process was repeated every 
2-3 days up to a maximum of 25 passages.  
 
2.1.3 Cell counting and seeding plates 
 
To count cells after trypsinization and re-suspensio , 10µl of suspended cells was 
diluted in 90µl of Trypan Blue Stain, 0.4% (Invitrogen, UK) to make a 1:10 dilution. 
10µl of this dilution was injected directly into a h emocytometer under a cover slip 
and viable cells counted in the central 16 marked squares. Viable cells in the marked 





cells counted by the dilution factor (in this case  factor of 10), by the relative area of 
the haemocytometer square (104 cm3). Counting cells was repeated on 4-6 replicates 
for each sample and the average count was taken. Counted cells were then further 
diluted in warm medium and seeded at specific densiti s in different sized sterile 
tissue culture flasks, dishes or plates (Nunc, UK). Seeding densities for NIH 3T3 and 
NIH 3T3-Bam25 cells in different sized tissue culture plates were as follows;  
• 48-well plates - 4x104 cells in 500µl medium per well 
• 24-well plates 1x105 cells in 1ml medium per well 
• 6-well plates 3x105 cells in 2ml medium per well 
 
2.1.4 Cryopreservation of cells 
 
To preserve NIH 3T3 and NIH 3T3-Bam25 cells for long term storage, cells were 
centrifuged as previously described and re-suspended in freezing medium containing 
DMEM 40%, calf serum 50%, and dimethyl sulfoxide (DMSO) 10%. 1ml aliquots 
were placed in cryovials (Corning, UK) containing 1x106 resuspended cells each. 
Cells were frozen at –80°C overnight to avoid fast cooling and breaking of the cell 
membrane and after 24 hours cells were transferred to a liquid nitrogen container (-
170°C) for long-term storage. 
 
2.1.5 Thawing cells from liquid nitrogen 
 
For resurrection of frozen cell lines from liquid nitrogen, individual vials of cells 
were thawed in a water bath at 37°C and added to 10ml of fresh warm growth 
medium in a sterile 15ml tube. Cells were then centrifuged at 1000 rpm for 5 
minutes. Supernatants were discarded and cell pellets re-suspended in 7ml fresh 








2.1.6 Preparation of L929 conditioned media for macrophage differentiation 
 
The L929 cell line was obtained from Sigma, UK (85011425) and is a subclone of 
the parental cell strain L derived from subcutaneous areolar and adipose tissue. This 
cell line is used to produce conditioned media containing Macrophage Colony 
Stimulating Factor 1 (CSF-1) for differentiating bone marrow monocyte progenitor 
cells into macrophages. CSF-1 is a cytokine secreted by mesenchymal cells that 
stimulates survival, proliferation and differentiation of bone marrow hematopoietic 
stem cells into mature monocytes. The L929 cell line is grown in DMEM/F-12 media 
with GlutaMAX (Invitrogen, UK) containing 10% fetal calf serum (Lonza, UK) and 
100 units of penicillin/streptomycin (Lonza, UK) per ml. L929 cells were grown in 
175 cm2 flasks for 14 days at which point the supernatant was removed, aliquotted 
into 50ml tubes and frozen at -20oC.  
 
2.1.7 Bone Marrow Derived Macrophages (BMDMs)  
 
2.1.7.1 Mouse bone marrow progenitor cell isolation and macrophage differentiation  
 
Bone marrow monocyte progenitor cells were extracted from mouse femurs from 
wild type C57BL/6 mice (BRR, University of Edinburgh, UK), and C57BL/6 mice 
lacking the Ifnb1 or Ifnar1 gene (Institute of Animal Breeding and Genetics, 
University of Vienna, Austria). All mice were aged between 10-12 weeks and male. 
Mice were sacrificed via cervical dislocation and femurs extracted under sterile 
conditions by animal technicians. Mouse femurs were cut at both ends and the 
marrow cavity was flushed with growth medium with cells recovered in a 50ml tube. 
Bone marrow cells were centrifuged at 1000 rpm for 5 minutes and re-suspended in 
fresh growth medium. Cells were counted as previously described and seeded in 24-
well plates at a density of 2.5x105 cells in 1ml per well. Precursor cells were cultured 
for a 7-day differentiation period into mature bone marrow-derived macrophages 
(BMDMs) in the presence of M-CSF in L929 conditioned media, with media 
changes on days 3 and 5. In the case of knockout mice, femurs were extracted at the 
Institute of Animal Breeding and Genetics, University of Vienna, Austria and 





2.1.7.2 Characterisation of BMDMs by flow cytometry  
  
To determine the proportion of macrophage-like cells in the BMDM cultures after 
the seven-day differentiation period, fluorescence-a tivated cell sorting (FACS) was 
used to measure the expression of macrophage-specific cell surface protein markers 
CD11b and F4/80. The FACS procedure consisted of binding specific antibodies to 
cell surface expressed proteins and adding fluorescently labelled secondary 
antibodies for detection. Fluorescently labelled cells were sorted one cell at a time 
based on their individual florescent emission signal to determine the proportion of 
macrophage-like cells in the heterogeneous cell population.  
 
For flow-cytometry analysis, BMDMs were washed twice with PBS on day seven of 
the differentiation period, then scraped and removed from tissue culture dishes and 
transferred to polystyrene FACS tubes (BD Falcon, UK). Tubes were centrifuged at 
1000g for 5 minutes at 4°C. After discarding the supernatant, cells were washed with 
cold PBS and resuspended in 100µl of blocking solution (10% mouse serum) for 30 
minutes on ice to avoid non-specific antibody binding. Allophycocyanin (APC) 
conjugated monoclonal rat-anti-mouse F4/80 (IgG2a·, C ltag Laboratories, UK) and 
fluorescein isothiocyanate (FITC) conjugated rat-anti mouse CD11b (IgG2b·, 
eBiosciences, UK) or their isotype controls were added to the cells (1/100 dilution in 
blocking solution) and incubated for a further 30 minutes in the dark. Cells were 
washed with cold PBS, centrifuged and resuspended in 250µl of cold PBS. A 
FACScan instrument (Becton Dickinson, UK) was used to perform FACS analysis of 
the samples and the data were analysed using FlowJo software (Treestar, USA). 
FACs analysis was performed with the assistance of Dr Kevin Robertson from The 











2.2 General methods for virology 
 
2.2.1 Viruses  
 
The parental murine cytomegalovirus (MCMV) strain was derived from recombinant 
bacterial artificial chromosome clone pSM3fr MW97.01 as described previously 
(250, 370). Recombinant MCMV immediate early (IE) gene deletion mutants for the 
ie1 gene (MCMVdie1) and ie3 gene (MCMVdie3) are also described previously 
((12, 113) and reviewed in (49)). Construction of a revertant virus for the ie3 deletion 
mutant (MCMVdie3rev) plus deletion mutants for ORFs M27 (MCMVdM27) and 
M45 (MCMVdM45), and large-scale deletion mutants for MCMV gene blocks 1 
(m01-m16), 6 (m144-m157) and 7 (m158-m170) has also been described previously 
(2, 12, 45, 60, 61, 230). Large deletion mutants were kindly provided by Lars 
Doelken, Max von Pettenkofer-Institute, Munich, Germany. 
 
2.2.2 Viral stock preparation  
 
To propagate bulk viral stocks for each MCMV strain, confluent 175cm2 flasks of 
NIH 3T3 cells were infected at MOI of 0.01 PFU/cell in 17ml of growth medium per 
flask. Using 6-9 flasks per viral stock, infections were left for 5-7 days until a nearly 
complete cytopathic effect (CPE) was observed for each virus. At this stage 
supernatant was harvested from multiple flasks, combined, centrifuged at 1000 rpm 
for 5 minutes, then separated from cell debris pellets and aliquoted into sterile 50ml 
tubes and stored at -80oC. This procedure was applied to all viral strains except 
MCMVdie3 which was propagated in the same way but on the complementing cell 
line NIH 3T3-Bam25. In some cases viruses were propagated in smaller vessels to 
increase viral titre of seed stocks before preparation of bulk stocks.  
 
2.2.3 Concentration of viral stocks 
 
To increase the titre of viral bulk stock preparations, viruses were concentrated using 
high-speed centrifugation on a sorbitol cushion. Frozen viral bulk stocks were 





completely thawed. In 30ml centrifuge tubes (Sorvall, UK), 10ml of 20% sorbitol 
solution (containing 0.01 M Tris-buffered saline (TBS) at pH 7.8) was added gently 
down the side of each tube followed by 20ml of viral supernatant added carefully 
above the sorbitol cushion. Tubes were balanced within 0.5 grams of each other and 
centrifuged at 26,000g for 70 minutes at 4oC in a high-speed centrifuge. After 
centrifugation, supernatant was removed and pellets re-suspended in 1ml DMEM 
growth medium containing 3% CS per tube. Re-suspended pellets were pooled 
together and aliquoted for storage at -80oC.  
 
2.2.4 Titration of virus by plaque assay  
 
To determine the infectivity of viral stocks, plaque assays were performed on NIH 
3T3 or NIH 3T3-Bam25 monolayers in 48-well plate format. The plaque assay is the 
gold standard technique to quantify the infectivity of a virus or measure the amount 
of infectious virus within a sample. The principle of a plaque assay is to perform 
serial dilutions or titration of the virus by a factor of ten, and then use the dilutions as 
innoculums to infect separate monolayers of cells. The infected cell monolayers are 
then covered with a thick layer of growth media containing agarose in order to 
prevent spreading of the virus during infection. After four days the number of 
plaques (individual areas of lysed cells) are counted per dilution and used to calculate 
the number of plaque forming units (PFU) per ml.  
 
For MCMV, low passage NIH 3T3 or NIH 3T3-Bam25 cells were seeded for 24 
hours in growth medium containing 10% CS in 48-well plates at a seeding density of 
4x104 cells in 500µl per well. A 10-fold serial dilution of the virus was performed in 
triplicate from 10-1 to 10-6 in a round-bottom 96-well plate by taking 11µl of virus 
into 100µl of growth media containing 3% CS over six dilutions. Depending on the 
expected titre of the virus, 100µl of up to four of the six dilutions were transferred 
onto confluent cell monolayers in 48-well plates. Infected cells were incubated for an 
adsorption period of 1.5 hours at 37oC. After the adsorption period, cells were 
washed with warm growth media. During this time, 2.5% agarose was heated to 





was added to 9ml of warm growth media (3% CS) in a 15ml tube and mixed 
vigorously for 10 seconds. The wash media was aspirted from the cell monolayers 
and replaced with 500µl of the 2.5% agarose-medium mixture which was added very 
gently down the side of each well. Cells were incubated for four days at 37oC and 
then number of plaques per well of the 48-well plate were counted on day 4. The 
number of plaques counted calculates the PFU/ml using the following equation: 
 
PFU/ml = number of plaques counted * individual dilution factor * 10  
 
Plaque counts were averaged over three replicates and over multiple dilutions if 
plaques appeared at more than one dilution. Once the titre (PFU/ml) for a given virus 
was calculated, it could be used to determine the infectious dose or multiplicity of 
infection (MOI) for future experiments. The MOI corresponds to the number of 
plaque forming units (PFUs) delivered per cell. 
  
2.2.5 Viral growth curves 
 
To monitor rates of MCMV infectivity and viral replication over the course of 
infection under a given set of conditions, growth curve analysis was performed 
whereby supernatants were taken periodically from an infected culture of cells and 
titred using plaque assay. To perform growth curve analysis, confluent cell 
monolayers for cell-types of interest were infected in 24-well plates. After infection, 
cells were aspirated, washed with warm media, and replenished with fresh growth 
media containing 10% CS. 70µl of supernatant was remov d from the culture every 
24 hours thereafter and stored at -80oC. After 5 or 6 days the infection was ceased 
and supernatants from each day were titred using plaque assays to determine the 
relative PFU/ml of virus over the course of the infection. Multi-step growth curves 
use low MOIs (typically 0.01 PFU per cell) resulting i  multiple rounds of viral 
infection. Single-step growth curves use high MOIs (typically 2 or more PFU per 








2.3 Infection / stimulation of cells for downstream molecular analyses 
 
For all MCMV infection experiments involving downstream molecular analysis, 
cells are first infected with a small volume of virus-containing media (3% CS) for an 
adsorption period of 1.5 hours at 37oC. This allows sufficient time for viral entry and 
establishment of infection to occur. At the end of the adsorption period the viral 
innoculum is removed by aspirator and cells are washed with warm media then 
replenished with fresh growth medium containing 10% serum. For time course 
analyses, T0 or zero hours post infection (0hpi) always corresponds to the end of the 
viral adsorption period (i.e. 90 minutes after first contact). For mock infections, 
standard growth medium containing 3% serum was useda  the innoculum but with 
no virus added. Mock-infected were washed and replenish d with fresh medium as 
per normal infections.  
 
For drug treatment experiments, cells were pre-treated in the presence of either 
50µg/ml cycloheximide (Sigma UK, C7698) or 20µM Ganciclovir (Sigma UK, 
G2536) for 60 minutes in 10% serum growth medium. During infection, 3% serum 
medium in the presence of the same concentration of the drug was used. Finally, 
cells were washed and replenished with fresh medium (10% serum) also containing 
the same concentration of the drug. For interferon beta (IFNβ) and polycytidylic acid 
potassium salt (polyIC) stimulation experiments, cells were treated with a regular 
volume of standard growth medium containing 10 units per ml of recombinant IFNβ 
(R&D Systems, UK) or 10µg/ml of polyIC (Enzo, UK). The IFNβ and polyIC were 
left in the growth medium for the duration of the exp riment and cells were not 
washed. In the case of time course analyses, cells w re stimulated with IFNβ and 
polyIC with the same timing as viral infections. This meant that T0 for IFNβ and 
polyIC stimulation experiments actually corresponded to 90 minutes after the initial 









2.4 Nucleic acid purification 
 
2.4.1 RNA extraction 
 
2.4.1.1 Extraction of total RNA using Invitrogen RNA Purification System  
 
To extract RNA, cell monolayers were aspirated to remove all growth medium and 
cells were lysed directly in the wells of tissue culture plates by adding either 250µl 
(24-well plates) or 500µl (6-well plates) per well of Trizol reagent (Invitrogen, UK)  
or RNA lysis buffer containing 1% 2-mercaptoethanol (Invitrogen, UK). Plates were 
tilted up and down to distribute the lysis reagent evenly and after 5 minutes samples 
were transferred to sterile 1.5ml microcentrifuge tubes. For 24-well plate 
experiments, two wells were pooled together into one 500µl sample. All samples 
were stored at -800C until RNA extraction began. On the day of RNA extrac ion, 
frozen Trizol or RNA lysis buffer samples were thawed to room temperature and 
flick mixed until homogenous. For Trizol samples, 150µl chloroform was added to 
each 500µl sample and tubes were capped and mixed vigorously by shaking for 15 
seconds. Trizol samples were incubated at room temperature for 2-3 minutes until the 
aqueous phase began to separate. At this stage Trizol samples were centrifuged at 
maximum speed (~12,000g) at 4oC for 15 minutes and after centrifugation the clear 
aqueous phase containing RNA was removed from the thick pink layer of Trizol 
containing cellular debris and proteins. 200-250µl of the aqueous phase was removed 
and transferred to a sterile 1.5ml microcentrifuge tube and a second extraction step 
was performed by adding another 100µl of chloroform and repeating the procedure. 
The aqueous phase after the second extraction (now generally only around 190µl) 
was removed and added to another sterile 1.5ml microcentrifuge tube. An equal 
volume of 70% ethanol (190µl) was added to obtain a f al ethanol concentration of 
35%. For RNA lysis buffer samples, lysates were thawed, flick mixed and transferred 
to QIAshredder columns (Qiagen, UK) and centrifuged for two minutes at 12,000g. 
An equal volume of 70% ethanol (350µl) was added to the samples to obtain a final 
ethanol concentration of 35%. At this stage, all samples whether derived from Trizol 
or lysis buffer were mixed by vortex for three seconds and transferred to spin 





were centrifuged at 12,000g for 15 seconds at room temperature to bind RNA then 
washed twice with 250µl of wash Buffer I (Invitrogen, UK), with centrifugation at 
12,000g for 15 seconds at room temperature after each w sh. The flow-through was 
collected in a collection tube beneath the spin cartridge and discarded after each 
wash. After the second wash, 80µl of DNase mix (Purelink DNase set, Invitrogen, 
UK) containing 8µl 10X DNase I reaction buffer, 10µl resuspended DNase (~3U/µl) 
and 62µl RNase-free water per sample was added directly to the membrane of each 
spin cartridge. Samples were incubated at room temperature for 15 minutes to ensure 
complete DNase I digestion of genomic DNA. After DNase treatment, spin 
cartridges were washed twice with Wash Buffer I (250µl) and twice with Wash 
Buffer II (500µl) by centrifugation at 12,000g for 15 seconds at room temperature 
after each wash. Flow-through was discarded and the spin cartridge is reinserted back 
into the same collection tube after each wash. After th  wash steps, spin cartridges 
were centrifuged at 12,000g for one minute at room te perature to dry the 
membrane with attached RNA. The collection tube wasdiscarded and the spin 
cartridge inserted into a sterile 1.5ml recovery tube and eluted with 38µl of RNase-
free water added directly to the centre of the membrane. After incubation at room 
temperature for one minute to elute the RNA, the spin cartridge was centrifuged with 
the recovery tube for 2 minutes at 12,000g at room te perature. Eluted, purified 
RNA was assessed for concentration and quality measur s by spectophotometer 
before being stored at -80oC. 
 
2.4.1.2 Extraction of viral RNA/DNA from cell-free samples  
 
The PureLink Viral RNA/DNA Kit (Invitrogen, UK) is designed to isolate viral 
nucleic acids from cell-free samples through the use of higher lysis temperatures, 
proteinase K and selective binding of viral nucleic acids by carrier RNA (yeast 
tRNA). The addition of carrier RNA increases binding of viral nucleic acids to a 
silica matrix and reduces viral nucleic acid degradation. This kit could be used to 
extract viral RNA/DNA from 200µl samples of viral stocks or from any 200µl cell-
free tissue culture samples from viral infections. I  each viral RNA/DNA 





which 200µl of the cell-free sample was added. To lyse samples, 200µl of Lysis 
Buffer (containing 5.6 µg Carrier RNA) was added before the tube was vortexed for 
15 seconds and incubated at 56oC for 15 minutes. 250µl of 100% ethanol was added 
and mixed by vortexing for 15 seconds then incubated  room temperature for five 
minutes. The lysate was transferred to a Viral Spin Column in a collection tube and 
centrifuged at 6,800g for one minute. The flow-through was discarded and the spin 
column placed into a new Wash Tube. The column was washed twice with 500µl 
Wash Buffer (W5) with ethanol by centrifugation forone minute at 6,800g. The flow 
through and collection tube were discarded and the spin column was placed in 
another clean Wash Tube. Spin columns were centrifuged at maximum speed for one 
minute to remove any residual Wash Buffer (W5) then placed in a clean 1.7-ml 
Recovery Tube and eluted with 10-50µl sterile RNase-free water added to the centre 
of the cartridge membrane. After incubation at room te perature for one minute, 
spin cartridges were centrifuged at maximum speed for one minute to elute the 
nucleic acids. 
 
2.4.1.3 Quality assessment of total RNA  
 
RNA concentration and purity were determined using a Nanodrop ND-1000 
spectrophotometer (Nanodrop Technologies, Germany). 1.5µl of purified RNA 
sample was loaded onto the spectrophotometer which places the sample between two 
optical surfaces, passes UV light through the sample and determines the emission 
path length at 230, 260 and 280nm. The absorption ratio at 260/280nm indicates 
RNA purity, and the ratio at 260/230nm indicates presence of organic (phenol, 
chloroform) contaminants within the sample. RNA samples with a 260/280 ratio 
<1.8 or a 260/230 <1.5 were deemed poor quality and excluded from further 
downstream analysis. To assess RNA integrity, the 2100 Bioanalyzer (Agilent, CA, 









2.4.2 DNA extraction 
 
For DNA extraction, cells were washed twice with ice cold PBS and scraped 
thoroughly in the second PBS wash. Scraped cells were transferred to sterile 1.5ml 
microcentrifuge tubes and centrifuged at 1000rpm for 5 minutes. PBS was removed 
and cell pellets were re-suspended in 200µl of NP-40 lysis buffer (Sodium Chloride 
150 mM, NP-40 1%, Tris, pH 8.0 50 mM) and incubated on ice for 20-30 minutes. 
After lysis, samples were centrifuged at maximum speed for 10 minutes at 4oC to 
remove cell debris. Supernatants were transferred to sterile 1.5ml tubes and stored at 
-80oC. To extract viral DNA from total DNA samples, the PureLink Viral 
RNA/DNA Kit (Invitrogen) was used as described in 2.4.1.3. 
 
2.5 Quantitative Polymerase Chain Reaction (qPCR) 
 
2.5.1 Quantification of viral genome copy number using qPCR  
 
A custom qPCR assay was developed to measure the quantity of MCMV genomes in 
infected cell samples and viral bulk stocks. The assay was used to complement the 
gold standard plaque assay as a measure of viral infectivity, but also provided a more 
sensitive and quantitative measure of viral genome copy number within samples. The 
principle of the assay was to use qPCR to amplify a common MCMV sequence 
found in both target MCMV samples and in a reference DNA plasmid of known size, 
quantity and molecule number. Assuming that the plasmid was roughly equivalent to 
a viral genome in the context of a qPCR reaction, the relative abundance of MCMV 
genomes in target samples could compared to the reference plasmid based on Ct 
values from a qPCR standard curve. 
 
 2.5.2 Construction of recombinant plasmid DNA contai ing the MCMV m115 gene 
 
To measure MCMV genome copy number, a reference DNA plasmid containing the 
MCMV m115 (gL) gene was constructed. Cloning the plasmid was originally 
performed by Even Fossum at The University of Edinburgh (for detailed 
methodology see (99)). Briefly, the MCMV m115 (gL) gene (nts 166387-167208 





PCR primers incorporating the attB1 and attB2 recombination sites and cloned into 
the GATEWAY recombinatorial cloning entry vector pDONR207 (Invitrogen, CA, 
USA). The pDONR207 vector plasmid is 5585nt in length, with a region of 2243nt 
removed between positions 413-2656nt. Into this region, the m115 gene (825nts) was 
inserted. 
Total plasmid length  = pDONR207 length – region removed + insert length 
= 5585 – (2656-413) + 825 
= 4167nt  
To generate large quantities of plasmid DNA, the pDONR207-MCMVm115 plasmid 
was re-transformed into competent bacterial cells (DH10D). 1µl of plasmid was 
mixed with 50µl cells, electroporated (2mm, 2.5kv), re-suspensded in lysogeny broth 
(LB) and incubated at 37oC for 60 minutes with shaking at 900rpm. Gentamicin 
(15ug/ml) was added to the bacteria/plasmid/LB soluti n and 100µl was then spread 
across gentamicin agar plates which were incubated ov rnight at 37oC. The next day 
a single colony was selected and placed in a beaker of LB with gentamicin and 
incubated overnight at 37oC shaking at 220rpm. To purify high-quality plasmid DNA 
from the preparation, the PureYield Plasmid Midiprep System (Promega, UK) was 
used according to manufacturer’s instructions. To determine purity of the plasmid, 
2µl of DNA was digested (BamHI) and run on a 1% agarose gel at 120v, 400mA, 
99W for 35min.  
 
The concentration of purified DNA was determined using NanoDrop 
spectrophotometer (NanoDrop Technologies, DE, USA). The plasmid size (4167nt) 
and the DNA concentration (1200ng/µl) were used together to calculate DNA copy 
number per µl in the purified plasmid stock using the online tool at 
http://www.uri.edu/research/gsc/resources/cndna.html  This tool makes a calculation 
based on the assumption that the average weight of a base pair (bp) is 650 Daltons 
meaning that one mole of a bp weighs 650g. It also ssumes that the molecular 
weight of any double stranded DNA template can be estimated by taking the product 
of  its length (in bp) and 650. Using Avogadro's number (6.022x1023 
molecules/mole) the number of molecules of the template per gram can be calculated 
using the following formula: 
 






The number of  molecules per gram can then be to converted to molecules per ng by 
multiplying by 1x109 then multiplying by the amount of template (in ng). For an 
alternative description of this approach see (331). The final number of calculated 
DNA copies in the pDONR207-MCMVm115 purified plasmid stock was 2.6x1011 
molecules per µl.  
 
Once the number of molecules in the reference plasmid DNA had been calculated, 
qPCR could then be used to compare against the quantity of MCMV genomes within 
a sample of interest by amplifying the same 82bp fragment of the m115 (gL) gene. 
To perform qPCR, the purified pDONR207-MCMVm115 plasmid first had to be 
linearized by restriction digest. 2µl plasmid DNA was added to 0.5µl BSA, 5µl 
BamII enzyme, 3µl buffer and 19.5µl RNase-free water. In this digestion the plasmid 
DNA was diluted by a factor of 1/15 (2µl DNA in a 30µl volume). This meant the 
molecule number per µl had to be adjusted accordingly to 2.6x1011 x (1/15) = 
1.7x1010 molecules per µl. After linearization, the plasmid DNA was diluted in a 10-
fold series in RNase-free water from 10-1 to 10-8.  Only dilutions spanning 10-3 to 10-7 
were used in qPCR reactions (corresponding to 1.7x107, 1.7x106 , 1.7x105 , 1.7x104  
and 1.7x103 molecules per µl). qPCR reactions were performed in 96-well PCR 
plates (Applied Biosystems, CA, USA), each in techni al duplicate with 1µl of 
diluted plasmid DNA used per reaction. Total reaction volume was 20µl containing 
10µl 2x Brilliant QRT-PCR Buffer (Stratagene, CA, USA), 8µl RNAse-free water, 
1µl plasmid DNA, and 1µl of Taqman FAM labelled custom probe/primer premix 
20x (Applied BioSystems, CA, USA). Mastermix contaiing 10x buffer, RNAse-free 
water and Taqman primer/probe mix was made up to scale for the appropriate 
number of reactions (wells) required plus an additional 10%. 19µl of mastermix was 
pipetted into each well of the 96-well plate, followed by 1µl of the diluted plasmid 
DNA which was added to the side of individual wells before plates were sealed with 
MicroAmp Optical Caps (Applied Biosystems, CA, USA) and centrifuged at 
1500rpm for 2 minutes. qPCR was performed on the MXPRO3000P cycler 
(Stratagene, CA, USA). In each reaction, the 82bp fragment from the m115 (gL) 
gene was amplified using a custom Taqman gene expression assay (Applied 
BioSystems, CA, USA) with primer sequences 5’ GAGCTCAACGACGAGTTCCT 





used was 10 minutes at 95oC, then 40 cycles of the following; 30 seconds at 95oC, 60 
seconds at 60oC, 30 seconds at 72oC.   
 
The qPCR data from the pDONR207-MCMVm115 reference plasmid dilution series 
was used to generate a standard curve with cycle threshold (Ct) values plotted on the 
y axis against molecule numbers on the x axis (see Figure 2.1), deriving the 
following equation;  Y = -3.444*LOG(X) + 38.95 (Y = Ct value, X= molecule 
number), the equation can then be rearranged to; X=10^((Y-38.95)/-3.444). At this 
stage Ct values derived from any sample could be ins rted into the formula (as Y) to 
calculate molecule number per µl compared to the reference plasmid.  
 
Figure 2.1 Amplification plots (2.1a) and standard curve (2.1b) for the 



















































2.5.3 Measurement of MCMV genome copy number in viral stocks  
 
Once the pDONR207-MCMVm115 reference plasmid and standard curve equation 
had been derived, comparisons against viral DNA extracted from MCMV viral 
stocks could be made. Viral DNA was isolated from 200µl of each viral stock using 
the PureLink Viral RNA/DNA Kit (Invitrogen, CA, USA) as described previously. 
The extracted DNA was eluted in 10µl of RNase-free water, and 2µl of this DNA 
was taken into a 10-fold serial dilution with dilutons spanning 10-1 to 10-5 used in 
qPCR reactions performed alongside the pDONR207m155 plasmid standard. In each 
qPCR reaction the same 82 bp fragment of the m115 (gL) gene was amplified and 
the same reaction volume, mastermix conditions, and primer sequences used as 
described previously for the reference plasmid. qPCR reactions were performed in 
technical duplicate and average Ct values were inserted into the standard curve 
formula to calculate genome copy number at each dilution for the target DNA 
samples. Calculations at the five different dilutions plus standard deviations for 
genomic MCMV DNA were averaged to calculate the final genome copy number 
(for raw data and calculations see Supplementary File 1). Once genome copy number 
per µl of DNA from viral stocks had been calculated, the number of viral genomes 
per PFU in the stocks could also be determined. As each viral DNA sample was 
extracted from 200µl of viral bulk stock and eluted in 10µl of water, the number of 
genomes per µl could be multiplied by 10 to determine the total number of viral 
genomes in the 10µl extracted DNA. This could then b  converted into total genomes 
per samples, genomes per ml of viral stock, and genom s per PFU. 
 
2.5.4 Quantification of intracellular MCMV genome copies in infected cell samples  
 
In addition to DNA extracted from viral stocks, DNA could also be extracted from 
MCMV infected cells and assayed for viral genome copy number. DNA was 
extracted from 24-well plates as previously described with each sample representing 
a single well containing 3.5x105 cells. DNA was eluted in 25µl RNase-free water and 
10µl of this was then taken into a 10-fold serial dlution from 10-1 to 10-8. Dilutions 
spanning 10-2 to 10-7 were used in qPCR reactions in parallel with the 





calculations were made in the same way to calculate the number of MCMV genomes 
per µl of extracted DNA. This figure could then be multiplied by the total volume of 
extracted DNA (25µl) to calculate the total number of MCMV genomes per sample, 
which also corresponded to the number of MCMV genomes per 3.5x105 cells in any 
given sample (for raw data and calculations see Supplementary File 2).  
 
2.6 Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) 
 
To measure the relative abundance of mRNA transcript  between samples, mRNA is 
reverse-transcribed into cDNA before being amplified using qPCR in a process 
termed qRT-PCR. After reverse transcription and PCR amplification, the relative 
quantity of cDNA between samples can be measured by comparative analysis of Ct 
values from PCR amplification plots. This is a stand rd technique for measuring 
relative gene expression. 
 
2.6.1 qRT-PCR detection of cellular transcripts 
 
2.6.1.1 One-Step qRT-PCR using Taqman 96-well format  
 
For qRT-PCR measurement of mRNA transcripts in 96-well format, the Brilliant II 
One-step qRT-PCR kit (Stratagene, CA, USA) and Taqman probe/primer system 
(Applied Biosystems, CA, USA) were used. The reverse-t anscriptase step is 
performed immediately prior to qPCR in the same plate in the same instrument, 
hence a 1-step reaction. The Brilliant II Master Mix contains reverse transcriptase 
(RT) enzyme plus oligonucleotides and magnesium to allow the formation of cDNA 
and the PCR amplification product in the same sample, rather than having to perform 
the RT step separately. Taqman gene expression assays can be bought off-the-shelf 
and contain a mixture of pre-optimized forward/reverse primers and sequence-
specific probes for a target gene of interest.  
 
PCR reaction volumes used in 96-well plates were 19µl per well with the following 
components; 10µl 2x Brilliant QRT-PCR Buffer (Stratagene, CA, USA), 0.1µl 





FAM- labelled custom probe/primer premix 20x (Applied BioSystems, CA, USA) 
and 1µl template RNA per reaction.  Mastermixes containing 10x buffer, RT enzyme 
and Taqman primer/probe mix were made up to scale for the appropriate number of 
reactions (wells) plus an additional 10%. 18µl of mastermix was pipetted manually 
into individual wells of MicroAmp Optical 96-well reaction plates (Applied 
Biosystems, CA, USA). 25ng/µl or 50ng/µl of RNA was used per reaction depending 
on the abundance of the target transcript. 1µl of diluted RNA was added to the side 
of each individual well before plates were sealed with MicroAmp Optical Caps 
(Applied Biosystems, CA, USA) and centrifuged at 1500rpm for 2 minutes. qPCR 
was performed on the MXPRO3000P cycler (Stratagene, CA, USA) with a 30 
minute reverse transcription step at 50oC followed by a hot-start step of 10 minutes at 
95oC, then 40 cycles of the following; 30 seconds at 95oC, 60 seconds at 60oC, 30 
seconds at 72oC. Target transcript levels were normalized to the housekeeping gene 
Glyceraldehyde 3-phosphate dehydrogenase (Gapdh) which is abundantly expressed 
and stable across a range of experimental conditions. Gapdh levels were measured 
using a pre-validated Gapdh Taqman assay (Stratagene, CA, USA) under the same 
PCR conditions. For a list of Taqman primer/probes used see Supplementary File 3. 
 
2.6.1.2 Two-step qRT-PCR using Roche Universal Probe Li rary 384-well format 
 
To scale up the capacity of qPCR analysis, a high-throughput system was developed 
using an automated liquid handling robot, 384-well plate format and 10µl reaction 
volumes. Using the 384-well format, four times more reactions could be performed 
per plate with only half the amount of reagent used p r reaction.  In addition, by 
using an automated liquid-handling robot, pipetting error was significantly reduced. 
The high-throughout qPCR assay was optimized at the Centre for Systems Biology 
Edinburgh (CSBE), University of Edinburgh with the kind technical assistance of 
Lorraine Kerr and Eliane Salvo-Chirnside. The LightCycler480 instrument (Roche, 
Switzerland) was used with the Roche Universal Probe Li rary (UPL) (Roche, 
Switzerland) in 2-step qPCR reactions. The Roche UPL is a library of 165 real-time 
PCR probes with individual sequences that when combined with gene-specific 






id=uplct_030000) 20-24nt primer sequences were designed for target genes of 
interested and matched to corresponding UPL probes. The assays are specifically 
designed to have a melting temperature (Tm) of 59-60oC, G-C content of ~50% and 
amplicon length of ~70-100nt. Primer and probe concentrations were optimized 
manually for each assay by performing standard curves. UPL assays were designed 
for a range of cellular and viral genes (for complete ist of all UPL primer sequences 
and probe numbers see see Supplementary File 4). Forward and reverse primers were 
ordered from Invitrogen, UK and diluted in RNase-fre water to a concentration of 
100nM.  
 
For 2-step UPL qPCR reactions, 1ug of extracted RNA was reverse-transcribed into 
cDNA using the Roche Transcriptor First Strand cDNA Synthesis Kit (Roche, 
Switzerland) as per manufactures instructions. Then in a separate reaction (hence 2-
step qPCR) the cDNA for each sample was diluted 1:5 and run in qPCR reactions. 
Total reaction volumes for 384-well plates were 10µl per well with the following 
components; 5µl LC480 Universal Probes 2x Buffer (Roche, Switzerland), 0.05µl 
Forward Primer (100 µM), 0.05µl Reverse Primer 1 (100 µM), 0.2µl Roche UPL 
Probe (10 µM) (Roche, Switzerland), and 3µl RNAse-fre  water. Mastermixes 
without cDNA were made up for the required number of reactions plus 10% extra. 
9µl of mastermix was pipetted into each well of a 384-well PCR plate (Roche, 
Switzerland) followed by 1µl of diluted cDNA using the Freedom Evo-2 150 liquid 
handling platform (Tecan, Switzerland). Prior to qPCR, plates were covered with 
plastic coating and centrifuged at 1500rpm for 2 minutes. qPCR was performed on 
the LightCycler480 (Roche, Switzerland) with a hot-start of 15 minutes at 95oC, 
followed by 50 cycles of the following; 5 seconds at 95oC, 10 seconds at 60oC, 30 
seconds at 72oC. Relative expression levels were normalized to the cellular 
housekeeping gene beta actin (ActB) which was also measured using UPL probes 








2.6.2 Analysis of qRT-PCR data 
 
Ct values were exported from MXPro software (Stratagene, CA, USA) or Roche 
LC480 software (Roche, Switzerland). For each condition three biological replicate 
samples were used, with averaged Ct values from technical duplicate qPCR 
reactions. This generated three raw data points per condition (three Ct values per 
target gene and three Ct values per reference). Gapdh or ActB were used as reference 
genes. From the Ct values, the relative transcript abundance for each gene of interest 
was calculated using the ∆∆C(T) method (224). This method calculates the ratio of 
Ct values of the gene of interest to the Ct value of a housekeeping gene to give a 
normalised value per sample (see below). The method also incorporates the qPCR 
efficiency of a given probe/primer assay if known.  
Ratio = ( (Efficiencytarget) ^ ∆CTtarget(control-treated) ) /  
( (Efficiencyreference) ^ ∆CTreference(control-treated) ) 
or 
Ratio = (Efft)^(∆CTt)/(Effr)^(∆CTr) 
 
The calculated ratio represents relative fold difference in transcript abundance 
between a control and treated sample. These ratios can be averaged over biological 
replicates to calculate an average fold change between conditions and standard 
deviations. In the case of Taqman probe/primers, PCR efficiency was assumed to be 
2. For UPL probe/primers, PCR efficiency was calculated by prior standard curve 
analysis to be between 1.8-2.2. After the relative abundance ratios including standard 
deviations were calculated, an independent two-sample Student’s t-test could be 










2.7  Microarray gene expression analysis  
 
Microarrays are a commonly used tool for the global measurement of mRNA 
expression based on sequence-specific DNA oligonucleotide probes printed on 
specialized slide surfaces which bind target materil (generally fluorophore-labelled 
cRNA or cDNA). The target material hybridizes to corresponding probe(s) and is 
quantified by fluorescence signal to determine relative abundance of nucleic acid 
sequences in the target.  
 
 
2.7.1 Analysis of viral gene expression using custom MCMV microarrays  
 
2.7.1.1 Design and annotation of custom MCMV array 
 
To measure genome-wide viral transcripts in MCMV, a custom oligonucleotide 
DNA microarray platform was developed. This array was designed, fabricated and 
optimized at the Division of Pathway Medicine, University of Edinburgh, and is 
based on the complete genome sequence of the MCMV Smith strain (299). The array 
consists of 55-mer oligonucleotide probes designed against each of the 170 viral 
open reading frames (ORFs) in the MCMV genome (299). Probes are desinged in 
both sense and antisense orientation for each ORF region. 192 positive control 
probes were also included against 192 mouse genes stably expressed and unchanging 
in NIH 3T3 fibroblasts during MCMV infection (unpublished data). 97 negative 
control probes were also designed against yeast sequences with no homology to the 
mouse or MCMV genomes. Positive and negative control probes were used for 
normalization purposes and to determine thresholds of etection for target probe 
signals. Probe sequences were originally designed by José J García-Ramírez, 
University of Edinburgh.  ORFs, strand, position, length, MW, HCMV homologue 
name and annotations were taken from Rawlinson et al. (299). Additional 
annotations for MCMV ORFs were taken from wherever possible in the literature 
and referenced (for complete list of probe sequences and annotations see 








2.7.1.2 Fabrication, printing, hybridization and scanning of MCMV microarray* 
 
*This work was performed by Alan Ross, Division of Pathway Medicine, University 
of Edinburgh, UK. 
 
Custom MCMV 55mers oligonucleotides (synthesized by Invitrogen, UK) were 
diluted in 50% glycerol, 0.01% triton to a concentration of 60uM using a RapidPlate 
liquid handler (Qiagen, Hilden, Germany). Microarrays were inkjet printed using a 
SuperMarathon Aj120 (Arrayjet, UK) onto Corning GAPII, aminosilane coated glass 
slides. Six identical sub-arrays were printed per slide and arrays were baked for 2 
hours at 70oC on a hotplate and then UV crosslinked at 300kJ. Slides were blocked 
using preheated 1% BSA, 5% SSC, 1% SDS for 45 minutes at 42oC, washed and 
spun dry. Print QC was tested using cyanine 3 labelled random 9-mers which were 
hybridised to a set of test arrays. The target RNA was labelled using the Agilent low 
input fluorescent linear amplification protocol (Agilent, CA, USA). A primer 
containing poly dT and T7 polymerase promoter was anne led to the polyA+ RNA. 
Reverse transcriptase was added to synthesize the first and second strands of cDNA 
from which cRNA was synthesized using T7 RNA polymeras  which simultaneously 
incorporates cyanine 5. For hybridization 3ug of each of the Cyanine 5 labelled 
target cRNAs was hybridised to microarray slides for 18 hours at 60oC in a rotating 
oven, washed in Agilent (CA, USA) wash solutions (1) 6% SSPE , 0.005% N-
lauroylsarcosine (2) 0.06% SSPE , and 0.01% N-lauroylsarcosine. Arrays were 
scanned using an excitation wavelength of 630 nm and Cyanine 5 detection filter in 
an Agilent (CA, USA) microarray scanner (G2505B).  Quantarray version 3.1 
(Packard BioChip Technologies, MA, USA) was used to feature extract the data 
from images. Each sample was hybridized to one slid containing six identical sub-
arrays with positive control, negative control and target MCMV probes printed in 
triplicate per array.  
 
2.7.1.3 MCMV microarray analysis, statistics and bioinformatics 
 
After background subtraction (subtraction of pre-hybridization signals), data from 
each set of triplicate probes was median-summarized to form raw data points. As 





per slide. Raw data was quality controlled and normalized between samples based on 
a subset of positive control probes highly correlated across the data set (Pearson 
r<0.90). On/off calls for normalized probe intensities were determined using receiver 
operating characteristic (ROC) set at 70% sensitivity (31) where the gold standard 
per condition is defined by the sets of known positive and negative controls. 
Statistical testing by empirical Bayes (336) was applied between mock and infected 
groups to identify the most highly significant MCMV ORFs. Technical replicates 
were included in the model as consensus correlation estimates. Statistical analysis 
was performed by Thorsten Forster, Division of Pathw y Medicine, University of 
Edinburgh, UK. 
 
2.7.2 Analysis of host gene expression using Affymetrix whole-genome microarrays 
  
2.7.2.1  Affymetrix Mouse Exon 1.0ST microarray (16-sample dataset) 
 
The Affymetrix Mouse Exon 1.0ST microarray provides full coverage of the mouse 
coding transcriptome and contains multiple probes for each mouse gene designed 
across the entire length of transcripts, without any 3’ bias. The Affymetrix Mouse 
Exon 1.0ST microarray platform was used to analyze global gene expression in 16 
samples from infected wild-type C57BL/6 BMDMs. The G neChip Whole 
Transcript (WT) Sense Target Labeling Assay protocol (Affymetrix, CA, USA) was 
followed according to manufacturer’s instructions, and modified only by using a 
starting RNA input of 300ng per sample.  Briefly, the four-day protocol consists of 
1st cycle cDNA synthesis, 1st cycle cRNA in-vitro transcription and amplification, 
clean-up of antisense cRNA, 2nd cycle cDNA synthesis, hydrolysis of cRNA, cleanup 
of sense strand DNA, fragmentation, terminal labelling, overnight hybridization, 
washing, scanning, and feature extraction.  For detailed methodology see GeneChip 








2.7.2.2  Affymetrix microarray data analysis (16-sample dataset) 
 
Quality control of Affymetrix Mouse Exon 1.0ST microarray data was performed 
using Affymetrix Expression Console (Affymetrix, CA, USA) following standard 
procedures. All arrays passed the quality control metrics and raw data was imported 
into Partek Genomics Suite (MO, USA) for downstream analysis. All probesets from 
the 'core' set of exons (188,596 probes) were imported and normalized using the 
gcRMA algorithm. Transcript-level summarization was performed using the mean of 
all probesets across each transcript based on the “cor ” set of exons to give gene-
level expression data for 16,761 mouse genes. Normalized expression data was 
visualized using boxplots, Principle Component Analysis (PCA) and sample 
histograms. An expression level filter was applied to exclude any genes with a 
maximum normalized antilog signal intensity below 100 over all arrays. This 
reduced the dataset to 7,890 genes expressed to a high confidence level. The filtered 
data was used to identify genes changing significantly over the time course either 
within or between conditions by performing a statisical analysis based on 
EDGE(213) (http://www.genomine.org/edge/0) with 500 iterations. Fold changes 
between conditions at each time point were also determined by ANOVA testing. For 
clustering analysis, identifiers and annotation (nodeclass) columns were loaded into 
BioLayout Express3D (103) and an all-versus-all Pearson correlation matrix was 
calculated based on the expression profile of all filtered probesets. Pearson 
correlations greater than r = 0.9 were stored and network graphs were constructed 
using this threshold. Graphs consisted of nodes repres nting transcripts connected by 
edges representing expression correlations above Pearson>0.9. The MCL algorithm 
was then used to cluster the data into network graphs ccording to the connectivity 
between nodes as defined by a mathematical bootstrapping procedure. Network 
graphs were explored for clusters which changed markedly over time or were altered 








2.7.2.3  Affymetrix Mouse Gene 1.0ST Microarray (72-sample dataset) 
 
The Affymetrix Mouse Gene 1.0ST microarray consists of a sub-set of probes from 
the Exon 1.0ST Array and also provides full-length transcript coverage for all mouse 
genes. The Mouse Gene 1.0ST microarray was used to analyze global gene 
expression in 72 samples from infected and immune-stimulated BMDMs from wild 
type, Ifnb1-/- and Ifnar-/- C57/BL6 mice. The processing and data analysis 
procedures for the Mouse Gene 1.0ST array are similar to the Exon 1.0ST array, 
however for this large study the array processing and hybridization was out-sourced 
to a contract research company (Gen-Probe Life Sciences Ltd, UK). An updated 
cDNA synthesis and labelling protocol was performed by Gen-Probe based on the 
Ambion WT Expression Kit (Ambion, UK) (for details see 
http://www.ambion.com/techlib/prot/fm_4411973.pdf).   
 
2.7.2.4 Affymetrix microarray data analysis (72-sample dataset) 
 
Quality control, normalization and importing of microarray data was performed as 
previously described. Normalized data was filtered to include only genes with a 
maximum expression value of above 150 across the data set (19,118 probes) to 
identify only genes expressed to a high confidence lev l. All control probes and un-
annotated probes were removed from the analysis reducing the dataset to 13,244 
probes. The 13,244 remaining probes were imported into BioLayout Express3D and 
arranged in a network graph using the threshold of Pearson>0.9.  3,517 probes 
formed a graph as this level. The data was then clustered at MCL=1.5 with a 
minimum cluster number of n=15. This arranged the data into 24 clusters containing 
a total of 2,325 probes which were used for subsequent analysis. 
 
2.7.3 Functional annotation of Affymetrix microarray data 
 
2.7.3.1 Database for Annotation, Visualization, andIntegrated Discovery (DAVID). 
 
The DAVID online annotation tool (79) takes annotati n classes from various 
different databases (e.g. NCBI, PIR, SWISS-PROT, GOOMIM, PubMed, KEGG, 





over-representation of annotation terms within an input gene list. Over-representation 
or enrichment statistics are determined using a modified Fisher Exact test with P-
values ranging from 0 to 1, indicating the likelihood of enrichment compared to that 
occurring by chance alone. If the Fisher Exact test d tects perfect enrichment of the 
gene list with a given term, the P-value will equal 0. Annotation categories with 
bonferroni-corrected p< 0.005 were considered significantly enriched. 
 
2.7.3.2 Ingenuity Pathway Analysis (IPA) 
 
IPA is a commercial software tool and database incorporating molecular interaction 
data from experiments and from the literature. Using a  input genelist, IPA will find 
associations, relationships and interactions between input genes, or with other genes 
as secondary interaction partners, and build networks f highly connected genes with 
related function. IPA will also incorporate chemical interaction data, cellular 
phenotypes, gene ontologies and disease processes to annotate an input genelist.  
 
2.7.3.3 Innate DB analysis 
 
InnateDB is a database of molecular interactions design d specifically to facilitate 
systems level analysis of the innate immune response in human and mice(229). It is a 
manually-curated database of genes, proteins, interactions, pathways and signalling 
responses involved in the mammalian innate immune response. The interactions are 
from publicly available sources and manually curated with contextual annotations 
including reference publications, interaction detection methods, and cell type 
information. InnateDB can either be mined as a knowledgebase or batch-searched to 
return all interactions or pathways associated witha list of genes. Interaction 
networks can also be visualized in the Cerebral java plugin for Cytoscape 
visualization software. InanteDB can also be used to statistically test for over-
representation of pathway or annotation terms within an input genelist based on an 






2.8  Protein methods 
 
2.8.1 Whole-cell lysis  
 
For protein extraction, cells were seeded in 6-well plates. Before lysis, cells were 
washed twice with ice cold PBS and then lysed directly in the wells by adding 100µl 
of NP-40 lysis buffer containing phosphatase inhibitors (Sigma, UK). Cells were 
scraped in the lysis buffer with a plastic scraper, transferred to sterile 1.5ml tubes and 
incubated on ice for 20-30 minutes. After lysis, cells were centrifuged at max speed 
at 4˚C for 10 minutes to remove cell debris and supernatants were transferred to fresh 
1.5ml tubes and stored at -80ºC. 
 
2.8.2 Measurement of whole-cell protein concentration 
 
Total protein concentration was determined using the Micro BCA protein assay 
(Pierce, UK) according to manufacturer’s instructions. Along with standards, 20µl of 
each target sample was loaded into a 96- well plate in duplicate wells. Protein 
concentration per sample was obtained via measurement of absorbance at 562 nm on 
the POLARstar OPTIMA Multifunction Microplate Reader (BMG LabTech, UK). 
 
2.8.3 Western blotting* 
 
* Western blots were performed by Christopher Millward under the supervision of 
Paul Lacaze at the Division of Pathway Medicine, University of Edinburgh, UK 
 
After determining protein concentration, equal amounts of protein for each sample 
were mixed with 2X Laemmli Sample Buffer, containing 10% of DTT and loaded 
onto 10% SDS-PAGE gels with 6µl of molecular weight marker (Prestained Protein 
Marker Broad Range, New England Bioloabs, UK). Gels were run for 45 minutes at 
200 V using a BioRad PowerPac 200 Power Supply. Filter papers (BioRad, UK) 
were soaked in transfer buffer along with fiber pads nd polyvinylidene difluoride 
(PVDF) membranes were cut to the dimension of the gel (maximum size 7.5 cm x 10 
cm). Membranes were soaked in methanol for 10 seconds, then washed in distilled 
water and soaked in transfer buffer. After electrophoresis, the cassette was 





membrane. The gel sandwich was placed in the TransBlot module with the cooling 
unit and cold water. The tank was filled with transfer buffer and run for 1 hour at 
100V/constant. When transfer was finished, the cassette was disassembled and the 
PVDF membranes were blocked with 20 ml of blocking buffer at room temperature 
with gentle shaking. The membrane was washed three im s for 15 minutes in 
washing buffer. The primary antibody was diluted into primary antibody dilution 
buffer and the membrane was incubated with the primary antibody overnight at 4oC 
with gentle rocking. After primary antibody incubation membranes were washed and 
then incubated with the secondary antibody, diluted in blocking solution for one hour 
at room temperature. The membrane was washed again nd laid onto a mixture of 
detection reagents (ECL Plus Western Blotting Detection Reagents, Amersham 
Biosciences, UK) for 5 minutes. Membrane exposure was performed using the 
VersaDoc imaging system 4000. MCMV antibodies CROMA101 and CROMA103 
were provided by Prof. Stipan Jonjinc (Faculty of Medicine Rijeka University, 
Croatia) 
 
2.8.4 Enzyme-linked immunosorbent assay (ELISA) 
 
Cytokines in the supernatant of tissue culture samples were measured using ELISA. 
TNF levels were measured using the mouse TNF DuoSet ELISA Development kit 
(R&D Systems, Europe) according to manufacturer’s instructions. This kit is 
designed to detect TNF in the range of 32.5-2000 pg/ml. IFNβ levels were measured 
using the Mouse Interferon Beta ELISA Kit v1.2 (PBL iomedical Laboratories, NJ, 
USA) according to manufacturer’s instructions with an assay Range of 15.6-1000 
pg/ml. Briefly, ELISAs were performed in 96-well plates coated with capture 
antibody incubated overnight, washed and blocked th following day. A series of 
standards prepared after blocking were added with 100µl of each sample to the plate. 
Standards and samples were left for one hour at room temperature, after which the 
plate was washed three times and incubated with the detection antibody. The plate is 
washed again before Streptavidin-horseradish peroxidase (HRP)-conjugated solution 
was added at the recommended working concentration. The plate was incubated in 
the dark at room temperature for 20 minutes, then washed and 100µl of substrate 





stop solution was added. Protein concentration was determined by reading 
absorbance at 450 nm using the POLARstar OPTIMA Multifunction Microplate 
Reader (BMG LabTech, UK). 
 
2.8.5 Multiplex detection of cytokines using Luminex assay 
 
To detect multiple cytokines in BMDM tissue culture supernatants, the Bio-Plex 
system (BioRad, USA) was used according to manufactrer’s instructions (for 
overview see Figure 2.2 and detailed protocol see http://www.bio-
rad.com/webroot/web/pdf/lsr/literature/4110004F.pdf). Briefly, the basic principle is 
based on sandwich immunoassay technique where antibody-coated beads are 
incubated with samples and standards, then washed and incubated further with 
detection antibodies. Streptavidin-PE is then added before beads are resuspended and 
measured for fluorescence signal using a lazer-based in trument. Protein quantities 
(in pg/ml) can then be calculated based on comparison to the internal standards using 
the Bioplex software (BioRad, USA). The mouse cytokines measured were IL-6, IL-






Figure 2.2 - Experimental workflow for multiplex bead-based Bioplex ELISA 





2.9 Sanger sequencing  
 
For DNA sequencing of the MCMV MIEP region for the MCMVdie3 strain, viral 
DNA was extracted from 200µl of the MCMVdie3 viral stock as previously 
described. The entire MCMVdie3 MIEP region (NC_004065, 182,796-184,368C, 
1572bps) was then amplified by PCR in three separate reactions using the Roche 
Expand Superscript System (Roche, Switzerland) using the following primer 
sequences (forward 5’ TCCGATGCGCTTCAGTAGCC 3’ and reverse 5’ 
GCAAGCACACTGAGTCAAATGG 3’). The three amplified PCR products were 
then sent to a sequencing service facility (The Gene Pool, University of Edinburgh, 
UK) and sequenced by capillary analysis using the Sanger sequencing method on the 
ABI3730 instrument (Applied Biosystems, CA, USA). The MIEP region was 
sequences in two separate contigs with the following two sets of primers; 
Contig 1 - forward 5’TCCGATGCGCTTCAGTAGCC 3’ and reverse 
5’CCGAGCCCAATGCAACCTTACC 
Contig 2 - forward 5’ CCCTATTGACTCACCCACATTG 3’ and reverse 5’ 
GCAAGCACACTGAGTCAAATGG 3’. 













The main question to be addressed in the first results chapter will be whether the 
MCMV deletion mutant MCMVdie3 can be used as a reliable control reagent to 
represent non-productive viral infection. Specifically, it will be tested whether the 
MCMVdie3 mutant strain is a) replication deficient, b) capable of viral entry, c) 
transcriptionally inactive, and d) incapable of promoting de novo viral protein 
synthesis.  The characterization work will allow sub equent experiments in 
macrophages to be designed whereby the host response to productive and non-
productive viral infection can be measured comparatively by infecting in parallel 
with MCMV and MCMVdie3. 
 
At the outset of this work, the MCMVdie3 mutant had been characterized for the 
purpose of studying ie3 function (12). This involved growth analysis and limited 
analysis of viral gene expression measuring MCMV genes ie1, M54, M55 and M115, 
with detectable expression limited to the ie1 gene(12). The MCMVdie3 virus had 
also been used in an investigation of ie3 in G1 and G2 cell cycle arrest in infected 
cells(379). The MCMVdie3 strain, however, had never b en previously used as a 
control reagent to represent non-productive infection. For this reason, the mutant 
required more extensive phenotypic characterization, especially regarding its 
transcriptional status. This chapter outlines the functional and phenotypic 
characterization undertaken to determine if MCMVdie3 was indeed a replication-
deficient, transcriptionally inert and non-productive virus capable of representing a 







3.1 MCMVdie3 is a replication-deficient virus in fibroblasts and BMDMs 
 
To corroborate previously published reports for the att nuated growth phenotype of 
MCMVdie3, as well as assess the growth characteristics of revertant 
(MCMVdie3rev), wild-type (MCMV) and ie1 deletion mutant (MCMVdie1) viruses, 
growth curve analyses were performed for each virus in NIH 3T3 fibroblasts and in 
the complementing cell line (NIH 3T3-Bam25).  A multi-step growth curve at a low 
multiplicity of infection (MOI) of 0.05 PFU/cell, and a single-step growth curve at a 
high MOI of 2 PFU/cell were conducted for each virus. One PFU (plaque forming 
unit) corresponds to one infectious unit as determined by titration of virus by plaque 
assay on NIH 3T3 cells (see Methods).  
 
Consistent with previous reports (12, 113, 232), the MCMVdie1 and MCMVie3rev 
strains grew identically to the parental MCMV strain in cell culture, resulting in 
productive infection and reaching titres of around 1x106 PFU/ml after four days (see 
Figure 3.1a). Also consistent with previous reports(12), no viral growth for the 
MCMVdie3 mutant was detectable in NIH 3T3. The growth curves were repeated at 
the same MOIs in the complementing cell line (NIH 3T3-Bam25) where IE3 is 
expressed in trans (Figure 3.1b), and growth of the MCMVdie3 was recovered to 
wild type levels. This indicated the MCMVdie3 virus is still functional if the IE3 





























Multi-step - Low MOI Single-step - High MOI
Figure 3.1 - MCMVdie3 is a replication-deficient virus in fibroblasts (NIH 3T3) 
but viral growth is recovered to wild-type levels in the complementing cell line 
(NIH 3T3-Bam25) NIH 3T3 (3.1a and 3.1b) or NIH 3T3-Bam25 (3.1c and 3.1d) 
cells were infected at an MOI of 0.05 PFU/cell (3.1a and 3.1c) or MOI of 2 PFU/cell 
(3.1b and 3.1d) with MCMV, MCMVdie1, MCMVdie3rev and MCMVdie3. At 
indicated days post infection (dpi), supernatants from infected cultures were 
harvested and titered on NIH 3T3-Bam25 monolayers. Error bars indicate standard 
deviation from three separate cultures.  Red indicates data from NIH 3T3 and green 
indicates data from the NIH 3T3-Bam25 complementing cell line. The astericks 




















Next, to evaluate viral replication of the MCMVdie3 strain in macrophages, growth 









(BMDMs) at low and high MOIs (Figure 3.2). Again, no viral growth was detected 
for the MCMVdie3 mutant at either MOI. 
 
Figure 3.2 MCMVdie3 is a replication-deficient virus in BMDMs. BMDMs were 
infected at MOI of 0.1 and 1 PFU/cell with MCMV and MCMVdie3. Every 24 
hours, supernatants from infected cultures were harvested and titered on NIH 3T3-
Bam25 monolayers. CSF-1 was present in the BMDM media at all times during the 
infection. Error bars indicate standard deviation from three cultures. The asterick 














3.2 Molecular characterization of the MCMVdie3 mutant  
 
3.2.1 MCMVdie3 is capable of viral entry but not viral replication in BMDMs 
 
Due to the limited sensitivity of the plaque assay, it was still possible that 
MCMVdie3 could be replicating at low levels below the threshold of detection. In 
addition, and perhaps more importantly, the plaque assay did not indicate whether 
MCMVdie3 and MCMV particles were actually entering host cells in an equivalent 
manner. To test these factors, a more sensitive assay based on qPCR detection of 
intracellular MCMV genomes was developed (for details see Methods section 2.5.1). 






cells at different stages post-infection, relative o plasmid reference DNA. Cells were 
washed free of supernatant, viral DNA was extracted and viral genome propagation 
in infected cells over the course of infection was measured (Figure 3.3). A possible 
caveat of this approach is that residual viral particles may still be bound to cells prior 
to DNA extraction and qPCR analysis at early time points. To avoid this, cells were 
washed thoroughly twice with PBS after the adsorptin period, however the retention 
of viral particles on the cell surface can not be excluded. 
 
Figure 3.3 No propagation of MCMV genomes occurs during MCMVdie3 
infection of BMDMs. Confluent BMDM monolayers were infected in 24-well plates 
at day 7 at MOI of 1 PFU/cell with parental MCMV, MCMVdie3 and 
MCMVdie3rev viruses. DNA was harvested from triplicate cultures at 2, 6, 24, 48 
and 72 hpi and qPCR amplification of the m115 (gL) ene from genomic MCMV 
DNA was measured against reference plasmid DNA to calculate MCMV genome 
copy number per sample. Each sample represents 3.5x105 cells. Error bars indicate 
standard deviation from three samples. The level of detection (dotted line) represents 

























The results of the qPCR assay show comparable numbers of MCMV and 
MCMVdie3 genomes detectable in BMDMs at 2hpi, however they are low compared 
to the initial MOI (roughly equating to only one viral genome copy per cell at 
3.5x105 cells per sample). This suggests viral entry occurs in an equivalent manner in 
both conditions at MOI of 1, but that only few viral genomes enter host cells. This 
suggests the level of infection at MOI of 1 in BMDM cultures is particularly low at 
the initial stages of infection.  
 
Consistent with the growth curve analysis, there was no synthesis of MCMVdie3 
genomes during the 72 hours of infection in BMDMs, further indicating MCMVdie3 
is a replication-deficient virus. As the infection progresses over 24, 48 and 72 hpi, 
the number of viral genomes propagated in the parent l a d revertant MCMV 
infections rises exponentially, indicating productive viral infection.  
 
3.2.2 MCMV genome/PFU ratios are equivalent between viral stocks 
 
To determine the number of viral particles (genomes) d livered per PFU for the 
different viruses, the qPCR assay was used to measure viral genomes in DNA 
extracted from MCMV and MCMVdie3 virus stocks. This provided an indication of 
how many viral genomes were delivered per PFU in MCMV and MCMVdie3 
infections, and whether propagating MCMVdie3 on a complementing cell line had 
drastically altered the number of non-infectious or defective viral particles produced 
per PFU. To conduct the analysis, viral DNA was extracted from 200µl of each viral 
stock and subjected to qPCR alongside the reference plasmid DNA (for details see 
Methods 2.5.1). The result shows the number of viral genome copies developed per 
PFU for the MCMVdie3 virus was not statistically different from the number 
developed by the wild-type MCMV strain (Student t-test pvalue=0.26) (Table 3.1). 
This ensured the amount of viral genomes delivered per PFU for subsequent 
experiments using MCMV and MCMVdie3 would be equivalent, despite the low 
level of infection. The MCMVdie1 and MCMVdie3rev viruses were also measured 






Table 3.1. Viral titres and viral genome/PFU ratios are not statistically different 
between four MCMV strains. Viral DNA was extracted from 200µl of viral stock 
from each strain and the number of MCMV genome copies er ml was measured 
using qPCR (for details see Methods section 2.5.1). Using the number of MCMV 
genome copies per ml for each virus, combined with the viral titre (PFU/ml), the 
number of MCMV genomes per PFU could also be calculted. The difference 
between MCMV genomes per PFU in MCMV and MCMVdie3 stocks was not 
statistically significant (* Students t-test >0.05). 
 
 Titre (PFU/ml)  
Genomes per ml in 
viral stocks 
Genomes per PFU in 
viral stocks 
MCMV  6.8 x 106 2.2±0.3 x 107 166.2 ± 3.4* 
MCMVdie1  3.0 x 106 1.7±0.8  x 107 283.3 ± 137.9 
MCMVdiie2  1.3 x 107 4.4±0.8  x 107 146.7 ± 18.8 
MCMVdie3  1.1 x 107 4.0±0.2  x 107 183.2 ± 2.4* 
 
These calculations indicate between ~150-200 viral genomes per PFU in the MCMV 
and MCMVdie3 virus stocks. This means, in theory, that at least 100 viral genomes 
should be delivered per cell in BMDM infections at MOI of 1 (according to these 
calculations).  In the previous qPCR analysis of intracellular viral DNA (Figure 3.3) 
however, only ~1 viral genome was detectable per cell at 2hpi using MOI of 1. This 
suggests only ~1/100 viral particles actually enter BMDMs and the initial level of 
infection in BMDM cultures at MOI of 1 is particular y low (actual MOI of ~0.01 
PFU/cell).  
 
To obtain a better indication of the level of infection in BMDM cultures at MOI of 1 
using an alternate technique, data from BMDMs infected with a MCMV-GFP 
reporter virus was used. The MCMV-GFP virus has a GFP reporter under the control 
of the major immediate early promoter which can be us d to identify GFP-positive 
cells(49). Flow cytometry analysis of MCMV-GFP infect d BMDMs at MOI of 1 
PFU/cell indicates that only around 12% of cells are GFP-positive (expressing viral 
genes) at 6hpi (1214 ± 652 GFP-positive cells per 10,000 over six experiments). This 
data was generated by Muhamad Fairus Noor Hassim (University of Edinburgh, 





delivered MCMV particles successfully enter cells and establish productive infection 
in BMDMs by 6hpi at MOI of 1.  Some cells may become abortively (non-
productively) infected despite receiving viral particles, and some cells may establish 
a state of latent infection in BMDM cultures, however the data indicates a low level 
of initial infection at MOI of 1 PFU/cell, consistent with the qPCR analysis. 
 
3.3 MCMV viral gene expression does not occur beyond the IE region in 
MCMVdie3  
 
3.3.1 Global detection of MCMV transcripts by custom MCMV microarray  
 
Experiments to this stage show MCMVdie3 to be a replication-deficient virus, 
however, it remained uncertain whether the mutant virus was still capable of 
transcribing viral genes at higher levels of infection. Previous reports found ie1 
expression from the MCMVdie3 template but reported no viral gene expression 
beyond the IE region in fibroblasts(12).  To furthe evaluate whether MCMVdie3 
was a transcriptionally inert virus beyond the IE region, a custom DNA microarray 
was used to measure global MCMV gene expression from all 170 MCMV open 
reading frames (ORFs) in infected NIH 3T3 fibroblasts. NIH 3T3 cells were used for 
this analysis rather than BMDMs to achieve higher leve s of infection and improve 
microarray signals.  
 
NIH 3T3 fibroblasts were infected in parallel at MOI of 1 PFU/cell with MCMV, 
MCMVdie3, MCMVdie3rev and MCMVdie1, and viral gene expression was 
profiled using a custom MCMV microarray. The MCMV microarray contains 55mer 
oligonucleotide probes designed against all 3’ coding ORFs regions from the MCMV 
genome(299). The array was designed, developed and optimized at the Division of 
Pathway Medicine, University of Edinburgh. For details on array design, fabrication, 
and printing see Methods section 2.7.1.2. 
 
Total RNA was harvested for microarray analysis at 0.5, 6.5 and 48hpi, with RNA 
from mock-infected cells. The i 1 deletion mutant (MCMVdie1) was included in this 





126, 249) and a modulator of host factors (267, 351) making its viral transcriptional 
profile of general interest. Figure 3.4 shows the comparative activation of viral 
transcriptomes of the four MCMV strains, and indicates a complete lack of 




Figure 3.4 - Viral gene expression does not occur beyond the IE region in 
MCMVdie3.  NIH 3T3 fibroblasts were infected in parallel at MOI of 1 PFU/cell 
with MCMV, MCMVdie3* , MCMVdie3rev and MCMVdie1. Total RNA was 
harvested for microarray analysis at 0.5, 6.5 and 48hpi, along with RNA from mock-
infected cells. 3.4a Volcano plots compare microarray signals from mock and
infected samples using p-value (y-axis) and fold change (x-axis) comparisons 
derived from empirical Bayes testing with two biological replicates per group. 3 4b 
Hierarchical clustering of significantly expressed MCMV probes with each row 
representing a single probe per-gene normalized to its mean value across the data set 
to show relative expression with yellow indicating i creased expression and blue 
decreased expression relative to the mean. Genes are clustered based on the 
similarity of their expression profile across the dataset, with similar genes being 
connected at the hierarchical tree on the left. Data in columns represents mean values 

























The MCMV microarray gene expression data is consistent with MCMVdie3 being a 
transcriptionally inactive virus incapable of transcribing viral genes beyond the IE 
region. Low levels of ie1 and ie2 transcripts were detected in MCMVdie3-infected 
cells, but were not expressed significantly above mock levels (empirical Bayes 
p>0.05). The transcriptomes of MCMVdie1 and MCMVdie3r v were expressed with 
similar dynamics to the parental MCMV strain over the 48-hour period. At the end of 
the infection (48hpi), there were equivalent numbers (within 10%) of MCMV probes 
detectable from MCMVdie1 (103 ORFs), MCMVdie3rev (114 ORFs) and the wild-
type MCMV strain (113 ORFs). The level of similarity n expression profiles shared 
between the MCMVdie1, MCMVdie3rev and wild-type MCMV strains suggests that 
ie1 and ie2 have a redundant or negligible transcriptional regulatory role in 
controlling downstream MCMV gene expression during f broblast infection. 
MCMV MCMVdie1 MCMVdiie2 MCMVdie3 Mock
b)
















































Hierarchical clustering (Figure 3.4b) further indicates few, if any, differences in the 
global gene expression profiles of MCMVdie1 and MCMVdie3rev compared to the 
parental strain, and again shows no MCMV transcripts detectable from the 
MCMVdie3 strain. 
 
Note: The MCMV microarray gene expression analysis revealed a number of 
interesting and novel observations regarding the gene expression programme of 
MCMV, including the presence of non-coding and antisense transcripts. These 
results have been published (Journal of Virology, in press) and can be found in 
Appendix I.  
 
3.3.2 Immediate early gene expression is attenuated in MCMVdie3  
 
Previous studies using MCMVdie3 report equivalent i 1 expression levels in MCMV 
and MCMVdie3 during fibroblast infection(12). This is consistent with the current 
knowledge of the MCMV major immediate early region, whereby ie1 and ie2 genes 
are transcribed independently of ie3 from the same promoter(49, 249). For this 
reason, the ie1 and ie2 transcripts should be expressed by the MCMVdie3 virus. In 
the MCMV microarray experiments however, ie1 and ie2 were considerably lower in 
MCMVdie3-infected cells compared to wild-type MCMV. To further investigate 
this, and to measure the expression of ie1 and ie3 with increased sensitivity, qRT-
PCR analysis was used to measure ie1 and ie3 levels in MCMV and MCMVdie3 
infected NIH 3T3 cells at immediate early time points; -0.5hpi (within the absorption 
period), 0.5hpi and 1.5hpi (see Figure 3.5a).  
 
Figure 3.5 - Immediate early gene 1 expression is attenuated in MCMVdie3 
Triplicate cultures of NIH 3T3 cells were infected at MOI of 1 PFU/cell with 
MCMV and MCMVdie3. Transcripts levels were measured by qRT-PCR for ie3 (i) 
and ie1 (ii ) at -0.5hpi (ie. within the absorption period), 0.5hpi and 2.5hpi. Fold 
induction is shown on the Y axis relative to the parental MCMV strain. The level of 
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The qRT-PCR analysis indicated no ie3 expression was detectable from the deleted 
ie3 locus in MCMVdie3 (Figure 3.5 a i), and also revealed a considerably lower level 
of ie1 transcription in the MCMVdie3 strain compared to wild-type MCMV (Figure 
3.5 a ii). The reduction was 1-2 orders of magnitude lower (Figure 3.5a), however 
ie1 transcripts were still detectable at very low levels (above mock). Although this 
was encouraging in the sense that MCMVdie3 was more transcriptionally inert than 
previously reported, the result was not consistent with previously published studies 
and warranted further investigation.  
 
In order to test whether the reduced i 1 levels in MCMVdie3 were due to the lack of 
a de novo MCMV protein, the infections were repeated in the pr sence of 50ug/ml 
cyclohexmide, a chemical inhibitor of protein synthesis. This would block viral 
protein synthesis in the wild-type MCMV infection ad determine whether the 
reduction in IE transcript levels in the MCMVdie3 infection had any link to de novo 
IE3 protein synthesis (IE3 had previously been repot d to regulate the MCMV 
MIEP promoter(12)).  
 
Figure 3.6 - Immediate early gene 1 expression is attenuated in MCMVdie3 in 
both the presence and absence of cycloheximide Triplicate cultures of NIH 3T3 
cells were infected at MOI 1 PFU/cell with MCMV and MCMVdie3 in the presence 










































































by qRT-PCR for ie3 (a) and ie1 (b) at 2.5hpi (i) and 15hpi (ii ). Fold induction is 
shown in log scale relative to parental MCMV strain in the absence of  CHX. The 






















In the presence of cycloheximide, the ie1 transcript levels from MCMVdie3 
compared to the parental strain were still attenuated by over two orders of magnitude 
at both 2.5hpi and 15hpi (Figure 3.6 b). The ie1 gene was however, still expressed in 
MCMVdie3 (Figure 3.6 b ii), but to significantly attenuated levels.  This result 
indicated attenuated ie1 gene expression in MCMVdei3 was not due to factors 
relating to viral protein function, and ruled out any positive auto-regulation by the 
IE3 protein.  At this stage, it appeared the attenuated MCMVdie3 ie1 gene 





MCMVdie3 strain, possibly within the MIEP regulatory region. This mutation may 
have been masked by the IE3 protein provided in tra s in the complementing cell 
line in which the MCMVdie3 strain was grown.  
 
3.4 Sequencing of the MCMVdie3 Major Immediate Early Promoter region 
 
The reduced levels of ie1 transcripts from MCMVdie3 in the presence of 
cycloheximide gave reason to believe the MCMVdie3 enhancer region may be 
mutated beyond the deleted ie3 region, possibly by a secondary site mutation within 
the MIEP causing attenuated ie1 expression. In order to test this, and to determine if 
any major aberrations had occurred in the MCMVdie3 MIEP region during passage 
in a complementing cell line, the MIEP region (NC_004 65, 182,796-184,368C, 
1572bps) from MCMVdie3 was amplified by PCR and sequenced using the Sanger 
method (for details see Methods). The resulting sequence was aligned against the 
reference MCMV MIEP sequence from the parental MCMV strain (299). The 
alignment showed no major deletions or rearrangements within the MCMVdie3 
MIEP region at the level of 70% identity (Figure 3.7), however the sequence quality 
was poor and not sensitive enough to detect changes at the single base-pair level.  
 
 
Figure 3.7 - Sequence alignment map of the MCMVdie3 MIEP region. The 
MCMV MIEP region from the MCMVdie3 strain (NC_004065, 182,796-184,368C, 
1572bps) was amplified by PCR in triplicate reactions and sequenced using the 
Sanger method. To cover the 1572 bp region, two contigs were sequenced, Region 
1(a); 182,796-183,923 and Region 2 (b); 183,743-184,368. The sequences were 
aligned against a reference MCMV MIEP sequence from the parental strain (299). 
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The results of the sequencing analysis suggest the MCMVdie3 MIEP region had not 
been affected by any major mutations at the level of 70% identity. The 
transcriptional silencing of the i 1 gene in MCMVdie3 must therefore have been due 
to another factor, possibly a mutation further within an exonic region, or by 
epigenetic factors. Regardless, the final outcome, was that the MCMVdie3 strain was 
even more transcriptionally silenced than first reported. 
 
3.5 Viral protein expression does not occur past the IE region in MCMVdie3 
 
Finally, to assess whether productive MCMV infection occurred in BMDMs at MOI 
of 1 PFU/cell despite the low level of initial infection, BMDMs were infected with 
MCMV or MCMVdie3 at MOI of 1 and viral protein expression was measured using 
Western Blots. MCMV immediate early (IE1), early (E1) and late (M6) proteins 
were measured. The result indicated that MCMV is capable of establishing 
productive infection in BMDMs within 4hpi, and showed that early and late viral 
protein expression does not occur in MCMVdie3-infected cells (Figure 3.8). Low 






Figure 3.8 - Viral protein expression in MCMVdie3 does not occur beyond the 
IE region in BMDMs. BMDMs were infected at MOI 1 with MCMV (lanes 3 and 
5) and MCMVdie3 (lanes 4 and 6) and whole cell lysate  were harvested at 2hpi 
(lanes 3 and 4) and 4hpi (lanes 5 and 6). Western blots were performed for 
immediate early protein IE1, early protein E1, and late protein M6 with β-actin used 
as a loading control. Protein from heavily infected fibroblasts was used as a positive 
control (lane 1) and protein from mock infected cells was used as a negative control 
(lane 2). *Western blots were performed by Christopher Millward under the 
















The Western blot indicated that IE1 was still expressed by MCMVdie3 at low levels. 
Other immediate early proteins may also be expressed in this same manner. Taking 
this into account, the potential effect of immediate early proteins on immune 
signalling in MCMVdie3-infected cells had to be considered for future experiments. 
This is significant given the role of IE1 in interacting with host factors during 
MCMV infection (49, 126, 188, 351). The MCMVdie3 virus, therefore, cannot be 
considered completely inactivated but rather only attenuated in viral gene expression 
beyond the IE region. 











The objective of the work in this chapter was to functionally and phenotypically 
characterize the MCMVdie3 mutant strain and ensure it is a non-productive, 
replication deficient and transcriptionally attenuated virus, capable of entering host 
cells but incapable of productive viral infection. Characterization of this phenotype 
meant the mutant strain could be used as an alternative approach to UV-inactivated 
MCMV virions to represent non-productive infection. The characterization was 
achieved using a range of virologic and molecular techniques, each of which was 
informative of the mutant phenotype in a different way. 
 
Firstly, viral growth was measured using plaque assay  to show MCMVdie3 was 
replication deficient in permissive fibroblast cells (NIH 3T3s) and mouse BMDMs, 
both at low and high multiplicities of infection. Furthermore, as viral growth was 
completely recoverable in the complementing cell line, it showed the mutant was still 
functional and capable of replication if the IE3 protein is provided in trans. These 
preliminary results were all consistent with previous characterization work on the 
MCMVdie3 strain(12, 49). 
 
Secondly, a qPCR assay was developed to measure equival ncy of infection between 
MCMV strains at the genomic level. This assay was vluable in establishing 
equivalent doses of viral particles delivered at the genomic level between infections, 
and equivalent genome/PFU ratios in each viral stock. The assay was also used to 
determine the number of viral genomes inside differentially infected cells, and 
revealed that only a small portion of delivered viral genomes successfully enter 
BMDMs at MOI of 1 PFU/cell. This result was supported by flow cytometry data 
generated using a MCMV-GFP reporter virus, indicating only around 12% of 
BMDMs are GFP-positive at 6hpi using MOI of 1 PFU/cell. The outcome of these 
findings indicates the initial level of infection iBMDM cultures at MOI of 1 is very 
low. Despite this, the numbers of MCMV genomes detectable in MCMV and 
MCMVdie3-infected cells were comparable at 2hpi, indicating levels of viral entry 
between the strains were comparable (albeit low). Further, it showed that deletion of 






The development of the qPCR assay also provided a more sensitive and accurate 
method for the detection of MCMV particles in infect d cells and viral stocks 
compared to the ‘gold standard’ plaque assay technique. The plaque assay only 
provides a measure of infectious plaque-forming units (PFUs), as indicated by 
regions of lysed cells of NIH 3T3 monolayers, rather t an providing a quantitative 
measure of MCMV genomes in infected BMDMs. Therefor, development of the 
qPCR assay was important in providing a more sensitive and flexible technique for 
the detection of MCMV in different experimental settings. The assay also showed the 
initial level of infection in BMDM cultures at MOI of 1 PFU/cell is very low. Similar 
approaches based on qPCR have been used elsewhere(331), however this assay will 
now be of direct future benefit for the study of MCV genome copy numbers.  
 
The gene expression phenotypes of the different MCMV strains were investigated 
using a custom DNA oligonucleotide microarray for global detection of MCMV 
transcripts. This analysis indicated MCMVdie3 is a transcriptionally attenuated virus 
in comparison to the parental MCMCV strain in fibrolasts. qRT-PCR analysis of 
immediate early viral gene expression in MCMVdie3 rvealed that ie1 was still 
expressed by MCMVdie3, but at considerably lower level compared to the wild-type 
virus. This result was contrary to previous reports(12) and seen in both the presence 
and absence of cycloheximide.  
 
For the purpose of this study, the attenuated IE transcriptional phenotype of the 
MCMVdie3 strain did not compromise further experiments. In contrast, it made the 
strain even more transcriptionally inactive, and therefore, even more appropriate for 
use as a control reagent to represent non-productive MCMV infection.  For future 
studies focusing on ie3 function, however, the MCMVdie3 strain will have to be 
used with extreme caution, or else re-propagated from the original C3X-die3 BAC 
plasmid. 
 
The attenuated ie1 levels in MCMVdie3 were investigated further by sequ ncing of 





The sequencing, however, did not identify any major deletions or re-arrangements in 
the MCMVdie3 MIEP region. The sequencing analysis, which was outsourced to a 
sequencing service company and performed using the Sanger method, did not yield 
high quality sequence data. The sequencing was repeat d three times using 
independent samples, but sequence quality remained poor. This could be due to 
technical issues related to the Sanger sequencing instrumentation, however, is more 
likely due to the high degree of sequence repeats and high GC content within the 
MCMV MIEP region(199). Repeats can lead to problems associated with primer 
design, both for PCR primers and for sequencing primers, leading to non-specific 
PCR products and/or non-identical sequences reads, resulting in poor sequence 
quality. To avoid non-specific PCR amplification and sequencing, different 
combinations of primers were used, and PCR products were run on gels after each 
reaction to confirm size. The sequence quality, however, remained poor and, 
therefore, the only conclusion that could be made from the data was that no major 
mutations or rearrangements had occurred, based on alignments at 70% identity.   
 
Finally, viral protein expression was measured in MCMV and MCMVdie3 infected 
BMDMs using Western blots. No viral protein expression beyond the IE region was 
detected in MCMVdie3-infected BMDMs. The Western blots also indicated 
productive MCMV infection occurs within four hours of infection in BMDMs using 
the wild-type MCMV strain. This suggested productive MCMV infection is still 
established in BMDMs at MOI of 1 PFU/cell, despite low levels of infection as 
indicated by qPCR and MCMV-GFP reporter virus.  
 
The only modification to the MCMVdie3 characterizaton work which, in hindsight, 
could be improved on would be performing direct comparisons of UV-inactivated 
MCMV virions with the MCMVdie3 virus. This would provide a direct comparison 
of the two conditions, and would indicate how similar and inter-changeable they 
might be from an experimental perspective. This comparison would have been 
particularly useful in the early stages, and if equivalency between the two conditions 





analyses. This, however, was not done due to technical complications with UV 
instrumentation early in the study.  
 
Another issue to consider is that MCMVdie3 virions still contain tegument proteins 
enclosed within the viral particle. Up to 38 different MCMV proteins have been 
detected in the MCMV virion by mass spectrometry(184), and many of these 
proteins are predicted to have immune-modulatory functions(181, 182). Tegument 
proteins, however, will be functional in both MCMVdie3 and UV-inactivated 
virions. At least in the case of MCMVdie3, immune-evasion as a result of de novo 
MCMV proteins can be ruled out. The effect of immediate early viral proteins, such 
as IE1, also cannot be ruled out in MCMVdie3 infections. 
Overall, the characterization work provided an essential foundation on which future 
work could be built, and meant that future experiments based on the host-response to 
productive versus non-productive MCMV infection could be conducted using 
MCMVdie3 as a control reagent instead of UV-inactivated virions. The MCMVdie3 
strain was shown to be capable of entering host cells, but incapable of replication, 
and considerably attenuated in viral gene and protein expression beyond the IE 
region. These characteristics made it an appropriate tool for non-productive viral 






Systems analysis of the host response to productive 





In the previous chapter, a mutant MCMV strain (MCMVdie3) was characterized and 
shown to be capable of entering host cells, but incapable of viral replication. The 
MCMVdie3 virus was also shown to be attenuated in viral gene and protein 
expression beyond the IE region. The MCMVdie3 strain was, therefore, deemed 
appropriate for use as a genetic tool and control reagent to represent non-productive 
viral infection. In the work described in this chapter, macrophages are infected in 
parallel with wild-type MCMV and MCMVdie3, and the innate immune response to 
both viruses is analyzed at the systems-level. These experiments address the central 
hypothesis of the thesis, and determine whether macophages are capable of 
responding differentially to productive and non-productive MCMV infection. 
 
In considering the macrophage innate immune response to productive and non-
productive MCMV infection, there are a number of possible outcomes that could 
occur regarding differential activation of signalling pathways and regulation of 
downstream genes in response to the two conditions. Firstly, activation of signalling 
pathways in response to MCMV and MCMVdie3 could be induced to roughly 
equivalent levels, resulting in an overlapping, or indistinguishable response. This 
outcome would suggest macrophages respond in an equivalent manner to productive 
and non-productive MCMV infection, and would refute th  hypothesis of this study. 
Secondly, activation of innate immune signalling and downstream gene expression 
could be induced to greater levels in response to productive MCMV infection, and be 





would support the hypothesis of the study, and suggest macrophages respond 
differently to productive MCMV infection. The third possible outcome, however, is 
that macrophages respond to the attenuated MCMVdie3 virus with higher levels of 
innate immune signalling and pro-inflammatory gene xpression. If this is the case, it 
suggests de novo MCMV proteins suppress the innate immune response in 
macrophages during productive infection. This outcome would refute the hypothesis, 
however, would be consistent with most previous studies using fibroblasts and UV-
inactivated virions to measure the response to productive and non-productive virus 
infection. Most of these studies report higher leves of type I IFN and ISG expression 
in response to UV-inactivated virions compared to productive viruses(43, 142, 260, 
263, 289, 345). 
 
In order to determine the outcome of macrophage infection with productive and non-
productive MCMV, the innate immune response to both c nditions was profiled 
temporally in BMDMs using a range of different techniques. The results presented in 
this chapter will provide a comprehensive account of the similarities and differences 







4.1 Characterization of bone marrow-derived macrophages (BMDMs) 
 
Before proceeding with macrophage host-response expriments, first the BMDM 
system required characterization. To determine the proportion of macrophage-like 
cells in BMDM cultures after the seven-day differentiation period, fluorescence-
activated cell sorting (FACS) was used to measure expression of macrophage-
specific cell surface protein markers CD11b and F4/80.  Figure 4.1 shows 99.5% of 
gated cells were positive for both F4/80 and CD11b, indicating differentiation of 
macrophages in the M-CSF conditioned medium yielded a homogenous population 
of mature BMDMs after 7 days. L929 conditioned growth medium and FCS used to 
culture BMDMs were also routinely tested for exdotoxin (<0.02 ng/ml) and 
mycoplasma. 
  
Figure 4.1 Phenotypic characterization of BMDMs by flow cytometry  
The level of expression of F4/80 and CD11b and their isotypes was analysed by flow 
cytometry. A) Dot blot showing gating of cells in forward scatter (FSC) and side 
scatter (SSC). B). Scatter plot showing double-staining signals for F4/80 (y-axis) and 
CD11b (x-axis) plotted against each other. C) Histogram of percentage enrichment of 
CD11b (Fitc) positive cells within the gated population. D) Histogram of percentage 




































4.2 Experimental overview: Macrophage host response to productive and non-
productive MCMV infection  
 
To measure the temporal, dynamic macrophage host response to productive and non-
productive MCMV infection, BMDMs were infected on day seven of culture at MOI 
of 1 PFU/cell with MCMV or MCMVdie3 and a time course analysis was 
undertaken with cell culture supernatants and totalRNA harvested at 0, 2, 4, 6, 8, 10, 
12 and 24hpi, from three replicates cultures per condition per time point. The first 
time point (0hpi) corresponded to the end of the 1.5 hour viral adsorption period after 
cells had been washed free of viral innoculum and replenished with fresh medium. 
This means at the 0hpi time point cells have already been in contact with viral 
particles for 1.5 hours. Mock infected samples were tak n at each time point over the 
course of the experiment (for an overview see Figure 4.2).  
 
Figure 4.2 Experimental overview: Macrophage antiviral host response. Bone-
marrow progenitor cells from male C57BL/6 mice were flushed from mouse femurs 
and differentiated in conditioned medium containing M-CSF1 for seven days, and re-
fed on days 3 and 5. Confluent BMDM monolayers were inf cted on day 7 with 
MCMV and MCMVdie3 in parallel and triplicate cell culture supernatants and total 

















4.3 IFNβ induction occurs more rapidly in response to productive MCMV 
infection  
 
The first question regarding the differential innate immune response to productive 
and non-productive MCMV infection in macrophages was hether IFNβ was 
induced equivalently in response to the two conditions. The induction of IFNβ is a 
key signalling event in the innate immune response and occurs directly after PRR 
activation (38). Several studies report IFNβ to be induced to higher levels in response 
to UV-inactivated virions compared to wild-type virus, including one study using 
MCMV(208).  
 
Ifnb1 transcripts were measured using qRT-PCR at 0, 2, 4, 6, and 8hpi in both 
MCMV and MCMVdie3 infected BMDMs (Figure 4.3). IFNβ is a single-exon gene, 
therefore all RNA samples were DNase-treated prior to qRT-PCR to avoid non-
specific amplification of genomic DNA. Furthermore, to ensure equivalency of 
infection between the two conditions (i.e. that equivalent number of MCMV 
genomes were delivered per cell) the viral genome copy number per PFU for MCMV 
and MCMVdie3 viral stocks was measured (see previous chapter Table 3.1). In 
addition, the number of MCMV genome copies detectable inside infected BMDMs at 
2hpi was measured and found to be equivalent (see previous chapter Figure 3.3).  
 
As seen in Figure 4.3, Ifnb1 transcripts were induced in response to both conditi s, 
suggesting the attenuated MCMV virion was still capable of inducing IFNβ in 
BMDMs. Notably, however, this induction was more rapid in response to productive 
MCMV infection by a period of 2-4 hours. The regulation of Ifnb1 expression in 
response to MCMV and MCMVdie3 was similar, but peak levels occurred at 
different time points. There was a two-fold or greater difference in Ifnb1 transcript 








Figure 4.3 Transcriptional induction of Ifnb1 occurs more rapidly in response 
productive MCMV infection. BMDMs were infected at MOI of 1 PFU/cell and 
Ifnb1 transcripts were measured at 0-8hpi in response to MCMV (solid lines) and 
MCMVdie3 (dotted lines) using Taqman qRT-PCR gene expr ssion assays. The 0hpi 
time point represents the end of the 1.5 hour viral adsorption period. Transcript levels 
were normalized to the housekeeping gene Gapdh and calibrated to mock levels to 
show relative expression. Error bars indicate standard eviation from three separate 
















Next, to assess whether the more rapid induction of IFNβ was also detectable at the 
protein level, secreted IFNB1 protein was measured in cell culture supernatants using 
ELISA at 2-10hpi. This indicated a more rapid induction of IFNβ in response to 
productive MCMV infection at the secreted protein level. Differences in IFNβ 
induction at both the gene expression and protein level between MCMV and 







Figure 4.4 Induction of IFNβ at the gene expression and protein level occurs 
more rapidly in response productive MCMV infection. BMDMs were infected at 
a MOI of 1 PFU/cell. Induction of IFNβ in response to MCMV (solid lines) and 
MCMVdie3 (dotted lines) was measured at the transcript level using Taqman qRT-
PCR gene expression assays (orange lines) and secreted p otein level using ELISA 
(blue lines). The 0hpi time point represents the end of the 1.5 hour viral adsorption 
















To validate the observation regarding IFNβ induction, the time course experiment 
was repeated using BMDMs from a different set of mice. Ifnb1 transcripts levels 
were again measured using qRT-PCR at 0-8hpi in response to MCMV and 
MCMVdie3. In the repeat experiment, Ifnb1 transcripts were again induced more 
rapidly in response to productive MCMV infection, with a greater than two-fold 
difference at 2hpi (Figure 4.5a). Results from an additional microarray experiment 







Figure 4.5 - Transcriptional induction of Ifnb1 occurs more rapidly in response 
productive MCMV infection (repeat experiments). BMDMs were infected at MOI 
of 1 PFU/cell. Ifnb1 transcript levels were measured in response to MCMV (solid 
lines) and MCMVdie3 (dotted lines) at 0-8hpi using Taqman qRT-PCR gene 
expression assays. The 0hpi time point represents the end of the 1.5 hour viral 
adsorption period. Transcript levels were normalized to the housekeeping gene 
Gapdh. Error bars indicate standard deviation from three s parate cultures. Asterisks 





























4.4 Induction of TNFα gene expression occurs in an equivalent manner in 
response to productive and non-productive MCMV infection  
 
Next, to test if the rapid induction of IFNβ in response to productive MCMV 
infection was a specific effect, or extended to other cytokines, TNFα (Tnf) transcript 
levels were measured at 0-6hpi in response to the two MCMV strains. TNFα is a pro-
inflammatory cytokine induced by mechanisms independent of IFN during the 
antiviral response(92). Difference in the kinetics TNFα induction were not seen at 
the gene expression level, as Tnf transcripts were induced with equivalent kinetics 
and to equivalent peak levels in response to MCMV and MCMVdie3 (Figure 4.6). 
This result indicated the more rapid induction seen for IFNβ did not apply to the pro-
inflammatory cytokine TNFα. It did, however, show the inactive MCMVdie3 virion 
is capable of inducing a pro-inflammatory response, a  well as a type I IFN response, 
at the transcriptional level in BMDMs. 
 
Figure 4.6 Induction of TNFα gene expression is equivalent in response to 
MCMV and MCMVdie3. BMDMs were infected at MOI of 1 PFU/cell. Tnf 
transcript levels in response to MCMV (solid lines) and MCMVdie3 (dotted lines) 
were measured at 0-6hpi using Taqman qRT-PCR gene expr ssion assays. The 0hpi 
time point represents the end of the 1.5 hour viral adsorption period. Transcript levels 
were normalized to the housekeeping gene Gapdh and calibrated to mock samples to 











4.5 Global gene expression profiling of the macrophage response to productive 
and non-productive MCMV infection 
 
4.5.1 Microarray data processing  
 
The next step was to assess differences in macrophage gene expression in response to 
productive and non-productive MCMV infection at the g nome-wide level. To 
achieve this, time-course microarray profiling of BMDMs was conducted. The 
objective of this analysis was to identify differentially regulated genes in response to 
the two conditions, and find genes induced specifically in response to productive 
MCMV infection. Total RNA from the BMDM time-course xperiment was 
extracted from MCMV and MCMVdie3-treated BMDM cultures at 0, 2, 4, 6, 8, 10, 
and 24hpi and hybridized to Affymetrix Mouse Exon 1.0ST microarrays. Mock-
infected samples at 0 and 24hpi were also included in the microarray analysis. 0hpi 
corresponded to the end of the 1.5 hour viral adsorption period. 
 
Microarray data from the exon-level microarray probes was quality controlled, log 
transformed and normalized according to standard Affymetrix workflows (for details 
see Methods section 2.7.2). All samples passed quality control measures and gene-
level data were obtained for a total of 16,761 annotated mouse genes. To remove 
genes not expressed across the dataset, a filter was applied to exclude any gene with 
a maximum normalized intensity of less than 100 across all samples. This value 
corresponded to the mean of all negative control prbes plus two standard deviations. 
This filter reduced the dataset to 7,890 genes expressed to a high confidence level.  
 
To determine if microarray measurements were equivalent to those made previously 
by qRT-PCR, the expression of Ifnb1 was assessed in the microarray data. The 
previously reported delay in Ifnb1 induction in response to MCMVdie3 was also 
detectable in the microarray in an equivalent manner as it was using qRT-PCR (see 







To determine how many genes were changing statisticlly in response to either the 
MCMV or MCMVdie3 infection over the time course, the EDGE tool was 
used(213). EDGE is open-source software specifically designed for the statistical 
analysis of time-series microarray data, and is based on using permutations to 
determine significance of gene changes over time bas d on a longitudinal model. 
Using time course function with 500 iterations, natural cubic spline and a Q-value 
cut-off of 0.001, 980 genes were found to be differentially expressed in response to 
MCMV over the time course (for details see Methods). Using the same settings, 1044 
genes were found to be differentially expressed in response to the attenuated 
MCMVdie3. This indicated the total number of genes statistically changing in 
response to productive (n980) or non-productive (n1044) MCMV infection in 
BMDMs was similar over the 24 hours of infection (for complete lists of EDGE 
genes see Supplementary Files 6 and 7).  
 
4.5.2 Hierarchical clustering analysis 
 
Next, in order to obtain an unbiased overview of the microarray data, and determine 
which samples were correlated based on their overall gene expression profile, 
unsupervised hierarchical clustering analysis of the 7,890 filtered genes was 
performed. The objective of this was to determine similarities between samples, and 
between groups of genes across the data set. The hierarchical clustering analysis 
generated a heatmap based on gene-to-gene correlatin (y-axis) and sample-to-
sample correlation (x-axis). Genes with similar expr ssion profiles were arranged 
together as rows into distinct groups or clusters. Similarly, individual samples 
sharing correlated expression profiles were clustered together as columns. This 
technique provided a qualitative assessment of the similarities and differences 
between genes and samples in the dataset (Figure 4.7). 
 
Figure 4.7 - Unsupervised hierarchical clustering of 7,890 genes and 16 
microarray samples in response to productive and non-productive MCMV 
infection. BMDMs were infected at MOI of 1 PFU/cell with MCMV or MCMVdie3 
and transcript levels were measured using Affymetrix Mouse Exon 1.0ST 

























































































each gene represented as a row and per-gene normalized to its mean value to show 
relative expression. Yellow indicates an increase relative to the mean for each gene 
and blue indicates a decrease. Genes are clustered on similarity of expression profile 
with similar genes connected by the hierarchical tree on the left. Samples (columns) 
are also clustered based on correlation and are conne ted by the hierarchical tree at 
the top. Samples are labelled at the bottom of the igure and colour-coded by green 










Figure 4.7 shows the clustering of 7,890 genes and 16 microarray samples across the 
dataset.  Based on the hierarchical tree at the top of the heatmap, the 16 samples are 
separated into three distinct clusters or groups based on the similarity of gene 
expression across the 7,890 genes (labelled a, b, c). The 16 samples fall into three 
distinct groups based on the kinetics of the respone. Firstly, on the far right side of 
the heatmap (a), the Mock, 0hpi and 2hpi samples from both MCMV and 
MCMVdie3 conditions have clustered together. This indicates that only few gene 
expression changes have occurred at these early time points (0hpi, 2hpi) relative to 
Mock. It also indicates that there have been only few gene expression differences 
between the MCMV and MCMVdie3 responses at these early time points (0-2hpi).  
 
On the left side of the heatmap (b), there is a second group of samples which is 
larger and consists of 4hpi, 6hpi and 8hpi samples from both MCMV and 
MCMVdie3. This larger group of samples is split into three sub-groups consisting of 
the two 4hpi samples together on the right, then th MCMV 6hpi, 8hpi, 10hpi 
samples, then finally the MCMVdie3 6hpi, 8hpi, 10hpi samples on the far left. These 
sub-groups indicate the macrophage transcriptional response to MCMV and 
MCMVdie3 is diverging kinetically between 6-10hpi. It also suggests MCMV and 
MCMVdie3 samples are different during these time points as they have clustered 
into separate sub-groups. Upon close inspection of the heatmap, the differences 
between MCMV and MCMVdie3 samples between 6-10hpi are both kinetic and 
quantitative, indicating differential immune responses occurring in response to the 
different conditions. These differences will be expanded on in later sections of the 
thesis. 
 
 Finally, the third overall group of samples are thwo 24hpi samples found in the 
centre of the heatmap (c). These two 24hpi samples cluster together to form their 
own sub-group. This again shows kinetic changes in macrophage gene expression 
occurring. Despite the 24hpi MCMV and MCMVdie3 samples clustering together, 
they are visibly different from each other, suggesting some transcriptional divergence 







Next, to examine global patterns of transcriptional regulation across the data set in a 
supervised manner, the hierarchical clustering approach was repeated on genes only. 
This meant the gene-to-gene correlation was still performed, but samples were not 
clustered, and instead were kept in their original temporal order and separated by 
condition. The heatmap in Figure 4.8 provides a visual zation of global gene 
expression changes in response to MCMV and MCMVdie3 over the temporal course 
of infection. This supervised approach identified specific areas of differential gene 
expression between the conditions. 
 
Figure 4.8. Hierarchical clustering of the macrophage transcriptional response 
to MCMV and MCMVdie3. Hierarchical clustering was performed on 7,890 
filtered genes, with each gene represented as a row. Genes were per-gene normalized 
to their mean value to show relative expression. Genes are clustered on similarity of 
expression profile with similar genes connected by the hierarchical tree on the left. 
Samples are arranged in temporal order, separated by condition and labelled at the 
bottom of the heatmap; MCMV (red) and MCMVdie3 (blue). 0hpi corresponds to the 
end of the 1.5 hour viral adsorption period, meaning cells had been in contact with 











4.6 Genes regulated in an equivalent manner in response to productive and non-
productive MCMV infection 
 
4.6.1 Identification of genes regulated in an equivalent manner in response to 
MCMV and MCMVdie3 
 
As indicated by the similarities between the left (MCMV) and right (MCMVdie3) 
side of the heatmap in Figure 4.8, the macrophage transcriptional response to 
MCMV and MCMVdie3 was quite similar overall at the g ne expression level. In 
particular, this was the case during the first four hours of infection, whereby many 
genes were up-regulated in an equivalent manner and with similar kinetics in 
response to both MCMV and MCMVdie3. Overall, the similarity in gene expression 
profiles induced by MCMV and MCMVdie3 indicates an overlapping transcriptional 
response to productive and non-productive MCMV infection in BMDMs at the gene-
expression level. 
  
Stat1 (signal transducer and activator of transcription 1) was induced in an equivalent 
manner in response to MCMV and MCMVdie3. To find other genes that also shared 
this profile (i.e. up-regulated in an equivalent manner in response to MCMV and 
MCMVdie3), a clustering analysis was performed whereby any gene with an 
expression profile highly correlated to Stat1 (Pearson>0.9) was identified. This was 
not designed to identify genes regulated by Stat1, but was merely a strategy to 
identify genes in the macrophage transcriptome induce  with equivalent kinetics by 
MCMV and MCMVdie3 infection. 131 genes were highly correlated with Stat1 over 
the time course and induced equivalently by MCMV and MCMVdie3 infection 
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Figure 4.9 - Genes up-regulated equivalently in response to MCMV and 
MCMVdie3. BMDMs were infected at MOI of 1 PFU/cell with either MCMV or 
MCMVdie3 and transcript levels were measured using Affymetrix Mouse Exon 
1.0ST microarrays. Pearson correlation was used to identify genes with expression 
profiles highly correlated with either Stat1 (r>0.9) commonly up-regulated by both 
MCMV and MCMVdie3. Each gene is represented by a row on the heatmap and is 
per-gene normalized to its mean value to show relativ  expression. Yellow indicates 
increased expression relative to the mean and blue indicates decreased expression. 





















Next, to find genes down-regulated equivalently by both MCMV and MCMVdie3, 
the same approach was taken using a different marker gene; Rasgrp3 (RAS guanyl 





Down-regulated by MCMV and MCMVdie3
Pearson>0.9 =362 genesd)
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expression profile in previous MCMV data sets (Sing et al. personal 
communications). Rasgrp3 is a member of the RAS subfamily of GTPases involved 
in signal transduction and acquisition of GTP(301). 362 genes were found to have a 
highly correlated expression profile with Rasgrp3 and commonly down-regulated in 
response to both MCMV and MCMVdie3 conditions (Figure 4.10) (for complete list 
see Supplementary File 9). 
 
Figure 4.10 - Genes down-regulated in response to MCMV and MCMVdie3. 
Pearson correlation was used to identify genes with expression profiles highly 
correlated with either Rasgrp3 (r>0.9) down-regulated by MCMV and MCMVdie3. 























4.6.2 Functional annotation of genes regulated in an equivalent manner in response 
to MCMV and MCMVdie3 
 
To determine the functional annotation of genes up-regulated or down-regulated in 
an equivalent manner in response to MCMV andMCMVdie3, the DAVID 
annotation tool(79) was used. This tool takes annotation classes from various 
different databases to measure over-representation of a notation terms within an 
input gene list (for details see Methods). If a particular annotation term is over-
represented, or enriched, within a list of genes (above the levels of chance alone), a 
low p-value will be assigned to that annotation term as determined by a Fisher’s 
exact test (for details see Methods). Databases accessed by the DAVID tool include 
Gene Ontology(1), which provides standardized and controlled vocabulary for gene 
attributes, Interpro(159), which provides a resource for protein family, domain, 
region and site information, and the Protein Information Resource (PIR)(381), which 
provides classification of  proteins into family, superfamily, domain and motif 
groups based on structural and functional features.  
  
Genes up-regulated equivalently by MCMV and MCMVdie3 contained over-
represented annotation terms associated with immune response, 2-5-oligoadenylate 
synthetase, and purine nucleotide binding (Table 4.1). The group also contained 
interferon-stimulated genes including guanylate binding proteins (Gbp2, Gbp4, 
Gpb6), 2'-5' oligoadenylate synthetase genes (Oas1a, Oas1b, Oas2, Oasl1, Oasl2 ), 
interferon induced genes (Ifi204, Ifi205, Ifi35, Ifi44, Ifit2, Isg20), regulators of 
interferon signalling (Ifr7, Stat2), proteosome components (Psmb8, Psmb9, Tap1, 
Tap2) chemokines (Cxcl9 MIG), pattern recognition receptors (Ddx58 RIG-I, Zbp1) 
and MHC class II genes (H2-gs10, H2-t10, HS-t22) (for complete gene list see 
Supplementary File 8). This indicated an overlapping transcriptional response 
induced by both the MCMV and MCMVdie3 virions related to type I IFN.  
 
The group of genes down-regulated in an equivalent manner by MCMV and 
MCMVdie3 group contained 362 members, many of which were involved in cell 
cycle control including cyclin-dependent kinases (Ccna2, Cdc2a, Cdc45l, Cdca2, 





topoisomerases (Top1, Top2a, Topbp1). Genes involved in cholesterol metabolism 
were also found to be down-regulated in this manner (I sig1, Mvd, Srebf1, Srebf2, 
Sqle). Over-represented functional annotation classes within the down-regulated 
group included cell cycle, mitosis, nuclear division and chromosome (Table 4.1b), 
suggesting a repression of the cell cycle during the macrophage response to MCMV 
and MCMVdi3 (for complete gene list see Supplementary File 9). The down-
regulation of this group indicates BMDMs are proliferating at the point of infection, 
but cease to proliferate after contact with virus. 
 
Table 4.1 Functional annotation of genes regulated equivalently in response to 
MCMV and MCMVdie3. 131 genes were highly correlated with Stat1 
(Pearson>0.9) and induced equivalently by both MCMV and MCMVdie3 (a). 362 
genes were highly correlated with Rasgrp3 (Pearson>0.9) and down-regulated 
equivalently by both MCMV and MCMVdie3 (b). Genes from these two groups 
were annotated using DAVID tool to find over-represented functional annotation 
classes. The Category column indicates the number of genes in the input list with 
annotation for that particular annotation category. The Term column indicates the 
annotation term of significance and the count column indicates the number of genes 
within the gene list associated with that term, also represented by a percentage (%). 
The unadjusted (PValue) and adjusted (Bonferroni) p-values columns represent the 
Fishers exact test results for over-representation. The top ten annotation classes for 
each list are shown with a cut-off of Bonferroni p<0.005. 
 
a) Commonly up-regulated genes n=131 
Category Term Count % PValue Bonferroni 
GOTERM_BP  





5 3.9 1.14E-07 3.33E-05 
SP_PIR_KEYWORDS  
114/131 immune response 11 8.7 2.62E-07 4.36E-05 
GOTERM_MF 
 88/131 GO:0017076~purine nucleotide binding 32 25.2 3.72E-07 8.77E-05 
GOTERM_MF  
88/131 GO:0032555~purine ribonucleotide binding 31 24.4 5.27E-07 1.24E-04 
GOTERM_MF  
88/131 GO:0032553~ribonucleotide binding 31 24.4 5.27E-07 1.24E-04 
INTERPRO  
116/131 
IPR018952:2'-5'-oligoadenylate synthetase 1, 
domain 2/C-terminal 











84/131 GO:0019882~antigen processing and presentation 8 6.3 9.67E-07 5.44E-04 
GOTERM_CC_FAT 
67/131 
GO:0042824~MHC class I peptide loading 
complex 
4 3.1 1.15E-05 0.001556 
b) Commonly down-regulated genes n=362 
Category Term Count % PValue Bonferroni 
SP_PIR_KEYWORDS 
349/362 cell cycle 58 16.0 2.93E-30 7.93E-28 
SP_PIR_KEYWORDS 
349/362 cell division 44 12.2 7.09E-28 1.92E-25 
SP_PIR_KEYWORDS 
349/362 phosphoprotein 223 61.6 8.38E-28 2.27E-25 
SP_PIR_KEYWORD 
349/362S mitosis 38 10.5 1.85E-27 5.01E-25 
GOTERM_BP_FAT 
278/362 GO:0051301~cell division 44 12.2 1.15E-25 1.76E-22 
GOTERM_BP_FAT 
278/362 GO:0000087~M phase of mitotic cell cycle 37 10.2 1.48E-24 2.27E-21 
GOTERM_CC_FAT 
246/362 GO:0000775~chromosome, centromeric region 29 8.0 1.06E-23 3.11E-21 
GOTERM_BP_FAT 
278/362 GO:0007049~cell cycle 60 16.6 2.58E-24 3.97E-21 
GOTERM_BP_FAT 
278/362 GO:0000278~mitotic cell cycle 40 11.0 4.81E-24 7.40E-21 
GOTERM_BP_FAT 
278/362 GO:0000280~nuclear division 36 10.0 8.76E-24 1.35E-20 
   
 
4.7 Genes differentially regulated between the MCMV and MCMVdie3 
responses 
 
4.7.1 Genes induced specifically by productive MCMV infection at 24hpi 
 
Next, to identify differences, rather than similarities in the macrophage response to 
MCMV and MCMVdie3, the 24 hour time point was examined in more detail. The 
24hpi time point was found to have the most variability and most gene expression 
changes between MCMV and MCMVdie3 (illustrated in Fgure 4.11). It also 
appeared some genes were induced specifically by productive MCMV infection but 






Figure 4.11. The transcriptional response to MCMV and MCMVdie3 is most 
different at 24hpi. a) Hierarchical clustering of 7,890 expressed genes in response 
to MCMV and MCMVdie3 as shown previously. b) Differences in the expression 






















To focus on the more pronounced differences in gene expression occurring late in the 
response at 24hpi, and to identify genes up-regulated specifically in response to 
productive MCMV infection, a filter was applied to the data whereby only genes 
with a 1.5-fold or higher gene expression level in MCMV-infected cells samples 
between 10-24hpi were identified. This resulted in 283 genes with a 1.5-fold or 
higher gene expression level in MCMV-infected cells above that of both mock and 
MCMVdie3 levels at both 10hpi and 24hpi (for complete list see Supplementary File 
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10). These 283 genes represented a transcriptional response occurring specifically in 
response to productive MCMV infection. These genes w re not induced by the 
inactive MCMV virion alone (Figure 4.12).  
 
Figure 4.12 A sub-set of macrophage genes is induced specifically by productive 
MCMV infection between 10-24hpi. 283 genes were induced specifically in 
response to productive MCMV infection by a factor of 1.5-fold or higher above 
mock and MCMVdie3 levels at 10hpi and 24hpi. The heatmap shows hierarchical 
clustering of these genes with each row representing an individual gene that has been 
per-gene normalized to its mean value to show relativ  expression. Each column 



















To determine the functional annotation of the 283 genes induced specifically by 
productive MCMV infection, annotation was performed again using DAVID(79), 





genes, proteins, interactions, and pathways designed sp cifically to facilitate systems 
level analysis of the innate immune response. Over-representation of annotation 
terms was determined using a corrected p-value<0.01 (for details see Methods). 
Significant over-representation of GO annotation terms included plasma membrane 
(GO:0044459 Bonferroni p=0.009) and glutathione transferase activity 
(GO:0004364 Bonferroni p=0.01). Using InnateDb, pathways involved in 
glutathione metabolism (KEGG p=0.001) and glutathione conjugation 
(REACTOME p=0.001) were identified as over-represented. No significant 
annotation was found associated with the innate immune response or IFN signalling 
in this group of genes, suggesting regulation via an lternative pathway (for a 
complete list of the genes in this group see Supplementary File 10). 
 
To validate the expression of some of the genes induce  specifically by productive 
MCMV infection at 10-24hpi, the experiment was repeated in cells from a different 
set of mice, and three marker genes were chosen for validation using qRT-PCR. The 
genes chosen were Elovl4 (elongation of very long chain fatty acids), Alox15 
(arachidonate 15-lipoxygenase), and Crabp1 (cellular retinoic acid binding protein). 
These genes were chosen due to their high expression levels (>2000 antilog) and fold 
changes (>2) in the microarray data set. For each of the three marker genes, 
significant up-regulation was again found in response to productive MCMV 
infection, and no induction was seen in response to the inactive MCMVdie3 virion at 
24hpi (Figure 4.12). The qRT-PCR data confirmed induction of these genes is 







Figure 4.13 Elovl4, Alox15 and Crabp1 are induced specifically in response to 
productive MCMV infection at 24hpi. BMDMs were infected at MOI of 1 
PFU/cell and total RNA was harvested at 24hpi. Transcript levels were measured for 
three marker genes (Elovl4, Alox15 and Crabp1) using qRT-PCR. Transcript levels 
were normalized to the cellular housekeeping gene Gapdh and calibrated to the 
MCMV 24hpi samples to show relative expression. Error bars indicate standard 












Next, to determine if up-regulation of these marker g nes was also dependent on 
viral DNA replication, the experiment was repeated in presence of 20uM Ganciclovir 
(GCV); a licensed antiviral drug capable of inhibiting the activity of CMV DNA 
polymerase, thereby terminating the elongation of viral DNA and inhibiting viral 
DNA replication(245). In the presence of Ganciclovir, Elovl4 was induced to wild-
type levels (Figure 4.13a) and other marker genes (Alox15 and Crabp2) were also 
induced, but slightly attenuated in their expression (Figure 4.14b-c). This result 
suggests viral DNA replication is not required for the transcriptional induction of 
Elovl4, Alox15 and Crabp1 at 24hpi in BMDMs. The induction of these genes may 




Figure 4.14 - Induction of Elovl4, Alox15 and Crabp1 in response to productive 
MCMV infection occurs in the presence of Ganciclovir. BMDMs were infected at 






























levels were measured at 24hpi for three marker genes (Elovl4, Alox15 and Crabp1) 
using qRT-PCR. Samples were calibrated to the MCMV 24hpi condition to show 










4.8 Cytokine secretion is markedly different in response to productive and non-
productive MCMV infection in macrophages 
 
Although differences at the gene expression level had been measured in response to 
MCMV and MCMVdie3, the differences did not necessarily reflect the functional 
immune-activation status of the differentially infect d macrophages. Therefore, in 
order to address the hypothesis more directly, and to obtain a more definitive and 
functional measure of immune activation, cytokine secretion was measured in 
supernatants from MCMV and MCMVdie3 infected BMDMs at 2hpi, 6hpi, and 
10hpi. This was done using a multiplexed bead-based ELISA assay to 
simultaneously measure pro-inflammatory cytokines (TNFα, IL-6) chemoattractant 
cytokines (RANTES, MIG, MIP-2) and the anti-inflammatory cytokine IL-10 in 
response to MCMV and MCMVdie3 infection. The cytokines were chosen based on 
their known roles in the innate immune response, their ranscriptional profiles which 
were of interest from in the microarray data, and their availability as part of a 
commercially available multiplexed ELISA platform (for details see Methods). 
Measuring cytokine secretion was intended to provide a more functional and 
definitive output for determining the final immunological status of the differentially 











































































Figure 4.15 - Chemoattractant cytokines are secreted to higher levels in 
response to productive MCMV infection in macrophages. BMDMs were infected 
at MOI of 1 PFU/cell with either MCMV or MCMVdie3 and secreted protein levels 
were measured in cell culture supernatants; RANTES (a ii), MIG (b ii), and MIP-2 (c 
ii ). Error bars indicate standard deviation from three s parate cultures. The response 
to MCMV is shown in light grey and MCMVdie3 in dark grey. Asterisks indicate a 
significant difference between conditions (Student’s t-test, *p<0.05, **p<0.001). 



























































As seen in Figure 4.15, chemoattractant cytokines RANTES, MIG and MIP-2 were 
secreted to significantly higher levels in response to productive MCMV infection 
compared to MCMVdie3 at the protein level (Figure 4.14 a ii, b ii, c ii). This was 
particularly significant for MIG (p<0.001). The result suggests a higher level of 
innate immune activation occurring in response to productive MCMV infection, 
based on the known roles of chemoattractant chemokines in the recruitment of 
immune cells to the site of infection(255). The difference at gene expression level, 
however, was only significantly detectable for MIG (Cxcl9). 
 
Figure 4.16 - Pro-inflammatory cytokines are secretd to higher levels in 
response to productive MCMV infection. BMDMs were infected at MOI of 1 
PFU/cell with MCMV and MCMVdie3 and secreted protein levels were measured in 
cell culture supernatants for TNF (a ii) and IL-6 (b ii). The response to MCMV is 
shown in light grey and the response to MCMVdie3 is shown in dark grey with error 
bars indicating standard deviation from three separate cultures. Asterisks indicate a 
significant difference between conditions (Student’s t-test, *p<0.05, **p<0.001). 
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The secretion of pro-inflammatory cytokines TNF and IL-6 was found to be 
significantly higher in response to productive MCMV infection compared to 
MCMVdie3 (Figure 4.16). This difference was particularly significant for TNF, 
which was found to be secreted only in response to productive MCMV infection. 
This result indicated an increased amount of pro-inflammatory immune activation 
occurring in response to productive MCMV infection, a d not in response to the 
inactive MCMVdie3 virion. The difference was not detectable at the gene expression 
level for TNF.  
 
The only cytokine secreted to higher levels in respon e to MCMVdie3 was IL-10, an 
anti-inflammatory cytokine with immunosuppressive properties(25, 322). IL-10 was 
secreted to significantly higher levels in response to MCMVdie3 at 10hpi (Figure 
4.17).  
 
Figure 4.17 - IL-10 secretion is lower in response to productive MCMV infection 
in macrophages. BMDMs were infected at MOI of 1 PFU/cell with either MCMV 
or MCMVdie3 and secreted protein levels were measured in cell culture supernatants 
for IL-10 (ii ). The response to MCMV is shown in light grey and the response to 
MCMVdie3 is shown in dark grey with error bars indicating standard deviation from 
three separate cultures. Asterisks indicate a significa t difference between conditions 
(Student’s t-test, *p<0.05). The mRNA microarray profile for the Il-10 gene is also 















Overall, the most significant difference between MCV and MCMVdie3 for the six 
cytokines measured was for TNFα (p<0.0005). TNFα was secreted specifically in 
response to wild-type MCMV at both 6hpi and 10hpi, but barely detectable in 
response to the attenuated MCMVdie3 virion (Figure 4.16a ii). This result was 
surprising given Tnf mRNA levels were induced equivalently in response to MCMV 
and MCMVdie3 at the gene expression level (Figure 4.16a i). To further investigate 
this observation, and to verify the result independently, the entire experiment was 
repeated again twice under the same conditions using BMDMs from a different set of 
mice. TNFα secretion was measured in BMDM supernatants at the same time points 
as the previous experiment, using individual TNFα ELISAs.  
 
In the repeat experiments, again no TNFα protein was detectable from MCMVdie3 
infected cells, but secretion occurred in response to wild-type MCMV at multiple 
time points (Figure 4.18). This result further suggested post-transcriptional regulation 
of TNFα occurs only in response to productive MCMV infection, and not in response 
to the inactive MCMVdie3 virion. This result indicated that BMDMs respond with a 
heightened level of pro-inflammatory innate immune signalling as a result of 
productive MCMV infection.  
 
Figure 4.18 - TNFα secretion in BMDMs only occurs in response to productive 
MCMV infection (repeat experiments). BMDMs were infected at MOI of 1 
PFU/cell and secreted cytokine levels for TNFα were measured in cell culture 
supernatants from two repeat experiments (a) and (b) using standard ELISA assays 
(R&D Systems, UK). Error bars indicate standard deviation from three separate 
cultures. The response to MCMV is shown in white and the response to MCMVdie3 















A number of findings were presented in this chapter regarding similarities and 
differences in the macrophage innate immune response to productive and non-
productive MCMV infection. Some of the key findings were; a) IFNβ is induced 
more rapidly in response to productive MCMV infection, b) sub-sets of genes are 
regulated in an equivalent manner in response to MCMV and MCMVdie3, c) sub-
sets of genes are up-regulated specifically in respon e to productive MCMV 
infection between 10-24hpi, and d) pro-inflammatory and chemoattractant cytokines 
are secreted to significantly higher levels in response to productive MCMV infection. 
These findings identify new aspects to consider in light of the hypothesis, and in light 
of the existing literature on the innate immune response to productive and non-
productive viral infection. 
 
IFNβ induction occurs more rapidly in response to productive MCMV infection  
 
Although IFNβ was induced to equivalent peak levels in MCMV and MCMVdie3 
infections, the induction was more rapid in response to wild-type MCMV by a period 
of 2-4 hours (Figure 4.3). This difference was detectable at both the gene expression 
and protein level, and across multiple experiments (Figures 4.4 and 4.5). A similar 
kinetic shift in IFNβ induction is not reported in literature for most comparable 
studies, however one study did report wild-type strains of polioviruses are more 
potent inducers of type I IFN than attenuated strains in human leukocytes (284). 
Most studies using UV-inactivated virions report higher expression of type I IFNs 
and ISGs in response to attenuated viruses compared to wild-type strains(43, 133, 
263, 289). Many of these studies have used fibroblasts or other permissive cell types, 
rather than macrophages, for their analyses.  
 
There are a number of possible reasons why a more rapid type I IFN induction might 
occur in response to productive MCMV infection than MCMVdie3 in BMDMs. 
Firstly, a difference in the number of incoming MCMV and MCMVdie3 virions may 





possibly be caused by variation in the genome/PFU ratio between the two viral 
stocks, although this factor was tested for in the optimization stages using qPCR 
(Figure 3.3, Table 3.1).  
 
Another factor to consider in light of the differences in IFNβ induction between the 
conditions is the low level of infection in BMDMs at MOI of 1 PFU/cell. Based on 
previous MCMV-GFP reporter virus data in Chapter 3, the proportion of infected 
cells at MOI of 1 PFU/cell is only around 15%. This suggests paracrine induction of 
IFNβ may play a major role in defining the innate immune response at MOI of 1 in 
BMDM cultures at this low level of infection. Differ nces in paracrine signalling 
effects may potentially contribute to the kinetics of IFNβ induction. 
 
Another possible explanation for the differences in IFNβ induction between MCMV 
and MCMVdie3 is that a viral PAMP signal is produced during the initial stages of 
the productive infection, but not during the non-productive infection. One candidate 
PAMP signal produced at this time may be a viral-trnscribed RNA capable of 
activating a PRR and rapidly inducing the IFNβ response. Previous experiments in 
Chapter 3 identified substantial differences in the ov rall amount of mRNA 
transcribed at immediate early times between MCMV and MCMVdie3 infections 
(Figures 3.5 and 3.6). In addition, double-stranded viral RNA (dsRNA) has 
previously been shown to be transcribed during MCMV infection(48), however only 
at late stages of infection. To test the possibility that viral-derived RNA produced 
during MCMV infection could contribute to the activation of IFNβ, an experiment 
was designed whereby 1250ng total RNA extracted from MCMV-, MCMVdie3- and 
mock-infected BMDMs was transfected into new BMDMs monolayers. The type I 
IFN response was then measured using the Mx2 marker gene, however, transfection 
of RNA from MCMV-, MCMVdie3-, and mock-infected BMDMs all induced the 








The overlapping transcriptional response to productive and non-productive MCMV 
infection 
 
Regardless of difference in IFNβ induction, many ISGs and innate immune response 
genes were regulated with equivalent kinetics and to equivalent peak expression 
levels in response to MCMV and MCMVdie3 (Figure 4.9). In addition, whole-
genome microarrays uncovered widespread overlapping macrophage gene expression 
at the genome-wide level (Figure 4.8). The overlapping transcriptional response was 
particularly similar between 0-8hpi, reflecting the activation of common signalling 
pathways by structural components of the incoming MCMV virions. The 
transcriptional overlap, which was characterized by up-regulation of innate immune 
response genes, is consistent with a number of other s udies using live and UV-
inactivated viruses(63, 142, 211, 289, 330, 359). The common induction of these 
transcripts is likely to be induced by viral membrane fusion and/or viral entry(211, 
330, 359). Down-regulation of cell cycle and mitosis genes also occurred in an 
equivalent manner in response to MCMV and MCMVdie3 infection (Figure 4.10). 
This down-regulation indicates incoming structural components of the MCMV virion 
are sufficient to repress macrophage gene expression.  
 
Another factor to consider in light of the overlapping transcriptional response to 
MCMV and MCMVdie3 is the high level of autocrine and paracrine signalling in 
BMDM cultures compared to other cell types. Even small numbers of infected 
macrophages induce widespread signalling responses via secretion of cytokines, such 
as IFNβ, with potent ability to induce signalling in neighbouring and un-infected 
cells(261). Paracrine responses can therefore potentially induce widespread gene 
expression changes in both infected and un-infected cells, and may blur the 
distinction between specific responses induced to productive and non-productive 
MCMV infection. This factor would be less pronounced in fibroblasts and cell lines 
with higher levels of infection and lower levels of cytokine secretion. In this sense it 
is difficult to differentiate between macrophage gene xpression induced directly by 
the virus, compared to that induced indirectly by paracrine signalling. This effect is 





Other important differences exist between this study in BMDMs compared to other 
studies using fibroblasts and more permissive cell types(43, 133, 263, 289).  For 
example, macrophages express a far broader range of PRRs in comparison to 
fibroblasts, and therefore have the ability to respond to virus infection with increased 
sensitivity. This may explain why IFNβ was induced so rapidly in response to both 
MCMV and MCMVdie3 infection in BMDMs, as discussed previously. In addition, 
macrophages have been shown to have a higher endocytotic capacity than 
fibroblasts(346), which may contribute to rates of viral uptake at the initial stages of 
infection. However the qPCR data on viral genome entry does not support this. 
Differences in the sensitivity of pDCs in comparison t  fibroblasts have been 
illustrated in the context of SFV infection, and pDCs were shown to respond 
significantly more rapidly than fibroblasts (MEFs) in response to SFV 
infection(142). 
 
Highly permissive cell types and high MOIs used in combination with UV-
inactivated virions has been the approach for most previous studies comparing the 
innate immune response to productive and non-productive virus infection(43, 63, 
142, 260, 263, 272, 289, 345). This has its advantages, as it results in very high levels 
of infection, high levels of viral protein activity, and strong suppression of the innate 
immune response.  This approach was not taken in the current study. Instead, 
primary BMDMs were used as a physiologically relevant cell type to conduct an 
extensive analysis of macrophage gene expression duri g the innate immune 
response. In addition, a modest MOI of 1 PFU/cell was used. For these reasons, 
suppression of the innate immune response by MCMV was less pronounced and 
more difficult to detect. 
 
Genes induced specifically by productive MCMV infection 
 
At later time points during the response to MCMV (10-24hpi), a secondary wave of 
macrophage genes were induced specifically in response to productive MCMV 
infection (Figure 4.12). This group consisted of 283 genes up-regulated specifically 





begins at 8hpi and increases in intensity by 24hpi. The induction of these genes 
suggests important biological differences occurring between 8-24hpi in productively 
versus non-productively infected BMDMs at MOI of 1 PFU/cell, despite the low 
levels of initial infection. Genes induced in this manner were associated with cellular 
metabolism and glutathione, rather than innate immunity. It is unclear whether g nes 
up-regulated in this manner are part of a secondary antiviral response, or up-
regulated by the virus as pro-viral genes. The possibility these genes are also merely 
a metabolic bi-product of lytic infection also cannot be ruled out. The genes could 
also be related to the ER stress response, or the unfolded protein response to CMV 
infection(165). The functional annotation of these genes only provides a limited 
insight into the overall function of these genes in relation to MCMV infection. 
siRNA screening approaches are currently being usedto determine the relative 
contribution of these genes to MCMV replication in fibroblasts. 
 
Despite the limitations of functional annotation analysis, significant annotation 
classes were found associated with glutathione transferase activity, glutathione 
metabolism, and glutathione conjugation for genes up-regulated specifically in 
response to productive MCMV infection. The glutathione synthetase gene (Gss) and 
six different glutathione S-transferase genes (G ta4, Gstk1, Gstm4, Gstm5, Gstp2, 
Gstt1) were also up-regulated as part of this group. Glutathione is an intracellular 
anti-oxidant found in millimolar concentrations in all mammalian cells(382) and is 
involved in a range of physiological processes. Theratio of reduced and oxidized 
glutathione (GSH:GSSG) can serve as a representative marker of the antioxidative 
capacity of a cell(101), and deficiencies in glutathione levels can put cells at risk for 
oxidative damage. Glutathione has also been reported to have antiviral properties 
against HSV1(277) and HIV1(276) replication (70, 104), and has been used as an 
antiviral therapy(101). Glutathione has also been repo ted to influence the 
immunomodulatory properties of macrophages in relation to Th1/Th2 
responses(102).  
 
This suggests there may be a relationship between glutathione and the antiviral 





specifically in response to productive MCMV infection between 10-24hpi in 
BMDMs. Caution must be given, however, to the functional annotation analysis 
which only provides an indication as to the real function of this group of genes. 
Preliminary siRNA screening experiments suggests that genes up-regulated in this 
group are pro-viral and required for efficient MCMV replication in fibroblasts, 
however results are only preliminary (Kai Kropp and Mathieu Blanc, personal 
communications). 
 
The expression of three marker genes within this group (Elolv4, Alox15 and Crabp1) 
were measured in the presence and absence of Ganciclovir, a drug inhibiting viral 
DNA polymerase activity, in response to MCMV and MCVdie3 infection (Figure 
4.13), in order to determine if their up-regulation was dependent on viral DNA 
replication. Up-regulation of these genes, however, was found to occur 
independently of Ganciclovir treatment, suggesting MCMV viral DNA replication is 
not required for the induction of these genes (Figure 4.14). This result provided some 
insight into how these genes are regulated during the MCMV replication cycle, and 
suggested their induction may be regulated by e novo MCMV proteins, rather than 
as a result of viral DNA replication. Further experimentation, however, will be 
required to uncover the MCMV proteins responsible for regulation at this level. 
 
Some additional experimentation strategies may be useful for future investigation of 
these genes. For example, other viruses could be used to determine if up-regulation 
of these genes is specific to productive infection with MCMV, or occurs in response 
to infection with other viruses. The antiviral role of the genes could also be 
investigated further using a siRNA screening approach, with individual genes 
suppressed using RNAi and MCMV replication subsequently measured. In addition, 
the regulation of these genes could be measured in other cell types, including 









Differences in cytokine secretion in response to MCMV and MCMVdie3  
 
To conduct a more comprehensive analysis beyond the level of gene expression, a 
protein-level technique was required to provide a more functional measurement of 
the BMDM response. Protein-level data would also complement the extensive 
amount of gene expression data generated in the microarray analysis. To achieve 
this, a number of different techniques were considere  such as mass spectrometry, 
Western blotting, multiplexed immunoblotting and ELISA analysis. The most 
reliable, cost effective and tractable method for gaining the most protein-level data 
regarding the macrophage innate immune response was a multiplex bead-based 
ELISA assay to measure secreted cytokine levels BMDM supernatants in response to 
MCMV and MCMVdie3 infection. 
 
This analysis revealed a number of important differences in response to productive 
and non-productive MCMV infection at the secreted protein level. Significantly 
higher levels of chemoattractant (RANTES, MIG, MIP-2) and pro-inflammatory (IL-
6, TNF) cytokines were secreted in response to productive MCMV infection 
compared to MCMVdie3 (Figures 4.15 and 4.16). This indicated important 
immunological differences occurring in productively and non-productively infected 
BMDMs at MOI of 1 PFU/cell, despite low levels of initial infection. The cytokine 
data also provided strong evidence in support of the central hypothesis of the study 
that macrophages respond differently to productive and non-productive MCMV 
infection through differential innate immune signalling.  
 
The difference was particularly significant for the s cretion of TNF, which occurred 
specifically in response to productive MCMV infection and not in response to the 
MCMVdie3 virion (Figures 4.16 and 4.18). The difference in TNF regulation was 
only seen at the secreted protein level, and was not een in the levels of Tnf mRNA 
which were induced to equivalent levels by MCMV and MCMVdie3 (Figure 4.16). 
This result indicates that productive MCMV infection results in a significantly higher 
level of TNF secretion compared to non-productive inf ction, and that differential 






The post-transcription regulation of TNF is a complex process involving several 
mechanisms. Tnf mRNA contains adenine/uridine-rich elements (AREs) in the 3'-
untranslated region which can be regulated post-transcriptionally via cis-acting 
factors(9, 389). Regulation of ARE elements can influence the rate of degradation 
and translation of TNF mRNA into protein. For example, cis-acting factors HuR and 
AUF1 can bind with opposing effects, stabilizing or destabilizing ARE-containing 
transcripts(9). ARE-mediated post-transcriptional regulation has been reported for 
TNF and other pro-inflammatory cytokines including IL-1β(314) and IL-6(390). 
Specifically for TNF, the ERK and p38 pathways have be n shown to be involved in 
regulation of mRNA stability (197, 246) by a proteasome-dependent mechanism(78).  
 
TNF can also be regulated at the level of membrane protein cleavage by the TNF-
alpha converting enzyme (TACE) to affect the level of secretion(67). The TACE 
enzyme cleaves the precursor form of TNF protein into a mature form which can be 
secreted from the cell. The precursor TNF is located close to the cell membrane, and 
cleavage results in secretion of mature TNF protein into extracellular space. In the 
context of the current study, it is likely that this post-translational cleavage event is 
regulated differentially in response to productive and non-productive MCMV 
infection in BMDMs, given equivalent levels of TNF mRNA are detectable inside 
MCMV and MCMVdie3-infected cells. To determine if the difference in TNF 
regulation was due to differences in intracellular TNF production, or alternatively 
due to differences in cleavage and secretion, intracellular TNF staining experiments 
are now being conducted. These experiments will determine if the amount of 
intracellular TNF produced in MCMV- and MCMVdie3-infected cells is equivalent, 
or whether differential regulation of cleavage is occurring.  
 
The increased level of TNF secretion in response to productive MCMV infection 
could also account for the increased level of IL-6 secretion (Figure 4.16b), and 
possibly the decreased level of IL-10 secretion (Figure 4.17) in response to 
productive infection. The regulation of other cytokines by TNF has been 






In order to explain why there would be an increased amount of pro-inflammatory and 
chemoattractant cytokine secretion in response to productive MCMV infection and 
not in response to MCMVdie3, there are two possible explanations. Firstly, the 
macrophage may be capable of sensing de novo virus activity during productive 
infection, leading to a heightened pro-inflammatory response. Alternatively, de novo 
viral proteins may induce TNF secretion and pro-inflammatory cytokine signalling.  
The MCMV immediate early enhancer region has been shown to be TNF-inducible 
(158, 331), suggesting the virus may use pro-inflammatory signalling to drive 
immediate early viral gene expression.   
 
The differences regarding cytokine secretion in respon e to productive infection have 
important implications if considered in light of potential downstream immunological 
outcomes at the site of a primary infection n vivo. Higher levels of chemoattractant 
and pro-inflammatory cytokines from macrophages at a primary site of infection will 
lead to increased inflammation and immune cell infitrate, potentially resulting in a 
more robust systemic response. In contrast, lower levels of chemoattractant and pro-
inflammatory cytokine secretion, or higher levels of anti-inflammatory cytokine 
secretion, will result in a reduced response with less inflammation and less immune 
cell infiltrate.  
 
The only cytokine to be secreted to higher levels in response to the non-productive 
MCMVdie3 infection was IL-10, an anti-inflammatory c tokine with known 
immunosuppressive properties(25, 322). IL-10 has been shown to reduce 
inflammatory cytokine production in macrophages(73, 96) and down-regulate the 
production of TNF and IL-6(83, 347). IL-10 has also been shown to suppress TNF 
and IL-6 production during the response to MCMV infection in vivo(348).  This 
raises the question of whether the increased IL-10 levels in response to MCMVdie3 
are responsible for the suppression of pro-inflammatory cytokines IL-6, TNF in 
MCMVdie3-infected cells, or vice versa?  





HCMV encodes an IL-10 viral homolog with potent immunosuppressive 
function(337) but MCMV does not encode this homolog. MCMV has been shown 
induce IL-10 to down-regulate MHC class II expression on macrophages(303). These 
factors indicate there is an important relationship between IL-10 regulation and the 
response to CMV infection. It is difficult, in this case however, to distinguish 
whether IL-10 is being targeted by the virus for modulation, or being regulated 
directly by the host via TNF or another mechanism.  
 
Overall, the data in this chapter supports the hypothesis of the thesis and suggests 
macrophages respond differently to productive and non-productive MCMV 
infections. In the next chapter, the activity of the virus rather than the host will be 
investigated in more depth during the same period of infection. New questions will 
be asked in relation to whether de novo MCMV proteins are capable of modulating 






Modulation of transcriptional networks during 
macrophage infection by MCMV  
 
Introduction   
 
In the previous chapter, the macrophage innate immune response to productive and 
non-productive MCMV infection was examined. In this chapter, a more targeted 
analysis of macrophage gene expression networks potentially modulated by MCMV 
during productive infection will be conducted. Particular focus will be made on the 
ability of de novo MCMV proteins to modulate macrophage gene expression 
between 4-10hpi in BMDMs.  
 
Understanding how CMV modulates the innate immune response in macrophages is 
important given the efficiency with which CMV infects macrophages both in vitro 
and in vivo(271, 334, 335). HCMV has also been reported to replicate more 
efficiently in differentiated macrophages than in immature monocytes(132), and even 
reprogram monocyte differentiation toward an activated M1 macrophage phenotype 
to favour viral replication(56). MCMV and HCMV have also been reported to use 
macrophages as a reservoir for latency (172, 256, 28 ).    
 
The primary objective of this chapter will be to identify macrophage gene expression 
networks modulated by MCMV during productive infection, and identify which 
networks are targeted and why. This will be done by re-analyzing the microarray 
data from the previous chapter using an alternative nalysis approach. The second 
objective of the chapter will be to determine which MCMV proteins (ORFs) might 







5.1 Interferon-stimulated genes (ISGs) are expressed to lower levels in response 
to productive MCMV infection  
 
Previous studies using UV-inactivated virions suggest strong inhibition of ISGs in 
response to productive virus infection in comparison to UV-inactivated virions (43, 
263, 289). To determine if productive MCMV infection also resulted in a similar 
suppression of ISGs in macrophages, BMDMs were infected in parallel with MCMV 
and MCMVdie3 and nine ISGs related to IFN signalling were measured using qRT-
PCR analysis. Measurements were made from triplicate BMDM cultures with the 
intention of having increased sensitivity than microar ay analysis.  
 
The ISGs measured included pattern recognition receptors involved in the detection 
of viruses (Ddx58 RIG-I and Tlr9,) interferon regulatory factors (Irf1, Irf7), 
antimicrobial effectors (Oasl1, Mx2), and chemokines (Ccl3, Ccl4, Cxcl10).  
These genes, based on their varying function and relationship to MCMV, were 
predicted to be candidates for potential suppression by MCMV at the gene 
expression during productive MCMV infection. 
 
Of the ISGs measured, Tlr9 and Irf1 have been shown to play a direct role in the 
antiviral defence against MCMV(95, 344). Ddx58 (RIG-I) is a cytosolic sensor of 
RNA viruses(385), Mx2 has a confirmed antiviral role against VSV(396), Irf7 is a 
well-established regulator of type I IFN genes(213) with a limited antiviral role 
against MCMV(339), Oasl1 is a member of the IFN-induced 2′-5′-oligoadenylate 
synthetase ubiquitin-like family(32), however has been reported to have an inactive 
function in mouse(91), and Ccl3, Ccl4, and Cxcl10 are chemokines involved in 






Figure 5.1 - Interferon-stimulated genes (ISGs) are xpressed to lower levels in 
response to productive MCMV infection. BMDMs were infected at MOI of 1 
PFU/cell and total RNA was harvested at 4hpi and 8hpi. Transcript levels were 
measured for nine ISGs in response to MCMV (light grey) and MCMVdie3 (dark 
grey) using qRT-PCR. Transcript levels were normalized to the cellular 
housekeeping gene Gapdh and calibrated to the first 4hpi MCMV sample to shw 
relative expression. Error bars indicate standard deviation from three separate 
cultures. Asterisks indicate statistically significant differences between the conditions 





















The qRT-PCR data show expression of ISGs is mildly, but consistently lower in 
response to productive MCMV infection (Figure 5.1). A statistically significant 
















one or more time point (Students t-test p<0.05). In every case the difference was a 
decrease in transcript abundance in response to productive MCMV infection relative 
to MCMVdie3, rather than an increase (Figure 5.1).  This result suggested a possible 
suppression of some ISGs by de novo MCMV proteins . 
 
Of the nine ISGs measured, toll-like receptor 9 (Tlr9) had by far the most significant 
difference between the conditions (p< 0.0003) (Figure 5.1a). Transcript levels for the 
Tlr9 gene were over three-fold lower in response to productive MCMV than to 
MCMVdie3. This suggested, in particular, that suppression of Tlr9 occurs during 
productive MCMV infection in BMDMs.  
 
 
5.2 Genome-wide identification of macrophage gene networks differentially 
regulated by productive MCMV infection  
 
The suppression of ISGs in response to productive MCMV infection provided 
justification to explore similar trends occurring throughout the macrophage 
transcriptome. It was particularly striking that the phenotype was still detectable 
despite the low levels of infection at MOI of 1 PFU/cell (discussed in the previous 
two chapters). The time course microarray data described in Chapter 4 was re-visited 
(for experimental overview see Figure 4.2). The objective of re-analyzing the data 
was to identify macrophage gene expression networks (i.e. groups of co-regulated 
genes) potentially modulated by MCMV during productive infection, in a similar 
way to the ISGs previously measured by RT-PCR. 
 
5.2.1 Statistical identification of differential gen  expression between the MCMV 
and MCMVdie3 responses  
 
The first approach for identifying genes regulated differentially in response to 
MCMV and MCMVdie3 over the time course was to determine a statistical measure 
of differential gene expression between the MCMV and MCMVdie3 conditions. For 





variable. The EDGE tool(213) has a specific function f r detecting differential gene 
expression between two microarray time courses. Using a Q-value cut-off of 0.001, 
the EDGE analysis identified 196 genes differentially expressed between MCMV 
and MCMVdie3 conditions, based on temporal profiles.  
 
Upon inspection of these genes, however, it was apparent that the EDGE algorithm 
was only identifying genes with anti-correlated expression profiles between the two 
conditions. Any gene that had a correlated gene expression profile between the two 
conditions (i.e. a gene that was induced with similar kinetics in both conditions but to 
different peak expression levels) was not identified. This was a problem, as the target 
genes of interest (ISGs) were predicted to be up-regulated by both MCMV and 
MCMVdie3, and therefore correlated in their expression, but induced to different 
peak levels. Therefore, in order identify genes correlated in their expression, but also 
differentially expressed between the MCMV and MCMVdie3 conditions, an 
alternative approach was required.  
 
5.2.2 Co-expression network analysis of differential gene expression between the 
MCMV and MCMVdie3 responses  
 
Using an alternative strategy, a filter was applied to the data whereby any gene with 
a 1.5 fold or greater difference between MCMV and MC Vdie3 conditions in at 
least three consecutive time points between 4-10hpi was identified. Using this 
approach, genes differentially expressed, but also correlated in their expression 
profiles, would still be identified.  952 genes passed the filter and had a 1.5 fold or 
greater difference between MCMV and MCMVdie3 at three or more consecutive 
time points between 4-10hpi. Genes with an increase or decrease in gene expression 
in MCMV relative to MCMVdie3 were included. 
 
Once the 952 differentially expressed genes had been filt red, the next step was to 
identify groups of genes that were co-regulated, or affected in the same way, by 





was to identify groups of co-regulated genes, rathe t an individual genes, possibly 
targeted for modulation by MCMV during productive infection. 
 
In order to identify co-regulated groups of genes, the time-course gene expression 
data for the 952 genes was imported into BioLayout Express 3D(103). This tool 
performs gene-to-gene Pearson correlation on every possible pair of input genes, and 
calculates rates of correlation for each gene pair (for details see Methods section 
2.7.2.2). The result is a large cross-correlation matrix of all Pearson correlation 
values for every possible gene-to-gene correlation. By using the most highly 
correlated gene pairs (Pearson>0.9), highly correlated genes can be arranged into a 
three-dimensional network based on the similarity of their gene expression profiles. 
A network graph is then generated, with nodes representing individual genes. Any 
two genes (nodes) sharing a highly correlated expression profile (Pearson>0.9) will 
be connected by a straight line (edge) in the graph.  
 
Once the network graph has been constructed in three dimensions, it can then be 
visualized and further clustered (sub-divided) into smaller groups based on a more 
stringent measures of co-expression (Markov MCL clustering).  The clusters, or sub-
groups, will then represent tightly co-expressed groups of genes regulated in the 
same manner across the data set. Any genes not passing the Pearson and MCL 
clustering measures will be excluded from the analysis. 
 
Applying this process to the 952 genes from the previous filter, a network graph of 
459 highly correlated genes was formed based on Pearson>0.9 (Figure 5.2). The 
graph contained genes differentially expressed betwe n the MCMV and MCMVdie3 
conditions, and correlated in their expression profiles across the data set. This 
approach identified transcriptional networks, or groups of genes, possibly targeted by 
MCMV during productive macrophage infection in the same manner. The resulting 
network graph was separated into four distinct clusters of co-expression based on 
MCL clustering. Each cluster represents a different class of genes with a different 
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Figure 5.2 - Co-expression analysis of differential gene expression between the 
MCMV and MCMVdie3 responses. 952 genes were identified as having a 1.5 fold 
of greater difference in gene expression levels betwe n MCMV and MCMVdie3 
conditions at three or more consecutive time points be ween 4-10hpi. These genes 
were arranged into a network graph based on co-expression using BioLayout Express 
3D (Pearson>0.9). Each node (ball) represents an individual gene. Any two nodes 
connected by a straight line (edge) are highly correlated in their expression profile 
across the time course (Pearson>0.9). The network graph contains 459 highly 
correlated genes in four distinct clusters of co-expr ssion, each shown with a 
















As shown in Figure 5.2, the co-expression analysis identified two up-regulated and 
two down-regulated gene expression clusters. Each of these clusters contained genes 
differentially regulated by a factor of 1.5 fold or higher between MCMV and 
MCVMdie3 over three or more consecutive time points between 4-10hpi. To further 
illustrate the differences between MCMV and MCMVdie3 r sponses for these 
clusters, in Figure 5.3 they are shown as relative expression heatmaps and mean 






Figure 5.3 - Co-expressed networks of macrophage genes differentially 
regulated in response to productive MCMV infection. (i) Four clusters are shown 
as heatmaps to illustrate differences between MCMV and MCMVdie3 and to show 
relative expression. Each gene is represented by a row nd per-gene normalized to its 
mean value. Yellow indicates increased expression relative to the mean and blue 
indicates a decrease. Each column represents a different time point as indicated 
below the heatmaps. (ii ) Mean expression profiles show the average for all genes 
within the cluster in response to MCMV (light grey) and MCMVdie3 (dark grey). 
Red arrows emphasize the overall difference between the MCMV and MCMVdie3 
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As shown in Figure 5.3, the genes up-regulated in Clusters 1 and 2 are induced by 
both MCMV and MCMVdie3 infection, but are expressed to lower levels (i.e. 
possibly suppressed) in response to productive MCMV infection (Figure 5.3a-b). 
Clusters 3 and 4 are down-regulated during the macrophage response to MCMV and 
MCMVdie3, but are seemingly blocked, or inhibited, in their down-regulation by 
productive MCMV infection (Figure 5.3c-d).  
 
Before proceeding with further analysis, at this point it was important to consider the 
possibility that host factors, rather than viral factors, could account for the changes in 
gene expression observed in Clusters 1-4. For example, if key negative regulators 
were expressed differentially between the MCMV and MCMVdie3 conditions, it 
could account for changes in downstream gene expression een in Clusters 1-4. This 
would particularly be the case if negative regulators of the innate immune response 
were expressed to higher levels during productive MCMV infection, leading to a 
suppressive effect that would appear to be the result of de novo viral proteins. To 
determine if such an effect was occurring, a list of negative regulators of toll-like 
receptor-mediated signalling was obtained from Liew et al(217). The expression 
levels of the mouse homologs of these negative regulators was used to give an 
indication of whether or not host factors were contributing to the regulation of genes 
in Clusters 1-4 at 4hpi. Table 5.1 shows the expression levels of negative regulator 
genes in mock, MCMV and MCMVdie3 infected BMDMs at 4hpi, corresponding to 






Table 5.1 –Expression level of negative regulators of Toll-like receptor-mediated 
signalling in response to MCMV and MCMVdie3 (normalized microarray 
intensity) 
 








Socs1  107.6 1338.0 1434.84 1.07 
Socs2  21.5 250.5 212.3 -1.17 
Socs3  10.6 81.4 134.2 1.65* 
Tnfaip3 A20 193.8 1060.9 1131.2 1.06 
Tollip  700.4 784.1 652.3 -1.20 
Pik3r1 PI3K 403.9 255.6 343.4 1.52* 
Nod2  38.6 107.9 162.9 -1.15 
Tmed1 St2L 96.0 162.4 140.7 1.02 
Irak3 Irak-m Below detection threshold Irak-m 
Sigirr  Below detection threshold 
 
Overall, the expression level of negative regulators in this list was similar between 
the MCMV and MCMVdie3 conditions (less than 1.5 fold difference at 4hpi). The 
only negative regulators in the list to have a 1.5 fold or greater difference in gene 
expression between MCMV and MCMVdie3 at 4hpi were Socs3 and Pik3r1 (a sub-
unit of PI3K). Although Socs3 is a well known negative regulator of innate immune 
signalling(82), the expression level of Socs3 and Pik3r1 was higher in response to 
MCMVdie3 than in response to MCMV, the opposite of what this exercise was 
trying to identify. This suggests, if anything, that Socs3 and Pik3r1 were suppressed 
during productive MCMV infection at 4hpi, and not expressed to higher levels 
during productive MCMV infection. This analysis suggested that at the beginning of 
the time period analyzed in section 5.2.2, the exprssion of negative regulators of the 






5.2.3 Functional annotation of co-expressed networks differentially regulated 
between MCMV and MCMVdie3  
 
Functional annotation of genes within Clusters 1-4 was conducted to help identify 
biological processes potentially affected by de novo viral proteins during productive 
MCMV infection. Within Cluster 1, innate immune signalling genes were found such 
as interleukins 10 and 18 (Il10, Il18), interleukin receptor components (Il18rap, 
Il21r, Il2ra, Il4ra), antimicrobial effector genes (Oas1b, Naip5) and members of the 
TNF superfamily (Tnfsf4, Tnfsf8). The negative regulator of IFN signalling Socs3 
was also in Cluster 1, as described above. In Cluster 2, genes involved in immune 
cell trafficking and leukocyte recruitment were found (Ccl8, Ccr1l1, Ccr2, Ccr3, 
Ccr5, Cd5l), as well as members of the Schlafen family (Slfn1, Slfn10), and toll-like 
receptors (Tlr9, Tlr13). The lower level of expression for these genes in the 
productive MCMV infection suggests possible suppression by de novo MCMV 
proteins. Genes in Cluster 1 were up-regulated early and transient in their expression, 
whereas genes in Cluster 2 were up-regulated late and sustained in their expression, 
indicating different kinetic classes of genes (Figure 5.3a-b). For a complete list of 
gene in Clusters 1 and 2, see Supplementary File 12. 
 
The down-regulated genes in Clusters 3 and 4 were seemingly blocked, or inhibited, 
in their down-regulation during productive MCMV infection (Figure 5.3c-d). This 
blocking, or inhibition effect was more pronounced in Cluster 4 (Figure 5.3d). Genes 
down-regulated in this manner were not associated with the innate immune response 
but were more associated with the cell cycle. In Cluster 3 (Figure 5.3c), there were a 
number of genes linked to cell cycle control (Ccdc21, Cdc35a, Chek2, Clock, Mcm3) 
and DNA/RNA polymerase activity (Pold2, Poldip2, Pole2, Polh, Polr1b, Polr3e). 
In Cluster 4 (Figure 5.3d) there were genes associated with ribosomal RNA 
processing (Rrp1b, Rrp8) and ATP/GTP-binding (Abcb6, Gtpbp4, Mtg1). For a 
complete list of gene in Clusters 3 and 4, see Supplementary File 13. 
 
To determine over-representation of annotation classes and biological processes for 





Analysis (IPA) were used. These tools identify functional links and associations 
between genes based on molecular and chemical interactions, cellular phenotypes, 
gene ontologies and disease processes. InnateDB is a manually-curated public 
database of interactions and pathways designed specifically to facilitate systems level 
analysis of the innate immune response. IPA is a commercial database and resource 
of molecular interactions from experimental platforms and from the literature. Both 
tools build interaction networks between genes based on their annotated molecular 
relationships. For the InnateDB and IPA analyses, the two up-regulated (induced) 
Clusters 1 and 2 were combined together into a single list, and the two down-
regulated (suppressed) Clusters 3 and 4 were combined together into a single list to 
simplify the interpretation.  
 
Using InnateDB, annotation of the up-regulated networks identified a highly 
significant over-representation of the Cytokine-cytokine receptor interaction pathway 
(KEGG map04060)(corrected p-value 6.91E-05). This suggests genes involved in 
this pathway are co-regulated in macrophages, and expressed to lower levels in 
response to productive MCMV infection. Using IPA, 27/153 of the genes in Clusters 
1 and 2 were found to have an association with the inflammatory response and 
21/153 with infectious disease. Genes with roles in the recruitment of leukocytes 
(Adora3, Ccr2, Ccr3, Ccr5, Hds, Il18, Kitlg, Txn), and genes involved in the IL10 
pathway (Il10, Ccr5, IL4r, Socs3) were also found.  
 
An interaction network for all genes in the up-regulated Clusters 1 and 2 was 
constructed using InnateDB. This network included all interactions between genes 
within the input list, and also incorporated secondary interactions with other genes in 





Figure 5.4 InnateDB interaction network of genes from Clusters 1 and 2.  
A network of interactions based on molecular and chemical interactions, cellular 
phenotypes, gene ontologies and disease processes wa  constructed using 153 highly 
correlated genes induced by MCMV and MCMVdie3 but expr ssed to lower levels 
in response to productive MCMV infection. Interactions between these genes, as well 

















The interaction network shown above suggests a high de ree of connectivity between 
the genes within Clusters 1 and 2, and indicates a number of ‘hub’ genes with many 
interactions to other genes in the network.   
 
Next, to identify a more focused network of genes from Clusters 1 and 2 representing 
a more defined area of biology, IPA was used to derive a network of 34 highly 








Figure 5.5 - Immune cell trafficking and leukocyte recruitment; Focused 
molecular interaction network from Clusters 1 and 2.  IPA was used to build an 
interaction network based on molecular and chemical interactions, cellular 
phenotypes, gene ontologies and disease processes. The most significant network 
constructed by IPA was associated with immune cell trafficking and leukocyte 
recruitment. Genes that were part of the original input list are shown in grey, and 




















Next, a similar network analysis was performed on dwn-regulated genes from 
Clusters 3 and 4 that were seemingly blocked, or inhib ted, by productive MCMV 
infection. InnateDB identified a number of significantly over-represented down-
regulated pathways including Metabolism of folate and pterines (p0.001), TRNA 
Aminoacylation (p0.002), Cell Cycle, Mitotic (p0.005), Activation of the pre-





replication (p0.007).  InnateDB was used to construct an interac ion network for all 
down-regulated genes in Clusters 3 and 4. This network included all interactions 
between genes in the input list and secondary interac ions with other genes in the 
genome (Figure 5.6). 
 
Figure 5.6 InnateDB interaction network of genes from Clusters 3 and 4.  
A network of interactions based on molecular and chemical interactions, cellular 
phenotypes, gene ontologies and disease processes wa  constructed using 306 genes 
down-regulated by MCMV and MCMVdie3 but block, or inh bited, in their down-
regulation by productive MCMV infection. Interactions between these genes, as well 

















The interaction network above shows a high degree of connectivity between genes 
blocked, or inhibited, in their down-regulation during productive MCMV infection. 
In particular, many genes within the nucleus involved in the cell cycle were found to 






To identify a more focused network of genes from Clusters 3 and 4 associated more 
with a common biological process, IPA was used to derive a network of highly 
associated genes (Figure 5.7). This network was highly enriched with annotation 
terms associated with cell cycle and DNA replication.  
  
Figure 5.7 - Cell cycle and DNA replication; Focused molecular interaction 
network of down-regulated genes in Clusters 3 and 4.  IPA was used to build an 
interaction network based on molecular and chemical interactions, cellular 
phenotypes, gene ontologies and disease processes from genes in Clusters 3 and 4. 
The most significant network constructed by IPA was as ociated with cell cycle and 
DNA replication. Genes part of the original input list are shown in grey, and 

























5.3 Identification of MCMV proteins capable of modulating macrophage gene 
expression during productive MCMV infection 
 
5.3.1 Detection of MCMV genes expressed at 12hpi in BMDMs 
 
After identifying macrophage gene expression networks differentially regulated 
during productive MCMV infection, the next step was to identify which MCMV 
proteins (or open reading frames) might be responsible for the modulation. For this 
analysis, the large MCMV genome of ~170 open reading frames (ORFs) was 
reduced down in any way possible to create a smaller candidate list of potential 
MCMV ORFs responsible. The first step in this process was to determine which 
MCMV ORFs were expressed in BMDMs in the relevant time frame. To do this, 
BMDMs were infected at MOI of 1 PFU/cell and total RNA was harvested from 
triplicate cultures at 6, 12 and 24hpi and hybridize  to the custom MCMV gene 
expression microarray to measure genome-wide MCMV transcript abundance (for 
details see Methods section 2.7.1.1). 
 
To identify only high-confidence MCMV ORFs expressed in BMDMs at12hpi, a 
stringent expression-level cut-off of a normalized log intensity value of 9 was used. 
This reduced the false positive rate and ensured only MCMV ORFs expressed to 
high confidence levels were identified. 70 MCMV ORFs were detectable at 12hpi to 







Table 5.2 - High confidence MCMV ORFs detectable in BMDMs at 12hpi. Total 
RNA was extracted from MCMV-infected BMDMs at 12hpi and was hybridized to a 
custom oligonucleotide MCMV microarray. Target probe intensities for MCMV 
ORFs were log transformed and normalized using a sub-set of positive control 































vMC003 m03 9.79  vMC086 M88 9.32 
vMC004 m04 11.59  vMC092 M94 10.87 
vMC006 m06 13.35  vMC096 M97 9.22 
vMC008 m08 10.24  vMC100 M102 12.69 
vMC013 m13 9.44  vMC103 M105 9.06 
vMC016 m16 10.39  vMC108 M113 11.00 
vMC017 m17 11.80  vMC109 M114 9.64 
vMC018 m18 12.47  vMC114 M118 12.19 
vMC020 m20 9.67  vMC115 m119 9.50 
vMC026 M25 10.53  vMC116 m119.1 10.63 
vMC027 m25.1 10.84  vMC117 m119.2 11.77 
vMC030 M28 11.34  vMC118 m119.3 9.36 
vMC034 M31 11.34  vMC121 m120 9.06 
vMC035 M32 9.06  vMC127 m124 11.13 
vMC037 M34 10.12  vMC132 m128 Ex3 9.42 
vMC038 M35 9.46  vMC136 m132 Ex2 12.71 
vMC039 M36 Ex1 9.24  vMC137 m132 Ex1 10.31 
vMC040 M36 Ex2 12.58  vMC141 m137 11.67 
vMC041 M37 12.68  vMC142 m138 13.19 
vMC042 M38 10.43  vMC143 m139 9.07 
vMC045 m41 11.72  vMC146 m142 11.57 
vMC046 m42 10.73  vMC149 m145 9.06 
vMC047 M43 11.40  vMC151 m147 11.59 
vMC049 M45 11.97  vMC156 m152 10.10 
vMC055 m48.2 11.06  vMC158 m154 11.61 
vMC056 M49 9.52  vMC159 m155 10.28 
vMC061 M54 9.59  vMC163 m159 9.34 
vMC064 M57 9.05  vMC164 m160 9.10 
vMC067 M69 9.96  vMC167 m163 10.44 
vMC070 M71 9.34  vMC168 m164 10.42 
vMC071 M72 10.68  vMC170 m166 11.58 
reM73c M73 9.28  vMC173 m169 13.00 
vMC077 M78 11.34  vMC176 m132 Ex2 12.80 
vMC079 M80 10.30  vMC180 m163 12.04 






5.3.2 Use of large-scale MCMV deletion mutants to identify MCMV ORFs capable 
of modulating macrophage gene expression during productive infection 
 
For experimental purposes, the list of 70 MCMV ORFs identified in the MCMV 
microarray analysis (Table 5.2) was still too long to test individual ORFs for their 
macrophage immune-modulating properties. Therefore, t  further reduce the list of 
potential candidate ORFs, an alternative approach was taken through the use of 
large-scale MCMV deletion mutants. The large-scale MCMV deletion mutants have 
large blocks of the MCMV genome deleted (60, 177), each of which contains a 
region of ~15 ORFs predicted to have role in immune-evasion. These deleted regions 
are removed from terminal ends of the MCMV genome which are not part of the 
essential conserved herpesvirus region. Their deletion, therefore, does not result in 
attenuation of viral growth in cell culture(60). Table 5.3 shows the three large-scale 
deletions mutants and the corresponding genomic regons deleted in each strain. 
Between the three strains, a total of 43 MCMV ORFs are deleted. 
 
Table 5.3 - MCMV deletion mutants with large regions of the genome removed. 
 
Strain name Genomic region 
deleted 
MCMV ORFs deleted  
MCMVdel1 Gene block 1 m01, m02, m03, m04, m05, m06, 
m07, m08, m09, m10, m11, m12, 
m13, m14, m15,m16 
MCMVdel6 Gene block 6 m144, m145, m146, m148, m149, 
m150, m151, m152, m153, m154, 
m155, m156, m157 
MCMVdel7 Gene block 7 m158, m159, m160, m161, m162, 
m163, m164, m165, m166, m167, 
m168, m169, m170 
 
To determine if MCMV ORFs responsible for modulating macrophage gene 
expression were located within the deleted regions of the MCMV mutants, a marker 
gene approach was used. The marker gene chosen was the toll-like receptor 9 gene 
(Tlr9) which would provide a representation of macrophage genes induced by 
MCMV and MCMVdie3, but expressed to lower levels in response to productive 





being significantly suppressed in response to productive MCMV infection compared 
to MCMVdie3 in qRT-PCR experiments (over 3-fold at the mRNA level - see Figure 
5.1). Tlr9 was also found in Cluster 2 of the co-expression network analysis (Figure 
5.3b), and Tlr9 is of high biological relevance given its direct role in the detection of 
MCMV dsDNA during infection (42, 148, 169, 200, 344). The Sectm1 gene (secreted 
and transmembrane 1) was also chosen for as a secondary marker for similar 
purposes. 
 
If Tlr9 was suppressed during infection with the large-scale MCMV deletion mutants 
relative to MCMVdie3, as it was during infection with wild-type MCMV, it would 
mean the viral ORF responsible for the suppression w uld not be located in the 
deleted regions. Alternatively, if the viral ORF responsible for the suppression was 
within the deleted region, the expression of Tlr9 should be de-repressed as was seen 
in response to MCMVdie3. If the ORF responsible for the suppression phenotype 
was not located within any of the three deleted regions, then at least a total of 43 
MCMV ORFs located within the deleted regions could be ruled out of the analysis. 
 
BMDMs were infected in parallel with MCMV, MCMVdie3, MCMVdel1, 
MCMVdel6, MCMVdel7 at MOI of 1 PFU/cell and total RNA was extracted from 
triplicate cultures at 10hpi. A deletion mutant forMCMV ORF M45 (MCMVd45) 
was also included in the analysis, given the known role of M45 in modulating the 
innate immune response during MCMV infection(45, 230, 64). Tlr9 transcript 
levels were then measured in response to each virus at 10hpi. Figure 5.8 shows the 
level of expression for Tlr9 at 10hpi in response to the each of the MCMV mutant 






Figure 5.8 Suppression of Tlr9 expression still occurs in response to MCMV 
large deletion mutant strains. BMDMs were infected at MOI of 1 PFU/cell with 
six different MCMV strains and total RNA was harvested at 10hpi. Transcript levels 
for Tlr9 (a) and Sectm1a (b) were measured in response to each strain using qRT-
PCR. Transcript levels were normalized to the cellular housekeeping gene Gapdh 
and calibrated to the first MCMV condition to show relative expression. Error bars 
indicate standard deviation from three separate cultures. Red arrows emphasize the 





















As shown in Figure 5.8, Tlr9 and Sectm1a were suppressed by wild-type MCMV 
infection (as emphasized by the red arrows), and expressed to higher levels in 
response to MCMVdie3. In response to the large-scale deletion mutants, however, 










indicated viral ORF responsible for the suppression of Tlr9 and Sectm1a was not 
located within the deleted genomic regions. It also ruled out M45 as a possible 
candidate for the phenotype.  
 
Taking this information into account, the list of candidate MCMV ORFs could now 
be shortened from 70 to 51 by removing any ORFs located within the three deleted 
regions from MCMVdel1, MCMVdel6 and MCMVdel7, and by removing M45. 
Also, any MCMV ORFs known to be encoding tegument pro eins or structural 
components of the virion (i.e glycoproteins etc) were also removed at this stage, 
reducing the list to 42 ORFs. 
 
 
Table 5.4 Remaining 42 candidate MCMV ORFs Of the 70 MCMV ORFs 
detectable at 12hpi during BMDM infection, 28 could be excluded from the analysis 
due to their location within one of the deleted genomic regions of the three large-

















Any further investigation to identify the MCMV ORF(s) responsible for modulation 
of macrophage gene expression was at this stage deeme  beyond the scope of the 
study.










vMC018 m18 12.47  vMC086 M88 9.32 
vMC020 m20 9.67  vMC096 M97 9.22 
vMC027 m25.1 10.84  vMC100 M102 12.69 
vMC030 M28 11.34  vMC103 M105 9.06 
vMC034 M31 11.34  vMC108 M113 11.00 
vMC037 M34 10.12  vMC109 M114 9.64 
vMC038 M35 9.46  vMC114 M118 12.19 
vMC039 M36 Ex1 9.24  vMC115 m119 9.50 
vMC040 M36 Ex2 12.58  vMC116 m119.1 10.63 
vMC041 M37 12.68  vMC117 m119.2 11.77 
vMC042 M38 10.43  vMC118 m119.3 9.36 
vMC045 m41 11.72  vMC121 m120 9.06 
vMC046 m42 10.73  vMC127 m124 11.13 
vMC047 M43 11.40  vMC132 m128 Ex3 9.42 
vMC056 M49 9.52  vMC136 m132 Ex2 12.71 
vMC064 M57 9.05  vMC137 m132 Ex1 10.31 
vMC070 M71 9.34  vMC141 m137 11.67 
vMC071 M72 10.68  vMC142 m138 13.19 
reM73c M73 9.28  vMC143 m139 9.07 
vMC077 M78 11.34  vMC146 m142 11.57 







The primary objective in this chapter was to identify macrophage gene expression 
networks modulated during productive MCMV infection a d determine their 
biological relevance to the macrophage innate immune response. This was achieved 
through temporal gene-expression profiling of macrophages infected with productive 
and non-productive MCMV, followed by a network clustering and functional 
annotation analysis. The secondary objective of the chapter was to identify MCMV 
ORFs responsible for immune-modulation in macrophages at the gene expression 
level between 4-10hpi. This secondary objective was not achieved, however a 
candidate list of 42 possible MCMV ORFs responsible for the phenotype was 
formulated.  
 
Suppression of ISG expression in response to productive MCMV infection 
 
Initially, nine ISGs were measured by qRT-PCR analysis in response to MCMV and 
MCMVdie3 infection. The ISGs were chosen due to their known or predicted role in 
the antiviral innate immune response to virus infection. Although the expression of 
almost all of ISGs measured was found to be lower in response to productive MCMV 
infection (Figure 5.1), the differences, overall, were quite small for many of the 
genes (fold change <2, p-values>0.02). This is likely due to the low level of infection 
achieved at MOI of 1 PFU/cell, and possibly due paracrine signalling in non-infected 
(bystander) cells in BMDM cultures.  In addition, there was no direct evidence that 
the lower level of expression for the ISGs was actully due to direct viral activity, as 
opposed to host factors. To investigate this point, the expression of negative 
regulator genes involved in innate immune suppression was assessed at 4hpi, and 
found to be similar (below 1.5 fold) between the MCV and MCMVdie3 conditions 
(Table 5.1) 
 
Tlr9 was expressed to significantly lower levels in response to productive MCMV 
infection compared to MCMVdie3. Transcript levels for Tlr9 were over three-fold 





of infection. This was by far the most significant difference detected for any of the 
nine ISGs measured by qRT-PCR analysis. This result suggested Tlr9 was 
suppressed with some degree of specificity by de novo MCMV proteins during 
productive MCMV infection. This result was of high biological relevance given the 
role of Tlr9 in the context of MCMV infection. Tlr9 has been shown by a number of 
studies to be involved in the direct recognition of CMV viral DNA in infected cells 
(42, 148, 169, 200, 344), and has also been shown t be a highly significant 
susceptibility factor for MCMV infection in Tlr9 knockout mice(344). In murine 
macrophages, the Tlr9 gene has been shown to be regulated by the PU.1 and ICSBP 
transcription factors(325), by interferon-regulatory factors (IRFs) 1 and 2(269), and 
by a distal regulatory region(127).  Suppression of Tlr9 expression would represent 
an immune evasion mechanism previously not described for MCMV. Direct 
evidence of the mechanism involved, and identification of the MCMV ORF 
responsible is still lacking. Recently, an EBV latent protein has been shown to 
suppress TLR9 mRNA in human primary B cells(93), suggesting targeting of TLR9 
may be conserved in other herpesviruses. 
 
Genome-wide identification of co-expressed gene networks differentially regulated in 
response to productive MCMV infection 
 
Many previous studies investigating the host respone to productive and non-
productive viral infection in fibroblasts and other non-immune cells report a strong 
suppression of type I IFN and ISGs expression in response to productive virus 
infection(43, 133, 263, 289). This is likely due to high levels of viral infection and an 
attenuated innate immune response in fibroblasts and no -immune cell types.  In the 
current study, however, due to the use of BMDMs, only a subtle modulation of the 
innate immune response was observed in response to productive MCMV infection. 
As a result, less conventional approaches were required to identify the subtle 
modulations in macrophage gene expression caused by MCMV activity. In addition, 
this study had the added objective of identifying co-regulated networks of genes, 






The approach used was to identify genes differentially expressed between MCMV 
and MCMVdie3 over the time course, then cluster these genes based on co-
expression. This lead to identification of four distinct groups, or clusters, of genes 
co-regulated and differentially expressed between MCMV and MCMVdie3 (Figure 
5.2). Subsequently, the four clusters of co-expressed genes (termed Clusters 1, 2, 3 
and 4) were investigating further using functional annotation and molecular 
interaction network analyses to determine the relationship of the genes to the 
macrophage response. 
 
Clusters 1 and 2 contained genes induced by MCMV and MCMVdie3, but expressed 
to lower level in response to productive MCMV infection (Figure 5.3a-b). Over-
representation of annotation categories for genes i these clusters included immune 
cell trafficking and leukocyte recruitment. This suggested MCMV may target these 
areas of biology for suppression during productive macrophage infection. Down-
regulated Clusters 3 and 4 contained genes involved in the cell cycle and DNA 
replication. Genes within these clusters were down-regulated by MCMV and 
MCMVdie3, but their down-regulation was inhibited (or blocked) by productive 
MCMV infection (Figure 5.3c-d). These genes were highly associated with the cell 
cycle and mitosis. 
 
Considering the annotation of the clusters in a biological context, the inhibition of 
leukocyte recruitment to a site of primary virus infection has clear benefits in giving 
the virus an overall replication advantage. Suppression of genes in Cluster 1 and 2 
may therefore reflect the ability of MCMV to inhibit immune cell recruitment during 
primary infection in vivo (237, 288), an observation which is consistent with a 
number of other studies(24, 27, 257).  
 
In relation to Clusters 3 and 4, the inhibition of apoptosis has been well described as 
an immune-evasion strategy for CMV(10, 119, 244, 379). Annotation of genes 
within these two clusters would be consistent with this activity (i.e. cell cycle and 





infection(105), and modulation of the cell cycle by CMV, in particular halting the 
cell cycle in G1 and G2 phase, has also been shown(10, 119, 244, 379).  
 
The adenosine A3 receptor (Adora3) was also up-regulated during the macrophage 
response to MCMV and MCMVdie3 but suppressed by productive MCMV infection. 
Adora3 has been shown to play an important role in haematopoiesis(146) and 
macrophage function(20, 21, 137, 238) in a number of different contexts. Interleukin 
10 (Il-10) and other members of the IL-10 signalling pathway (Il10, Ccr5, IL4r, 
Socs3) were also found to be induced by MCMV but suppressed by productive 
MCMV infection.  
 
Although the biological process reflected by the four co-expressed clusters are 
consistent with previously documented mechanisms of CMV immune evasion, there 
is still the possibility that genes within these clusters are regulated purely by host 
factors, and not affected by direct MCMV activity. This, in fact, was a major 
limitation of the line of experimentation used in this chapter. More mechanistic 
studies of MCMV proteins and their direct interaction with host factors will be 
required to directly link the activity of the virus to modulation of these genes. 
 
One such study that has already been conducted, is an investigation of Stat2 
modulation by the MCMV protein M27(392). This study showed M27 was capable 
of modulating the Stat2 transcription factor during the IFNγ antiviral signalling 
response. In relation to the four co-expressed geneclusters potentially modulated in 
BMDMs, it is possible that MCMV may target a specific transcription factor in a 
similar manner, and achieve coordinate modulation of many downstream co-
expressed genes. The possibility of M27 modulation of Stat2 in BMDMs is currently 










Identification of candidate MCMV proteins capable of modulating macrophage gene 
expression during productive infection 
  
After identifying macrophages genes potentially modulated by productive MCMV 
infection, an attempt was made to find which viral proteins might be responsible. 
This objective was always challenging given more than 170 ORFs are encoded in the 
MCMV genome, many of which have no annotation. The first step in this process 
was to identify MCMV ORFs expressed to high confidenc  levels in BMDMs at 
12hpi. This was done using a custom MCMV gene expression microarray with 
probes designed against coding MCMV ORFs. Although this exercise was valuable 
in narrowing down the number of potential ORFs respon ible, it was also subject to 
limitations associated with the sensitivity and specificity of the MCMV microarray. 
The variation in probe efficiency and arbitrary cut-off used to determine detection 
thresholds meant there was a high possibility of false negatives (i.e. MCMV ORFs 
expressed in the infected cell but not detected by the microarray). The MCMV 
microarray analysis did, however, effectively rule out a number of candidate ORFs 
from the analysis (Table 5.2).  
 
Next, three large-scale MCMV deletion mutants were us d to screen the MCMV 
genome for deleted regions that were rich in immune-evasion genes (Table 5.3). This 
approach was promising in principle, but the ORF responsible for the suppression of 
marker genes Tlr9 and Sectm1a was not found within any of the deleted regions 
(Figure 5.8). The final combined analysis left 42 remaining MCMV ORFs as 
potential candidates for the macrophage immune-modulation phenotype, excluding 
structural, virion-associated or tegument proteins (Table 5.4).  
 
Although the approach undertaken to identify the MCMV ORF responsible for the 
immune-modulation was somewhat informative, it was also flawed for a number of 
reasons. Firstly, it did not account for the fact that multiple MCMV ORFs could 
target macrophage transcriptional networks simultaneously, rather than just a single 
ORF.  The capacity for functional redundancy within the MCMV genome is 





four different networks individually. In this case, a single marker gene approach may 
not be valid. There is also the possibility that small non-coding RNAs, such as 
miRNAs were responsible for the phenotype, rather tan a protein-coding MCMV 
ORF. This in fact, is quite possible given the important role of miRNAs during 
MCMV infection(46, 47, 84, 85, 321).  
 
For the reasons outlined above, the investigation to identify the MCMV ORF 
responsible was deemed beyond the scope of the study. Ideally, a siRNA library 
would have been designed against all the remaining 42 MCMV ORFs, or indeed 
against the whole MCMV genome, and used to screen for the suppression of Tlr9. A 
siRNA screening approach, in this case, would be more systematic and tractable to 
identify candidate ORFs, however, was not possible due to the difficulty in 
transfecting primary BMDMs with siRNA without inducing apoptosis and/or the IFN 
response. 
 
Overall, in this chapter, macrophage gene expression networks were identified as 
potentially modulated by MCMV during productive infection. The mutant 
MCMVdie3 strain was again valuable in making this process possible. Some new 
aspects of macrophage biology may have been identified in relation to MCMV 
immune evasion at the gene expression level, however further experimentation will 
be required to confirm the significance of these findings. The complexity of the 
host/pathogen relationship has also been illustrated in this chapter, and  some results 
suggest MCMV is capable of targeting macrophage gens with specificity. 
Furthermore, it was found that MCMV appears to target the Tlr9 gene for 
suppression with particular specificity, potentially meaning MCMV suppresses the 
expression of its own pattern recognition receptor during productive macrophage 
infection.   
 
In the next chapter, aspects of host regulatory control of the macrophage 
transcriptome will be investigated, particularly in relation to the role of type I IFN in 
regulating the macrophage antiviral response to productive and non-productive 










The type I IFN pathway plays a key role in regulating the macrophage antiviral 
response, and controls the downstream expression of hundreds of antiviral genes 
during innate immunity. In the previous two chapters, macrophage gene expression 
networks have been identified representing different aspects of the macrophage 
response to productive and non-productive MCMV infection. The main objective of 
this chapter will be to determine the relative contribution of the type I IFN receptor 
in regulating each of these networks at the gene expression level. This will be done 
through transcriptional profiling of BMDMs derived from knockout mice lacking the 
Ifnar1 gene.  
 
The second objective of the chapter will be to conduct an exploratory analysis of 
gene expression in IFN-deficient BMDMs. This will involve use of BMDMs from 
from mice lacking the type I IFN receptor (Ifnar1-/-) and mice lacking the IFNβ gene 
(Ifnb1-/-), in comparison to wild-type BMDMs. Macrophages will be infected in 
parallel with productive and non-productive MCMV, or stimulated with polyIC, a the 
synthetic dsRNA inducer of type I IFN(242). Temporal gene expression profiling of 
the transcriptional responses to these stimuli will be performed, followed by a 
clustering analysis of the microarray data. This analysis will provide an insight into 
the kinetic regulation of IFN-dependent and IFN-independent gene expression during 
the macrophage antiviral response. 
 
Although gene expression profiling analyses of the LPS response in Ifnb1-/- 
macrophages(355) and the response to Listeria monocytogenes in Ifnar1-/- 
macrophages(210) has been conducted previously, the analysis presented here will 
provide the first account of macrophage temporal gene expression in response to 












































6.1 Experimental design  
 
To conduct a system-level temporal analysis of the macrophage innate immune 
response to productive and non-productive MCMV infection in wild type and IFN-
deficient macrophages, BMDMs were cultured in parallel from wild type mice (WT) 
and mice lacking either the IFNβ (Ifnb1-/-) or type I IFN receptor (Ifnar1-/-) gene. 
All mice were the same genetic background (C57BL/6), male and aged 10-12 weeks. 
On day 7, triplicate BMDM monolayers were either mock infected, infected with 
MCMV, infected with MCMVdie3, or stimulated with 10ug/ml synthetic 
polyinosinic-polycytidylic acid potassium salt (polyIC). Cell culture supernatants, 
total RNA samples, and whole cell lysates were harvested in triplicate every two 
hours between 0-10hpi and at 24hpi (for experimental overview see Figure 6.1). 0hpi 
corresponds to the end of the 1.5 hour viral adsorption period.  
 
Figure 6.1 Experimental overview Bone-marrow progenitor cells from male wild-
type, Ifnb1-/- or Ifnar1-/- C57BL/6 mice were flushed from mouse femurs and 
differentiated in parallel for seven days using conditioned medium containing M-
CSF1. Confluent BMDM monolayers were infected on day 7 with MCMV or 
MCMVdie3 at MOI 1 pfu/cell, or stimulated with 10ug/ml polyIC. Triplicate cell 
culture supernatants, cell lysates and total RNA samples were harvested every two 














Global gene expression profiling of BMDMs 
 
6.2 Microarray data processing and preliminary analysis 
 
Total RNA samples were harvested for each condition/cell type at 0, 2, 4, 6, 8, 10 
and 24hpi and hybridized to Affymetrix Mouse Gene 1.0ST arrays. A total of 72 
samples were hybridized with mock-infected samples taken at 0hpi and 24hpi for 
each cell type. An additional three MCMV-infected samples at -1 hpi (within the 
adsorption period) were also hybridized to complete the 72 sample data set.  
 
Quality control and normalization of raw microarray data was performed using 
standard Affymetrix analysis methodologies (see Methods section 2.7.2.3). A total of 
35,556 probes on the array were filtered based on their maximum expression level 
across the data set. The threshold of detection used for filtering genes was set 150 
(antilog), slightly above the threshold used for previous analyses. This was to ensure 
only high-confidence genes would be included in the final analysis. The value of 150 
corresponded to roughly the mean of all negative control probes plus three standard 
deviations. 19,118 probes had intensities above the detection threshold (above 150 in 
one or more samples across the data set) and were de me  ‘expressed’. The list of 
19,118 probes was further reduced to 13,244 annotated mouse genes by removing 
control probes and un-annotated probes.  
 
6.2.1 Expression of control probes and housekeeping ge es in wild type, Ifnb1-/- and 
Ifnar1-/- BMDMs  
 
The first step before proceeding to downstream microarray data analysis was to 
verify basal levels of gene expression in the different samples were equivalent 
between wild-type, Ifnb1-/- and Ifnar1-/- BMDMs. To do this, a cross-correlation 
matrix was generated based on 157 Affymetrix control p bes. The Affymetirx 
controls consist of negative control probes designed again non-mouse genes, and 
positive controls probes designed against mouse gens (for complete list of control 
probes see Supplementary File 14). The control probes were used to generate a 
measure of sample-to-sample correlation between the 72 samples in the data set. A 






































sample-to-sample comparison based on the 157 control probes. Pearson correlation is 
used to determine the rate of correlation between any two given samples. As seen in 
Figure 6.2, all samples within the data set were corelated to a high level 
(Pearson>0.934), indicating the expression of the 157 control probes was equivalent 
across all 72 samples. The level of correlation wasparticularly high between Ifnb1-/- 
and Ifnar1-/- samples (Pearson>98). 
 
Figure 6.2 - Sample-to-sample cross-correlation plot based 157 Affymetrix 
control probes. Correlation between 72 microarray samples was performed using 
Pearson correlation on sample-to-sample comparisons based on 157 Affymetrix 
control probes. Each square represents an individual sample-to-sample comparison 

















The cross-correlation matrix indicates 157 Affymetrix control probes were expressed 
to equivalent levels and highly correlated amongst all samples in the data set. This 
suggests array performance was consistent, and there were no outlier samples. It also 
suggests the basal level of transcription occurring in wild type, Ifnb1-/- and Ifnar1-/- 






Next, in order to check the expression of individual housekeeping genes (i.e genes 
required for maintenance of basal cellular function), three commonly used 
housekeeping genes; Beta actin (Actb), glyceraldehyde 3-phosphate dehydrogenase 
(Gapdh) and lactate dehydrogenase A (Ldha) were assessed. These genes were found 
to be expressed stably and consistently in wild type, Ifnb1-/- and Ifnar1-/- BMDMs 
(Figure 6.3), indicating transcription of housekeeping genes was comparable across 
wild type and IFN-deficient BMDMs.  
 
Figure 6.3 Housekeeping genes are expressed to equivalent levels in wild type, 
Ifnb1-/- and Ifnar1-/- macrophages. The expression profiles of Actb (a), Gapdh 
(b), and Ldha (c) are shown with normalized microarray intensity on the Y axis. 
Samples are arranged in temporal order on the X axis. The 0hpi time point represents 















































The next step was to assess the levels of basal endog ous type I IFN signalling in 
wild type versus Ifnar1-/- BMDMs. Deficiency in basal type I IFN signalling, both at 
the level of ISG expression and STAT1 phosphorylation, have been reported 
previously for Ifnar1-/- BMDMs compared to wild type (97). Fleetwood et al 
showed that basal expression of ISGs (i.e. Mx1, Mx2, Ifi203, Ccl5, Stat1, Stat2, 
Socs1 and Tlr3) was significantly higher in wild-type BMDMs compared to Ifnar1-/- 
due higher STAT1 phosphorylation and higher basal endogenous type I IFN 
expression. To determine if this was also the case in the current study using MCMV, 
expression levels of ISGs were compared in mock-infected wild type and Ifnar1-/- 
BMDMs at basal levels (Table 6.1) . Consistent with the Fleetwood et al study (97), 
the expression of a number of key ISGs was considerably higher in wild-type 
BMDMs than in Ifnar1-/- at basal levels. This included Oas1a, Oas2, Ifit1, Ifit3, Irf7, 
Mx1, Gbp2 and Stat1 which were all expressed two-fold or higher in wild-type 
BMDMs than in Ifnar1-/- (Table 6.1). This finding indicated the level of endogenous 
type I IFN signalling in wild type BMDM cultures was considerably higher than in 
Ifnar1-/-  BMDMs, an observation which was taken into consideration for the 
interpretation of all further data from this experiment. 
 
Table 6.1 - Genes expressed to higher levels in wild type BMDMs compared to 





6.2.2 Induction of innate immune response genes in Ifnb1-/- and Ifnar1-/- BMDMs  
 
To determine if the Ifnb1-/- and Ifnar1-/- BMDMs were still capable of inducing the 
innate immune response following the three treatmens, T f transcript levels were 
assessed across the data set. Tnf is an IFN-independent innate immune response gene 
activated upon viral infection(92). Tnf was up-regulated to equivalent levels in wild-
type, Ifnb1-/- and Ifnar1-/- BMDMs, however expression was sustained for a longer 
period in wild-type BMDMs. This indicated that IFN-deficient BMDMs were still 
capable of mounting an innate immune response to virus infection at the gene 
expression level (Figure 6.4). Icam1 (intercellular adhesion molecule 1) was also up-
regulated in all three treatments independently of IFN and provided further evidence 
of an intact IFN-independent innate immune response i  Ifnb1-/- and Ifnar1-/- 
BMDMs at the gene expression level. 
 
Figure 6.4 - Tnf and Icam1 are induced in Ifnb1-/- and Ifnar1-/- BMDMs in 
response to MCMV, MCMVdie3 and polyIC. The expression profiles of Tnf (a) 
and Icam1 (b)) are shown with normalized microarray intensity on the Y axis. 
Individual samples are arranged in temporal order on the X axis. The 0hpi time point 




































6.2.3 Expression of type I IFNs 
 
Next, IFNβ (Ifnb1) transcript levels were assessed across the dataset in response to 
the three stimuli (Figure 6.5). As expected, no If b1 expression was detectable from 
Ifnb1-/- BMDMs. In wild-type BMDMs Ifnb1 was induced in response to all three 
stimuli (MCMV, MCMVdie3 and polyIC). In agreement with the published 
literature(242), the synthetic ligand polyIC was found to be a potent and rapid 
inducer of IFNβ, and induced Ifnb1 transcripts over two-fold higher than MCMV 
infection at 0hpi.  The transcriptional induction of IFNβ was diminished in response 
to MCMVdie3 compared to MCMV in wild-type BMDMs. Low levels of Ifnb1 just 
above the limit of detection were observed in BMDMs lacking the type I IFN 
receptor (Ifnar1-/-) in response to MCMV and polyIC. The attenuated Ifnb1 levels in 





IFN signalling in Ifnar1-/- BMDM cultures, and evidence for an absence of the typ I 
IFN positive feedback loop.  
 
Figure 6.5 - Expression profile of Ifnb1 in response to MCMV, MCMVdie3 and 
polyIC in wild type, Ifnb1-/- and Ifnar1-/- macrophages.  The expression profile 
of Ifnb1 is shown with normalized microarray intensity on the Y axis. Individual 
samples are arranged in temporal order on the X axis. The 0hpi time point represents 


















To further investigate the role of Ifnb1 and Ifnar1 in the regulation of other type I 
IFNs, the expression levels for other type I IFNs on the array (other than Ifnb1) were 
assessed. The type I IFNs (other than Ifnb1) expressed above the limit of detection on 
the array were Ifna1, Ifna2, Ifna5 and Ifna7. Interestingly, none of these genes were 
found to be induced in Ifnb1-/- or Ifnar1-/- BMDMs, despite strong induction by 
MCMV and polyIC in wild type cells (Figure 6.6). This result also indicates the 






Figure 6.6 - The transcriptional induction of IFNα genes (Ifna1, Ifna2, Ifna5, 
Ifna7) is dependent on IFNβ signalling. The expression profiles of Ifna1 (a), Ifna2 
(b), Ifna5 (c) and Ifna7 (d) are shown with normalized microarray intensity on the Y 
axis. Individual samples are arranged in temporal order on the X axis. The 0hpi time 
















































6.2.4 Expression of CMV pattern recognition receptors  
 
The transcriptional regulation of pattern recognition receptor genes involved in 
detection of CMV was of general interest. Figure 6.7 shows the expression of Tlr3, 
Tlr9, Zbp1 and Aim2 in wild-type, Ifnb1-/- and Ifnar1-/- BMDMs. These genes are 
all inducible by MCMV infection and have a strong dependency on type I IFN 
receptor for their induction. 
 
Figure 6.7 - Pattern recognition receptors involved in the detection of MCMV 
are regulated in an IFN-dependent manner. The expression profiles of Tlr3 (a), 
Tlr9 (b), Zbp1 (c) and Aim2 (d) are shown with normalized microarray intensity on 
the Y axis. Individual samples are arranged in temporal order on the X axis. The 0hpi 




































6.3 Focused analysis of previously identified macrophage gene expression 
networks in the presence and absence of type I IFN signalling 
 
The main objective of this chapter is to determine the role of type I IFN in the 
regulation of macrophage gene expression networks identified in previous chapters. 
To do this, expression profiles in BMDMs derived from Ifnar1-/- mice were 
compared directly alongside wild-type BMDMs. In the data presented below, the 
Ifnb1-/- BMDMs and polyIC samples have been excluded from the analysis to 
simplify the interpretation and allow a straightforward comparison between wild-
type and Ifnar1-/- BMDMs.  
 
The networks of interest from previous chapters are summarized in Table 6.2. Genes 
from each of the networks were overlaid onto the new data set using unique 
Affymetrix probe IDs. 
 
Table 6.2 - Previously identified macrophage gene expression networks  
 
Chapter 
presented Network description 
No. of 
Genes 
Predicted function and 
relationship to type I IFN 
4 
Genes up-regulated in response to 
MCMV and MCMVdie3  
129 
PRR response, non-specific, 
IFN-dependent? 
4 
Genes down-regulated in response 
to MCMV and MCMVdie3  
362 
Non-specific, down-regulation 
of cell cycle 
4 
Genes up-regulated specifically in 
response to productive MCMV 
infection at 24hpi  
283 Antiviral? Proviral? Metabolic? 
5 
MCMV-modulated “Cluster 1”  
Up-regulated early, transient, 
Suppressed by productive MCMV 
100 
Antiviral? Specific to MCMV? 
partially IFN-dependent? 
5 
MCMV-modulated “Cluster 2” 
Up-regulated late, sustained 
Suppressed by productive MCMV 
53 
Antiviral? Specific to MCMV? 
partially IFN-dependent? 
5 
MCMV-modulated “Cluster 3”  
Down-regulated, partially blocked 
by productive MCMV 
236 
Antiviral? down-regulation of 
cell cycle, apoptosis-related, 
IFN-independent? 
5 
MCMV-modulated “Cluster 4” 
Down-regulated, completely 
blocked by productive MCMV 
70 
Antiviral? down-regulation of 






The expression of each network listed above will now be shown in wild-type and 
Ifnar1-/- BMDMs. The networks will be presented as heatmaps to show relative 
expression, and as mean expression profiles to showt e average difference between 
the MCMV and MCMVdie3 conditions. The expression levels in wild-type BMDMs 
will provide independent validation of the previous microarray experiment, and the 
expression levels in Ifnar1-/- BMDMs will indicate if type I IFN contributes to 
regulation at the gene expression level. 
 
6.3.1 Genes regulated in an equivalent manner in response to MCMV and 
MCMVdie3 infection 
 
The first gene networks to be assessed for their expression in IFN-deficient BMDMs 
were those induced or suppressed in an equivalent ma ner in response to MCMV and 
MCMVdie3 infection (as presented in Chapter 4). These networks represent the 
initial macrophage response to incoming structural components of the MCMV virion, 
and are regulated equivalently in response to MCMV and MCMVdie3 infection. The 
networks consisted of 129 genes up-regulated in an equivalent manner, and 362 
genes down-regulated in an equivalent manner. Figure 6.8 shows expression of the 
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Common up-regulation n=129 Mean profile n=129
Figure 6.8 - Expression of genes up-regulated and down-regulated in an 
equivalent manner in response to MCMV and MCMVdie3.  (i) Heatmaps show 
the relative expression of genes in wild-type and If ar1-/- BMDMs with each gene 
represented by a row and per-gene normalized to itsmean value to show relative 
expression. Yellow indicates an increase in expression relative to the mean and blue 
indicates a decrease. Genes are clustered based on similarity of expression profiles 
with similar genes connected at the hierarchical tree on the left. Columns represent 
different time points as indicated beneath the heatmap, and MCMV and MCMVdie3 
conditions are separated. Wild-type and Ifnar1-/- cells are also shown separately. (ii ) 
Mean expression profiles show the average expression level of the network in 

















As shown in Figure 6.8a i, the up-regulation of this network of genes is completely 
dependent on the type I IFN receptor. This result indicates genes up-regulated in an 
equivalent manner by MCMV and MCMVdie3 are IFN-depend nt. For the network 





(Figure 6.8b). This suggests type I IFN contributes to the down-regulation of these 
genes in response to MCMV and MCMVdie3.  
  
6.3.2 Genes differentially expressed between productive and non-productive MCMV 
infection 
 
Next, the four clusters identified in Chapter 5 as potentially MCMV-modulated were 
assessed for their regulation by type I IFN (Figure 6.9). The objective of this analysis 
was to determine if MCMV was targeting IFN-dependent or IFN-independent genes 
for modulation during productive infection. 
 
 
Figure 6.9 - Expression of gene networks modulated by productive MCMV 
infection. (i) Heatmaps show the relative expression of genes in wild-type and 
Ifnar1-/- BMDMs with each gene represented by a row and per-gene normalized to 
its mean value to show relative expression. Yellow indicates an increase in 
expression relative to the mean and blue indicates  decrease. Genes are clustered 
based on similarity of expression profiles with similar genes connected at the 
hierarchical tree on the left. Columns represent different time points as indicated 
beneath the heatmap, and MCMV and MCMVdie3 conditions are separated. Wild-
type and Ifnar1-/- BMDMs are also shown separately. (ii ) Mean expression profiles 
show the average expression level of the network in esponse to MCMV (light grey) 
and MCMVdie3 (dark grey) in both wild-type and Ifnar1-/- BMDMs. Red arrows 
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As shown in Figure 6.9a, Cluster 1 was again induce by both MCMV strains in 
wild-type BMDMs, but expressed to lower level in response to productive MCMV 
infection, relative to MCMVdie3. Strikingly, the induction of almost every gene in 
Cluster 1 was completely dependent on the type I IFN receptor, as genes in the 
cluster were non-inducible in Ifnar1-/- BMDMs. This suggests MCMV may be 
capable of suppressing IFN-regulated genes during poductive infection. Cluster 2 
also had a strong dependency on the type I IFN receptor, with only few genes 
inducible in Ifnar1-/- BMDMs (Figure 6.9b i). This provides further evidenc  
MCMV may target IFN-regulated gene expression for suppression during productive 
macrophage infection. The toll-like receptor 9 gene (Tlr9) was part of Cluster 2. 
 
Clusters 3 and 4 were down-regulated in response to MCMV and MCMVdie3, but 
blocked, or inhibited, in their down-regulation by productive MCMV infection in 
wild type BMDMs (Figure 6.9c-d). This effect was more apparent in Cluster 4, 
whereby the down-regulation of genes was almost completely blocked by productive 
MCMV infection (Figure 6.6d i). Surprisingly however, both of these down-
regulated clusters were found to have a strong dependence on the type I IFN receptor 
for their down-regulation.  
 
6.3.3 Genes up-regulated specifically in response to productive MCMV infection 
 
The final macrophage network to be assessed in the Ifnar1-/- BMDMs was the 
cluster of genes induced specifically in response to productive MCMV infection 
between 10-24 hpi, as identified in Chapter 4 (Figure 4.12). Assessing the expression 
of this group of genes in Ifnar1-/- BMDMs would determine if type I IFN played a 
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Figure 6.10 - Genes induced specifically by productive MCMV infection in wild-
type and Ifnar1-/- BMDMs. (i) Heatmaps show the relative expression of genes in 
wild-type and Ifnar1-/- BMDMs with each gene represented by a row and per-gene 
normalized to its mean value to show relative expression. Yellow indicates an 
increase in expression relative to the mean and blue indicates a decrease. Genes are 
clustered based on similarity of expression profiles with similar genes connected at 
the hierarchical tree on the left. Columns represent different time points as indicated 
beneath the heatmap, and MCMV, MCMVdie3 and polyIC conditions are separated. 
Wild-type and Ifnar1-/- BMDMs are also shown separately. (ii ) Mean expression 
profiles show the average expression level of the network in response to MCMV 
(light grey) and MCMVdie3 (dark grey) in both wild-type and Ifnar1-/- BMDMs. 
























As seen in Figure 6.10, this group of genes was again induced specifically by 
productive MCMV infection in wild-type BMDMs, and not in response to 
MCMVdie3 or polyIC. These genes were still inducible in Ifnar1-/- BMDMs, 
suggesting IFN-independent regulation.  
 
Overall, the behaviour of the different macrophage gene expression networks in wild 
type BMDMs was consistent with observations from previous experiments in 





6.4 Global exploratory analysis  
 
 6.4.1 Unsupervised clustering  
 
After investigating each of the macrophage networks from previous chapters in 
Ifnar1-/- BMDMs, the next step was to investigate global patterns of transcriptional 
regulation in the macrophage transcriptome. For this purpose, the Ifnb1-/- 
macrophages and the additional polyIC condition were included, and an exploratory, 
unsupervised clustering approach for the entire data se  of 72 samples was 
undertaken. For this analysis, the BioLayout Express 3D tool (103) was used.  
 
13,244 filtered microarray probes across 72 samples were imported into BioLayout 
3D and a network graph was generated using a cut-off level of Pearson=0.9 (for 
details see Methods). Using this approach, a network graph containing 3,517 highly 
connected genes was formed. This network contained all the genes most highly 
correlated and changing across the data set. To identify distinct cliques or clusters of 
co-expressed genes within the data set, the MCL algorithm was applied at a level of 
MCL=1.5 with minimum cluster number of n=15 (meaning only clusters with 15 or 
more genes would be included). Clustering with MCL resulted in 2,325 genes 
arranged into 24 different clusters of co-expression.  
 
An overview of the clusters will now be presented to assess the core relationship 
between IFN regulation and the macrophage antiviral response to MCMV. Gene lists 
for all clusters and over-represented functional annotation categories can be found in 
Supplementary Files 15-26. Clusters will be shown with the expression profiles of 
each individual gene in the cluster on a single axis with the mean cluster profiled 






6.4.2 IFN-independent genes  
 
6.4.2.1 Genes induced specifically in response to productive MCMV infection  
 
Upon clustering of the data, the largest group of genes to emerge were those up-
regulated specifically by productive MCMV infection at 24hpi (Figure 6.11). These 
genes had similar expression profiles to genes previously identified in Chapter 4 
(Figure 4.11, Figure 6.10), and were regulated in an IFN-independent manner. Using 
the clustering approach, however, identified considerably more genes with this 
profile (827 genes using the clustering analysis ver us 283 genes using the fold 
change cut-off in Chapter 4). This suggested there wer  considerably more genes up-
regulated specifically in response to productive MCMV infection than previously 
thought.  
 
Figure 6.11 - Genes induced specifically in response to productive MCMV 
infection are IFN-independent (n827). The individual expression profiles of every 
gene in the cluster are shown in grey and the average expression profile of the cluster 
is shown in solid blue. Normalized log microarray intensity is shown on the Y axis 















To determine functional annotation for the 827 genes up-regulated specifically in 
response to productive MCMV infection, the DAVID annotation tool(79) was used. 
Consistent with the previous analysis in Chapter 4, the genes up-regulated 
specifically in response to productive  MCMV infection at 24hpi had mostly 
metabolic annotation associated with glycoprotein and membrane activity, rather 
than associations with the innate immune response or IFN-signalling (Table 6.3). 
 
Table 6.3 - Functional annotation of genes up-regulated specifically in response 
to productive MCMV infection (n827). The DAVID annotation tool finds over-
represented functional annotation classes within a group of 827 highly correlated 
genes. The Category column indicates annotation database, the Term column 
indicates the functional annotation category of signif cance and the count column 
indicates the number of genes within the group associated with that term, also 
represented by a percentage (%). The unadjusted (PValue) and adjusted (Bonferroni) 
p-values columns show results from Fishers exact tests generated by DAVID. The 
top ten annotation classes are shown cut-off with a cut-off of Bonferroni p<0.005. 
 
Category n=827 Annotation Term Count % PValue Bonferoni 
SP_PIR_KEYWORDS glycoprotein 279 35.05 3.13E-29 1.16E-26 
GOTERM_CC_FAT GO:0005886~plasma membrane 249 31.28 2.33E-28 6.59E-26 
SP_PIR_KEYWORDS membrane 369 46.36 4.43E-28 1.64E-25 
SP_PIR_KEYWORDS signal 229 28.77 9.94E-23 3.69E-20 
SP_PIR_KEYWORDS cell membrane 155 19.47 3.47E-21 1.29E-18 
GOTERM_CC_FAT GO:0044459~plasma membrane part 140 17.59 3.54E-14 1.00E-11 
GOTERM_MF_FAT GO:0004714~transmembrane receptor 
protein tyrosine kinase activity 21 2.64 3.59E-14 2.51E-11 
SP_PIR_KEYWORDS disulfide bond 177 22.24 8.75E-14 3.25E-11 
SP_PIR_KEYWORDS Immunoglobulin domain 50 6.28 4.07E-10 1.51E-07 
SP_PIR_KEYWORDS cell junction 46 5.78 6.55E-10 2.43E-07 
 
In addition to the large cluster of 827 genes shown above, another smaller cluster 
induced specifically in response to productive MCMV infection was also found, but 
with earlier kinetics. This group of 62 genes was also induced independently of the 
type I IFN pathway, but did not contain any significantly over-represented functional 






Figure 6.12 - Genes induced specifically by productive MCMV infection at 8hpi 
are IFN-independent (n62).  The individual expression profiles of every gene i the 
cluster are shown in grey and the average expression profile of the cluster is shown 
in solid blue. Normalized log microarray intensity is shown on the Y axis and 





















6.4.2.2 Genes induced equivalently by MCMV, MCMVdie3 and polyIC in an IFN-
independent manner 
 
In contrast to genes induced specifically by productive MCMV infection, there were 
also many genes induced by all three stimuli (MCMV, MCMVdie3 and polyIC). 
Notably, these genes were early-response genes up-reg lated in an IFN-independent 
manner (Figure 6.13).  
 
Figure 6.13 - Pro-inflammatory genes induced in an equivalent manner by 
MCMV, MCMVdie3 and polyIC are IFN-independent (n48). The individual 
expression profiles of every gene in the cluster ar shown in grey and the average 
expression profile of the cluster is shown in solid blue. Normalized log microarray 
intensity is shown on the Y axis and individual samples are arranged in temporal 

















Genes in this group were mostly pro-inflammatory genes including tumor necrosis 





associated genes (Traf2, Fas), and transcription factors regulating apoptosis 
(Bcl2a1a, Bcl2a1b, Bcl2a1c, Bcl2a1d). These genes were induced rapidly by 0hpi 
(end of viral adsorption period) but were transient in their expression and returned to 
basal levels by 10hpi. This group represents IFN-independent early response genes, 
also described as primary response genes (PRGs)(134).This cluster of 48 genes is 
enriched with annotation terms associated with apoptosis (mmu04210 p1.11E-05, 
GO:0042981 p0.00323, GO:0043067 p0.003576). This suggested an apoptotic/NFkB 
response occurring independently of the type I IFN pathway. The rapid induction of 
this class of inflammatory genes has been shown to occur independently of new 
protein synthesis and chromatin remodelling after TLR stimulation(100, 247). These 
genes have also been shown to have unique promoter pr perties in order to allow 
rapid transcriptional induction(134).  
 
A similar group of 25 genes was found to be induced rapidly and independently of 
IFN, but the expression of these genes was shut-off quickly in Ifnb1-/- and Ifnar1-/- 
BMDMs (Figure 6.14). The expression of the genes, however, was sustained in wild 
type BMDMs. The profile suggests type I IFN only partially contributes to the 
regulation of these genes.  
 
Figure 6.14 - A sub-set of early response genes is induced rapidly by all stimuli 
but shut-off in the absence of IFN signalling (n25).  The individual expression 
profiles of every gene in the cluster are shown in grey and the average expression 
profile of the cluster is shown in solid blue. Normalized log microarray intensity is 























Amongst the group of 25 genes in Figure 6.14, which were induced rapidly but shut-
off in the absence of IFN signalling, was Irf1 (interferon regulatory factor 1) and the 
negative regulator of IFN signalling Socs3 (suppressor of cytokine signalling 3). 
Also in this cluster were macrophage activation markers MIP-1α (Ccl3) and MIP-1β 
(Ccl4), immune-stimulated transcription factors (Junb, Nfkbiz) and signalling 
components (Nod2, Tank). The profile of this cluster suggested co-ordinate 
regulation by both IFN and other mechanisms during the antiviral response, as genes 
were inducible in Ifnb1-/- and Ifnar1-/- BMDMs, but could not be sustained in their 
induction without type I IFN. In addition, genes within this cluster were induced very 
early by 0hpi (i.e. within the viral adsorption period) suggesting they are rapid-
response genes. Three individual examples of genes with this cluster are shown in 






Figure 6.15 – Expression of Ccl4, Irf1 and Socs3 is sustained in wild-type 
BMDMs but shut-off rapidly in Ifnb1-/- and Ifnar1-/- BMDMs. The expression 
profiles of Ccl4 (a), Irf1 (b) and Socs3 (c) are shown with normalized microarray 
intensity on the Y axis. Individual samples are arranged in temporal order on the X 
































Another important macrophage gene with the same expression profile was colony 
stimulating factor 1 (Csf1) which was induced to high and sustained levels in wild 
type BMDMs in response to MCMV, MCMVdie3 and polyIC, but induced to lower 
levels and shut-off in Ifnb1-/- and Ifnar1-/- BMDMs (Figure 6.16). 
 
Figure 6.16 -Transcriptional induction of Csf1 is partially dependent on the type 
I IFN receptor. The expression profile of Csf1 is shown with normalized microarray 
intensity on the Y axis. Individual samples are arranged in temporal order on the X 



















Returning to the clustering analysis, many genes were found to be down-regulated in 
an equivalent manner by MCMV, MCMVdie3 and polyIC, independently of the type 
I IFN pathway (Figure 6.17). Genes in this cluster w e significantly associated with 






Figure 6.17. IFN-independent down-regulation of genes in response to MCMV, 
MCMVdie3 and polyIC (n141).  The individual expression profiles of every gene 
in the cluster are shown in grey and the average expression profile of the cluster is 
shown in solid blue. Normalized log microarray intensity is shown on the Y axis and 

















A second cluster of 428 commonly down-regulated genes was also found with a 
slightly different expression profile (Figure 6.18). Annotation of these genes 
identified significant over-represented annotation erms associated with 
chromosomes, mitosis and cell division (Table 6.4). The down-regulation of these 
genes was more distinct in the wild-type BMDMs in comparison to the Ifnb1-/- and 






Figure 6.18 - IFN-independent down-regulation of cell cycle genes in response to 
MCMV, MCMVdie3 and polyIC (n428). The individual expression profiles of 
every gene in the cluster are shown in grey and the average expression profile of the 
cluster is shown in solid blue. Normalized log microarray intensity is shown on the Y 





















Table 6.4 - Annotation of genes down-regulated in response to MCMV, 
MCMVdie3 and polyIC in wild-type, Ifnb1 and Ifnar1-/- BMDMs (n428). The 
DAVID annotation tool finds over-represented functional annotation classes within a 
group of 428 highly correlated genes. The Category column indicates annotation 
database, the Term column indicates the functional annotation category of 
significance and the count column indicates the number of genes within the group 
associated with that term, also represented by a percentage (%). The unadjusted 
(PValue) and adjusted (Bonferroni) p-values columns show results from Fishers 
exact tests generated by DAVID. The top ten annotation classes are shown cut-off 
with a cut-off of Bonferroni p<0.005. 
 
Category Annotation Term Count % PValue Bonferoni 
GOTERM_CC_FAT GO:0005694~chromosome 98 27.00 1.67E-92 3.47E-90 
GOTERM_BP_FAT GO:0007049~cell cycle 124 34.16 2.26E-92 2.40E-89 
SP_PIR_KEYWORDS cell cycle 109 30.03 3.94E-91 8.47E-89 
GOTERM_CC_FAT GO:0044427~chromosomal part 86 23.69 1.30E-81 2.71E-79 
GOTERM_BP_FAT GO:0022403~cell cycle phase 93 25.62 2.81E-81 2.98E-78 
GOTERM_BP_FAT GO:0000279~M phase 88 24.24 1.72E-80 1.82E-77 
GOTERM_BP_FAT GO:0022402~cell cycle process 98 27.00 4.42E-80 4.68E-77 








150 41.32 3.55E-73 7.38E-71 







6.4.3 IFN-dependent genes 
 
6.4.3.1 IFN-dependent up-regulated genes  
 
The second largest cluster emerging from exploratory analysis contained 776 IFN-
inducible genes up-regulated by all three stimuli in w ld-type BMDMs, with partial 
dependency on Ifnb1 and complete dependency on type I IFN receptor (Figure 6.19).  
 
Figure 6.19. Interferon-stimulated genes induced in response to MCMV, 
MCMVdei3 and polyIC with partial dependency on Ifnb1 and complete 
dependency on Ifnar1 (n776). The individual expression profiles of every gene i 
the cluster are shown in grey and the average expression profile of the cluster is 
shown in solid blue. Normalized log microarray intensity is shown on the Y axis and 

















Within this cluster were known, or ‘classical’ ISGs including interferon-induced 





regulatory factors (Irf2, Irf7, Irf9), antimicrobial effectors (Mx1, Mx2, Oas1a, Oas1b, 
Oas1c, Oas1g, Oas2, Oas3), Jak-Stat signalling genes (Jak2, Stat1, Stat2), 
proteosome components (Psmb8, Psmb9, Tap1, Tap2), guanylate binding proteins 
(Gbp1, Gbp3, Gbp4, Gbp5), pattern recognition receptors (Tlr3, Tlr9, Tlr11, Zbp1) 
and many MHC class II genes (>10).  The cluster also contained interleukins (Il-6, Il-
10, Il-15, Il-18). A large number of non-annotated or ‘unknown’ genes with no 
previously annotation related to the IFN response were also found within this cluster 
(for complete list see Supplementary File 21).  Themoderate up-regulation of these 
genes in Ifnb1-/- BMDMs indicates some contribution of other type I IFNs (i.e. IFN 
alphas) in regulating ISG expression during the macrophage antiviral response. 
 
The cluster of 776 ISGs represents genes induced in response to both productive and 
non-productive MCMV infection, and in response to polyIC stimulation. These 
genes likely reflect the type I IFN-response induced through JAK-STAT signalling. 
Annotation of these genes, as expected, identified ov r-representation of classes 
associated with the innate immune response (GO:0006955 immune response 
p=8.03E-27, GO:009615 response to virus p=2.77E-08) and antigen presentation 
(GO:0019882 p=3.09E-07, GO:0042612 p=6.90E-05). Enriched pathways included 
Cytosolic DNA-sensing (mmu04623 p=0.002) and Toll-like receptor signalling 
(mmu04620 p=0.004) 
 
Although the induction of all ISGs within this cluster was found to be completely 
dependent on the type I IFN receptor, the induction of some genes also showed a 
strict dependency on the Ifnb1 gene which was not expected. The best examples of 
such genes were Gbp4, Serpina3f and Nos2 (Figure 6.20).  
 
 
Figure 6.20. The induction of some macrophage ISGs i  strictly dependent on 
Ifnb1. The expression profiles of Gbp4 (a), Sepina3f (b) and Nos2 (c) are shown 
with normalized microarray intensity on the Y axis. Individual samples are arranged 
in temporal order on the X axis. The 0hpi time point represents the end of the 1.5 














































The strict dependency of some, but not all ISGs on Ifnb1 indicates Ifnb1 may have 
some level of specificity in binding the type I IFN receptor and regulating a sub-set 
of ISGs. It is worth noting however that there were relatively few ISGs with this 
strict level of Ifnb1 dependency (i.e. not enough to form their own individual cluster) 
 
Despite small sub-sets of genes regulated with strict Ifnb1 dependency, most genes 
within the large cluster of 776 ISGs had only a partial dependency on Ifnb1 and were 
still semi-inducible in Ifnb1-/- BMDMs (see Figure 6.19). This indicates Ifnb1-/- 
BMDMs have an intermediate phenotype compared to Ifnar1-/- cells as inducers of 
ISGs. Examples of well known ISGs to highlight this intermediate phenotype in 
Ifnb1-/- BMDMs are Stat1, and Mx1 (Figure 6.21). 
 
Figure 6.21 - Induction of Stat1, and Mx1 is partially dependent on Ifnb1 
expression The expression profiles of  Stat1 (a) and Mx1 (b) are shown with 
normalized microarray intensity on the Y axis. Indivi ual samples are arranged in 
temporal order on the X axis. The 0hpi time point represents the end of the 1.5 hour 




























The expression profiles of Irf7, Stat1, and Mx1 in Ifnb1-/- BMDMs indicates other 
type I IFNs regulate ISGs in the absence of Ifnb1. This reflects the functional 
redundancy amongst type I IFNs during the macrophage antiviral response.  
 
A smaller cluster of genes was also found to be up-regulated in an IFN-dependent 
manner (Figure 6.22), but with later kinetics than the previous group. These late-
induced genes represent a secondary wave of IFN-depen nt gene expression 
peaking between 10-24hpi. These genes were induced to higher levels by polyIC 
than by MCMV infection, indicating a possible link to dsRNA response.  
  
Figure 6.22 – Genes induced with late kinetics expressed higher in response to 
polyIC than to MCMV (n86).  The individual expression profiles of every gene i 
the cluster are shown in grey and the average expression profile of the cluster is 
shown in solid blue. Normalized log microarray intensity is shown on the Y axis and 






















6.4.3.2 IFN-dependent down-regulated genes  
 
An interesting class of genes found in this study were those down-regulated by all 
three stimuli in an IFN-dependent manner. Figure 6.23 shows the common down-
regulation of 66 genes by MCMV, MCMVdie3 and polyIC in an IFN-dependent 
manner. 
 
Figure 6.23- Genes down-regulated in an IFN-dependent manner by MCMV, 
MCMVdie3 and polyIC (n66).  The individual expression profiles of every gene i 
the cluster are shown in grey and the average expression profile of the cluster is 
shown in solid blue. Normalized log microarray intensity is shown on the Y axis and 


















In addition to the cluster shown above, two other IFN-dependent down-regulated 
clusters were found. Figure 6.24 shows down-regulation of a cluster of 263 genes, 
whereby down-regulation only occurs in response to MCMVdie3 and polyIC in wild 





Ifnar1-/- BMDMs, the ability to down-regulate these genes has been completely lost, 
and in many cases de-repression or up-regulation of genes occurs in the absence of 
IFN signalling.  
 
Figure 6.24- IFN-dependent down-regulation inhibited during productive 
MCMV infection (n263).  The individual expression profiles of every gene i the 
cluster are shown in grey and the average expression profile of the cluster is shown 
in solid blue. Normalized log microarray intensity is shown on the Y axis and 

















The 263 genes shown above were functionally annotated using DAVID (see Table 
6.5), and this indicated highly significant over-repr sentation of genes associated 
with the nucleolus (p=5.4E-70) and membrane enclosed lumen (p=2.96E-49), and 






Table 6.5 - Annotation of 263 genes down-regulated in wild-type BMDMs, but 
de-repressed in Ifnb1-/- and Ifnar1-/- BMDMs. The DAVID annotation tool was 
used to find over-represented functional annotation classes within a group of  263 
highly correlated genes. The top ten over-representd annotation classes are shown. 
Category n=263 Annotation Term Count % PValue Bonferoni 
GOTERM_CC_FAT GO:0005730~nucleolus 72 28.8 3.65E-72 5.40E-70 
GOTERM_CC_FAT GO:0031974~membrane-enclosed lumen 92 36.8 2.00E-51 2.96E-49 
GOTERM_CC_FAT GO:0070013~intracellular organelle lumen 90 36 1.63E-50 2.41E-48 
GOTERM_CC_FAT GO:0043233~organelle lumen 90 36 2.04E-50 3.02E-48 




42 16.8 2.68E-47 1.67E-44 
GOTERM_BP_FAT GO:0042254~ribosome biogenesis 39 15.6 3.33E-46 2.07E-43 
GOTERM_BP_FAT GO:0034470~ncRNA processing 43 17.2 5.16E-46 3.21E-43 
GOTERM_BP_FAT GO:0034660~ncRNA metabolic process 46 18.4 1.44E-45 8.96E-43 
 
 
The other cluster to be found down-regulated in an IFN-dependent manner contained 
28 genes that were highly associated with the cholesterol and sterol biosynthesis 




Figure 6.25- IFN-dependent down-regulation of cholesterol biosynthesis genes 
(n28). The individual expression profiles of every gene in the cluster are shown in 
grey and the average expression profile of the cluster i  shown in solid blue. 
Normalized log microarray intensity is shown on theY axis and individual samples 




























Table 6.6 - Annotation of 28 genes down-regulated in response to MCMV, 
MCMVdie3 and polyIC in an IFN-dependent manner. The DAVID annotation 
tool was used to find over-represented functional anotation classes within a group 
of 28 highly correlated genes. The top ten annotation classes are shown. 
 
Category n=28 Annotation Term Count % PValue Bonferoni 
SP_PIR_KEYWORDS Steroid biosynthesis 17 68 9.04E-39 6.23E-37 
SP_PIR_KEYWORDS lipid synthesis 19 76 6.26E-37 4.32E-35 
SP_PIR_KEYWORDS sterol biosynthesis 14 56 2.07E-33 1.43E-31 








13 52 2.20E-29 3.57E-27 
GOTERM_BP_FAT GO:0016125~sterol metabolic process 16 64 2.21E-29 3.58E-27 
SP_PIR_KEYWORDS Cholesterol biosynthesis 12 48 5.39E-29 3.72E-27 
GOTERM_BP_FAT GO:0008610~lipid biosynthetic process 20 80 5.81E-29 9.41E-27 





Note: In order to improve the visualization and accessibility of microarray data 
generated in this experiment, an online web-visualization tool was created. This tool 
allows the user to query the data set based on gene symbol or Affymetrix Transcript 
ID. Individual expression profiles can be generated for any gene (probe) on the array. 
The web tool contains a database of expression profile images for every probe. These 
can be queried and returned as .png image files showing expression across all the 
conditions of the experiment. This tool is now available for members of the lab and 





6.5 Cytokine secretion in response to MCMV and MCMVdie3 in wild-type and 
Ifnar1-/- BMDMs 
 
Although many interesting observations had been made at the transcriptional level 
via the microarray profiling of IFN-deficient BMDMs, additional validation and 
assessment of macrophage immunological activity was required at the protein level. 
This would provide a more functional measure of immune activation in response to 
MCMV and MCMVdie3 infection in both the absence and presence of type I IFN 
signalling. For this purpose, a multiplexed bead-based ELISA assay was used to 
measure cytokine secretion in cell culture supernatants in response to MCMV and 
MCMVdie3 infection in wild-type and Ifnar1-/- BMDMs. Pro-inflammatory (TNFα, 
IL-6), chemoattractant (RANTES, MIG, MIP-2) and anti-i flammatory (IL-10) 
cytokines were measured at 2hpi, 6hpi and 10hpi and n mock-infected cells.  
 
As seen in Figure 6.26, the secretion of chemoattractant cytokines RANTES and 
MIG were found to be completely dependent on the typ  I IFN receptor. The 
secretion of MIP-2 however, was found to occur independently of IFN and was 
secreted in Ifnar1-/- (Figure 6.26). 
 
Figure 6.26 – Secretion of RANTES and MIG is dependent on the type I IFN 
receptor, but secretion of MIP-2 occurs in an IFN-independent manner. 
BMDMs from wild-type and Ifnar1-/- mice were infected at MOI of 1 PFU/cell with 
either MCMV or MCMVdie3 and secreted protein levels were measured in cell 
culture supernatants for RANTES (a ii), MIG (b ii), and MIP-2 (c ii). Error bars 
indicate standard deviation from three separate cultures. The response to MCMV is 
shown in light grey and the response to MCMVdie3 is shown in dark grey. mRNA 













































































The secretion of pro-inflammatory cytokines TNF and IL-6 were measured in 
response to MCMV and MCMVdie3 in wild type and Ifnar1-/- BMDMs (Figure 
6.27). TNF was induced independently of the IFN respon e in Ifnar-/- BMDMs, 
however levels of secretion for TNF were lower in Ifnar1-/- BMDMs compared to 
wild-type. The induction of IL-6, surprisngly, was found to be completely dependent 
on type I IFN receptor and no IL-6 was detectable in Ifnar1-/- BMDMs, at either the 
mRNA or secreted protein level.  
 
Figure 6.27 - Secretion of TNF is partially dependent on Ifnar1 and secretion of 
IL-6 in completely dependent on Ifnar1 in BMDMs infected with MCMV. 
BMDMs from wild-type and Ifnar1-/- mice were infected at MOI of 1 PFU/cell with 
either MCMV or MCMVdie3 and secreted protein levels were measured in cell 
culture supernatants for TNF (a ii) and IL-6 (b ii)). Error bars indicate standard 
deviation from three separate cultures. The response to MCMV is shown in light 
grey and the response to MCMVdie3 is shown in dark grey. mRNA microarray 
profiles for each gene are also shown on the left (i). 















































Figure 6.28 shows production of the anti-inflammatory cytokine IL-10 was also 
completely dependent on the type I IFN receptor. Again, in a similar manner to IL-6, 
induction of IL-10 at both the mRNA and protein level was undetectable in Ifnar1-/- 
BMDMs.  
 
Figure 6.28 – Secretion of IL-10 is dependent on Ifnar1 in BMDMs infected with 
MCMV. BMDMs from wild-type and Ifnar1-/- mice were infected at MOI of 1 
PFU/cell with either MCMV or MCMVdie3 and secreted protein levels were 
measured in cell culture supernatants for TNF (a ii) and IL-6 (b ii)). Error bars 
indicate standard deviation from three separate cultures. The response to MCMV is 
shown in light grey and the response to MCMVdie3 is shown in dark grey. mRNA 


















The primary objective of this chapter was to determine the role of type I IFN in 
regulating previously identified gene expression networks during the macrophage 
response to MCMV infection. This was achieved through dynamic gene-expression 
profiling of wild type and Ifnar1-/- BMDMs infected with MCMV and MCMVdie3. 
In addition, the relationship between type I IFN and the macrophage transcriptome 
was investigated in depth using an exploratory clustering approach. This uncovered 
an extensive body of data providing unique insights into the different classes of 
genes regulated by type I IFN during the macrophage innate immune response. 
Finally, in order to integrate transcriptional and protein level data, cytokine secretion 
was measured in wild type and Ifnar1-/- BMDMs in response to MCMV and 
MCMVdie3 infection. In order to aid the discussion, Table 6.7 provides a summary 
of the findings in this chapter;   
 
Table 6.7 Summary of Chapter 6 results 
 
Preliminary analysis 
Fig. Result Significance 
6.4 
Tnf and Icam1 are induced in Ifnb1-/- 
and Ifnar1-/- BMDMs 
Induction of innate immune response 
genes still occurs in Ifnb1-/-, Ifnar1-/- 
BMDMs  
6.5 
Ifnb1 induction is lower in Ifnar1-/- 
BMDMs than wild type 
Basal endogenous type I IFN signalling is 
lower in Ifnb1-/- and Ifnar1-/- BMDMs 
6.6 
Ifna1, Ifna2, Ifna5 and Ifna7 are not 
induced in Ifnb1-/- and Ifnar1-/- 
BMDMs 
Inducible type I IFN signalling is lower in 
Ifnb1-/- and Ifnar1-/- BMDMs 
6.7 
Induction of PRRs involved in MCMV 
detection (Tlr3, Tlr9, Zbp1, Aim2) is 
IFN-dependent 
Up-regulation of MCMV detection 
mechanisms in BMDMs is regulated by 
type I IFN  
Focused analysis on previously identified gene networks 
Fig. Result Significance 
6.8 
Genes up-regulated by MCMV and 
MCMVdie3 are strictly IFN-dependent 
Genes induced by viral entry and/or pre-
existing structural components of the 
virion are IFN-regulated 
6.8 
Genes down-regulated by MCMV and 
MCMVdie3 are partially IFN-
dependent 
Genes suppressed by viral entry and/or 
pre-existing structural components of the 






Gene networks potentially modulated 
by productive MCMV infection are 
IFN-dependent  
De novo MCMV proteins may modulate 




Genes induced specifically in response 
to productive MCMV are IFN-
independent  
Mechanisms other than type I IFN up-
regulate genes during the BMDM antiviral 
response to MCMV 
Exploratory clustering analysis  
Fig. Result Significance 
6.13 
Genes involved in apoptosis are 
rapidly up-regulated in an IFN-
independent manner 
The apoptosis/NFkB response to virus 
infection is not regulated by type I IFN  
6.14 
6.15 
Genes rapidly induced then shut-off in 
IFN-deficient BMDMs, but sustained 
in wild type BMDMs 
Some genes require coordinate regulation 
from type I IFN and other mechanisms for 
sustained induction 
6.16 
Induction of Csf1 is partially 
dependent on the type I IFN receptor  
Type I IFN plays a role in Csf1 regulation 
during the antiviral response in BMDMs 
6.17 
6.18 
Genes down-regulated in an IFN-
independent manner in response to all 
treatments 
Many of the processes suppressed during 
the macrophage innate immune response 
are not controlled by type I IFN 
6.19 
Transcriptional induction of 776 genes 
with a strict dependence on the type I 
IFN receptor  
776 “ISGs” in the BMDM transcriptome  
6.20 
Induction of Gbp4, Serpina3f and Nos2 
is strictly dependent on the Ifnb1 gene 
Some genes have a complete dependency 
on the Ifnb1 gene for their induction, and 
others do not 
6.23 
6.24 
Genes are down-regulated in an IFN-
dependent manner in response to 
MCMV 
Some down-regulated processes are 
controlled by type I IFN and others are not 
6.25 
Cholesterol biosynthesis genes are 
down-regulated upon MCMV infection 
in an IFN-dependent manner 
Metabolic pathways in addition to innate 
immune response pathways are regulated 
by type I IFN  
Cytokine secretion  




RANTES, MIG, IL-6, and IL-10 
secretion occurs in an IFN-dependent 
manner  
Regulation of some cytokines at the 
protein level is under strict IFN-control in 
BMDMs 
6.26 
MIP-2 secretion occurs in an IFN-
independent manner 
Regulation of some cytokines at the 
protein level are not under IFN control in 
BMDMs  
6.27 
TNF secretion is attenuated in If ar1-/-  
BMDMs in response to MCMV 
infection 
Type I IFN may contribute to the 









Before proceeding with in-depth analyses of the microarray data, it was important to 
first establish whether the data was reliable from a technical and biological 
perspective. The cross-correlation plot (Figure 6.2) helped achieve this by showing 
157 Affymetrix control probes highly correlated in their expression across all 
samples (Pearson>0.93). This indicated levels of transcription were comparable in 
the different samples, based on positive and negative controls, and that no outlier 
samples existed in the data set. In addition, commonly-used housekeeping genes 
Gapdh, ActB and Ldh were expressed to equivalent levels across all treatments and 
cell types.  
 
The basal expression of type I ISGs was found to be considerably higher in wild-type 
BMDMs that in Ifnar1-/- or Ifnb1-/- BMDMs (Table 6.1). This is likely to be due to  
higher levels of STAT1-phosphorylation and higher rates of basal endogenous type I 
IFN signalling in wild-type BMDM cultures. This would be consistent with data 
previously shown by Fleetwood et al(97). The wild type BMDMs can therefore not 
be considered equivalent at the initial point of infection in comparison to Ifnar1-/- 
BMDMs. The implication of this result effects the interpretation of all data in this 
chapter.  
 
As expected, Ifnb1 and Ifnar1 transcripts were not detected from the respective 
deleted loci in the knock-out BMDMs. Ifnb1 transcripts were detected in If ar1-/- 
BMDMs, but notably attenuated (Figure 6.5). This provided more evidence of lower 
basal endogenous type I IFN signalling in Ifnar1-/- BMDMs, and evidence of a lack 
IFNβ positive feedback (125, 149, 150). The IFNβ feedback loop has been 
previously described in the literature to amplify the type I IFN response after the 
initial wave of IFNβ induction. During the primary wave, IFNβ is induced and 
secreted from the cell, then binds to the type I IFN receptor in an autocrine or 
paracrine manner to activate signalling through the JAK-STAT pathway. JAK-STAT 
signalling then leads to IRF7 activation which, in turn, results in a second 





therefore dependent the type I IFN receptor for autocrine/paracrine signaling, and 
will, therefore, not occur in Ifnar1-/- BMDMs. A similar attenuation was also seen 
for the expression of I na1, Ifna2, Ifna5 and Ifna7 genes in Ifnar1-/- BMDMs, which 
is consistent with this interpretation (Figure 6.6). 
 
Expression of Ifna1, Ifna2, Ifna5 and Ifna7 genes, however, was lso attenuated in 
Ifnb1-/- BMDMs. In fact, these IFNα genes were not induced by any treatment in 
Ifnb1-/- or Ifnar1-/- cells, despite being induced to considerable levels in response to 
MCMV and polyIC in wild-type BMDMs (Figure 6.6). This result suggests that 
induction of Ifna1, Ifna2, Ifna5 and Ifna7 transcripts may also be dependent on the 
basal endogenous levels of IFN signalling, as well as the type I IFN positive 
feedback loop. A previous study also suggested IFNβ is required for induction of 
IFNα in mouse fibroblasts(90). 
 
Another factor worth consideration, is the possibility that a deletion of the Ifnb1 gene 
in construction of the Ifnb1-/- knockout mouse may have possibly caused a 
disruption in the expression of other type I IFN genes (Ifna1, Ifna2, Ifna5 and Ifna7) 
which are all located within ~160-320kb of the Ifnb1 locus on chromosome 4 of the 
mouse genome (NCBI37/mm9 July 2007 Assembly). It could be possible that 
deletion of the Ifnb1 gene may have affected the other IFNα genes given their close 
proximity to the Ifnb1 locus. Deletions in knock-out mice have been known to effect 
the expression of other genes in close proximity, especially those located on the 
opposite strand, or within the proximity of a regulatory region(266). Deletion of the 
Ifnar1-/- gene, however, could not have caused such an effect, as Ifnar1 is located on 
a different chromosome (chr.16) in comparison to the type I IFNs (chr.4). 
 
After assessing the expression of type I IFNs in wild-type, Ifnb1-/- and Ifnar1-/- 
BMDMs, Tnf and Icam1 transcript levels were assessed to determine if th IFN-
deficient BMDMs were still capable of mounting an in ate immune response against 
MCMV infection and polyIC. These are IFN-independent genes known to be 
involved in the innate immune response to infection. Tnf and Icam1 were strongly 





and polyIC (Figure 6.4). This result indicated that Ifnb1-/- and Ifnar1-/- BMDMs 
were still capable of mounting an innate immune respon e to MCMV infection and 
polyIC stimulation at the gene expression level. 
 
The transcriptional induction of intracellular pattern recognition receptors involved 
in detection of MCMV was also assessed as a general point of interest. This gave an 
indication as to the transcriptional profile for some key genes involved in the MCMV 
response. The expression profiles for Tlr3, Tlr9, Zbp1, and Aim2 were all regulated 
in an IFN-dependent manner and with similar kinetics (Figure 6.7).  
  
Focused analysis on previously identified gene networks 
 
The networks identified in previous chapters were ov rlaid onto the new microarray 
data and assessed in parallel for their expression in both the presence and absence of 
type I IFN signalling. This was a fruitful exercise and revealed a number of 
significant and unexpected results regarding the transcriptional control of these 
networks by type I IFN. 
  
Firstly, genes up-regulated as part of the initial PRR response to MCMV (i.e. genes. 
induced in an equivalent manner in response to MCMV and MCMVdie3) were 
strictly dependent on the type I IFN receptor for their regulation (Figure 6.8a). This 
result suggested the initial PRR response to incoming structural components of the 
MCMV virion is controlled by type I IFN in BMDMs. This observation is consistent 
with previous studies reporting IFN-induced transcription in response to both live 
and UV-inactivated virions early in the response(43, 211, 263, 330, 359). These 
genes may also be regulated by paracrine type I IFN signalling in BMDM cultures. 
 
Genes down-regulated equivalently by MCMV and MCMVdie3 infection were also 
found to have a strong dependency on the type I IFN receptor (Figure 6.8b). This 
observation suggests suppression of genes, as well as induction of genes, is under 
IFN-control during the early stages of the antiviral response (0-6hpi). Furthermore, it 





induce the down-regulation, as well as up-regulation, of many genes in an IFN-
dependent manner. Genes down-regulated in this fashion were mostly involved in 
cell cycle and DNA replication, suggesting a close link between type I IFN 
regulation and the cell cycle. This is consistent with the well-documented anti-
proliferative properties of type I IFNs(16, 26, 38). Genes in this group are also likely 
to be regulated, at least in part, by paracrine typI IFN signalling in BMDM 
cultures.  
 
The four gene networks identified as potentially modulated by productive MCMV 
infection in Chapter 5 (suppressed or inhibition by wild-type virus only) were also 
found to have a strong dependency on the type I IFN receptor for their regulation 
(Figure 6.9). This dependency was seen for up-regulated Cluster 1 and 2 (Figure 
6.9a-b), and down-regulated Clusters 3 and 4 (Figure 6.9c-d). This result indicated 
candidate genes potentially targeted for modulation by de novo MCMV proteins are 
part of the type I IFN response. However not all IFN-regulated genes appear to be 
affected in this manner. This may suggest that MCMV is capable of targeting certain 
sub-sets of IFN-regulated genes with specificity during productive infection. The 
ability of viruses to target the type I IFN response with some level of specificity has 
been described in detail (44, 185, 282, 295, 306, 37 76), including for 
MCMV(237), but the ability of MCMV to target specific transcriptional gene 
networks has not been described in depth. This effect may be related to the function 
of MCMV protein M27, which has been shown to modulate Stat2 activity during 
infection(392).  
 
If MCMV is capable of targeting macrophage gene expr ssion networks with 
specificity, it is logical that those networks should be involved in the antiviral 
response to MCMV infection. This appears to be the case, as the up-regulated 
MCMV-modulated gene networks are closely associated with immune cell 
trafficking and leukocyte recruitment (Figure 5.6), and were regulated in an IFN-
dependent manner (Figure 6.9a-b). The down-regulated candidate genes are 
associated with cell cycle control and apoptosis (Figure 5.8), areas which are known 






Further evidence of the specificity of MCMV in targeting certain macrophage genes 
during the antiviral response is the suppression of Tlr9 (discussed in detail in Chapter 
5). From a biological and evolutionary perspective, t is particularly logical for the 
virus to target the expression of PRRs directly involved in its own detection. Tlr9 is 
an example of this, and appears to be targeted with particular specificity by MCMV. 
The induction of the Tlr9 gene is also IFN-dependent (Figure 6.7), again suggesting 
MCMV may be capable of targeting specific IFN-regulated genes during 
macrophage infection. In the case of Tlr9, this effect may be restricted to mouse 
given that TLR9 is not expressed by human macrophages. 
 
Next, the network of genes induced specifically by productive MCMV infection 
between 10-24hpi was assessed. These genes were found to be induced in an IFN-
independent manner, specifically in response to productive MCMV infection (Figure 
6.10). These genes were induced to equivalent levels in wild type and Ifnar1-/- 
BMDMs, but were not induced by MCMVdie3 or polyIC in any cells. The clustering 
analysis further identified over 800 genes displaying a similar induction profile 
(induced specifically in response to productive MCMV infection, Pearson>0.9), 
suggesting this response is more widespread than origi ally thought. In fact, this 
class of genes was the most abundant class of any to be found by the clustering 
analysis (Figure 6.13). This indicates a marked difference in the transcriptomes of 
productively and non-productively infected BMDMs, even despite low levels of 
infection at MOI of 1.  
 
The unanswered question regarding these genes is still, however, are they pro- or 
anti-viral, or merely a metabolic bi-product of lytic infection? Further 
experimentation is ongoing to answer these questions. Functional annotation of this 
class of genes identified over-represented terms associated with glycoprotein 
(p1.16E-26) and plasma membrane (p6.59E-26). Although these terms are 
generalized and non-specific, they may indicate some requirement of membrane 
synthesis and/or glycoprotein production for newly synthesized MCMV virions 






Exploratory clustering analysis 
  
The core relationship between type I IFN and the macrophage transcriptome was 
made apparent by distinct clustering of co-expressed genes in the exploratory 
analysis. This identified of both IFN-dependent andIFN-independent gene clusters 
regulating during the macrophage response to MCMV infection.  
 
The profile of each cluster was presented, along with over-represented functional 
annotation terms for each cluster. The functional anotation analysis, although 
informative, was limited in describing the function f each cluster.  Some annotation 
terms (e.g. glycoprotein, phosphoprotein activity, membrane, and signal) were non-
specific and non-informative. Despite this, the functional annotation still provided a 
reasonable indication of gene activity for most of he different clusters. It also 
provided an indication of which biological processes were influenced most, or least, 
by type I IFN signalling.  
 
IFN-independent gene expression 
 
In addition to identifying genes directly regulated by type I IFN, it was also equally 
important to identify genes regulated in an IFN-independent manner.  IFN-
independent genes represent alternate signalling pathways activated in parallel to 
type I IFN during the antiviral response, and may therefore indicate distinct areas of 
biology not associated with type I IFN regulation. 
 
48 pro-inflammatory genes were induced in an IFN-independent manner in response 
to all three treatments (Figure 6.13). Genes in this group included Tnf, NF-kB 
subunits (Nfkb1, Nfkb2, Nfkbia, Nfkbie, Relb), TNF associated genes (Traf2, Fas), 
and transcription factors regulating apoptosis (Bcl2a1a, Bcl2a1b, Bcl2a1c, Bcl2a1d). 
The up-regulation of these genes represents an alter tive arm of the innate immune 
response induced by MCMV that is Myd88-dependent and regulated independently 





this group were apoptosis and NF-kB signalling, suggesting type I IFN does not 
contribute to the control of these processes at the transcriptional level in BMDMs.  
 
In the literature however, there is evidence of cross-talk between the type I IFN and 
NF-kB systems (88, 203, 304, 371), and the relationships between type I IFN and 
apoptosis (153, 179, 371), and type I IFN and the pro-inflammatory response (196). 
It is possible that the type I IFN and NF-kB responses are regulated independently at 
the transcriptional level, as seen in this study and elsewhere(120, 264), but interact or 
overlap at the protein level. Alternatively, some genes may play a role in signalling 
to both IFN and NF-kB pathways, but are regulated in a different manner to genes in 
this cluster.  
 
In addition to the up-regulation of IFN-independent genes, there were 25 genes 
induced rapidly (by 2hpi) in response to all three tr atments, but shutoff in Ifnb1-/- 
and Ifnar1-/- BMDMs by 6hpi (Figure 6.14 and 6.15). The expression of these genes 
in wild type BMDMs, however, was sustained until past 10hpi. Genes in this group, 
therefore, appear to be regulated by both IFN-dependent and IFN-independent 
mechanisms. It was notable that these genes, although attenuated, were still inducible 
in Ifnb1-/- and Ifnar1-/- BMDMs. This suggests their initial induction does not
require type I IFN signalling, however, their sustained expression does require IFN. 
Genes in this group included Irf1 and Socs3, and other important innate immune 
response genes (Ccl3, Ccl4, Junb, Nfkbiz, Nod2, Tank).  
 
Csf1 also displayed a similar profile to this cluster and was strongly induced by 
MCMV infection (Figure 6.16). This has potentially significant implications, as CSF-
1 is required for macrophage proliferation and survival (156). The induction of Csf1 
was higher in wild type BMDMs than Ifnb1-/- and Ifnar1-/- BMDMs, suggesting a 
contribution of type I IFN regulation to Csf1 induction. Evidence exists of regulation 
at the Csf1 promoter by NF-kB(147), AP1 and CNBP(195), cAMP and IL1α(183), 
the SWI/SNF-like BAF Complex(222). There has also been a report of IFNγ-





appears that Csf1 may be regulated by both IFN-dependent and IFN-independent 
factors. This also appears to be the case for Irf1(161, 192) and Socs3(19, 139, 292). 
 
The exploratory analysis identified clusters of genes down-regulated in an IFN-
independent manner in response to all three treatments (Figures 6.17 and 6.18). One 
of these clusters (Figure 6.18) contained 428 genes which were highly associated 
with the cell cycle (i.e. chromosome, cell cycle, cell cycle phase, M phase, cell 
division, mitosis etc). The p-values for over-representation of these annotation terms 
were highly significant (ranging from 3.47E-90 to 1.15E-70). This high level of 
significance suggests regulation of the cell cycle is under strict control at the gene 
expression level in BMDMs. These genes, however, wee only moderately 
influenced by type I IFN signalling. The generalized down-regulation of cell cycle 
genes during the macrophage innate immune response may be associated with a shift 







IFN-dependent gene expression 
 
One of the key novel aspects of conducting the transcriptional profiling analysis of 
IFN-deficient macrophages was to identify ISGs with a strict dependency on the type 
I IFN receptor. This would provide a level of mechanistic dependence above and 
beyond the ISGs described in current ISG databases(8, 72, 318) that have been 
derived based on exogenous IFN treatment.  
 
For this purpose, a cluster of 776 IFN-dependent inducible genes was identified 
(Figure 6.19). Genes in this cluster were generally induced strongly by MCMV, 
MCMVdie3 and polyIC in wild type BMDMs, and not induced in Ifnar1-/- BMDMs. 
This cluster effectively identifies ISGs during the macrophage innate immune 
response with a strict dependency on the type I IFN receptor for their induction. 
Interestingly, many genes within this cluster do not have annotation associated with 
the IFN response (for complete list see Supplementary File 21). 
 
Most genes in the ‘ISG’ cluster were induced to mild levels in Ifnb1-/- BMDMs, 
indicating either a partial contribution of other type I IFNs (i.e. IFNα genes), or a 
deficiency in basal type I IFN signalling in Ifnb1-/- BMDMs. IFNβ is known to have 
an increased affinity of binding to the type I IFN receptor in comparison to 
IFNα(204, 205, 215, 236, 296) which may explain, in part, the profile of this cluster. 
However, the expression of IFNα genes themselves was very low in Ifnb1-/- 
BMDMs (Figure 6.6), suggesting a lower basal level of endogenous IFN signalling 
prior to infection/stimulation.  
 
Some ISGs in the data set were completely non-induced in the Ifnb1-/- BMDMs, 
suggesting a complete dependency on the Ifnb1 gene. The best examples of such 
genes were Gbp4, Serpina3f and Nos2 (Figure 6.20). The strict dependency of these 
genes on Ifnb1 suggests redundancy amongst type I IFNs is not applicable for all 
ISGs. Examples of genes with this strict dependency, however, were rare and may be 
attributable to variations in probe efficiencies and/or signal below the limit of 






Genes down-regulated in an IFN-dependent manner also provided valuable insights 
into the type I IFN response (Figures 6.23, 6.24 and 6.25). One down-regulated gene 
cluster was blocked, or inhibited, in its down-regulation by productive MCMV 
infection (Figure 6.24). This group of genes was down-regulated in response to 
MCMVdie3 and polyIC, but not in response to the parental strain of MCMV in wild-
type BMDMs. Genes in this cluster were highly associated with the nucleolus, 
membrane enclosed lumen, and ribosome biogenesis (Table 6.5). These genes 
represent an area of biology possibly targeted by MCMV proteins during productive 
macrophage infection. 
 
If this is the case, it could be related to MCMV replication occurring in and around 
the nucleus, or could be related to specific de novo MCMV protein function. Viral 
proteins have been shown to localize to the nucleolus during HSV, IBV and HIV 
infection (reviewed in (372), and interactions betwen MCMV(50, 287) and 
HCMV(14, 383) proteins have been shown to occur with d stinct compartments of 
the nucleus during infection. Therefore, it may be possible that MCMV proteins 
influence the expression of nucleolus-related genes during infection. A direct 
functional link between the type I IFN response andthis group of genes is difficult to 
establish. IFN-induced proteins have also been report d to localize in the 
nucleolus(29, 59, 173, 221, 378), and it may be possible that these genes contribute 
to the regulation of this particular cluster.  
 
Finally, a group of 28 co-regulated genes were found to be down-regulated by all 
three treatments in wild type BMDMs, but not down-regulated in Ifnb1-/- or Ifnar1-/- 
BMDMs (Figure 6.25). This group indicated another biological process down-
regulated in an IFN-dependent manner, as genes in this cluster were highly 
associated with cholesterol biosynthesis and lipid metabolism (Table 6.6). This result 
suggests genes involved in cholesterol biosynthesis are regulated by type I IFN at the 
gene expression during the response to MCMV infection. This is consistent with the 







Overall, the results from the exploratory clustering analysis provided an unique 
insight into type I IFN regulation of macrophage gene expression during MCMV 
infection. These insights have not previously been made on this scale, especially in 
relation to the kinetics of IFN-regulated genes during virus infection. One other study 
however did investigate temporal gene expression in If b1-/- macrophages 
stimulated with LPS response (355) and found distinct patterns of macrophage gene 
expression affected by IFNβ. Many of the genes regulated by IFNβ in response to 
LPS were overlapping with genes regulated by IFNβ in response to MCMV 
infection. For example, genes such as Nos2 (iNOS), Cxcl10 (IP-10) and Il12 p40 had 
a strong dependency on IFNβ in both studies, whereas Tnf gene expression had little 
or no dependency on IFNβ in either study. Comparable measurements were also 
made at the secreted protein level for cytokines IP-10, RANTES and TNF in both 
studies. IP-10 and RANTES had a strong dependence on type I IFN for secretion in 
both cases, where as there was only a partial affect o  type I IFN on TNF secretion in 
both studies. 
 
Similar results were also seen in another study investigating the response to 
Coronavirus infection in Ifnar1-/- BMDMs(391). This study showed induction of 
IFNβ and ISGs (RIG-I, MDA5) was dependent on the type I IFN receptor in 
response to Coronavirus infection.  Secretion of cytokines CXCL10 and IL-10 was 
also shown to have a strong dependency on the type I rec ptor, whereas secretion of 
TNF was only partially reduced in Ifnar1-/- BMDMs. These observations were not 
seen in BMDCs used in the same study. 
 
The response to Listeria monocytogenes(210) has also been investigated in depth 
using Ifnar1-/- macrophages. The response to LPS and bacteria, however, has 
important differences to the antiviral response at the genome-wide level(174).Tissues 
from virus-infected IFN knockout mice have also been previously profiled using 
microarrays(120, 293), however these studies did not e compass any temporal 






In terms of the overall patterns of transcriptional regulation and genetic dependency 
observed in this study, it is unclear as to whether se patterns will be equivalent in 
other cell types, in other experimental settings, or indeed in vivo. There will certainly 
be some major differences in IFN-regulated gene expression in BMDMs and in other 
contexts, however for many genes, if a true mechanistic dependency on the type I 
IFN receptor does exists, the dependency should be maintained across other cell 
types and tissues. If this is the case, the level of inf rmation presented here should be 
of genuine value to the wider community.  
 
 
Cytokine secretion  
 
After conducting an extensive transcriptional profiling analysis of macrophages at 
the gene-expression level, it was also important to make measurements at the protein 
level to provide a more function indication of the response. Having data at both the 
transcriptional and protein level would provide a more comprehensive systems-level 
analysis in terms of understanding the response to productive and non-productive 
MCMV infection, especially in relation to type I IFN signalling. To achieve this, a 
multiplex bead-based ELISA assay was used to measur secreted cytokine levels 
BMDM supernatants in response to MCMV and MCMVdie3 infection. 
 
Pro-inflammatory (TNF, IL-6), chemoattractant (RANTES, MIG, MIP-2) and anti-
inflammatory (IL-10) cytokines were measured in wild type and Ifnar1-/- BMDMs at 
2hpi, 6hpi and 10hpi. These cytokines were chosen based on a) their known roles in 
the innate immune response, b) transcriptional profiles of interest from in the 
microarray data, and c) availability as part of a multiplexed ELISA platform (see 
Methods).  
 
Analysis of chemoattractant cytokine secretion indicated secretion of RANTES 
(Ccl5) and MIG (Cxcl9) were strictly dependent on the type I IFN receptor a  the 
protein level (Figure 6.26). This result indicated an example IFN-regulated cytokine 





(Cxcl9) were also not induced at the gene expression level in Ifnar1-/- BMDMs, 
suggesting a mechanistic dependency on type I IFN for their transcriptional 
regulation.  
 
In contrast, secretion of MIP-2 (Cxcl2) occurred independently of the type I IFN 
receptor (Figure 6.26). Expression of MIP-2 was equivalent or higher in Ifnar1-/- 
BMDMs than in wild type cells, at both the mRNA and protein level. This represents 
an example of IFN-independent chemoattractant cytokine secretion during the innate 
immune response in macrophages.  
 
TNF was secreted to high levels specifically in response to productive MCMV 
infection in wild type BMDMs as per previous experiments (see Chapter 4), however 
the levels of TNF secretion in Ifnar1-/- BMDMs were notably attenuated in 
comparison to wild type BMDMs (Figure 6.27). This result was unexpected as TNF 
regulation is controlled primarily by NF-kB and induction has been previously 
described to occur independent of IFN signalling(92, 281). Some evidence does, 
however, exist for the contribution of type I IFN signalling in regulation of TNF 
(355, 384).  
 
IL-6, which has also been shown to regulated primarily by NF-kB at the gene-
expression level(216, 327, 368), was induced in a strictly IFN-dependent manner. IL-
6 secretion was not detectable in If ar1-/- BMDMs, and Il6 transcripts were also 
below the detection limit of the microarray (Figure 6.27). This result was not 
expected, and suggested IL-6 may be regulated in an IFN-dependent manner in 
BMDMs. This is not consistent with the literature, as most published reports focus on 
the contribution of NF-kB in the transcriptional control of the Il6 gene(216, 327, 
368). Interestingly, however, interferon regulatory factor 1 (Irf1) has been shown to 
play a role in Il6 regulation(319). 
 
IL-10, the only anti-inflammatory cytokine to be measured, was also found to be 
induced in a strictly IFN-dependent manner at both the transcriptional and secreted 





traditionally not been associated with type I IFN signalling(201), and therefore the 
strict type I IFN dependency observed was not expected. The human Il10 gene has 
been shown to be regulated by Stat3(363), and mouse Il10 has also been shown to be 
regulated by type I IFN in response to LPS stimulation in BMDMs(97).  
 
The results for IL-6 and IL-10, from these experiments, suggest some degree of 
mechanistic dependence on type I IFN in BMDMs. This result, however, may be 
related to the attenuated level of basal endogenous type I IFN signalling in Ifnar1-/- 
BMDMs or the level of TNF in the BMDM supernatants. I  is also worth noting that 
protein levels for some of the cytokines, especially Il-6, were quite low (below 
200pg/ml). Although this level is still above the dtection limit of the assay, higher 
expression would give more confidence in the data. In ddition, the dependency of 
these factors on type I IFN could potentially be cell-type specific phenomenon, only 
seen in BMDMs. Again, further experimentation will be required to determine if this 
is the case.  
 
Overall, the cytokine data provided evidence of a close link between type I IFN 
regulation and the expression of chemoattractant, pro-inflammatory, and anti-
inflammatory cytokines during the macrophage antiviral response to MCMV, 








The results presented in this thesis represent a number of new findings. Firstly, a 
genetically modified MCMV strain has been used to represent attenuated (non-
productive) viral infection. This approach is an alternative to the UV-inactivation of 
MCMV which has been used for a number of previous st dies(18, 48, 373, 379). The 
approach of using the MCMVdie3 as an alternative to UV-MCMV has some key 
advantages, such as the propagation of large quantities of virus on a complementing 
cells line, and the avoidance of variation between UV-inactivation batches. The 
approach, however, also has some disadvantages includi g residual expression of IE 
genes by the mutant virus, and the potential for secondary site mutations during 
repeated passage in a complementing cell line.  
 
A major issue in this thesis was the low level of infection achieved in BMDM 
cultures at MOI of 1 PFU per cell. This meant the pnotypes measured in many of 
the BMDM experiments were possibly due to paracrine s gnalling factors, rather than 
the direct effects of viral infection. To avoid this problem, in hindsight a higher MOI 
could have been used, or alternatively a more permissive cell-type could have been 
used. The approach of using a high MOI in a more pemissive cell type is consistent 
with most of the comparable studies in the literature (43, 142, 260, 263, 289, 345). 
Using BMDMs, however, represents a more physiologically relevant system and a 
more robust innate immune response to viral infection.  
 
Despite the low levels of infection, important differences were still seen between the 
response to MCMV and MCMVdie3 at MOI for 1 PFU/cell in BMDMs. This was 
particularly the case for sub-sets of genes induced sp cifically by productive 
infection at 10-24hpi, and the secretion of TNF which occurred only in response to 
productive infection. These two results represent nw findings in light of the 





are sufficient to induce higher levels of innate immune signalling, either due to host 
factors or as a result of de novo MCMV proteins.  
 
The other novel aspect of the thesis is the time-seri  gene expression data generated 
using macrophages from wild-type, Ifnb1-/- and Ifnar1-/- BMDMs. This data 
represents a rich and unique resource that does not currently exist in the published 
literature. Other gene expression profiling studies have been conducted using cells 
from Ifnb1-/- and/or Ifnar1-/-  mice to investigate the LPS response in 
macrophages(355), the response to Listeria monocytogenes in macrophages (210), 
the response to MHV infection in mouse brain tissue (293), and the response to 
influenza in fibroblasts(120). The response to Coronavirus in Ifnar1-/- macrophages 
has also been measured, but only for a limited number of genes using qRT-
PCR(391). None of the abovementioned studies have the depth or resolution of 
temporal genome-wide profiling compared to the data generated in this thesis. The 
most similar study, which uses LPS stimulation(355), is comparable in many of the 
genes identified, but represents a distinct immune stimulus (LPS) compared to virus 
infection.  
 
The line of experimentation taken in this thesis, like for most studies, has been 
shaped by the range of techniques available over the period of the investigation. At 
the beginning of the study, there was a unique opportunity to have access to 
Affymetrix facilities, including wash, scan and hybridization stations. In addition, 
there was access to considerable expertise in microarray data analysis and 
bioinformatics, and an abundance of pre-existing microarray data generated from 
within the group. The BMDM culture system had also been optimized and was fully 
operational. For these reasons, a genomics data-driven approach in BMDMs, rather 
than a hypothesis-driven approach, was taken from the outset. 
 
There are a number of advantages and disadvantages in using a data-driven approach, 
as opposed to a purely hypothesis-driven approach. One of the key advantages is 
generating large data sets which are unbiased and can lead to unexpected and 





experiments based on data, rather than on preconceptions. The disadvantages of 
using a data-driven approach, however, are that investigations can often become 
observational and descriptive, rather than mechanistic in their scope, especially in the 
case of microarray data. This, I believe, has occurred somewhat with the current 
body of work, which could be considered by some to be descriptive, rather than 
mechanistic in its scope. In addition, generalized observations made at the gene 
expression level can often be misleading, and may not necessarily reflect the most 
important functional aspects. For these reasons, an attempt to expand the study to the 
protein level was made through the use of ELISA, and lthough this was informative, 
the study could still be further strengthened by the addition of more functional 
protein-level data. 
 
There are now a number of new techniques available to the group, either directly or 
through collaborators, that could improve the overall scope of this study. These were 
not available at the outset and include the use of proteomic and lipidomic profiling 
techniques to measure the macrophage response to MCMV infection. These 
techniques are now generating informative data sets to complement gene expression-
level observations made in this study.  In addition, the transcriptional regulation of 
macrophage genes can be investigated in more detailusing ChIP-seq analysis. 
Incorporating data from these new techniques, into the observations made in this 
study, would be undoubtedly beneficial to the overall understanding of the system. In 
addition, there are a number of other experiments that have been planned to follow 
up observations from made in this study. These include an investigation of the 
MCMV M27 ORF, and siRNA screening approach for IFN-dependent and IFN-
independent antiviral genes. Although screening will be conducted in fibroblasts, it 
should still provide valuable insights into the function of macrophage genes in 
relation to MCMV infection.  
 
Other key findings of this study include the suppression of Tlr9 by de novo MCMV 
proteins, the differential regulation of IL-10, and the specific up-regulation of genes 
in response to productive MCMV infection. These findings are being investigated 





were also been developed as part of this thesis. These are the qPCR assay to measure 
MCMV genome copies in infected cells, and the MCMVdie3 mutant virus which can 
now be used as a valuable control reagent. These tools are useful to other members 
of the group, and are already being used to aid other studies.  
 
The thesis has filled a niche in the field, and has provided the first investigation of 
the host response to productive and non-productive MCMV infection in 
macrophages. As a result, our understanding of the macrophage response to MCMV 
infection, and to virus infection in general, has been improved. The study has also 
provided arguably the most detailed account macrophage gene expression in the 
presence and absence of type I IFN signalling to dae. This should be of significant 
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transcriptomes 
 
Accepted for publication in The Journal of Virology, 30/03/2010 









1. 2001. Creating the gene ontology resource: design and implementation. 
Genome Res 11:1425-33. 
2. Abenes, G., M. Lee, E. Haghjoo, T. Tong, X. Zhan, and F. Liu. 2001. 
Murine cytomegalovirus open reading frame M27 plays n important role in 
growth and virulence in mice. J Virol 75:1697-707. 
3. Abraham, A. K., L. Kagan, S. Kumar, and D. E. Mager. Type I interferon 
receptor is a primary regulator of target-mediated drug disposition of 
interferon-beta in mice. J Pharmacol Exp Ther 334:327-32. 
4. Adam, E., J. L. Melnick, J. L. Probtsfield, B. L. Petrie, J. Burek, K. R. 
Bailey, C. H. McCollum, and M. E. DeBakey. 1987. High levels of 
cytomegalovirus antibody in patients requiring vascular surgery for 
atherosclerosis. Lancet 2:291-3. 
5. Adler, B., and C. Sinzger. 2009. Endothelial cells in human 
cytomegalovirus infection: one host cell out of many or a crucial target for 
virus spread? Thromb Haemost 102:1057-63. 
6. Alcami, A. 2003. Viral mimicry of cytokines, chemokines and their 
receptors. Nat Rev Immunol 3:36-50. 
7. Amit, I., M. Garber, N. Chevrier, A. P. Leite, Y. Donner, T. Eisenhaure, 
M. Guttman, J. K. Grenier, W. Li, O. Zuk, L. A. Schubert, B. Birditt, T. 
Shay, A. Goren, X. Zhang, Z. Smith, R. Deering, R. C. McDonald, M. 
Cabili, B. E. Bernstein, J. L. Rinn, A. Meissner, D. E. Root, N. Hacohen, 
and A. Regev. 2009. Unbiased reconstruction of a mammalian transcriptional 
network mediating pathogen responses. Science 326:257-63. 
8. Anan'ko, E. A., S. I. Bazhan, O. E. Belova, and A. E. Kel. 1997. 
[Mechanisms of transcriptional regulation of interferon-induced genes: 
description in the IIG-TRRD information system]. Mol Biol (Mosk) 31:701-
13. 
9. Anderson, P., K. Phillips, G. Stoecklin, and N. Kedersha. 2004. Post-
transcriptional regulation of proinflammatory proteins. J Leukoc Biol 76:42-
7. 
10. Andoniou, C. E., and M. A. Degli-Esposti. 2006. Insights into the 
mechanisms of CMV-mediated interference with cellular apoptosis. Immunol 
Cell Biol 84:99-106. 
11. Andrejeva, J., K. S. Childs, D. F. Young, T. S. Carlos, N. Stock, S. 
Goodbourn, and R. E. Randall. 2004. The V proteins of paramyxoviruses 
bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the 
IFN-beta promoter. Proc Natl Acad Sci U S A 101:17264-9. 
12. Angulo, A., P. Ghazal, and M. Messerle. 2000. The major immediate-early 
gene ie3 of mouse cytomegalovirus is essential for viral growth. J Virol 
74:11129-36. 
13. Ank, N., and S. R. Paludan. 2009. Type III IFNs: new layers of complexity 
in innate antiviral immunity. Biofactors 35:82-7. 
14. Arcangeletti, M. C., F. De Conto, F. Ferraglia, F. Pinardi, R. Gatti, G. 





Valcavi, S. V. Razin, C. Chezzi, and G. Dettori. 2003. Human 
cytomegalovirus proteins PP65 and IEP72 are targeted to distinct 
compartments in nuclei and nuclear matrices of infected human embryo 
fibroblasts. J Cell Biochem 90:1056-67. 
15. Asselin-Paturel, C., A. Boonstra, M. Dalod, I. Durand, N. Yessaad, C. 
Dezutter-Dambuyant, A. Vicari, A. O'Garra, C. Biron , F. Briere, and G. 
Trinchieri.  2001. Mouse type I IFN-producing cells are immature APCs with 
plasmacytoid morphology. Nat Immunol 2:1144-50. 
16. Bach, E. A., M. Aguet, and R. D. Schreiber. 1997. The IFN gamma 
receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol 
15:563-91. 
17. Baechler, E. C., F. M. Batliwalla, G. Karypis, P. M. Gaffney, W. A. 
Ortmann, K. J. Espe, K. B. Shark, W. J. Grande, K. M. Hughes, V. 
Kapur, P. K. Gregersen, and T. W. Behrens. 2003. Interferon-inducible 
gene expression signature in peripheral blood cellsof patients with severe 
lupus. Proc Natl Acad Sci U S A 100:2610-5. 
18. Bale, J. F., Jr., M. E. O'Neil, and T. Greiner. 1985. The interaction of 
murine cytomegalovirus with murine neutrophils: effect on migratory and 
phagocytic activities. J Leukoc Biol 38:723-34. 
19. Barclay, J. L., S. T. Anderson, M. J. Waters, and J. D. Curlewis. 2007. 
Characterization of the SOCS3 promoter response to prostaglandin E2 in 
T47D cells. Mol Endocrinol 21:2516-28. 
20. Barczyk, K., J. Ehrchen, K. Tenbrock, M. Ahlmann, J. Kneidl, D. 
Viemann, and J. Roth. Glucocorticoids promote survival of anti-
inflammatory macrophages via stimulation of adenosie receptor A3. Blood 
116:446-55. 
21. Barnholt, K. E., R. S. Kota, H. H. Aung, and J. C. Rutledge. 2009. 
Adenosine blocks IFN-gamma-induced phosphorylation of STAT1 on serine 
727 to reduce macrophage activation. J Immunol 183:6767-77. 
22. Barral, P. M., J. M. Morrison, J. Drahos, P. Gupta, D. Sarkar, P. B. 
Fisher, and V. R. Racaniello. 2007. MDA-5 is cleaved in poliovirus-
infected cells. J Virol 81:3677-84. 
23. Barton, G. M., and J. C. Kagan. 2009. A cell biological view of Toll-like 
receptor function: regulation through compartmentalization. Nat Rev 
Immunol 9:535-42. 
24. Basta, S., and J. R. Bennink. 2003. A survival game of hide and seek: 
cytomegaloviruses and MHC class I antigen presentatio  pathways. Viral 
Immunol 16:231-42. 
25. Bazzoni, F., N. Tamassia, M. Rossato, and M. A. Cassatella. 
Understanding the molecular mechanisms of the multifaceted IL-10-mediated 
anti-inflammatory response: lessons from neutrophils. Eur J Immunol 
40:2360-8. 
26. Beare, D., M. Learmonth, V. Wells, A. Aitken, and L. Mallucci. 1996. 
Characterisation and antiproliferative activity of an alpha-type murine 
interferon from embryonic fibroblasts. Biochim Biophys Acta 1310:81-5. 
27. Beisser, P. S., C. S. Goh, F. E. Cohen, and S. Michelson. 2002. Viral 





and interaction with the immune system. CMV chemokine receptors. Curr 
Top Microbiol Immunol 269:203-34. 
28. Bereczky, S., G. Lindegren, H. Karlberg, S. Akerstrom, J. Klingstrom, 
and A. Mirazimi.  Crimean-Congo hemorrhagic fever virus infection is lethal 
for adult type I interferon receptor-knockout mice. J Gen Virol 91:1473-7. 
29. Besse, S., D. Rebouillat, I. Marie, F. Puvion-Dutilleul, and A. G. 
Hovanessian. 1998. Ultrastructural localization of interferon-iducible 
double-stranded RNA-activated enzymes in human cells. Exp Cell Res 
239:379-92. 
30. Beutler, B. A. 2009. TLRs and innate immunity. Blood 113:1399-407. 
31. Bilban, M., L. K. Buehler, S. Head, G. Desoye, and V. Quaranta. 2002. 
Defining signal thresholds in DNA microarrays: exemplary application for 
invasive cancer. BMC Genomics 3:19. 
32. Bisbal, C., T. Salehzada, M. Silhol, C. Martinand, F. Le Roy, and B. 
Lebleu. 2001. The 2-5A/RNase L pathway and inhibition by RNase L 
inhibitor (RLI). Methods Mol Biol 160:183-98. 
33. Blanc, M., W. Y. Hsieh, K. A. Robertson, S. Watterson, G. Shui, P. 
Lacaze, M. Khondoker, P. Dickinson, G. Sing, S. Rodriguez-Martin, P. 
Phelan, T. Forster, B. Strobl, M. Muller, R. Riemersma, T. Osborne, M. 
R. Wenk, A. Angulo, and P. Ghazal. Host Defense against Viral Infection 
Involves Interferon Mediated Down-Regulation of Sterol Biosynthesis. PLoS 
Biol 9:e1000598. 
34. Boehme, K. W., M. Guerrero, and T. Compton. 2006. Human 
cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 
activation in permissive cells. J Immunol 177:7094-102. 
35. Boehme, K. W., J. Singh, S. T. Perry, and T. Compton. 2004. Human 
cytomegalovirus elicits a coordinated cellular antiviral response via envelope 
glycoprotein B. J Virol 78:1202-11. 
36. Bogdan, C., and C. Nathan. 1993. Modulation of macrophage function by 
transforming growth factor beta, interleukin-4, and i terleukin-10. Ann N Y 
Acad Sci 685:713-39. 
37. Bogdan, C., Y. Vodovotz, and C. Nathan. 1991. Macrophage deactivation 
by interleukin 10. J Exp Med 174:1549-55. 
38. Borden, E. C., G. C. Sen, G. Uze, R. H. Silverman, R. M. Ransohoff, G. 
R. Foster, and G. R. Stark. 2007. Interferons at age 50: past, current and 
future impact on biomedicine. Nat Rev Drug Discov 6:975-90. 
39. Borst, E. M., K. Wagner, A. Binz, B. Sodeik, and M. Messerle. 2008. The 
essential human cytomegalovirus gene UL52 is requird for cleavage-
packaging of the viral genome. J Virol 82:2065-78. 
40. Bourette, R. P., and L. R. Rohrschneider. 2000. Early events in M-CSF 
receptor signaling. Growth Factors 17:155-66. 
41. Bowie, A. G., and L. Unterholzner. 2008. Viral evasion and subversion of 
pattern-recognition receptor signalling. Nat Rev Immunol 8:911-22. 
42. Bozza, S., R. Gaziano, P. Bonifazi, T. Zelante, L. Pitzurra, C. 
Montagnoli, S. Moretti, R. Castronari, P. Sinibaldi, G. Rasi, E. Garaci, F. 
Bistoni, and L. Romani. 2007. Thymosin alpha1 activates the 
TLR9/MyD88/IRF7-dependent murine cytomegalovirus sensing for induction 





43. Browne, E. P., B. Wing, D. Coleman, and T. Shenk. 2001. Altered cellular 
mRNA levels in human cytomegalovirus-infected fibrolasts: viral block to 
the accumulation of antiviral mRNAs. J Virol 75:12319-30. 
44. Brukman, A., and L. W. Enquist. 2006. Suppression of the interferon-
mediated innate immune response by pseudorabies virus. J Virol 80:6345-56. 
45. Brune, W., C. Menard, J. Heesemann, and U. H. Koszinowski. 2001. A 
ribonucleotide reductase homolog of cytomegalovirus and endothelial cell 
tropism. Science 291:303-5. 
46. Buck, A. H., J. Perot, M. A. Chisholm, D. S. Kumar, L. Tuddenham, V. 
Cognat, L. Marcinowski, L. Dolken, and S. Pfeffer. Post-transcriptional 
regulation of miR-27 in murine cytomegalovirus infection. RNA 16:307-15. 
47. Buck, A. H., J. Santoyo-Lopez, K. A. Robertson, D. S. Kumar, M. 
Reczko, and P. Ghazal. 2007. Discrete clusters of virus-encoded micrornas 
are associated with complementary strands of the genom  and the 7.2-
kilobase stable intron in murine cytomegalovirus. J Virol 81:13761-70. 
48. Budt, M., L. Niederstadt, R. S. Valchanova, S. Jonjic, and W. Brune. 
2009. Specific inhibition of the PKR-mediated antiviral response by the 
murine cytomegalovirus proteins m142 and m143. J Virol 83:1260-70. 
49. Busche, A., A. Angulo, P. Kay-Jackson, P. Ghazal, and M. Messerle. 
2008. Phenotypes of major immediate-early gene mutants of mouse 
cytomegalovirus. Med Microbiol Immunol 197:233-40. 
50. Buser, C., F. Fleischer, T. Mertens, D. Michel, V. Schmidt, and P. 
Walther. 2007. Quantitative investigation of murine cytomegalovirus 
nucleocapsid interaction. J Microsc 228:78-87. 
51. Calvo-Pinilla, E., J. M. Nieto, and J. Ortego. Experimental oral infection of 
bluetongue virus serotype 8 in IFNAR(-/-) mice. J Gen Virol. 
52. Cannon, M. J., D. S. Schmid, and T. B. Hyde. Review of cytomegalovirus 
seroprevalence and demographic characteristics associ ted with infection. 
Rev Med Virol 20:202-13. 
53. Cardin, R. D., G. B. Abenes, C. A. Stoddart, and E. S. Mocarski. 1995. 
Murine cytomegalovirus IE2, an activator of gene expr ssion, is dispensable 
for growth and latency in mice. Virology 209:236-41. 
54. Caruso, C., S. Buffa, G. Candore, G. Colonna-Romano, D. Dunn-
Walters, D. Kipling, and G. Pawelec. 2009. Mechanisms of 
immunosenescence. Immun Ageing 6:10. 
55. Cecchini, M. G., M. G. Dominguez, S. Mocci, A. Wetterwald, R. Felix, H. 
Fleisch, O. Chisholm, W. Hofstetter, J. W. Pollard, and E. R. Stanley. 
1994. Role of colony stimulating factor-1 in the establishment and regulation 
of tissue macrophages during postnatal development of the mouse. 
Development 120:1357-72. 
56. Chan, G., E. R. Bivins-Smith, M. S. Smith, P. M. Smith, and A. D. 
Yurochko. 2008. Transcriptome analysis reveals human cytomegalovirus 
reprograms monocyte differentiation toward an M1 macrophage. J Immunol 
181:698-711. 
57. Child, S. J., and A. P. Geballe. 2009. Binding and relocalization of protein 





58. Chiu, Y. H., J. B. Macmillan, and Z. J. Chen. 2009. RNA polymerase III 
detects cytosolic DNA and induces type I interferons through the RIG-I 
pathway. Cell 138:576-91. 
59. Choubey, D., and P. Lengyel. 1992. Interferon action: nucleolar and 
nucleoplasmic localization of the interferon-inducible 72-kD protein that is 
encoded by the Ifi 204 gene from the gene 200 cluster. J Cell Biol 116:1333-
41. 
60. Cicin-Sain, L., I. Bubic, M. Schnee, Z. Ruzsics, C. Mohr, S. Jonjic, and 
U. H. Koszinowski. 2007. Targeted deletion of regions rich in immune-
evasive genes from the cytomegalovirus genome as a novel vaccine strategy. 
J Virol 81:13825-34. 
61. Cicin-Sain, L., Z. Ruzsics, J. Podlech, I. Bubic, C. Menard, S. Jonjic, M. 
J. Reddehase, and U. H. Koszinowski. 2008. Dominant-negative FADD 
rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral 
gene. J Virol 82:2056-64. 
62. Coelho, L. F., G. Magno de Freitas Almeida, F. J. Mennechet, A. Blangy, 
and G. Uze. 2005. Interferon-alpha and -beta differentially regulate 
osteoclastogenesis: role of differential induction of chemokine CXCL11 
expression. Proc Natl Acad Sci U S A 102:11917-22. 
63. Collins, S. E., R. S. Noyce, and K. L. Mossman. 2004. Innate cellular 
response to virus particle entry requires IRF3 but not virus replication. J Virol 
78:1706-17. 
64. Compton, T. 2004. Receptors and immune sensors: the complex entry path 
of human cytomegalovirus. Trends Cell Biol 14:5-8. 
65. Compton, T., E. A. Kurt-Jones, K. W. Boehme, J. Belko, E. Latz, D. T. 
Golenbock, and R. W. Finberg. 2003. Human cytomegalovirus activates 
inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 
77:4588-96. 
66. Compton, T., R. R. Nepomuceno, and D. M. Nowlin. 1992. Human 
cytomegalovirus penetrates host cells by pH-independent fusion at the cell 
surface. Virology 191:387-95. 
67. Conway, J. G., R. C. Andrews, B. Beaudet, D. M. Bickett, V. Boncek, T. 
A. Brodie, R. L. Clark, R. C. Crumrine, M. A. Leenitzer, D. L. 
McDougald, B. Han, K. Hedeen, P. Lin, M. Milla, M. Moss, H. Pink, M. 
H. Rabinowitz, T. Tippin, P. W. Scates, J. Selph, S. A. Stimpson, J. 
Warner, and J. D. Becherer. 2001. Inhibition of tumor necrosis factor-alpha 
(TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor 
of TNF-alpha-converting enzyme and matrix metalloproteinases. J Pharmacol 
Exp Ther 298:900-8. 
68. Dalod, M., T. P. Salazar-Mather, L. Malmgaard, C. Lewis, C. Asselin-
Paturel, F. Briere, G. Trinchieri, and C. A. Biron. 2002. Interferon 
alpha/beta and interleukin 12 responses to viral infections: pathways 
regulating dendritic cell cytokine expression in vivo. J Exp Med 195:517-28. 
69. Davison, A. J. 2002. Evolution of the herpesviruses. Vet Microbiol 86:69-88. 
70. De Flora, S., C. Grassi, and L. Carati. 1997. Attenuation of influenza-like 
symptomatology and improvement of cell-mediated immunity with long-term 





71. de Jong, H. K., T. van der Poll, and W. J. Wiersinga. The systemic pro-
inflammatory response in sepsis. J Innate Immun 2:422-30. 
72. de Veer, M. J., M. Holko, M. Frevel, E. Walker, S. Der, J. M. Paranjape, 
R. H. Silverman, and B. R. Williams. 2001. Functional classification of 
interferon-stimulated genes identified using microar ays. J Leukoc Biol 
69:912-20. 
73. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de 
Vries. 1991. Interleukin 10(IL-10) inhibits cytokine synthesis by human 
monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp 
Med 174:1209-20. 
74. DeFilippis, V. R. 2007. Induction and evasion of the type I interferon 
response by cytomegaloviruses. Adv Exp Med Biol 598:309-24. 
75. DeFilippis, V. R., D. Alvarado, T. Sali, S. Rothenburg, and K. Fruh. 
Human cytomegalovirus induces the interferon respone via the DNA sensor 
ZBP1. J Virol 84:585-98. 
76. DeFilippis, V. R., T. Sali, D. Alvarado, L. White, W. Bresnahan, and K. 
J. Fruh. Activation of the interferon response by human cytomegalovirus 
occurs via cytoplasmic double-stranded DNA but not glycoprotein B. J Virol 
84:8913-25. 
77. Delaloye, J., T. Roger, Q. G. Steiner-Tardivel, D. Le Roy, M. Knaup 
Reymond, S. Akira, V. Petrilli, C. E. Gomez, B. Perdiguero, J. Tschopp, 
G. Pantaleo, M. Esteban, and T. Calandra. 2009. Innate immune sensing 
of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, 
MDA-5 and the NALP3 inflammasome. PLoS Pathog 5:e1000480. 
78. Deleault, K. M., S. J. Skinner, and S. A. Brooks. 2008. Tristetraprolin 
regulates TNF TNF-alpha mRNA stability via a proteasome dependent 
mechanism involving the combined action of the ERK and p38 pathways. 
Mol Immunol 45:13-24. 
79. Dennis, G., Jr., B. T. Sherman, D. A. Hosack, J. Yang, W. Gao, H. C. 
Lane, and R. A. Lempicki. 2003. DAVID: Database for Annotation, 
Visualization, and Integrated Discovery. Genome Biol 4:P3. 
80. Deonarain, R., A. Alcami, M. Alexiou, M. J. Dallman, D. R. Gewert, and 
A. C. Porter. 2000. Impaired antiviral response and alpha/beta interferon 
induction in mice lacking beta interferon. J Virol 74:3404-9. 
81. Deonarain, R., D. Cerullo, K. Fuse, P. P. Liu, and E. N. Fish. 2004. 
Protective role for interferon-beta in coxsackievirus B3 infection. Circulation 
110:3540-3. 
82. Dimitriou, I. D., L. Clemenza, A. J. Scotter, G. Chen, F. M. Guerra, and 
R. Rottapel. 2008. Putting out the fire: coordinated suppression of the innate 
and adaptive immune systems by SOCS1 and SOCS3 proteins. Immunol Rev 
224:265-83. 
83. Dokter, W. H., S. B. Koopmans, and E. Vellenga. 1996. Effects of IL-10 
and IL-4 on LPS-induced transcription factors (AP-1, NF-IL6 and NF-kappa 
B) which are involved in IL-6 regulation. Leukemia 10:1308-16. 
84. Dolken, L., A. Krmpotic, S. Kothe, L. Tuddenham, M. Tanguy, L. 
Marcinowski, Z. Ruzsics, N. Elefant, Y. Altuvia, H. Margalit, U. H. 





facilitate persistent virus infection in salivary glands. PLoS Pathog 
6:e1001150. 
85. Dolken, L., J. Perot, V. Cognat, A. Alioua, M. John, J. Soutschek, Z. 
Ruzsics, U. Koszinowski, O. Voinnet, and S. Pfeffer. 2007. Mouse 
cytomegalovirus microRNAs dominate the cellular small RNA profile during 
lytic infection and show features of posttranscriptional regulation. J Virol 
81:13771-82. 
86. Dorner, B. G., H. R. Smith, A. R. French, S. Kim, J. Poursine-Laurent, 
D. L. Beckman, J. T. Pingel, R. A. Kroczek, and W. M. Yokoyama. 2004. 
Coordinate expression of cytokines and chemokines by NK cells during 
murine cytomegalovirus infection. J Immunol 172:3119-31. 
87. Doyle, S. E., R. O'Connell, S. A. Vaidya, E. K. Chow, K. Yee, and G. 
Cheng. 2003. Toll-like receptor 3 mediates a more potent antiviral response 
than Toll-like receptor 4. J Immunol 170:3565-71. 
88. Du, Z., L. Wei, A. Murti, S. R. Pfeffer, M. Fan, C. H. Yang, and L. M. 
Pfeffer. 2007. Non-conventional signal transduction by type 1 interferons: 
the NF-kappaB pathway. J Cell Biochem 102:1087-94. 
89. Englen, M. D., Y. E. Valdez, N. M. Lehnert, and B. E. Lehnert. 1995. 
Granulocyte/macrophage colony-stimulating factor is expressed and secreted 
in cultures of murine L929 cells. J Immunol Methods 184:281-3. 
90. Erlandsson, L., R. Blumenthal, M. L. Eloranta, H. Engel, G. Alm, S. 
Weiss, and T. Leanderson. 1998. Interferon-beta is required for interferon-
alpha production in mouse fibroblasts. Curr Biol 8:223-6. 
91. Eskildsen, S., J. Justesen, M. H. Schierup, and R. Hartmann. 2003. 
Characterization of the 2'-5'-oligoadenylate synthetas  ubiquitin-like family. 
Nucleic Acids Res 31:3166-73. 
92. Falvo, J. V., A. V. Tsytsykova, and A. E. Goldfeld. Transcriptional control 
of the TNF gene. Curr Dir Autoimmun 11:27-60. 
93. Fathallah, I., P. Parroche, H. Gruffat, C. Zannetti, H. Johansson, J. Yue, 
E. Manet, M. Tommasino, B. S. Sylla, and U. A. Hasan. EBV latent 
membrane protein 1 is a negative regulator of TLR9. J Immunol 185:6439-
47. 
94. Feire, A. L., H. Koss, and T. Compton. 2004. Cellular integrins function as 
entry receptors for human cytomegalovirus via a highly conserved 
disintegrin-like domain. Proc Natl Acad Sci U S A 101:15470-5. 
95. Fernandez, J. A., E. G. Rodrigues, and M. Tsuji. 2000. Multifactorial 
protective mechanisms to limit viral replication in the lung of mice during 
primary murine cytomegalovirus infection. Viral Immunol 13:287-95. 
96. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. 
O'Garra.  1991. IL-10 inhibits cytokine production by activated 
macrophages. J Immunol 147:3815-22. 
97. Fleetwood, A. J., H. Dinh, A. D. Cook, P. J. Hertzog, and J. A. Hamilton. 
2009. GM-CSF- and M-CSF-dependent macrophage phenotypes display 
differential dependence on type I interferon signaling. J Leukoc Biol 86:411-
21. 
98. Fletcher, T. M., 3rd, M. A. Soares, S. McPhearson, H. Hui, M. 





B. H. Hahn. 1997. Complementation of integrase function in HIV-1 virions. 
EMBO J 16:5123-38. 
99. Fossum, E., C. C. Friedel, S. V. Rajagopala, B. Titz, A. Baiker, T. 
Schmidt, T. Kraus, T. Stellberger, C. Rutenberg, S. Suthram, S. 
Bandyopadhyay, D. Rose, A. von Brunn, M. Uhlmann, C. Zeretzke, Y. A. 
Dong, H. Boulet, M. Koegl, S. M. Bailer, U. Koszinowski, T. Ideker, P. 
Uetz, R. Zimmer, and J. Haas. 2009. Evolutionarily conserved herpesviral 
protein interaction networks. PLoS Pathog 5:e1000570. 
100. Foster, S. L., D. C. Hargreaves, and R. Medzhitov. 2007. Gene-specific 
control of inflammation by TLR-induced chromatin modifications. Nature 
447:972-8. 
101. Fraternale, A., M. F. Paoletti, A. Casabianca, L. Nencioni, E. Garaci, A. 
T. Palamara, and M. Magnani. 2009. GSH and analogs in antiviral therapy. 
Mol Aspects Med 30:99-110. 
102. Fraternale, A., M. F. Paoletti, A. Casabianca, J. Oiry, P. Clayette, J. U. 
Vogel, J. Cinatl, Jr., A. T. Palamara, R. Sgarbanti, E. Garaci, E. Millo, 
U. Benatti, and M. Magnani. 2006. Antiviral and immunomodulatory 
properties of new pro-glutathione (GSH) molecules. Curr Med Chem 
13:1749-55. 
103. Freeman, T. C., L. Goldovsky, M. Brosch, S. van Dongen, P. Maziere, R. 
J. Grocock, S. Freilich, J. Thornton, and A. J. Enright. 2007. 
Construction, visualisation, and clustering of transcription networks from 
microarray expression data. PLoS Comput Biol 3:2032-42. 
104. Friel, H., and H. Lederman. 2006. A nutritional supplement formula for 
influenza A (H5N1) infection in humans. Med Hypotheses 67:578-87. 
105. Galluzzi, L., O. Kepp, E. Morselli, I. Vitale, L. Senovilla, M. Pinti, L. 
Zitvogel, and G. Kroemer. Viral strategies for the evasion of immunogenic 
cell death. J Intern Med 267:526-42. 
106. Garko-Buczynski, K. A., R. H. Smith, S. K. Kim, and D. J. O'Callaghan. 
1998. Complementation of a replication-defective mutant of equine 
herpesvirus type 1 by a cell line expressing the immediate-early protein. 
Virology 248:83-94. 
107. Gay, N. J., and F. J. Keith. 1991. Drosophila Toll and IL-1 receptor. Nature 
351:355-6. 
108. Geissmann, F., S. Gordon, D. A. Hume, A. M. Mowat, and G. J. 
Randolph. Unravelling mononuclear phagocyte heterogeneity. Nat Rev 
Immunol 10:453-60. 
109. Geissmann, F., M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. 
Ley. Development of monocytes, macrophages, and dendritic cells. Science 
327:656-61. 
110. Gerrity, D., H. Ryu, J. Crittenden, and M. Abbaszadegan. 2008. UV 
inactivation of adenovirus type 4 measured by integrated cell culture qPCR. J 
Environ Sci Health A Tox Hazard Subst Environ Eng 43:1628-38. 
111. Ghazal, P., H. Lubon, B. Fleckenstein, and L. Hennighausen. 1987. 
Binding of transcription factors and creation of a large nucleoprotein complex 






112. Ghazal, P., M. Messerle, K. Osborn, and A. Angulo. 2003. An essential 
role of the enhancer for murine cytomegalovirus in vivo growth and 
pathogenesis. J Virol 77:3217-28. 
113. Ghazal, P., A. E. Visser, M. Gustems, R. Garcia, E. M. Borst, K. 
Sullivan, M. Messerle, and A. Angulo. 2005. Elimination of ie1 
significantly attenuates murine cytomegalovirus virulence but does not alter 
replicative capacity in cell culture. J Virol 79:7182-94. 
114. Gilchrist, M., V. Thorsson, B. Li, A. G. Rust, M. Korb, J. C. Roach, K. 
Kennedy, T. Hai, H. Bolouri, and A. Aderem. 2006. Systems biology 
approaches identify ATF3 as a negative regulator of Toll-like receptor 4. 
Nature 441:173-8. 
115. Gilliet, M., W. Cao, and Y. J. Liu. 2008. Plasmacytoid dendritic cells: 
sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev 
Immunol 8:594-606. 
116. Glaros, T., M. Larsen, and L. Li. 2009. Macrophages and fibroblasts during 
inflammation, tissue damage and organ injury. Front Biosci 14:3988-93. 
117. Glass, M., A. Busche, K. Wagner, M. Messerle, and E. M. Borst. 2009. 
Conditional and reversible disruption of essential herpesvirus proteins. Nat 
Methods 6:577-9. 
118. Goins, W. F., P. Marconi, D. Krisky, D. Wolfe, J. C. Glorioso, R. 
Ramakrishnan, and D. J. Fink. 2002. Construction of replication-defective 
herpes simplex virus vectors. Curr Protoc Hum Genet Chapter 12:Unit 12 
11. 
119. Goldmacher, V. S. 2005. Cell death suppression by cytomegaloviruses. 
Apoptosis 10:251-65. 
120. Goodman, A. G., H. Zeng, S. C. Proll, X. Peng, C. Cilloniz, V. S. Carter, 
M. J. Korth, T. M. Tumpey, and M. G. Katze. The alpha/beta interferon 
receptor provides protection against influenza virus replication but is 
dispensable for inflammatory response signaling. J Virol 84:2027-37. 
121. Gordon, S. 2003. Alternative activation of macrophages. Nat Rev Immunol 
3:23-35. 
122. Gough, D. J., N. L. Messina, L. Hii, J. A. Gould, K. Sabapathy, A. P. 
Robertson, J. A. Trapani, D. E. Levy, P. J. Hertzog, C. J. Clarke, and R. 
W. Johnstone. Functional crosstalk between type I and II interferon through 
the regulated expression of STAT1. PLoS Biol 8:e1000361. 
123. Gow, D. J., D. P. Sester, and D. A. Hume. CSF-1, IGF-1, and the control of 
postnatal growth and development. J Leukoc Biol 88:475-81. 
124. Grant, K. G., D. M. Krisky, M. M. Ataai, and J. C. Glorioso, 3rd. 2009. 
Engineering cell lines for production of replication defective HSV-1 gene 
therapy vectors. Biotechnol Bioeng 102:1087-97. 
125. Green, N. M., A. Laws, K. Kiefer, L. Busconi, Y. M. Kim, M. M. 
Brinkmann, E. H. Trail, K. Yasuda, S. R. Christensen, M. J. Shlomchik, 
S. Vogel, J. H. Connor, H. Ploegh, D. Eilat, I. R. Rifkin, J. M. van 
Seventer, and A. Marshak-Rothstein. 2009. Murine B cell response to 
TLR7 ligands depends on an IFN-beta feedback loop. J Immunol 183:1569-
76. 
126. Gribaudo, G., S. Ravaglia, L. Guandalini, R. Cavallo, M. Gariglio, and S. 





stimulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 
promoter. Virus Res 45:15-27. 
127. Guo, Z., S. Garg, K. M. Hill, L. Jayashankar, M. R. Mooney, M. 
Hoelscher, J. M. Katz, J. M. Boss, and S. Sambhara. 2005. A distal 
regulatory region is required for constitutive and IFN-beta-induced 
expression of murine TLR9 gene. J Immunol 175:7407-18. 
128. Hale, B. G., R. E. Randall, J. Ortin, and D. Jackson. 2008. The 
multifunctional NS1 protein of influenza A viruses. J Gen Virol 89:2359-76. 
129. Haller, O., G. Kochs, and F. Weber. 2007. Interferon, Mx, and viral 
countermeasures. Cytokine Growth Factor Rev 18:425-33. 
130. Hamilton, J. A. 1997. CSF-1 signal transduction. J Leukoc Biol 62:145-55. 
131. Hanson, L. K., J. S. Slater, Z. Karabekian, G. Cioco-Schmitt, and A. E. 
Campbell. 2001. Products of US22 genes M140 and M141 confer ef icient 
replication of murine cytomegalovirus in macrophages and spleen. J Virol 
75:6292-302. 
132. Hanson, L. K., J. S. Slater, Z. Karabekian, H. W. t. Virgin, C. A. Biron, 
M. C. Ruzek, N. van Rooijen, R. P. Ciavarra, R. M. Stenberg, and A. E. 
Campbell. 1999. Replication of murine cytomegalovirus in differentiated 
macrophages as a determinant of viral pathogenesis. J Virol 73:5970-80. 
133. Haralambieva, I. H., I. G. Ovsyannikova, N. Dhiman, R. A. Vierkant, R. 
M. Jacobson, and G. A. Poland. Differential cellular immune responses to 
wild-type and attenuated edmonston tag measles virust ains are primarily 
defined by the viral phosphoprotein gene. J Med Virol 82:1966-75. 
134. Hargreaves, D. C., T. Horng, and R. Medzhitov. 2009. Control of 
inducible gene expression by signal-dependent transc iptional elongation. 
Cell 138:129-45. 
135. Harton, J. A., M. W. Linhoff, J. Zhang, and J. P. Ting. 2002. Cutting 
edge: CATERPILLER: a large family of mammalian genes containing 
CARD, pyrin, nucleotide-binding, and leucine-rich repeat domains. J 
Immunol 169:4088-93. 
136. Harty, R. N., P. M. Pitha, and A. Okumura. 2009. Antiviral activity of 
innate immune protein ISG15. J Innate Immun 1:397-404. 
137. Hasko, G., P. Pacher, E. A. Deitch, and E. S. Vizi. 2007. Shaping of 
monocyte and macrophage function by adenosine receptors. Pharmacol Ther 
113:264-75. 
138. Hayden, M. S., A. P. West, and S. Ghosh. 2006. NF-kappaB and the 
immune response. Oncogene 25:6758-80. 
139. He, B., L. You, K. Uematsu, M. Matsangou, Z. Xu, M. He, F. 
McCormick, and D. M. Jablons. 2003. Cloning and characterization of a 
functional promoter of the human SOCS-3 gene. Biochem Biophys Res 
Commun 301:386-91. 
140. Helming, L., J. Bose, J. Ehrchen, S. Schiebe, T. Frahm, R. Geffers, M. 
Probst-Kepper, R. Balling, and A. Lengeling. 2005. 1alpha,25-
Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated 
macrophage activation. Blood 106:4351-8. 
141. Hengel, H., U. H. Koszinowski, and K. K. Conzelmann. 2005. Viruses 





142. Hidmark, A. S., G. M. McInerney, E. K. Nordstrom, I. Douagi, K. M. 
Werner, P. Liljestrom, and G. B. Karlsson Hedestam. 2005. Early 
alpha/beta interferon production by myeloid dendritic cells in response to 
UV-inactivated virus requires viral entry and interferon regulatory factor 3 
but not MyD88. J Virol 79:10376-85. 
143. Himeda, T., Y. Ohara, K. Asakura, Y. Kontani, M. Murakami, H. 
Suzuki, and M. Sawada. 2005. A lentiviral expression system demonstrates 
that L* protein of Theiler's murine encephalomyelitis virus (TMEV) is 
essential for virus growth in a murine macrophage-lik  cell line. Virus Res 
108:23-8. 
144. Himes, S. R., D. P. Sester, T. Ravasi, S. L. Cronau, T. Sasmono, and D. 
A. Hume. 2006. The JNK are important for development and survival of 
macrophages. J Immunol 176:2219-28. 
145. Hochrein, H., B. Schlatter, M. O'Keeffe, C. Wagner, F. Schmitz, M. 
Schiemann, S. Bauer, M. Suter, and H. Wagner. 2004. Herpes simplex 
virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent 
and -independent pathways. Proc Natl Acad Sci U S A 101:11416-21. 
146. Hofer, M., A. Vacek, M. Pospisil, J. Hola, D. Streitova, and V. Znojil. 
2009. Activation of adenosine A(3) receptors potentiates stimulatory effects 
of IL-3, SCF, and GM-CSF on mouse granulocyte-macrophage 
hematopoietic progenitor cells. Physiol Res 58:247-52. 
147. Hohensinner, P. J., C. Kaun, K. Rychli, A. Niessner, S. Pfaffenberger, G. 
Rega, R. de Martin, G. Maurer, R. Ullrich, K. Huber, and J. Wojta. 
2007. Macrophage colony stimulating factor expression in human cardiac 
cells is upregulated by tumor necrosis factor-alpha via an NF-kappaB 
dependent mechanism. J Thromb Haemost 5:2520-8. 
148. Hokeness, K. L., W. A. Kuziel, C. A. Biron, and T. P. Salazar-Mather. 
2005. Monocyte chemoattractant protein-1 and CCR2 interactions are 
required for IFN-alpha/beta-induced inflammatory responses and antiviral 
defense in liver. J Immunol 174:1549-56. 
149. Honda, K., A. Takaoka, and T. Taniguchi. 2006. Type I interferon 
[corrected] gene induction by the interferon regulatory factor family of 
transcription factors. Immunity 25:349-60. 
150. Honda, K., H. Yanai, A. Takaoka, and T. Taniguchi. 2005. Regulation of 
the type I IFN induction: a current view. Int Immunol 17:1367-78. 
151. Hornung, V., and E. Latz. Intracellular DNA recognition. Nat Rev Immunol 
10:123-30. 
152. Hu, X., K. H. Park-Min, H. H. Ho, and L. B. Ivashkiv. 2005. IFN-gamma-
primed macrophages exhibit increased CCR2-dependent migration and 
altered IFN-gamma responses mediated by Stat1. J Immunol 175:3637-47. 
153. Huang, Y., A. Walstrom, L. Zhang, Y. Zhao, M. Cui, L. Ye, and J. C. 
Zheng. 2009. Type I interferons and interferon regulatory factors regulate 
TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected 
macrophages. PLoS One 4:e5397. 
154. Hume, D. A. 2008. Differentiation and heterogeneity in the mononuclear 
phagocyte system. Mucosal Immunol 1:432-41. 






156. Hume, D. A. 2006. The mononuclear phagocyte system. Curr Opin Immunol 
18:49-53. 
157. Hume, D. A., W. Allan, B. Fabrus, M. J. Weidemann, A. J. Hapel, and S. 
Bartelmez. 1987. Regulation of proliferation of bone marrow-derived 
macrophages. Lymphokine Res 6:127-39. 
158. Hummel, M., and M. M. Abecassis. 2002. A model for reactivation of CMV 
from latency. J Clin Virol 25 Suppl 2:S123-36. 
159. Hunter, S., R. Apweiler, T. K. Attwood, A. Bairoch, A. Bateman, D. 
Binns, P. Bork, U. Das, L. Daugherty, L. Duquenne, R. D. Finn, J. 
Gough, D. Haft, N. Hulo, D. Kahn, E. Kelly, A. Laugraud, I. Letunic, D. 
Lonsdale, R. Lopez, M. Madera, J. Maslen, C. McAnulla, J. McDowall, 
J. Mistry, A. Mitchell, N. Mulder, D. Natale, C. Orengo, A. F. Quinn, J. 
D. Selengut, C. J. Sigrist, M. Thimma, P. D. Thomas, F. Valentin, D. 
Wilson, C. H. Wu, and C. Yeats. 2009. InterPro: the integrative protein 
signature database. Nucleic Acids Res 37:D211-5. 
160. Huys, L., F. Van Hauwermeiren, L. Dejager, E. Dejonckheere, S. 
Lienenklaus, S. Weiss, G. Leclercq, and C. Libert. 2009. Type I interferon 
drives tumor necrosis factor-induced lethal shock. J Exp Med 206:1873-82. 
161. Imanishi, D., K. Yamamoto, H. Tsushima, Y. Miyazaki, K. Kuriyama, 
M. Tomonaga, and T. Matsuyama. 2000. Identification of a novel cytokine 
response element in the human IFN regulatory factor-1 gene promoter. J 
Immunol 165:3907-16. 
162. Inohara, N., and G. Nunez. 2001. The NOD: a signaling module that 
regulates apoptosis and host defense against pathogens. Oncogene 20:6473-
81. 
163. Isaacson, M. K., and T. Compton. 2009. Human cytomegalovirus 
glycoprotein B is required for virus entry and cell-to-cell spread but not for 
virion attachment, assembly, or egress. J Virol 83:3891-903. 
164. Isern, E., M. Gustems, M. Messerle, E. Borst, P. Ghazal, and A. Angulo. 
The activator protein 1 binding motifs within the human cytomegalovirus 
major immediate-early enhancer are functionally redundant and act in a 
cooperative manner with the NF-{kappa}B sites during acute infection. J 
Virol 85:1732-46. 
165. Isler, J. A., A. H. Skalet, and J. C. Alwine. 2005. Human cytomegalovirus 
infection activates and regulates the unfolded protein response. J Virol 
79:6890-9. 
166. Isomura, H., M. F. Stinski, A. Kudoh, S. Nakayama, S. Iwahori, Y. Sato, 
and T. Tsurumi. 2007. The late promoter of the human cytomegalovirus 
viral DNA polymerase processivity factor has an impact on delayed early and 
late viral gene products but not on viral DNA synthesis. J Virol 81:6197-206. 
167. Isomura, H., M. F. Stinski, A. Kudoh, S. Nakayama, T. Murata, Y. Sato, 
S. Iwahori, and T. Tsurumi. 2008. A cis element between the TATA Box 
and the transcription start site of the major immediate-early promoter of 
human cytomegalovirus determines efficiency of viral replication. J Virol 
82:849-58. 
168. Ito, T., Y. H. Wang, and Y. J. Liu. 2005. Plasmacytoid dendritic cell 
precursors/type I interferon-producing cells sense viral infection by Toll-like 





169. Iversen, A. C., B. Steinkjer, N. Nilsen, J. Bohnhorst, S. H. Moen, R. Vik, 
P. Stephens, D. W. Thomas, C. A. Benedict, and T. Espevik. 2009. A 
proviral role for CpG in cytomegalovirus infection. J Immunol 182:5672-81. 
170. Jackson, S. E., G. M. Mason, and M. R. Wills. Human cytomegalovirus 
immunity and immune evasion. Virus Res. 
171. Janeway, C. A., Jr. 1989. Approaching the asymptote? Evolution and 
revolution in immunology. Cold Spring Harb Symp Quant Biol 54 Pt 1:1-13. 
172. Jarvis, M. A., and J. A. Nelson. 2002. Human cytomegalovirus persistence 
and latency in endothelial cells and macrophages. Curr Opin Microbiol 
5:403-7. 
173. Jeffrey, I. W., S. Kadereit, E. F. Meurs, T. Metzger, M. Bachmann, M. 
Schwemmle, A. G. Hovanessian, and M. J. Clemens. 1995. Nuclear 
localization of the interferon-inducible protein kinase PKR in human cells 
and transfected mouse cells. Exp Cell Res 218:17-27. 
174. Jenner, R. G., and R. A. Young. 2005. Insights into host responses against 
pathogens from transcriptional profiling. Nat Rev Microbiol 3:281-94. 
175. Jensen, K., R. Talbot, E. Paxton, D. Waddington, and E. J. Glass. 2006. 
Development and validation of a bovine macrophage specific cDNA 
microarray. BMC Genomics 7:224. 
176. Ji, X., R. Cheung, S. Cooper, Q. Li, H. B. Greenberg, and X. S. He. 2003. 
Interferon alfa regulated gene expression in patients initiating interferon 
treatment for chronic hepatitis C. Hepatology 37:610-21. 
177. Jonjic, S., A. Krmpotic, J. Arapovic, and U. H. Koszinowski. 2008. 
Dissection of the antiviral NK cell response by MCMV mutants. Methods 
Mol Biol 415:127-49. 
178. Joo, C. H., Y. C. Shin, M. Gack, L. Wu, D. Levy, and J. U. Jung. 2007. 
Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal 
transduction by the Kaposi's sarcoma-associated herpesvi us viral IRF 
homolog vIRF3. J Virol 81:8282-92. 
179. Juang, S. H., S. J. Wei, Y. M. Hung, C. Y. Hsu, D. M. Yang, K. J. Liu, W. 
S. Chen, and W. K. Yang. 2004. IFN-beta induces caspase-mediated 
apoptosis by disrupting mitochondria in human advanced stage colon cancer 
cell lines. J Interferon Cytokine Res 24:231-43. 
180. Juckem, L. K., K. W. Boehme, A. L. Feire, and T. Compton. 2008. 
Differential initiation of innate immune responses induced by human 
cytomegalovirus entry into fibroblast cells. J Immunol 180:4965-77. 
181. Kalejta, R. F. 2008. Functions of human cytomegalovirus tegument proteins 
prior to immediate early gene expression. Curr Top Microbiol Immunol 
325:101-15. 
182. Kalejta, R. F. 2008. Tegument proteins of human cytomegalovirus. 
Microbiol Mol Biol Rev 72:249-65, table of contents. 
183. Kamthong, P. J., F. M. Wu, and M. C. Wu. 2000. cAMP attenuates 
interleukin-1-stimulated macrophage colony-stimulating factor (M-CSF) 
expression. Biochem J 350 Pt 1:115-22. 
184. Kattenhorn, L. M., R. Mills, M. Wagner, A. Lomsadze, V. Makeev, M. 
Borodovsky, H. L. Ploegh, and B. M. Kessler. 2004. Identification of 






185. Katze, M. G., Y. He, and M. Gale, Jr. 2002. Viruses and interferon: a fight 
for supremacy. Nat Rev Immunol 2:675-87. 
186. Kawai, T., and S. Akira. The role of pattern-recognition receptors in innate 
immunity: update on Toll-like receptors. Nat Immunol 11:373-84. 
187. Kawai, T., and S. Akira. 2007. Signaling to NF-kappaB by Toll-like 
receptors. Trends Mol Med 13:460-9. 
188. Keil, G. M., A. Ebeling-Keil, and U. H. Koszinowski. 1987. Immediate-
early genes of murine cytomegalovirus: location, transcripts, and translation 
products. J Virol 61:526-33. 
189. Keil, G. M., A. Ebeling-Keil, and U. H. Koszinowski. 1987. Sequence and 
structural organization of murine cytomegalovirus immediate-early gene 1. J 
Virol 61:1901-8. 
190. Keil, G. M., A. Ebeling-Keil, and U. H. Koszinowski. 1984. Temporal 
regulation of murine cytomegalovirus transcription and mapping of viral 
RNA synthesized at immediate early times after infection. J Virol 50:784-95. 
191. Kim, S. K., A. E. Fouts, and J. C. Boothroyd. 2007. Toxoplasma gondii 
dysregulates IFN-gamma-inducible gene expression in human fibroblasts: 
insights from a genome-wide transcriptional profiling. J Immunol 178:5154-
65. 
192. Kirchhoff, S., A. Oumard, M. Nourbakhsh, B. Z. Levi, and H. Hauser. 
2000. Interplay between repressing and activating domains defines the 
transcriptional activity of IRF-1. Eur J Biochem 267:6753-61. 
193. Koffron, A. J., M. Hummel, B. K. Patterson, S. Yan, D. B. Kaufman, J. 
P. Fryer, F. P. Stuart, and M. I. Abecassis. 1998. Cellular localization of 
latent murine cytomegalovirus. J Virol 72:95-103. 
194. Kondo, K., H. Kaneshima, and E. S. Mocarski. 1994. Human 
cytomegalovirus latent infection of granulocyte-macrophage progenitors. 
Proc Natl Acad Sci U S A 91:11879-83. 
195. Konicek, B. W., X. Xia, T. Rajavashisth, and M. A. Harrington.  1998. 
Regulation of mouse colony-stimulating factor-1 gene promoter activity by 
AP1 and cellular nucleic acid-binding protein. DNA Cell Biol 17:799-809. 
196. Koyama, S., K. J. Ishii, C. Coban, and S. Akira. 2008. Innate immune 
response to viral infection. Cytokine 43:336-41. 
197. Kraatz, J., L. Clair, J. L. Rodriguez, and M. A. West. 1999. Macrophage 
TNF secretion in endotoxin tolerance: role of SAPK, p38, and MAPK. J Surg 
Res 83:158-64. 
198. Krmpotic, A., I. Bubic, B. Polic, P. Lucin, and S. Jonjic. 2003. 
Pathogenesis of murine cytomegalovirus infection. Microbes Infect 5:1263-
77. 
199. Kropp, K. A., C. O. Simon, A. Fink, A. Renzaho, B. Kuhnapfel, J. 
Podlech, M. J. Reddehase, and N. K. Grzimek. 2009. Synergism between 
the components of the bipartite major immediate-early transcriptional 
enhancer of murine cytomegalovirus does not accelerat  virus replication in 
cell culture and host tissues. J Gen Virol 90:2395-401. 
200. Krug, A., A. R. French, W. Barchet, J. A. Fischer, A. Dzionek, J. T. 
Pingel, M. M. Orihuela, S. Akira, W. M. Yokoyama, and M. Colonna. 





coordinated cytokine responses that activate antiviral NK cell function. 
Immunity 21:107-19. 
201. Kube, D., H. Rieth, J. Eskdale, P. G. Kremsner, and G. Gallagher. 2001. 
Structural characterisation of the distal 5' flanking region of the human 
interleukin-10 gene. Genes Immun 2:181-90. 
202. Kumar, V., O. Lockerbie, S. D. Keil, P. H. Ruane, M. S. Platz, C. B. 
Martin, J. L. Ravanat, J. Cadet, and R. P. Goodrich. 2004. Riboflavin and 
UV-light based pathogen reduction: extent and consequence of DNA damage 
at the molecular level. Photochem Photobiol 80:15-21. 
203. Lacaze, P., S. Raza, G. Sing, D. Page, T. Forster, P. Storm, M. Craigon, 
T. Awad, P. Ghazal, and T. C. Freeman. 2009. Combined genome-wide 
expression profiling and targeted RNA interference in primary mouse 
macrophages reveals perturbation of transcriptional networks associated with 
interferon signalling. BMC Genomics 10:372. 
204. Lamken, P., S. Lata, M. Gavutis, and J. Piehler. 2004. Ligand-induced 
assembling of the type I interferon receptor on supported lipid bilayers. J Mol 
Biol 341:303-18. 
205. Langer, J. A., E. C. Cutrone, and S. Kotenko. 2004. The Class II cytokine 
receptor (CRF2) family: overview and patterns of receptor-ligand 
interactions. Cytokine Growth Factor Rev 15:33-48. 
206. Larrubia, J. R., S. Benito-Martinez, M. Calvino, E. Sanz-de-Villalobos, 
and T. Parra-Cid. 2008. Role of chemokines and their receptors in viral 
persistence and liver damage during chronic hepatitis C virus infection. 
World J Gastroenterol 14:7149-59. 
207. Larsson, S., C. Soderberg-Naucler, and E. Moller. 1998. Productive 
cytomegalovirus (CMV) infection exclusively in CD13-positive peripheral 
blood mononuclear cells from CMV-infected individuals: implications for 
prevention of CMV transmission. Transplantation 65:411-5. 
208. Le, V. T., M. Trilling, A. Zimmermann, and H. Hengel. 2008. Mouse 
cytomegalovirus inhibits beta interferon (IFN-beta) gene expression and 
controls activation pathways of the IFN-beta enhanceosome. J Gen Virol 
89:1131-41. 
209. Leaman, D. W., M. Chawla-Sarkar, B. Jacobs, K. Vyas, Y. Sun, A. 
Ozdemir, T. Yi, B. R. Williams, and E. C. Borden. 2003. Novel growth 
and death related interferon-stimulated genes (ISGs) in melanoma: greater 
potency of IFN-beta compared with IFN-alpha2. J Interferon Cytokine Res 
23:745-56. 
210. Leber, J. H., G. T. Crimmins, S. Raghavan, N. P. Meyer-Morse, J. S. 
Cox, and D. A. Portnoy. 2008. Distinct TLR- and NLR-mediated 
transcriptional responses to an intracellular pathogen. PLoS Pathog 4:e6. 
211. Lee, G. C., H. A. Yi, and C. H. Lee. 2006. Stimulation of interferon-beta 
gene expression by human cytomegalovirus via nuclear factor kappa B and 
phosphatidylinositol 3-kinase pathway. Virus Res 117:209-14. 
212. Lee, H. R., Y. H. Huh, Y. E. Kim, K. Lee, S. Kim, and J. H. Ahn. 2007. 
N-terminal determinants of human cytomegalovirus IE1 protein in nuclear 
targeting and disrupting PML-associated subnuclear structures. Biochem 





213. Leek, J. T., E. Monsen, A. R. Dabney, and J. D. Storey. 2006. EDGE: 
extraction and analysis of differential gene expression. Bioinformatics 
22:507-8. 
214. Levy, D. E., I. Marie, E. Smith, and A. Prakash. 2002. Enhancement and 
diversification of IFN induction by IRF-7-mediated positive feedback. J 
Interferon Cytokine Res 22:87-93. 
215. Lewerenz, M., K. E. Mogensen, and G. Uze. 1998. Shared receptor 
components but distinct complexes for alpha and beta interferons. J Mol Biol 
282:585-99. 
216. Libermann, T. A., and D. Baltimore. 1990. Activation of interleukin-6 gene 
expression through the NF-kappa B transcription factor. Mol Cell Biol 
10:2327-34. 
217. Liew, F. Y., D. Xu, E. K. Brint, and L. A. O'Neill.  2005. Negative 
regulation of toll-like receptor-mediated immune responses. Nat Rev 
Immunol 5:446-58. 
218. Lin, R., P. Genin, Y. Mamane, M. Sgarbanti, A. Battistini, W. J. 
Harrington, Jr., G. N. Barber, and J. Hiscott. 2001. HHV-8 encoded 
vIRF-1 represses the interferon antiviral response by blocking IRF-3 
recruitment of the CBP/p300 coactivators. Oncogene 20:800-11. 
219. Lischka, P., and H. Zimmermann. 2008. Antiviral strategies to combat 
cytomegalovirus infections in transplant recipients. Curr Opin Pharmacol 
8:541-8. 
220. Liu, B., S. Mink, K. A. Wong, N. Stein, C. Getman, P. W. Dempsey, H. 
Wu, and K. Shuai. 2004. PIAS1 selectively inhibits interferon-inducible 
genes and is important in innate immunity. Nat Immunol 5:891-8. 
221. Liu, C. J., H. Wang, and P. Lengyel. 1999. The interferon-inducible 
nucleolar p204 protein binds the ribosomal RNA-specific UBF1 transcription 
factor and inhibits ribosomal RNA transcription. EMBO J 18:2845-54. 
222. Liu, R., H. Liu, X. Chen, M. Kirby, P. O. Brown, and K. Zhao. 2001. 
Regulation of CSF1 promoter by the SWI/SNF-like BAF complex. Cell 
106:309-18. 
223. Liu, Z. G.  2005. Molecular mechanism of TNF signaling and beyond. Cell 
Res 15:24-7. 
224. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene 
expression data using real-time quantitative PCR and the 2(-Delta Delta 
C(T)) Method. Methods 25:402-8. 
225. Loewendorf, A., and C. A. Benedict. Modulation of host innate and 
adaptive immune defenses by cytomegalovirus: timing is everything. J Intern 
Med 267:483-501. 
226. Lovinger, G. G., H. P. Ling, R. V. Gilden, and M. Hatanaka. 1975. Effect 
of UV Light on RNA-Directed DNA Polymerase Activity of Murine 
Oncornaviruses. J Virol 15:1273-5. 
227. Lu, L. L., M. Puri, C. M. Horvath, and G. C. Sen. 2008. Select 
paramyxoviral V proteins inhibit IRF3 activation byacting as alternative 






228. Lund, J., A. Sato, S. Akira, R. Medzhitov, and A. Iwasaki. 2003. Toll-like 
receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid 
dendritic cells. J Exp Med 198:513-20. 
229. Lynn, D. J., G. L. Winsor, C. Chan, N. Richard, M. R. Laird, A. Barsky, 
J. L. Gardy, F. M. Roche, T. H. Chan, N. Shah, R. Lo, M. Naseer, J. Que, 
M. Yau, M. Acab, D. Tulpan, M. D. Whiteside, A. Chikatamarla, B. 
Mah, T. Munzner, K. Hokamp, R. E. Hancock, and F. S. Brinkman. 
2008. InnateDB: facilitating systems-level analyses of the mammalian innate 
immune response. Mol Syst Biol 4:218. 
230. Mack, C., A. Sickmann, D. Lembo, and W. Brune. 2008. Inhibition of 
proinflammatory and innate immune signaling pathways b  a 
cytomegalovirus RIP1-interacting protein. Proc Natl Acad Sci U S A 
105:3094-9. 
231. Malmgaard, L., J. Melchjorsen, A. G. Bowie, S. C. Mogensen, and S. R. 
Paludan. 2004. Viral activation of macrophages through TLR-dependent and 
-independent pathways. J Immunol 173:6890-8. 
232. Manning, W. C., and E. S. Mocarski. 1988. Insertional mutagenesis of the 
murine cytomegalovirus genome: one prominent alpha gene (ie2) is 
dispensable for growth. Virology 167:477-84. 
233. Mantovani, A., A. Sica, and M. Locati. 2005. Macrophage polarization 
comes of age. Immunity 23:344-6. 
234. Marcello, T., A. Grakoui, G. Barba-Spaeth, E. S. Machlin, S. V. 
Kotenko, M. R. MacDonald, and C. M. Rice. 2006. Interferons alpha and 
lambda inhibit hepatitis C virus replication with distinct signal transduction 
and gene regulation kinetics. Gastroenterology 131:1887-98. 
235. Marie, I., J. E. Durbin, and D. E. Levy. 1998. Differential viral induction of 
distinct interferon-alpha genes by positive feedback through interferon 
regulatory factor-7. EMBO J 17:6660-9. 
236. Marijanovic, Z., J. Ragimbeau, J. van der Heyden, G. Uze, and S. 
Pellegrini. 2007. Comparable potency of IFNalpha2 and IFNbeta on 
immediate JAK/STAT activation but differential down-regulation of 
IFNAR2. Biochem J 407:141-51. 
237. Marshall, E. E., and A. P. Geballe. 2009. Multifaceted evasion of the 
interferon response by cytomegalovirus. J Interferon Cytokine Res 29:609-
19. 
238. Martin, L., S. C. Pingle, D. M. Hallam, L. P. Rybak, and V. Ramkumar. 
2006. Activation of the adenosine A3 receptor in RAW 264.7 cells inhibits 
lipopolysaccharide-stimulated tumor necrosis factor-alpha release by 
reducing calcium-dependent activation of nuclear factor-kappaB and 
extracellular signal-regulated kinase 1/2. J Pharmacol Exp Ther 316:71-8. 
239. Martinez, F. O., S. Gordon, M. Locati, and A. Mantovani. 2006. 
Transcriptional profiling of the human monocyte-to-macrophage 
differentiation and polarization: new molecules and patterns of gene 
expression. J Immunol 177:7303-11. 
240. Martinez, F. O., A. Sica, A. Mantovani, and M. Locati. 2008. Macrophage 





241. Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: a 
molecular platform triggering activation of inflammatory caspases and 
processing of proIL-beta. Mol Cell 10:417-26. 
242. Matsumoto, M., and T. Seya. 2008. TLR3: interferon induction by double-
stranded RNA including poly(I:C). Adv Drug Deliv Rev 60:805-12. 
243. Maul, G. G., and D. Negorev. 2008. Differences between mouse and human 
cytomegalovirus interactions with their respective hosts at immediate early 
times of the replication cycle. Med Microbiol Immunol 197:241-9. 
244. McCormick, A. L.  2008. Control of apoptosis by human cytomegalovirus. 
Curr Top Microbiol Immunol 325:281-95. 
245. McGavin, J. K., and K. L. Goa. 2001. Ganciclovir: an update of its use in 
the prevention of cytomegalovirus infection and disease in transplant 
recipients. Drugs 61:1153-83. 
246. Means, T. K., R. P. Pavlovich, D. Roca, M. W. Vermeulen, and M. J. 
Fenton. 2000. Activation of TNF-alpha transcription utilizes distinct MAP 
kinase pathways in different macrophage populations. J Leukoc Biol 67:885-
93. 
247. Medzhitov, R., and T. Horng. 2009. Transcriptional control of the 
inflammatory response. Nat Rev Immunol 9:692-703. 
248. Menard, C., M. Wagner, Z. Ruzsics, K. Holak, W. Brune, A. E. 
Campbell, and U. H. Koszinowski. 2003. Role of murine cytomegalovirus 
US22 gene family members in replication in macrophages. J Virol 77:5557-
70. 
249. Messerle, M., B. Buhler, G. M. Keil, and U. H. Koszinowski. 1992. 
Structural organization, expression, and functional ch racterization of the 
murine cytomegalovirus immediate-early gene 3. J Virol 66:27-36. 
250. Messerle, M., I. Crnkovic, W. Hammerschmidt, H. Ziegler, and U. H. 
Koszinowski. 1997. Cloning and mutagenesis of a herpesvirus genom  as an 
infectious bacterial artificial chromosome. Proc Natl Acad Sci U S A 
94:14759-63. 
251. Messerle, M., G. M. Keil, and U. H. Koszinowski. 1991. Structure and 
expression of murine cytomegalovirus immediate-early gene 2. J Virol 
65:1638-43. 
252. Mettenleiter, T. C. 2004. Budding events in herpesvirus morphogenesis. 
Virus Res 106:167-80. 
253. Mezger, M., M. Steffens, C. Semmler, E. M. Arlt, M. Zimmer, G. I. 
Kristjanson, T. F. Wienker, M. R. Toliat, T. Kessler, H. Einsele, and J. 
Loeffler. 2008. Investigation of promoter variations in dendritic cell-specific 
ICAM3-grabbing non-integrin (DC-SIGN) (CD209) and their relevance for 
human cytomegalovirus reactivation and disease after llogeneic stem-cell 
transplantation. Clin Microbiol Infect 14:228-34. 
254. Mibayashi, M., L. Martinez-Sobrido, Y. M. Loo, W. B. Cardenas, M. 
Gale, Jr., and A. Garcia-Sastre. 2007. Inhibition of retinoic acid-inducible 
gene I-mediated induction of beta interferon by the NS1 protein of influenza 
A virus. J Virol 81:514-24. 
255. Miller, M. D., and M. S. Krangel. 1992. Biology and biochemistry of the 






256. Mitchell, B. M., A. Leung, and J. G. Stevens. 1996. Murine 
cytomegalovirus DNA in peripheral blood of latently infected mice is 
detectable only in monocytes and polymorphonuclear leukocytes. Virology 
223:198-207. 
257. Mocarski, E. S., Jr. 2002. Immunomodulation by cytomegaloviruses: 
manipulative strategies beyond evasion. Trends Microb ol 10:332-9. 
258. Mocarski, E. S., Jr., and G. W. Kemble. 1996. Recombinant 
cytomegaloviruses for study of replication and pathogenesis. Intervirology 
39:320-30. 
259. Mocarski, E. S., G. W. Kemble, J. M. Lyle, and R. F. Greaves. 1996. A 
deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is 
replication defective due to a failure in autoregulation. Proc Natl Acad Sci U 
S A 93:11321-6. 
260. Mogensen, T. H., J. Melchjorsen, L. Malmgaard, A. Casola, and S. R. 
Paludan. 2004. Suppression of proinflammatory cytokine exprssion by 
herpes simplex virus type 1. J Virol 78:5883-90. 
261. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of 
macrophage activation. Nat Rev Immunol 8:958-69. 
262. Mossman, K. L. 2002. Activation and inhibition of virus and interf ron: the 
herpesvirus story. Viral Immunol 15:3-15. 
263. Mossman, K. L., P. F. Macgregor, J. J. Rozmus, A. B. Goryachev, A. M. 
Edwards, and J. R. Smiley. 2001. Herpes simplex virus triggers and then 
disarms a host antiviral response. J Virol 75:750-8. 
264. Mukhopadhyay, A., S. Shishodia, X. Y. Fu, and B. B. Aggarwal. 2002. 
Lack of requirement of STAT1 for activation of nuclear factor-kappaB, c-Jun 
NH2-terminal protein kinase, and apoptosis by tumor necrosis factor-alpha. J 
Cell Biochem 84:803-15. 
265. Mulhern, O., B. Harrington, and A. G. Bowie. 2009. Modulation of innate 
immune signalling pathways by viral proteins. Adv Exp Med Biol 666:49-63. 
266. Muller, U.  1999. Ten years of gene targeting: targeted mouse mutants, from 
vector design to phenotype analysis. Mech Dev 82:3-21. 
267. Munch, K., M. Messerle, B. Plachter, and U. H. Koszinowski. 1992. An 
acidic region of the 89K murine cytomegalovirus immediate early protein 
interacts with DNA. J Gen Virol 73 ( Pt 3):499-506. 
268. Natarajan, M., K. M. Lin, R. C. Hsueh, P. C. Sternweis, and R. 
Ranganathan. 2006. A global analysis of cross-talk in a mammalian cellular 
signalling network. Nat Cell Biol 8:571-80. 
269. Nhu, Q. M., N. Cuesta, and S. N. Vogel. 2006. Transcriptional regulation of 
lipopolysaccharide (LPS)-induced Toll-like receptor (TLR) expression in 
murine macrophages: role of interferon regulatory factors 1 (IRF-1) and 2 
(IRF-2). J Endotoxin Res 12:285-95. 
270. Nilsson, R., V. B. Bajic, H. Suzuki, D. di Bernardo, J. Bjorkegren, S. 
Katayama, J. F. Reid, M. J. Sweet, M. Gariboldi, P. Carninci, Y. 
Hayashizaki, D. A. Hume, J. Tegner, and T. Ravasi. 2006. Transcriptional 
network dynamics in macrophage activation. Genomics 88:133-42. 
271. Noda, S., S. A. Aguirre, A. Bitmansour, J. M. Brown, T. E. Sparer, J. 





mobilization and recruitment of myeloid progenitor cells to facilitate 
dissemination. Blood 107:30-8. 
272. Noyce, R. S., S. E. Collins, and K. L. Mossman. 2009. Differential 
modification of interferon regulatory factor 3 follwing virus particle entry. J 
Virol 83:4013-22. 
273. Noyce, R. S., S. E. Collins, and K. L. Mossman. 2006. Identification of a 
novel pathway essential for the immediate-early, interferon-independent 
antiviral response to enveloped virions. J Virol 80:226-35. 
274. Oualikene, W., L. Lamoureux, J. M. Weber, and B. Massie. 2000. 
Protease-deleted adenovirus vectors and complementing cell lines: potential 
applications of single-round replication mutants for vaccination and gene 
therapy. Hum Gene Ther 11:1341-53. 
275. Paladino, P., D. T. Cummings, R. S. Noyce, and K. L. Mossman. 2006. 
The IFN-independent response to virus particle entry provides a first line of 
antiviral defense that is independent of TLRs and retinoic acid-inducible gene 
I. J Immunol 177:8008-16. 
276. Palamara, A. T., C. F. Perno, S. Aquaro, M. C. Bue, L. Dini, and E. 
Garaci. 1996. Glutathione inhibits HIV replication by acting at late stages of 
the virus life cycle. AIDS Res Hum Retroviruses 12:1537-41. 
277. Palamara, A. T., C. F. Perno, M. R. Ciriolo, L. Dini, E. Balestra, C. 
D'Agostini, P. Di Francesco, C. Favalli, G. Rotilio, and E. Garaci. 1995. 
Evidence for antiviral activity of glutathione: in vitro inhibition of herpes 
simplex virus type 1 replication. Antiviral Res 27:237-53. 
278. Panne, D., T. Maniatis, and S. C. Harrison. 2007. An atomic model of the 
interferon-beta enhanceosome. Cell 129:1111-23. 
279. Park, G. W., K. G. Linden, and M. D. Sobsey. Inactivation of murine 
norovirus, feline calicivirus and echovirus 12 as surrogates for human 
norovirus (NoV) and coliphage (F+) MS2 by ultraviolet ight (254 nm) and 
the effect of cell association on UV inactivation. Lett Appl Microbiol 52:162-
7. 
280. Patel, D., Y. Nan, M. Shen, K. Ritthipichai, X. Zhu, and Y. J. Zhang. 
Porcine reproductive and respiratory syndrome virus inhibits type I interferon 
signaling by blocking STAT1/STAT2 nuclear translocation. J Virol 
84:11045-55. 
281. Pelletier, C., N. Varin-Blank, J. Rivera, B. Iannascoli, F. Marchand, B. 
David, A. Weyer, and U. Blank. 1998. Fc epsilonRI-mediated induction of 
TNF-alpha gene expression in the RBL-2H3 mast cell line: regulation by a 
novel NF-kappaB-like nuclear binding complex. J Immunol 161:4768-76. 
282. Perdiguero, B., and M. Esteban. 2009. The interferon system and vaccinia 
virus evasion mechanisms. J Interferon Cytokine Res 29:581-98. 
283. Pfeffer, L. M., J. G. Kim, S. R. Pfeffer, D. J. Carigan, D. P. Baker, L. 
Wei, and R. Homayouni. 2004. Role of nuclear factor-kappaB in the 
antiviral action of interferon and interferon-regulated gene expression. J Biol 
Chem 279:31304-11. 
284. Pitkaranta, A., K. Linnavuori, M. Roivainen, and T. Hovi. 1988. 
Induction of interferon-alpha in human leukocytes by polioviruses: wild-type 





285. Pixley, F. J., and E. R. Stanley. 2004. CSF-1 regulation of the wandering 
macrophage: complexity in action. Trends Cell Biol 14:628-38. 
286. Pollock, J. L., R. M. Presti, S. Paetzold, and H. W. t. Virgin.  1997. Latent 
murine cytomegalovirus infection in macrophages. Virology 227:168-79. 
287. Popa, M., Z. Ruzsics, M. Lotzerich, L. Dolken, C. Buser, P. Walther, and 
U. H. Koszinowski. Dominant negative mutants of the murine 
cytomegalovirus M53 gene block nuclear egress and inhibit capsid 
maturation. J Virol 84:9035-46. 
288. Powers, C., V. DeFilippis, D. Malouli, and K. Fruh. 2008. 
Cytomegalovirus immune evasion. Curr Top Microbiol Immunol 325:333-59. 
289. Prescott, J., C. Ye, G. Sen, and B. Hjelle. 2005. Induction of innate immune 
response genes by Sin Nombre hantavirus does not require viral replication. J 
Virol 79:15007-15. 
290. Prescott, J. B., P. R. Hall, V. S. Bondu-Hawkins, C. Ye, and B. Hjelle. 
2007. Early innate immune responses to Sin Nombre hantavirus occur 
independently of IFN regulatory factor 3, characterized pattern recognition 
receptors, and viral entry. J Immunol 179:1796-802. 
291. Prichard, M. N., N. Gao, S. Jairath, G. Mulamba, P. Krosky, D. M. 
Coen, B. O. Parker, and G. S. Pari. 1999. A recombinant human 
cytomegalovirus with a large deletion in UL97 has a severe replication 
deficiency. J Virol 73:5663-70. 
292. Qin, H., K. L. Roberts, S. A. Niyongere, Y. Cong, C. O. Elson, and E. N. 
Benveniste. 2007. Molecular mechanism of lipopolysaccharide-induced 
SOCS-3 gene expression in macrophages and microglia. J Immunol 
179:5966-76. 
293. Raaben, M., M. J. Groot Koerkamp, P. J. Rottier, and C. A. de Haan. 
2009. Type I interferon receptor-independent and -dependent host 
transcriptional responses to mouse hepatitis coronavirus infection in vivo. 
BMC Genomics 10:350. 
294. Ramsey, S. A., S. L. Klemm, D. E. Zak, K. A. Kennedy, V. Thorsson, B. 
Li, M. Gilchrist, E. S. Gold, C. D. Johnson, V. Litvak, G. Navarro, J. C. 
Roach, C. M. Rosenberger, A. G. Rust, N. Yudkovsky, A. Aderem, and I. 
Shmulevich. 2008. Uncovering a macrophage transcriptional program by 
integrating evidence from motif scanning and expression dynamics. PLoS 
Comput Biol 4:e1000021. 
295. Randall, R. E., and S. Goodbourn. 2008. Interferons and viruses: an 
interplay between induction, signalling, antiviral esponses and virus 
countermeasures. J Gen Virol 89:1-47. 
296. Rani, M. R., and R. M. Ransohoff. 2005. Alternative and accessory 
pathways in the regulation of IFN-beta-mediated gene xpression. J 
Interferon Cytokine Res 25:788-98. 
297. Rapp, M., P. Lucin, M. Messerle, L. C. Loh, and U. H. Koszinowski. 
1994. Expression of the murine cytomegalovirus glycoprotein H by 
recombinant vaccinia virus. J Gen Virol 75 ( Pt 1):183-8. 
298. Rathinam, V. A., Z. Jiang, S. N. Waggoner, S. Sharma, L. E. Cole, L. 
Waggoner, S. K. Vanaja, B. G. Monks, S. Ganesan, E.Latz, V. Hornung, 





inflammasome is essential for host defense against cytosolic bacteria and 
DNA viruses. Nat Immunol 11:395-402. 
299. Rawlinson, W. D., H. E. Farrell, and B. G. Barrell. 1996. Analysis of the 
complete DNA sequence of murine cytomegalovirus. J Virol 70:8833-49. 
300. Raza, S., K. A. Robertson, P. A. Lacaze, D. Page, A. J. Enright, P. 
Ghazal, and T. C. Freeman. 2008. A logic-based diagram of signalling 
pathways central to macrophage activation. BMC SystBiol 2:36. 
301. Rebhun, J. F., A. F. Castro, and L. A. Quilliam. 2000. Identification of 
guanine nucleotide exchange factors (GEFs) for the Rap1 GTPase. 
Regulation of MR-GEF by M-Ras-GTP interaction. J Biol Chem 275:34901-
8. 
302. Reddehase, M. J., J. Podlech, and N. K. Grzimek. 2002. Mouse models of 
cytomegalovirus latency: overview. J Clin Virol 25 Suppl 2:S23-36. 
303. Redpath, S., A. Angulo, N. R. Gascoigne, and P. Ghaz l. 1999. Murine 
cytomegalovirus infection down-regulates MHC class II expression on 
macrophages by induction of IL-10. J Immunol 162:6701-7. 
304. Reimer, T., M. Brcic, M. Schweizer, and T. W. Jungi. 2008. poly(I:C) and 
LPS induce distinct IRF3 and NF-kappaB signaling during type-I IFN and 
TNF responses in human macrophages. J Leukoc Biol 83:1249-57. 
305. Rock, R. B., S. Hu, A. Deshpande, S. Munir, B. J. May, C. A. Baker, P. 
K. Peterson, and V. Kapur. 2005. Transcriptional response of human 
microglial cells to interferon-gamma. Genes Immun 6:712-9. 
306. Rose, K. M., R. Elliott, L. Martinez-Sobrido, A. Garcia-Sastre, and S. R. 
Weiss. Murine coronavirus delays expression of a subset of interferon-
stimulated genes. J Virol 84:5656-69. 
307. Roth-Cross, J. K., L. Martinez-Sobrido, E. P. Scott, A. Garcia-Sastre, 
and S. R. Weiss. 2007. Inhibition of the alpha/beta interferon response by 
mouse hepatitis virus at multiple levels. J Virol 81:7189-99. 
308. Roy, C. R., and E. S. Mocarski. 2007. Pathogen subversion of cell-intrinsic 
innate immunity. Nat Immunol 8:1179-87. 
309. Sabat, R., G. Grutz, K. Warszawska, S. Kirsch, E. Witte, K. Wolk, and J. 
Geginat. Biology of interleukin-10. Cytokine Growth Factor Rev 21:331-44. 
310. Sabbah, A., T. H. Chang, R. Harnack, V. Frohlich, K. Tominaga, P. H. 
Dube, Y. Xiang, and S. Bose. 2009. Activation of innate immune antiviral 
responses by Nod2. Nat Immunol 10:1073-80. 
311. Sadler, A. J., and B. R. Williams. 2008. Interferon-inducible antiviral 
effectors. Nat Rev Immunol 8:559-68. 
312. Saederup, N., S. A. Aguirre, T. E. Sparer, D. M. Bouley, and E. S. 
Mocarski. 2001. Murine cytomegalovirus CC chemokine homolog MCK-2 
(m131-129) is a determinant of dissemination that increases inflammation at 
initial sites of infection. J Virol 75:9966-76. 
313. Saederup, N., Y. C. Lin, D. J. Dairaghi, T. J. Schall, and E. S. Mocarski. 
1999. Cytomegalovirus-encoded beta chemokine promotes monocyte-
associated viremia in the host. Proc Natl Acad Sci U S A 96:10881-6. 
314. Saklatvala, J., J. Dean, and A. Clark. 2003. Control of the expression of 





315. Salazar-Mather, T. P., and K. L. Hokeness. 2003. Calling in the troops: 
regulation of inflammatory cell trafficking through innate 
cytokine/chemokine networks. Viral Immunol 16:291-306. 
316. Salazar-Mather, T. P., and K. L. Hokeness. 2006. Cytokine and chemokine 
networks: pathways to antiviral defense. Curr Top Microbiol Immunol 
303:29-46. 
317. Salazar-Mather, T. P., C. A. Lewis, and C. A. Biron. 2002. Type I 
interferons regulate inflammatory cell trafficking and macrophage 
inflammatory protein 1alpha delivery to the liver. J Clin Invest 110:321-30. 
318. Samarajiwa, S. A., S. Forster, K. Auchettl, and P. J. Hertzog. 2009. 
INTERFEROME: the database of interferon regulated gnes. Nucleic Acids 
Res 37:D852-7. 
319. Sanceau, J., T. Kaisho, T. Hirano, and J. Wietzerbin. 1995. Triggering of 
the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-
alpha in monocytic cells involves cooperation between interferon regulatory 
factor-1, NF kappa B, and Sp1 transcription factors. J Biol Chem 270:27920-
31. 
320. Sanders, R. L., C. L. Clark, C. S. Morello, and D. H. Spector. 2008. 
Development of cell lines that provide tightly controlled temporal translation 
of the human cytomegalovirus IE2 proteins for complementation and 
functional analyses of growth-impaired and nonviable IE2 mutant viruses. J 
Virol 82:7059-77. 
321. Santhakumar, D., T. Forster, N. N. Laqtom, R. Fragkoudis, P. 
Dickinson, C. Abreu-Goodger, S. A. Manakov, N. R. Choudhury, S. J. 
Griffiths, A. Vermeulen, A. J. Enright, B. Dutia, A. Kohl, P. Ghazal, and 
A. H. Buck. Combined agonist-antagonist genome-wide functional screening 
identifies broadly active antiviral microRNAs. Proc Natl Acad Sci U S A 
107:13830-5. 
322. Saraiva, M., and A. O'Garra. The regulation of IL-10 production by 
immune cells. Nat Rev Immunol 10:170-81. 
323. Scalzo, A. A., A. J. Corbett, W. D. Rawlinson, G. M. Scott, and M. A. 
Degli-Esposti. 2007. The interplay between host and viral factors in shaping 
the outcome of cytomegalovirus infection. Immunol Ce l Biol 85:46-54. 
324. Schleiss, M. R. 2008. Cytomegalovirus vaccine development. Curr Top
Microbiol Immunol 325:361-82. 
325. Schroder, K., M. Lichtinger, K. M. Irvine, K. Brion , A. Trieu, I. L. Ross, 
T. Ravasi, K. J. Stacey, M. Rehli, D. A. Hume, and M. J. Sweet. 2007. 
PU.1 and ICSBP control constitutive and IFN-gamma-regulated Tlr9 gene 
expression in mouse macrophages. J Leukoc Biol 81:1577-90. 
326. Scrivano, L., J. Esterlechner, H. Muhlbach, N. Ettischer, C. Hagen, K. 
Grunewald, C. A. Mohr, Z. Ruzsics, U. Koszinowski, and B. Adler. The 
m74 gene product of murine cytomegalovirus (MCMV) is a functional 
homolog of human CMV gO and determines the entry pathw y of MCMV. J 
Virol 84:4469-80. 
327. Shimizu, H., K. Mitomo, T. Watanabe, S. Okamoto, and K. Yamamoto. 
1990. Involvement of a NF-kappa B-like transcription factor in the activation 






328. Shirota, H., K. J. Ishii, H. Takakuwa, and D. M. Klinman. 2006. 
Contribution of interferon-beta to the immune activa on induced by double-
stranded DNA. Immunology 118:302-10. 
329. Siegal, F. P., N. Kadowaki, M. Shodell, P. A. Fitzgerald-Bocarsly, K. 
Shah, S. Ho, S. Antonenko, and Y. J. Liu. 1999. The nature of the principal 
type 1 interferon-producing cells in human blood. Science 284:1835-7. 
330. Simmen, K. A., J. Singh, B. G. Luukkonen, M. Lopper, A. Bittner, N. E. 
Miller, M. R. Jackson, T. Compton, and K. Fruh. 2001. Global 
modulation of cellular transcription by human cytomegalovirus is initiated by 
viral glycoprotein B. Proc Natl Acad Sci U S A 98:7140-5. 
331. Simon, C. O., C. K. Seckert, D. Dreis, M. J. Reddehase, and N. K. 
Grzimek. 2005. Role for tumor necrosis factor alpha in murine 
cytomegalovirus transcriptional reactivation in latently infected lungs. J Virol 
79:326-40. 
332. Sindre, H., G. Haraldsen, S. Beck, K. Hestdal, D. Kvale, P. Brandtzaeg, 
M. Degre, and H. Rollag. 2000. Human intestinal endothelium shows high 
susceptibility to cytomegalovirus and altered expression of adhesion 
molecules after infection. Scand J Immunol 51:354-60. 
333. Sindre, H., G. E. Tjoonnfjord, H. Rollag, T. Ranneberg-Nilsen, O. P. 
Veiby, S. Beck, M. Degre, and K. Hestdal. 1996. Human cytomegalovirus 
suppression of and latency in early hematopoietic progenitor cells. Blood 
88:4526-33. 
334. Smith, M. S., G. L. Bentz, J. S. Alexander, and A. D. Yurochko. 2004. 
Human cytomegalovirus induces monocyte differentiation and migration as a 
strategy for dissemination and persistence. J Virol 78:4444-53. 
335. Smith, M. S., G. L. Bentz, P. M. Smith, E. R. Bivins, and A. D. Yurochko. 
2004. HCMV activates PI(3)K in monocytes and promotes monocyte motility 
and transendothelial migration in a PI(3)K-dependent manner. J Leukoc Biol 
76:65-76. 
336. Smyth, G. K. 2004. Linear models and empirical bayes methods for 
assessing differential expression in microarray experiments. Stat Appl Genet 
Mol Biol 3:Article3. 
337. Spencer, J. V., K. M. Lockridge, P. A. Barry, G. Lin, M. Tsang, M. E. 
Penfold, and T. J. Schall. 2002. Potent immunosuppressive activities of 
cytomegalovirus-encoded interleukin-10. J Virol 76:1285-92. 
338. Stanier, P., A. D. Kitchen, D. L. Taylor, and A. S. Tyms. 1992. Detection 
of human cytomegalovirus in peripheral mononuclear cells and urine samples 
using PCR. Mol Cell Probes 6:51-8. 
339. Steinberg, C., K. Eisenacher, O. Gross, W. Reindl, F. Schmitz, J. Ruland, 
and A. Krug. 2009. The IFN regulatory factor 7-dependent type I IFN 
response is not essential for early resistance against murine cytomegalovirus 
infection. Eur J Immunol 39:1007-18. 
340. Stenberg, R. M., D. R. Thomsen, and M. F. Stinski. 1984. Structural 
analysis of the major immediate early gene of human cytomegalovirus. J 
Virol 49:190-9. 
341. Stockinger, S., B. Reutterer, B. Schaljo, C. Schellack, S. Brunner, T. 
Materna, M. Yamamoto, S. Akira, T. Taniguchi, P. J. Murray, M. 





of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-
independent mechanism. J Immunol 173:7416-25. 
342. Sweet, M. J., C. C. Campbell, D. P. Sester, D. Xu, R. C. McDonald, K. J. 
Stacey, D. A. Hume, and F. Y. Liew. 2002. Colony-stimulating factor-1 
suppresses responses to CpG DNA and expression of tll-like receptor 9 but 
enhances responses to lipopolysaccharide in murine macrophages. J Immunol 
168:392-9. 
343. Sweet, M. J., and D. A. Hume. 2003. CSF-1 as a regulator of macrophage 
activation and immune responses. Arch Immunol Ther Exp (Warsz) 51:169-
77. 
344. Tabeta, K., P. Georgel, E. Janssen, X. Du, K. Hoebe, K. Crozat, S. Mudd, 
L. Shamel, S. Sovath, J. Goode, L. Alexopoulou, R. A. Flavell, and B. 
Beutler. 2004. Toll-like receptors 9 and 3 as essential components of innate 
immune defense against mouse cytomegalovirus infecton. Proc Natl Acad 
Sci U S A 101:3516-21. 
345. Taddeo, B., A. Esclatine, and B. Roizman. 2002. The patterns of 
accumulation of cellular RNAs in cells infected with a wild-type and a 
mutant herpes simplex virus 1 lacking the virion host shutoff gene. Proc Natl 
Acad Sci U S A 99:17031-6. 
346. Takahama, H., T. Kinoshita, and F. Sasaki. 1992. Structural and 
endocytotic differences of fibroblasts and macrophages in the tail fin of 
amphibian larvae during metamorphosis. Arch Histol Cytol 55:437-48. 
347. Takeshita, S., J. R. Gage, T. Kishimoto, D. L. Vredevoe, and O. 
Martinez-Maza. 1996. Differential regulation of IL-6 gene transcription and 
expression by IL-4 and IL-10 in human monocytic cell lines. J Immunol 
156:2591-8. 
348. Tang-Feldman, Y. J., G. R. Lochhead, S. R. Lochhead, C. Yu, and C. 
Pomeroy. Interleukin-10 repletion suppresses pro-inflammatory cytokines 
and decreases liver pathology without altering viral replication in murine 
cytomegalovirus (MCMV)-infected IL-10 knockout mice. Inflamm Res. 
349. Tang, F., Q. Du, and Y. J. Liu. Plasmacytoid dendritic cells in antiviral 
immunity and autoimmunity. Sci China Life Sci 53:172-82. 
350. Tang, Q., L. Li, and G. G. Maul. 2005. Mouse cytomegalovirus early 
M112/113 proteins control the repressive effect of IE3 on the major 
immediate-early promoter. J Virol 79:257-63. 
351. Tang, Q., and G. G. Maul. 2003. Mouse cytomegalovirus immediate-early 
protein 1 binds with host cell repressors to relieve suppressive effects on viral 
transcription and replication during lytic infection. J Virol 77:1357-67. 
352. Tassiulas, I., X. Hu, H. Ho, Y. Kashyap, P. Paik, Y. Hu, C. A. Lowell, 
and L. B. Ivashkiv. 2004. Amplification of IFN-alpha-induced STAT1 
activation and inflammatory function by Syk and ITAM-containing adaptors. 
Nat Immunol 5:1181-9. 
353. Taylor, R. T., and W. A. Bresnahan. 2005. Human cytomegalovirus 
immediate-early 2 gene expression blocks virus-induce  beta interferon 
production. J Virol 79:3873-7. 
354. Taylor, R. T., and W. A. Bresnahan. 2006. Human cytomegalovirus 






355. Thomas, K. E., C. L. Galligan, R. D. Newman, E. N. Fish, and S. N. 
Vogel. 2006. Contribution of interferon-beta to the murine macrophage 
response to the toll-like receptor 4 agonist, lipopolysaccharide. J Biol Chem 
281:31119-30. 
356. Travassos, L. H., L. A. Carneiro, M. Ramjeet, S. Hussey, Y. G. Kim, J. 
G. Magalhaes, L. Yuan, F. Soares, E. Chea, L. Le Bourhis, I. G. Boneca, 
A. Allaoui, N. L. Jones, G. Nunez, S. E. Girardin, and D. J. Philpott. 
Nod1 and Nod2 direct autophagy by recruiting ATG16L to the plasma 
membrane at the site of bacterial entry. Nat Immunol 11:55-62. 
357. Trevani, A. S., A. Chorny, G. Salamone, M. Vermeulen, R. Gamberale, 
J. Schettini, S. Raiden, and J. Geffner. 2003. Bacterial DNA activates 
human neutrophils by a CpG-independent pathway. Eur J Immunol 33:3164-
74. 
358. Tross, D., L. Petrenko, S. Klaschik, Q. Zhu, and D. M. Klinman.  2009. 
Global changes in gene expression and synergistic interactions induced by 
TLR9 and TLR3. Mol Immunol 46:2557-64. 
359. Tsitoura, E., J. Thomas, D. Cuchet, K. Thoinet, P. Mavromara, and A. L. 
Epstein. 2009. Infection with herpes simplex type 1-based amplicon vectors 
results in an IRF3/7-dependent, TLR-independent activation of the innate 
antiviral response in primary human fibroblasts. J Gen Virol 90:2209-20. 
360. Tsuchimoto, D., A. Tojo, and S. Asano. 2004. A mechanism of 
transcriptional regulation of the CSF-1 gene by interferon-gamma. Immunol 
Invest 33:397-405. 
361. Tsutsui, Y., I. Kosugi, and H. Kawasaki. 2005. Neuropathogenesis in 
cytomegalovirus infection: indication of the mechanisms using mouse 
models. Rev Med Virol 15:327-45. 
362. Uematsu, S., and S. Akira. 2008. Toll-Like receptors (TLRs) and their 
ligands. Handb Exp Pharmacol:1-20. 
363. Unterberger, C., K. J. Staples, T. Smallie, L. Williams, B. Foxwell, A. 
Schaefer, B. Kempkes, T. P. Hofer, M. Koeppel, M. Lohrum, H. 
Stunnenberg, M. Frankenberger, and L. Ziegler-Heitbrock. 2008. Role of 
STAT3 in glucocorticoid-induced expression of the human IL-10 gene. Mol 
Immunol 45:3230-7. 
364. Upton, J. W., W. J. Kaiser, and E. S. Mocarski. 2008. Cytomegalovirus 
M45 cell death suppression requires receptor-interac ing protein (RIP) 
homotypic interaction motif (RHIM)-dependent interaction with RIP1. J Biol 
Chem 283:16966-70. 
365. Valchanova, R. S., M. Picard-Maureau, M. Budt, and W. Brune. 2006. 
Murine cytomegalovirus m142 and m143 are both requir d to block protein 
kinase R-mediated shutdown of protein synthesis. J Virol 80:10181-90. 
366. Valentine, R., and G. L. Smith. Inhibition of the RNA polymerase III-
mediated dsDNA-sensing pathway of innate immunity by vaccinia virus 
protein E3. J Gen Virol 91:2221-9. 
367. Valledor, A. F., M. Comalada, L. F. Santamaria-Babi, J. Lloberas, and 
A. Celada. Macrophage proinflammatory activation and deactivation: a 
question of balance. Adv Immunol 108:1-20. 
368. Vanden Berghe, W., K. De Bosscher, E. Boone, S. Plais nce, and G. 





acetyltransferase activity for transcriptional activa on of the interleukin-6 
gene promoter. J Biol Chem 274:32091-8. 
369. Varnum, S. M., D. N. Streblow, M. E. Monroe, P. Smith, K. J. Auberry, 
L. Pasa-Tolic, D. Wang, D. G. Camp, 2nd, K. Rodland, S. Wiley, W. 
Britt, T. Shenk, R. D. Smith, and J. A. Nelson. 2004. Identification of 
proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. 
J Virol 78:10960-6. 
370. Wagner, M., S. Jonjic, U. H. Koszinowski, and M. Messerle. 1999. 
Systematic excision of vector sequences from the BAC-cloned herpesvirus 
genome during virus reconstitution. J Virol 73:7056-60. 
371. Wang, K., D. Scheel-Toellner, S. H. Wong, R. Craddock, J. Caamano, A. 
N. Akbar, M. Salmon, and J. M. Lord. 2003. Inhibition of neutrophil 
apoptosis by type 1 IFN depends on cross-talk between phosphoinositol 3-
kinase, protein kinase C-delta, and NF-kappa B signaling pathways. J 
Immunol 171:1035-41. 
372. Wang, L., X. M. Ren, J. J. Xing, and A. C. Zheng. The nucleolus and viral 
infection. Virol Sin 25:151-7. 
373. Wang, X., and D. G. Chen. 2009. Recombinant murine cytomegalovirus 
vector activates human monocyte-derived dendritic cells in a NF-kappaB 
dependent pathway. Mol Immunol 46:3462-5. 
374. Wang, Z., M. K. Choi, T. Ban, H. Yanai, H. Negishi, Y. Lu, T. Tamura, 
A. Takaoka, K. Nishikura, and T. Taniguchi. 2008. Regulation of innate 
immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing 
molecules. Proc Natl Acad Sci U S A 105:5477-82. 
375. Weber, B., and H. W. Doerr. 1994. Diagnosis and epidemiology of 
transfusion-associated human cytomegalovirus infection: recent 
developments. Infusionsther Transfusionsmed 21 Suppl 1:32-9. 
376. Weber, F., G. Kochs, and O. Haller. 2004. Inverse interference: how 
viruses fight the interferon system. Viral Immunol 17:498-515. 
377. Weinstock-Guttman, B., D. Badgett, K. Patrick, L. Hartrich, R. Santos, 
D. Hall, M. Baier, J. Feichter, and M. Ramanathan. 2003. Genomic 
effects of IFN-beta in multiple sclerosis patients. J Immunol 171:2694-702. 
378. Welsh, G. I., S. Kadereit, E. M. Coccia, A. G. Hovanessian, and E. F. 
Meurs. 1999. Colocalization within the nucleolus of two highly related IFN-
induced human nuclear phosphoproteins with nucleolin. Exp Cell Res 
250:62-74. 
379. Wiebusch, L., A. Neuwirth, L. Grabenhenrich, S. Voigt, and C. 
Hagemeier. 2008. Cell cycle-independent expression of immediat -e rly 
gene 3 results in G1 and G2 arrest in murine cytomegalovirus-infected cells. J 
Virol 82:10188-98. 
380. Wilkins, C., and M. Gale, Jr. Recognition of viruses by cytoplasmic 
sensors. Curr Opin Immunol 22:41-7. 
381. Wu, C. H., H. Huang, L. Arminski, J. Castro-Alvear, Y. Chen, Z. Z. Hu, 
R. S. Ledley, K. C. Lewis, H. W. Mewes, B. C. Orcutt, B. E. Suzek, A. 
Tsugita, C. R. Vinayaka, L. S. Yeh, J. Zhang, and W. C. Barker. 2002. 
The Protein Information Resource: an integrated public resource of functional 





382. Wu, G., Y. Z. Fang, S. Yang, J. R. Lupton, and N. D. Turner. 2004. 
Glutathione metabolism and its implications for health. J Nutr 134:489-92. 
383. Xu, Y., K. S. Colletti, and G. S. Pari. 2002. Human cytomegalovirus UL84 
localizes to the cell nucleus via a nuclear localization signal and is a 
component of viral replication compartments. J Virol 76:8931-8. 
384. Yarilina, A., and L. B. Ivashkiv. Type I interferon: a new player in TNF 
signaling. Curr Dir Autoimmun 11:94-104. 
385. Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. 
Miyagishi, K. Taira, S. Akira, and T. Fujita.  2004. The RNA helicase 
RIG-I has an essential function in double-stranded RNA-induced innate 
antiviral responses. Nat Immunol 5:730-7. 
386. Yurochko, A. D., E. S. Hwang, L. Rasmussen, S. Keay, L. Pereira, and E. 
S. Huang. 1997. The human cytomegalovirus UL55 (gB) and UL75 (gH) 
glycoprotein ligands initiate the rapid activation f Sp1 and NF-kappaB 
during infection. J Virol 71:5051-9. 
387. Zabel, B. A., L. Zuniga, T. Ohyama, S. J. Allen, J. Cichy, T. M. Handel, 
and E. C. Butcher. 2006. Chemoattractants, extracellular proteases, and the 
integrated host defense response. Exp Hematol 34:1021-32. 
388. Zeremski, M., L. M. Petrovic, and A. H. Talal. 2007. The role of 
chemokines as inflammatory mediators in chronic hepatitis C virus infection. 
J Viral Hepat 14:675-87. 
389. Zhang, T., V. Kruys, G. Huez, and C. Gueydan. 2002. AU-rich element-
mediated translational control: complexity and multiple activities of trans-
activating factors. Biochem Soc Trans 30:952-8. 
390. Zhao, W., M. Liu, and K. L. Kirkwood.  2008. p38alpha stabilizes 
interleukin-6 mRNA via multiple AU-rich elements. J Biol Chem 283:1778-
85. 
391. Zhou, H., J. Zhao, and S. Perlman. Autocrine interferon priming in 
macrophages but not dendritic cells results in enhanced cytokine and 
chemokine production after coronavirus infection. MBio 1. 
392. Zimmermann, A., M. Trilling, M. Wagner, M. Wilborn,  I. Bubic, S. 
Jonjic, U. Koszinowski, and H. Hengel. 2005. A cytomegaloviral protein 
reveals a dual role for STAT2 in IFN-{gamma} signali g and antiviral 
responses. J Exp Med 201:1543-53. 
393. Zornetzer, G. A., M. B. Frieman, E. Rosenzweig, M. J. Korth, C. Page, 
R. S. Baric, and M. G. Katze. Transcriptomic analysis reveals a mechanism 
for a prefibrotic phenotype in STAT1 knockout mice during severe acute 
respiratory syndrome coronavirus infection. J Virol 84:11297-309. 
394. Zucchini, N., G. Bessou, S. Traub, S. H. Robbins, S. Uematsu, S. Akira, 
L. Alexopoulou, and M. Dalod. 2008. Cutting edge: Overlapping functions 
of TLR7 and TLR9 for innate defense against a herpesvirus infection. J 
Immunol 180:5799-803. 
395. Zucchini, N., K. Crozat, T. Baranek, S. H. Robbins, M. Altfeld, and M. 
Dalod. 2008. Natural killer cells in immunodefense against fective agents. 
Expert Rev Anti Infect Ther 6:867-85. 
396. Zurcher, T., J. Pavlovic, and P. Staeheli. 1992. Mouse Mx2 protein inhibits 
vesicular stomatitis virus but not influenza virus. Virology 187:796-800. 
  
